Digital Brands (DBGI) S-118 Sep 23IPO registrationFinancial data

Company Profile

Document and Entity Information

Document and Entity Information	6 Months Ended
Document and Entity Information	Jun. 30, 2023
Document and Entity Information [Abstract]
Document Type	S-1
Entity Registrant Name	Digital Brands Group, Inc.
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Central Index Key	0001668010
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 335,470	$ 1,275,616	$ 515,796
Accounts receivable, net	196,919	583,368	67,384
Due from factor, net	438,142	839,400	985,288
Inventory	4,771,271	5,122,564	2,660,203
Prepaid expenses and other current assets	872,142	766,901	288,474
Assets per discontinued operations, current		241,544	259,190
Total current assets	6,613,944	8,829,394	4,776,334
Deferred offering costs		104,512	367,696
Property, equipment and software, net	98,170	104,512	69,367
Goodwill	8,973,501	10,103,812	8,583,274
Intangible assets, net	11,421,311	12,906,238	9,263,131
Deposits	106,547	193,926	133,378
Right of use asset	339,085	102,349
Assets per discontinued operations.		2,628,136	13,292,043
Total assets	27,552,558	33,738,056	36,485,224
Current liabilities:
Accounts payable	8,143,991	8,016,173	6,507,709
Accrued expenses and other liabilities	5,038,937	3,936,920	2,078,087
Due to related parties	472,790	555,217	256,274
Contingent consideration liability		12,098,475	12,179,476
Convertible note payable, net	100,000	2,721,800	100,000
Accrued interest payable	1,779,274	1,561,795	1,110,679
Venture debt, net of discount			6,001,755
Loan payable, current	1,190,405	1,829,629	2,279,768
Promissory note payable, net	5,613,839	9,000,000	3,500,000
Right of use liability, current portion	312,226	40,893,791
Liabilities per discontinued operations, current		1,071,433	1,033,518
Total current liabilities	22,651,462	40,893,792	35,047,266
Convertible note payable, net		150,000	5,723,846
Loans payable, net of current portion	443,635	150,000	342,050
Right of use liability	33,501
Derivative liability		0	2,294,720
Warrant liability			18,223
Liabilities per discontinued operations		147,438	148,900
Total liabilities	23,128,598	41,191,230	43,575,005
Commitments and contingencies
Stockholders' deficit:
Additional paid-in capital		96,294,123	58,614,160
Accumulated deficit	(104,839,404)	(103,747,316)	(65,703,954)
Total stockholders' deficit	4,423,960	(7,453,174)	(7,089,781)
Total liabilities and stockholders' deficit	27,552,558	33,738,056	36,485,224
Undesignated preferred stock
Stockholders' deficit:
Preferred stock
Series A preferred stock
Stockholders' deficit:
Preferred stock
Series A Convertible Preferred Stock
Stockholders' deficit:
Preferred stock	1	1
Series C convertible preferred stock
Stockholders' deficit:
Preferred stock	1
Common stock
Stockholders' deficit:
Common stock, $0.0001 par, 1,000,000,000 shares authorized, 317,102 and 178,758 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	31	18	$ 13
Additional paid-in capital	$ 109,263,332	$ 96,294,123

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)	Jun. 30, 2023 USD ($) $ / shares shares
Common stock par value \| $ / shares	$ 0.0001
Common stock, share authorized (in shares)	1,000,000,000
Common stock, share issued (in shares)	316,906
Common stock, shares outstanding (in shares)	316,906
Undesignated preferred stock
Preferred stock \| $
Preferred stock, par value (in dollars per share) \| $ / shares	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000
Preferred stock, shares issued (in shares)	0
Preferred stock, shares outstanding (in shares)	0
Series A preferred stock
Preferred stock \| $
Preferred stock, par value (in dollars per share) \| $ / shares	$ 0.0001
Preferred stock, shares authorized (in shares)	1
Preferred stock, shares issued (in shares)	0
Preferred stock, shares outstanding (in shares)	0
Series A Convertible Preferred Stock
Preferred stock \| $	$ 1
Preferred stock, par value (in dollars per share) \| $ / shares	$ 0.0001
Preferred stock, shares authorized (in shares)	6,800
Preferred stock, shares issued (in shares)	6,300
Preferred stock, shares outstanding (in shares)	6,300
Series C convertible preferred stock
Preferred stock \| $	$ 1
Preferred stock, par value (in dollars per share) \| $ / shares	$ 0.0001
Preferred stock, shares authorized (in shares)	5,671
Preferred stock, shares issued (in shares)	5,671
Preferred stock, shares outstanding (in shares)	5,671

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Net revenues	$ 4,493,424		$ 2,649,432		$ 8,869,803	$ 5,278,562	$ 10,333,558	$ 5,764,963
Cost of net revenues	2,157,349		1,536,703		4,540,488	3,552,396	6,789,314	3,828,496
Gross profit	2,336,075		1,112,729		4,329,315	1,726,166	3,544,244	1,936,467
Operating expenses:
General and administrative	4,074,051		4,243,031		8,380,063	8,073,621	14,067,681	16,149,510
Sales and marketing	1,097,326		1,372,568		2,036,677	2,230,087	4,018,985	3,269,710
Distribution	242,214		221,925		512,399	424,773	611,569	489,371
Impairment							5,503,095	3,400,000
Change in fair value of contingent consideration	(10,698,475)		5,920,919		(10,698,475)	7,121,240	564,303	8,764,460
Total operating expenses	(5,284,884)		11,758,443		230,664	17,849,721	24,765,633	32,073,050
Income (loss) from operations	7,620,959		(10,645,714)		4,098,651	(16,123,555)	(21,221,389)	(30,136,583)
Other income (expense):
Interest expense	(1,086,889)		(2,173,769)		(2,951,487)	(3,730,612)	(8,961,410)	(3,619,093)
Other non-operating income (expenses)	2,240		3,336,963		(676,749)	2,653,375	3,068,080	1,321,472
Total other income (expense), net	(1,084,649)		1,163,194		(3,628,236)	(1,077,237)	(5,893,330)	(2,297,621)
Income tax benefit (provision)								1,100,120
Net income (loss) from continuing operations	6,536,310		(9,482,520)		470,415	(17,200,792)	(27,114,719)	(31,334,084)
Income (loss) from discontinued operations, net of tax	(1,492,050)		(51,404)		(1,562,503)	(166,074)	(10,928,643)	(1,023,873)
Net income (loss)	$ 5,044,260	$ (6,136,349)	$ (9,533,924)	$ (7,832,942)	$ (1,092,088)	$ (17,366,866)	$ (38,043,362)	$ (32,357,957)
Weighted average common shares outstanding - basic	246,809		14,329		236,824	9,836	30,852	3,052
Weighted average common shares outstanding -diluted	834,604		14,329		824,619	9,836	30,852	3,052
Net income (loss) from continuing per common share - basic	$ 26.48		$ (661.78)		$ 1.99	$ (1,748.68)	$ (878.87)	$ (10,268.22)
Net income (loss) from continuing per common share - diluted	$ 7.83		$ (661.78)		$ 0.57	$ (1,748.68)	$ (878.87)	$ (10,268.22)

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)	Preferred Stock Series Seed Preferred Stock	Preferred Stock Series A preferred stock	Preferred Stock Series B Preferred Stock	Preferred Stock Series A Convertible Preferred Stock	Preferred Stock Series C convertible preferred stock	Preferred Stock Series A-2 Preferred Stock	Preferred Stock Series A-3 Preferred Stock	Preferred Stock Series CF Preferred Stock	Common Stock	Accumulated Deficit	Additional Paid-in Capital	Total
Beginning balance at Dec. 31, 2020	$ 2,071	$ 565	$ 2,075	$ 0		$ 593	$ 904	$ 83	$ 0	$ (33,345,997)	$ 27,482,061	$ (5,857,645)
Beginning balance (in shares) at Dec. 31, 2020	20,714,518	5,654,072	20,754,717			5,932,742	9,032,330	836,331	266
Issuance of common stock in public offering											10,000,002	10,000,002
Issuance of common stock in public offering (in shares)									964
Offering costs											(2,116,957)	(2,116,957)
Warrants issued in connection with note											501,658	501,658
Warrants issued in connection with note (in shares)									52
Stock-based compensation											4,278,337	4,278,337
Stock-based compensation (Shares)									29
Net Income (loss)										(32,357,957)		(32,357,957)
Conversion of preferred stock into common stock	$ (2,071)	$ (565)	$ (2,075)			$ (593)	$ (904)	$ (83)			6,291	6,291
Conversion of preferred stock into common stock (shares)	(20,714,518)	(5,654,072)	(20,754,717)			(5,932,742)	(9,032,330)	(836,331)	1,611
Exercise of over-allotment option, net of offering costs											1,364,997	1,364,997
Exercise of over-allotment option, net of offering costs (in shares)									145
Conversion of debt into common stock (In shares)									454
Conversion of related party notes and payables into common stock											257,515	257,515
Conversion of related party notes and payables into common stock (in shares)									61
Common stock issued in connection with business combination											11,428,738	11,428,738
Common stock issued in connection with business combination (in shares)									1,318
Exercise of warrants											1,768,046	1,768,046
Exercise of warrants (in shares)									155
Common stock issued pursuant to consulting agreement											595,500	595,500
Common stock issued pursuant to consulting agreement (in shares)									97
Issuance of common stock pursuant to equity line of credit											367,696	367,696
Issuance of common stock pursuant to equity line of credit (in shares)									51
Ending balance (in shares) at Dec. 31, 2021									521
Ending balance at Dec. 31, 2021									$ 0	(65,703,954)	58,614,173	(7,089,781)
Conversion of notes into common stock											1,201,582	1,201,582
Conversion of notes into common stock (in shares)									350
Stock-based compensation											139,093	139,093
Net Income (loss)										(7,832,942)		(7,832,942)
Ending balance (in shares) at Mar. 31, 2022									870
Ending balance at Mar. 31, 2022									$ 0	(73,536,896)	59,954,848	(13,582,048)
Beginning balance at Dec. 31, 2021									$ 0	(65,703,954)	58,614,173	(7,089,781)
Beginning balance (in shares) at Dec. 31, 2021									521
Net Income (loss)												(17,366,866)
Ending balance (in shares) at Jun. 30, 2022									16,470
Ending balance at Jun. 30, 2022									$ 2	(83,070,820)	68,190,600	(14,880,218)
Beginning balance at Dec. 31, 2021									$ 0	(65,703,954)	58,614,173	(7,089,781)
Beginning balance (in shares) at Dec. 31, 2021									521
Issuance of common stock in public offering									$ 1		9,347,449	9,347,450
Issuance of common stock in public offering (in shares)									14,956
Offering costs											(2,921,646)	(2,921,646)
Conversion of notes and derivative liability into common stock									$ 8		11,983,381	11,983,389
Conversion of notes and derivative liability into common stock (in shares)									79,807
Stock-based compensation											479,038	479,038
Net Income (loss)										(38,043,362)		(38,043,362)
Issuance of common stock and exercise of pre-funded warrants in public offering (in shares)									72,727
Issuance of common stock and exercise of pre-funded warrants in public offering									$ 7		9,999,989	9,999,996
Common stock issued in connection with business combination											1,000,000	1,000,000
Common stock issued in connection with business combination (in shares)									3,636
Common stock issued pursuant to consulting agreement											123,000	123,000
Common stock issued pursuant to consulting agreement (in shares)									30
Warrant and common shares issued with notes											1,368,741	1,368,741
Warrant and common shares issued with notes (in shares)									2,400
Conversion of venture debt into Series A convertible preferred stock				$ 1							6,299,999	6,300,000
Conversion of venture debt into Series A convertible preferred stock (in shares)				6,300
Ending balance (in shares) at Dec. 31, 2022				6,300					178,758
Ending balance at Dec. 31, 2022				$ 1					$ 18	(103,747,316)	96,294,123	(7,453,174)
Beginning balance at Mar. 31, 2022									$ 0	(73,536,896)	59,954,848	(13,582,048)
Beginning balance (in shares) at Mar. 31, 2022									870
Issuance of common stock in public offering									$ 1		9,347,449	9,347,450
Issuance of common stock in public offering (in shares)									14,956
Offering costs											(1,930,486)	(1,930,486)
Conversion of notes and derivative liability into common stock											600,790	600,790
Conversion of notes and derivative liability into common stock (in shares)									644
Warrants issued in connection with note											98,241	98,241
Stock-based compensation											119,759	119,759
Net Income (loss)										(9,533,924)		(9,533,924)
Ending balance (in shares) at Jun. 30, 2022									16,470
Ending balance at Jun. 30, 2022									$ 2	(83,070,820)	68,190,600	(14,880,218)
Beginning balance at Dec. 31, 2022				$ 1					$ 18	(103,747,316)	96,294,123	(7,453,174)
Beginning balance (in shares) at Dec. 31, 2022				6,300					178,758
Issuance of common stock pursuant to private placement									$ 5		4,999,998	5,000,003
Issuance of common stock pursuant to private placement (in shares)									50,890
Offering costs											(536,927)	(536,927)
Shares issued for services											499,338	499,338
Shares issued for services (in shares)									4,756
Shares and warrants issued with notes											658,494	658,494
Shares and warrants issued with notes (in shares)									4,400
Stock-based compensation											105,594	105,594
Net Income (loss)										(6,136,349)		(6,136,349)
Ending balance (in shares) at Mar. 31, 2023				6,300					238,803
Ending balance at Mar. 31, 2023				$ 1					$ 23	(109,883,665)	102,020,620	(7,863,022)
Beginning balance at Dec. 31, 2022				$ 1					$ 18	(103,747,316)	96,294,123	$ (7,453,174)
Beginning balance (in shares) at Dec. 31, 2022				6,300					178,758
Issuance of common stock pursuant to private placement (in shares)												50,890
Net Income (loss)												$ (1,092,088)
Ending balance (in shares) at Jun. 30, 2023			1	6,300	5,761				316,906
Ending balance at Jun. 30, 2023				$ 1	$ 1				$ 31	(104,839,404)	109,263,332	4,423,960
Beginning balance at Mar. 31, 2023				$ 1					$ 23	(109,883,665)	102,020,620	(7,863,022)
Beginning balance (in shares) at Mar. 31, 2023				6,300					238,803
Conversion of notes into preferred stock					$ 1						5,759,177	5,759,177
Conversion of notes into preferred stock (in shares)					5,761
Issuance of Series B preferred stock											25,000	25,000
Issuance of Series B preferred stock (in shares)			1
Issuance of common stock pursuant to disposition									$ 8		1,357,035	1,357,043
Issuance of common stock pursuant to disposition (in shares)									78,103
Stock-based compensation											101,500	101,500
Net Income (loss)										5,044,260		5,044,260
Ending balance (in shares) at Jun. 30, 2023			1	6,300	5,761				316,906
Ending balance at Jun. 30, 2023				$ 1	$ 1				$ 31	$ (104,839,404)	$ 109,263,332	$ 4,423,960

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended		12 Months Ended
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (1,092,088)	$ (17,366,866)	$ (38,043,362)	$ (32,357,957)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,765,619	1,113,188	1,653,819	862,888
Amortization of loan discount and fees	1,611,433	2,818,174	6,506,384	1,382,222
Loss on extinguishment of debt	689,100
Loss on disposition of business	1,523,940
Stock-based compensation	207,094	258,852	602,038	4,800,337
Shares issued for services	499,338
Accounts Receivable, Credit Loss Expense (Reversal)			(118,840)	36,893
Change in credit reserve	344,140	(5,053)
Change in fair value of contingent consideration	(10,698,475)	7,121,240	564,303	8,764,460
Discontinued operations	7,666
Fees incurred in connection with debt financings			568,149	560,309
Change in fair value of warrant liability		(18,223)	(18,223)	11,958
Change in fair value of derivative liability		(880,388)	(1,354,434)	(910,204)
Forgiveness of Payroll Protection Program		(1,760,755)	(1,760,755)	(407,994)
Deferred offering costs			367,696
Deferred income tax benefit				(1,100,120)
Changes in operating assets and liabilities:
Accounts receivable, net	375,685	(100,662)	(452,030)	150,288
Due from factor, net	(96,955)	202,787	655,708	(399,701)
Inventory	454,011	(128,255)	479,394	(911,293)
Prepaid expenses and other current assets	(44,213)	(395,781)	(445,798)	(151,917)
Accounts payable	92,494	435,110	892,120	456,690
Accrued expenses and other liabilities	1,346,068	1,461,572	1,631,512	834,489
Deferred revenue	(183,782)	(55,034)		4,882
Due to related parties			298,943	(63,550)
Accrued interest	217,479	690,624	984,358	461,113
Net cash used in operating activities	(2,981,446)	(6,609,470)	(10,767,706)	(14,230,957)
Cash flows from investing activities:
Cash acquired (consideration) pursuant to business combination			(7,247,303)	(5,936,757)
Deposits	(18,192)		(60,548)	(31,117)
Purchase of property, equipment and software	(27,855)		(61,286)	(43,179)
Deposits	87,378
Net cash provided by (used in) investing activities	41,331		(7,369,137)	(6,011,053)
Cash flows from financing activities:
Proceeds (repayments) from related party advances	(57,427)	(172,036)
Advances (repayments) from factor	154,073	(142,436)	(3,096)	(41,200)
Repayment of contingent consideration			(645,304)
Issuance of loans and note payable	4,194,799	548,808
Repayments of convertible notes and loans payable	(6,604,552)	(3,068,750)	(7,350,276)	(2,006,628)
Issuance of convertible notes payable		2,301,250	6,951,250	8,433,650
Issuance of common stock in public offering	5,000,003	9,347,450	19,347,446	10,000,002
Exercise of over-allotment option with public offering, net				(1,364,997)
Exercise of warrants				1,768,046
Offering costs	(686,927)	(1,930,486)	(2,921,216)	(2,116,957)
Net cash provided by financing activities	1,999,969	6,883,800	18,896,664	20,181,820
Net change in cash and cash equivalents	(940,146)	274,330	759,820	(60,190)
Cash and cash equivalents at beginning of period	1,275,616	515,796	515,796	575,986
Cash and cash equivalents at end of period	335,470	802,724	1,275,616	515,796
Supplemental disclosure of cash flow information:
Cash paid for interest	686,071	191,152	734,869	902,089
Supplemental disclosure of non-cash investing and financing activities:
Conversion of notes into common stock		1,802,372	11,983,389	2,680,289
Conversion of notes into preferred stock	5,759,177
Right of use asset	$ 467,738	201,681	102,349
Warrant and common shares issued with notes.		$ 98,241	1,368,741
Conversion of venture debt into preferred stock			$ 6,300,000
Conversion of related party notes and payables into preferred and common stock				257,515
Conversion of preferred stock into common stock				6,291
Conversion of contingent consideration into common stock				73,500
Common shares issued pursuant to equity line of credit				$ 367,696

NATURE OF OPERATIONS

NATURE OF OPERATIONS	6 Months Ended	12 Months Ended
NATURE OF OPERATIONS	Jun. 30, 2023	Dec. 31, 2022
NATURE OF OPERATIONS
NATURE OF OPERATIONS	NOTE 1: NATURE OF OPERATIONS Digital Brands Group, Inc. (the “Company” or “DBG”), was organized on September 17, 2012 under the laws of Delaware as a limited liability company under the name Denim.LA LLC. The Company converted to a Delaware corporation on January 30, 2013 and changed its name to Denim.LA, Inc. Effective December 31, 2020, the Company changed its name to Digital Brands Group, Inc. (DBG). The Company is a curated collection of lifestyle brands, including Bailey, DSTLD, Harper & Jones, Stateside and ACE Studios, that offers a variety of apparel products through direct-to-consumer and wholesale distribution. On February 12, 2020, Denim.LA, Inc. entered into an Agreement and Plan of Merger with Bailey 44, LLC (“Bailey”), a Delaware limited liability company. On the acquisition date, Bailey, LLC became a wholly owned subsidiary of the Company. On May 18, 2021, the Company closed its acquisition of Harper & Jones, LLC (“H&J”) pursuant to its Membership Interest Stock Purchase Agreement with D. Jones Tailored Collection, Ltd. to purchase 100% of the issued and outstanding equity of Harper & Jones, LLC. On the acquisition date, H&J became a wholly owned subsidiary of the Company. On August 30, 2021, the Company closed its acquisition of Mosbest, LLC dba Stateside (“Stateside”) pursuant to its Membership Interest Purchase Agreement with Moise Emquies to purchase 100% of the issued and outstanding equity of Stateside. On the acquisition date, Stateside became a wholly owned subsidiary of the Company. On December 30, 2022, the Company closed its previously announced acquisition of Sunnyside, LLC dba Sundry (“Sundry”) pursuant to its Second Amended and Restated Membership Interest Purchase Agreement with Moise Emquies to purchase 100% of the issued and outstanding equity of Sundry. On the acquisition date, Sundry became a wholly owned subsidiary of the Company. On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 78,103 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. The H&J Settlement was accounted for a business disposition.	NOTE 1: NATURE OF OPERATIONS Digital Brands Group, Inc. (the “Company” or “DBG”), was organized on September 17, 2012 under the laws of Delaware as a limited liability company under the name Denim.LA LLC. The Company converted to a Delaware corporation on January 30, 2013 and changed its name to Denim.LA, Inc. Effective December 31, 2020, the Company changed its name to Digital Brands Group, Inc. (DBG). On February 12, 2020, Denim.LA, Inc. entered into an Agreement and Plan of Merger with Bailey 44, LLC (“Bailey”), a Delaware limited liability company. On the acquisition date, Bailey became a wholly owned subsidiary of the Company. See Note 4. On May 18, 2021, the Company closed its acquisition of Harper & Jones, LLC (“H&J”) pursuant to its Membership Interest Stock Purchase Agreement with D. Jones Tailored Collection, Ltd. to purchase 100% of the issued and outstanding equity of Harper & Jones, LLC. On the acquisition date, H&J became a wholly owned subsidiary of the Company. See Note 4. On August 30, 2021, the Company closed its acquisition of Mosbest, LLC dba Stateside (“Stateside”) pursuant to its Membership Interest Purchase Agreement with Moise Emquies to purchase 100% of the issued and outstanding equity of Stateside. On the acquisition date, Stateside became a wholly owned subsidiary of the Company. See Note 4. On December 30, 2022, the Company closed its previously announced acquisition of Sunnyside, LLC dba Sundry (“Sundry”) pursuant to its Second Amended and Restated Membership Interest Purchase Agreement with Moise Emquies to purchase 100% of the issued and outstanding equity of Sundry. On the acquisition date, Sundry became a wholly owned subsidiary of the Company. See Note 4. Reverse Stock Split On May 12, 2021, the Board of Directors approved a one On October 21, 2022, the Board of Directors approved a one Initial Public Offering On May 13, 2021, the Company’s registration statement on Form S-1 relating to its initial public offering of its common stock (the “IPO”) was declared effective by the Securities and Exchange Commission (“SEC”). Further to the IPO, which closed on May 18, 2021, the Company issued and sold 964 shares of common stock at a public offering price of $10,375 per share. Additionally, the Company issued warrants to purchase 1,111 shares, which includes 145 warrants sold upon the partial exercise of the over-allotment option. The aggregate net proceeds to the Company from the IPO, were $8.6 million after deducting underwriting discounts and commissions of $0.8 million and direct offering expenses of $0.6 million. Concurrent with this offering, the Company acquired H&J (see Note 4). The Company incurred an additional $0.6 million in offering costs related to the IPO that were not paid directly out of the proceeds from the offering.

GOING CONCERN

GOING CONCERN	6 Months Ended	12 Months Ended
GOING CONCERN	Jun. 30, 2023	Dec. 31, 2022
GOING CONCERN
GOING CONCERN	NOTE 2: GOING CONCERN The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not generated profits since inception, has sustained net losses of $1,092,088 and $17,366,866 for the six months ended June 30, 2023 and 2022, respectively, and has incurred negative cash flows from operations for the six months ended June 30, 2023 and 2022. The Company has historically lacked liquidity to satisfy obligations as they come due and as of June 30, 2023, and the Company had a working capital deficit of $16,037,518. These factors, among others, arise substantial doubt about the Company’s ability to continue as a going concern. The Company expects to continue to generate operating losses for the foreseeable future. The accompanying consolidated financial statements do not include any adjustments as a result of this uncertainty. The Company’s ability to continue as a going concern for the next 12 months from the date the financial statements were available to be issued is dependent upon its ability to generate sufficient cash flows from operations to meet its obligations, which it has not been able to accomplish to date, and/or to obtain additional capital financing. Through the date the financial statements were available to be issued, the Company has been primarily financed through the issuance of capital stock and debt. In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities. The issuance of additional equity would result in dilution to existing shareholders. If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations. No assurance can be given that the Company will be successful in these efforts.	NOTE 2: GOING CONCERN The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not generated profits since inception, has sustained net losses of $38,043,362 and $32,357,957 for the years ended December 31, 2022 and 2021, respectively, and has incurred negative cash flows from operations for the years ended December 31, 2022 and 2021. The Company has historically lacked liquidity to satisfy obligations as they come due and as of December 31, 2022, and the Company had a working capital deficit of $32,064,398. These factors, among others, arise substantial doubt about the Company’s ability to continue as a going concern. The Company expects to continue to generate operating losses for the foreseeable future. The accompanying consolidated financial statements do not include any adjustments as a result of this uncertainty. The Company’s ability to continue as a going concern for the next 12 months from the date the financial statements were available to be issued is dependent upon its ability to generate sufficient cash flows from operations to meet its obligations, which it has not been able to accomplish to date, and/or to obtain additional capital financing. Through the date the financial statements were available to be issued, the Company has been primarily financed through the issuance of capital stock and debt. In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities. The issuance of additional equity would result in dilution to existing shareholders. If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations. No assurance can be given that the Company will be successful in these efforts.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”). Reverse Stock Split On October 21, 2022, the Board of Directors approved a one Unaudited Interim Financial Information The accompanying unaudited condensed consolidated balance sheet as of June 30, 2023, the unaudited condensed consolidated statements of operations for the six and six months ended June 30, 2023 and 2022 and of cash flows for the six months ended June 30, 2023 and 2022 have been prepared by the Company, pursuant to the rules and regulations of the SEC for the interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to rules and regulations. However, the Company believes that the disclosures are adequate to make the information presented not misleading. The unaudited interim consolidated financial statements have been prepared on a basis consistent with the audited consolidated financial statements and in the opinion of management, reflect all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the consolidated results for the interim periods presented and of the consolidated financial condition as of the date of the interim consolidated balance sheet. The results of operations are not necessarily indicative of the results expected for the year ended December 31, 2023. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2022 included in the Company’s Annual Form 10-K filed with SEC on April 17, 2023. Principles of Consolidation These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Bailey, H&J and Stateside from the dates of acquisition. All inter-company transactions and balances have been eliminated on consolidation. As of June 21, 2023, the Company no longer consolidated the assets, liabilities, revenues and expenses of H&J (see Note 4). Use of Estimates The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, inventory, impairment of long-lived assets, contingent consideration and derivative liabilities. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates. Reclassification of Previously Issued Financial Statements Certain prior year accounts have been reclassified to conform with current year presentation pertaining to cost of net revenue and general and administrative expenses. The Company has reclassified $297,696 and $630,976 in general and administrative expenses per previously reported financial statements to cost of net revenues in the accompanying consolidated statements of operations for the three and six months ended June 30, 2022, respectively. The reclassified costs from general and administrative expense to cost of net revenues are primarily personnel and warehouse related costs. The reclassification had no effect on the reported results of operations. Certain prior year accounts have been reclassified to conform with current year presentation regarding income (loss) from discontinued operations. H&J’s assets and liabilities as of December 31, 2022 have also been reclassified on the consolidated balance sheet. See Note 4. Cash and Equivalents and Concentration of Credit Risk The Company considers all highly liquid securities with an original maturity of less than six months to be cash equivalents. As of June 30, 2023 and December 31, 2022, the Company did not hold any cash equivalents. The Company’s cash and cash equivalents in bank deposit accounts, at times, may exceed federally insured limits of $250,000. Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued expenses, due to related parties, related party note payable, and convertible debt. The carrying value of these assets and liabilities is representative of their fair market value, due to the short maturity of these instruments. The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy used to determine such fair values: Fair Value Measurements as of June 30, 2023 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ — $ — $ — $ — $ — $ — Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ 12,098,475 $ 12,098,475 $ — $ — $ 12,098,475 $ 12,098,475 Contingent Consideration The Company recorded a contingent consideration liability relating to stock price guarantees included in its acquisitions of Bailey44 and H&J. The estimated fair value of the contingent consideration was recorded using significant unobservable measures and other fair value inputs and was therefore classified as a Level 3 financial instrument. The Company estimates and records the acquisition date fair value of contingent consideration as part of purchase price consideration for acquisitions. Additionally, each reporting period, the Company estimates changes in the fair value of contingent consideration and recognizes any change in fair in the consolidated statement of operations. The estimate of the fair value of contingent consideration requires very subjective assumptions to be made of future operating results, discount rates and probabilities assigned to various potential operating result scenarios. Future revisions to these assumptions could materially change the estimate of the fair value of contingent consideration and, therefore, materially affect the Company’s future financial results. The contingent consideration liability is to be settled with the issuance of shares of common stock once contingent provisions set forth in respective acquisition agreements have been achieved. Upon achievement of contingent provisions, respective liabilities are relieved and offset by increases to common stock and additional paid-in capital in the stockholders’ equity section of the Company’s consolidated balance sheets. Norwest Waiver On June 21, 2023, the Company, on the one hand, and Norwest Venture Partners XI, LP and Norwest Venture Partners XII, LP (together, the “Norwest Investors”), on the other hand, executed a Waiver and Amendment (the “Norwest Amendment”) whereby the Norwest Investors agreed to waive and terminate certain true up rights of the Norwest Investors under the Agreement and Plan of Merger, dated February 12, 2020 (the “Bailey Merger Agreement”), among the Company, Bailey 44, LLC, Norwest Venture Partners XI, LP, and Norwest Venture Partners XII, LP and Denim.LA Acquisition Corp. This transaction is known as the “Norwest Waiver”. As a result of the Norwest Waiver, the Company recorded a fair value of H&J Settlement Agreement On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby the Company transferred 100% of its membership interests in H&J to D. Jones (the “H&J Seller”). Pursuant to the Settlement Agreement, the Company agreed to make an aggregate cash payment of shares of common stock to the H&J Seller. In connection with the Settlement Agreement, the parties agreed that no further shares were owed to the H&J Seller resulting from the stock price guarantee pursuant to the May 2021 H&J acquisition. As a result, the Company recorded a fair value of The detail of contingent consideration by company is as follows: June 30, December 31, 2023 2022 Bailey $ — $ 10,698,475 Harper & Jones — 1,400,000 $ — $ 12,098,475 Inventory Inventory is stated at the lower of cost or net realizable value and accounted for using the weighted average cost method for DSTLD and first-in, first-out method for Bailey, Stateside and Sundry. The inventory balances as of June 30, 2023 and December 31, 2022 consist substantially of finished good products purchased or produced for resale, as well as any raw materials the Company purchased to modify the products and work in progress. Inventory consisted of the following: June 30, December 31, 2023 2022 Raw materials $ 1,508,416 $ 1,611,134 Work in process 653,412 888,643 Finished goods 2,609,443 2,725,505 Inventory $ 4,771,271 $ 5,225,282 Goodwill Goodwill and identifiable intangible assets that have indefinite useful lives are not amortized, but instead are tested annually for impairment and upon the occurrence of certain events or substantive changes in circumstances. The annual goodwill impairment test allows for the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An entity may choose to perform the qualitative assessment on none, some or all of its reporting units or an entity may bypass the qualitative assessment for any reporting unit and proceed directly to step one of the quantitative impairment test. If it is determined, on the basis of qualitative factors, that the fair value of a reporting unit is, more likely than not, less than its carrying value, the quantitative impairment test is required. Annual Impairment At December 31, 2022, management determined that certain events and circumstances occurred that indicated that the carrying value of the Company’s brand name assets, and the carrying amount of the reporting units, pertaining to Bailey44 and Harper & Jones may not be recoverable. The qualitative assessment was primarily due to reduced or stagnant revenues of both entities as compared to the Company’s initial projections at the time of each respective acquisition, as well as the entities’ liabilities in excess of assets. As such, the Company compared the estimated fair value of the brand names with its carrying value and recorded an impairment loss of $3,667,000 in the consolidated statements of operations. Additionally, the Company compared the fair value of the reporting units to the carrying amounts and recorded an impairment loss of $11,872,332 Net Loss per Share Net earnings or loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period, excluding shares subject to redemption or forfeiture. The Company presents basic and diluted net earnings or loss per share. Diluted net earnings or loss per share reflect the actual weighted average of common shares issued and outstanding during the period, adjusted for potentially dilutive securities outstanding. Potentially dilutive securities are excluded from the computation of the diluted net loss per share if their inclusion would be anti-dilutive. The following table sets forth the computation of basic and diluted net income (loss) per share: Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 Numerator: Net income (loss) from continuing operations $ 6,536,310 $ (9,482,520) $ 470,415 $ (17,200,792) Income (loss) from discontinued operations, net of tax (1,492,050) (51,404) (1,562,503) (166,074) Net income (loss) $ 5,044,260 $ (9,533,924) $ (1,092,088) $ (17,366,866) Denominator: Weighted average common shares outstanding - basic 246,809 14,329 236,824 9,836 Weighted average common shares outstanding - diluted 834,604 14,329 824,619 9,836 Net income (loss) from continuing operations per share - basic $ 26.48 $ (661.78) $ 1.99 $ (1,748.68) Net income (loss) from continuing operations per share - diluted $ 7.83 $ (661.78) $ 0.57 $ (1,748.68) Net income (loss) from discontinued operations per common share – basic $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) from discontinued operations per common share – diluted $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) per share – $ 20.44 $ (665.36) $ (4.61) $ (1,765.57) Net income (loss) per share – $ 6.04 $ (665.36) $ (4.61) $ (1,765.57) The following table sets forth the a) the dilutive items included in the weighted average common shares – diluted amount above as of June 30, 2023 and b) the number of potential common shares excluded from the calculations of net loss per diluted share because their inclusion would be anti-dilutive as of June 30, 2022: June 30, 2023 2022 — 18,496 Convertible notes 27,097 — Series A convertible preferred stock 321,395 — Series C convertible preferred stock 237,746 2,533 Common stock warrants 1,558 1,558 Stock options 587,795 22,588 The stock options and warrants above are out-of-the-money as of June 30, 2023 and 2022. Recent Accounting Pronouncements In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which amends and clarifies several provisions of Topic 326. In May 2019, the FASB issued ASU 2019-05, Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief, which amends Topic 326 to allow the fair value option to be elected for certain financial instruments upon adoption. ASU 2019-10 extended the effective date of ASU 2016-13 until December 15, 2022. The Company adopted this new guidance, including the subsequent updates to Topic 326, on January 1, 2023 and the adoption did not have a material impact on the Company’s condensed consolidated financial statements and related disclosures. Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are Unaudited Pro Forma Financial Information The following unaudited pro forma financial information presents the Company’s financial results as if the Sundry acquisition had occurred as of January 1, 2022. The unaudited pro forma financial information is not necessarily indicative of what the financial results actually would have been had the acquisitions been completed on this date. In addition, the unaudited pro forma financial information is not indicative of, nor does it purport to project, the Company’s future financial results. The following unaudited pro forma financial information includes incremental property and equipment depreciation and intangible asset amortization as a result of the acquisitions. The pro forma information does not give effect to any estimated and potential cost savings or other operating efficiencies that could result from the acquisition: Six Months Ended June 30, 2022 Net revenues $ 14,728,296 Net loss $ (16,907,152) Net loss per common share $ (1,718.83)	NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”). H&J Disposition On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 78,103 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. This transaction is known as the “H&J Settlement”. The H&J Settlement was accounted for a business disposition in accordance with ASC 810-40-40-3A. In accordance with the provisions of ASC 205-20, the Company has excluded the results of discontinued operations from its results of continuing operations in the accompanying consolidated statements of operations for the three and six months ended June 30, 2023 and 2022 in it’s Form 10-Q Quarterly Report filed on August 21, 2023. Accordingly, the consolidated financial statements as of and for the years ended December 31, 2022 and 2021 have been adjusted retroactively to account for the discontinued operations classification of H&J. Principles of Consolidation These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Bailey, H&J, Stateside and Sundry from the dates of acquisition. All inter-company transactions and balances have been eliminated on consolidation. H&J has been retroactively adjusted to be presented as discontinued operations (see above). Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Restatement of Previously Issued Financial Statements Certain prior year accounts have been reclassified to conform with current year presentation pertaining to cost of net revenue and general and administrative expenses. The Company has reclassified The reclassified costs from general and administrative expense to cost of net revenues made in the fourth quarter of 2022 and 2021 are fixed in nature as they are personnel and warehouse related costs. The impact of the reclassification was approximately for each of the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022. The impact of the reclassification was approximately Cash and Equivalents and Concentration of Credit Risk The Company considers all highly liquid securities with an original maturity of less than three months to be cash equivalents. As of December 31, 2022 and 2021, the Company did not hold any cash equivalents. The Company’s cash and cash equivalents in bank deposit accounts, at times, may exceed federally insured limits of $250,000. Fair Value of Financial Instruments FASB guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 3 — Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, due from factor, prepaid expenses, accounts payable, accrued expenses, deferred revenue, due to related parties, related party note payable, accrued interest, loan payable and convertible debt. The carrying value of these assets and liabilities is representative of their fair market value, due to the short maturity of these instruments. The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy used to determine such fair values: Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ — $ — $ — Contingent consideration — — 12,098,475 12,098,475 Derivative liability — — — — $ — $ — $ 12,098,475 $ 12,098,475 Fair Value Measurements as of December 31, 2021 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ 18,223 $ — $ 18,223 Contingent consideration — — 12,179,476 12,179,476 Derivative liability — — 2,294,720 2,294,720 $ — $ 18,223 $ 14,474,196 $ 14,492,419 Warrant Liability Certain of the Company’s common stock warrants are carried at fair value. As of December 31, 2020, the fair value of the Company’s common stock warrant liabilities was measured under the Level 3 hierarchy using the Black-Scholes pricing model as the Company’s underlying common stock had no observable market price (see Note 10). The warrant liability was valued using a market approach. Upon the IPO, the warrant liabilities were valued using quoted prices of identical assets in active markets, and was reclassified under the Level 2 hierarchy. Changes in common stock warrant liability during the years ended December 31, 2022 and 2021 are as follows: Warrant Liability Outstanding as of December 31, 2020 $ 6,265 Change in fair value 11,958 Outstanding as of December 31, 2021 18,223 Change in fair value (18,223) Outstanding as of December 31, 2022 $ — Contingent Consideration The Company records a contingent consideration liability relating to stock price guarantees included in its acquisition and consulting agreements. The estimated fair value of the contingent consideration is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument. The Company estimates and records the acquisition date fair value of contingent consideration as part of purchase price consideration for acquisitions. Additionally, each reporting period, the Company estimates changes in the fair value of contingent consideration and recognizes any change in fair in the consolidated statement of operations. The estimate of the fair value of contingent consideration requires very subjective assumptions to be made of future operating results, discount rates and probabilities assigned to various potential operating result scenarios. Future revisions to these assumptions could materially change the estimate of the fair value of contingent consideration and, therefore, materially affect the Company’s future financial results. The contingent consideration liability is to be settled with the issuance of shares of common stock once contingent provisions set forth in respective acquisition agreements have been achieved. Upon achievement of contingent provisions, respective liabilities are relieved and offset by increases to common stock and additional paid-in capital in the stockholders’ equity section of the Company’s consolidated balance sheets. The fair value of the contingent consideration liability related to the Company’s business combinations is valued using the Monte Carlo simulation model. The Monte Carlo simulation inputs include the stock price, volatility of common stock, timing of settlement and resale restrictions and limits. The fair value of the contingent consideration is then calculated based on guaranteed equity values at settlement as defined in the acquisition agreements. Changes in contingent consideration liability during the years ended December 31, 2022 and 2021 are as follows: Contingent Consideration Liability Balance as of December 31, 2020 $ — Initial recognition in connection with acquisition of Harper & Jones 3,421,516 Stock price guarantee per consulting agreement 67,000 Conversion into shares (73,500) Change in fair value 8,764,460 Outstanding as of December 31, 2021 12,179,476 Repayments to Harper & Jones seller (645,304) Change in fair value 564,303 Outstanding as of December 31, 2022 $ 12,098,475 During the year ended December 31, 2022, the Company utilized the following inputs for the fair value of the contingent consideration: volatilities of 79.3% and 88.9%, risk-free rate of 0.25%, expected share increase of 5% per annum, and the guaranteed stock price of $828 for Bailey and $10,375 for Harper & Jones. The detail of contingent consideration by company is as follows: December 31, 2022 2021 Bailey $ 10,698,475 7,935,016 Harper & Jones 1,400,000 4,244,460 $ 12,098,475 $ 12,179,476 The contingent consideration liabilities were revalued for a final time as of May 18, 2022, the anniversary date of the Company’s initial public offering. As of the date of the issuance of these financial statements, the contingent consideration liabilities were not yet settled with shares. In December 2022, the Company paid $645,304 to the H&J Seller to partially reduce the contingent consideration balance owed. The Company and the H&J Seller are in the process of amending the May 2021 purchase agreement to determine the ultimate settlement of the Company’s common stock to the H&J Seller by May 16, 2023. Refer to Note 12. Derivative Liability In connection with the Company’s convertible notes, the Company recorded a derivative liability (see Note 7). The estimated fair value of the derivative liability is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument. The fair value of the derivative liability is valued using a multinomial lattice model. The multinomial lattice inputs include the underlying stock price, volatility of common stock and remaining term of the convertible note. Changes in derivative liability during the years ended December 31, 2022 and 2021 are as follows: Derivative Liability Outstanding as of December 31, 2020 $ — Initial fair value on issuance of convertible note 3,204,924 Change in fair value (910,204) Outstanding as of December 31, 2021 2,294,720 Initial fair value on issuance of convertible note 559,957 Conversion of underlying notes into common stock (1,500,243) Change in fair value (1,354,434) Outstanding as of December 31, 2022 $ — During the year ended December 31, 2022, the Company utilized the following inputs for the fair value of the derivative liability: volatility of 70.9% - 96.7%, risk-free rate of 2.71% - 3.74%, and remaining term ranging from .08 years - 0.62 years. The change in fair value of the derivative liability is included in other non-operating income (expense), net in the consolidated statements of operations. Inventory Inventory is stated at the lower of cost or net realizable value and accounted for using the weighted average cost method for DSTLD and H&J and first-in, first-out method for Bailey, Stateside and Sundry. The inventory balances as of December 31, 2022 and 2021 consist substantially of finished good products purchased or produced for resale, as well as any raw materials the Company purchased to modify the products and work in progress. Inventory consisted of the following: December 31, 2022 2021 Raw materials $ 1,508,416 $ 292,167 Work in process 888,643 242,673 Finished goods 2,725,505 2,220,519 Inventory $ 5,122,564 $ 2,660,203 Property, Equipment, and Software Property, equipment, and software are recorded at cost. Depreciation/amortization is recorded for property, equipment, and software using the straight-line method over the estimated useful lives of assets. The Company reviews the recoverability of all long-lived assets, including the related useful lives, whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset might not be recoverable. The balances at December 31, 2022 and 2021 consist of software with three (3) year lives, property and equipment with three (3) to ten (10) year lives, and leasehold improvements which are depreciated over the shorter of the lease life or expected life. Depreciation and amortization charges on property, equipment, and software are included in general and administrative expenses and amounted to $75,126 and $92,213 for the years ended December 31, 2022 and 2021, respectively. Business Combinations The Company accounts for acquisitions in which it obtains control of one or more businesses as a business combination. The purchase price of the acquired businesses is allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date. The excess of the purchase price over those fair values is recognized as goodwill. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments, in the period in which they are determined, to the assets acquired and liabilities assumed with the corresponding offset to goodwill. If the assets acquired are not a business, the Company accounts for the transaction or other event as an asset acquisition. Under both methods, the Company recognizes the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest in the acquired entity. In addition, for transactions that are business combinations, the Company evaluates the existence of goodwill or a gain from a bargain purchase. Goodwill represents the excess of the purchase price of an acquired entity over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed in a business combination. Intangible assets are established with business combinations and consist of brand names and customer relationships. Intangible assets with finite lives are recorded at their estimated fair value at the date of acquisition and are amortized over their estimated useful lives using the straight-line method. The estimated useful lives of amortizable intangible assets are as follows: Customer relationships 3 years Impairment Long-Lived Assets The Company reviews its long-lived assets (property and equipment and amortizable intangible assets) for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. If the sum of the expected cash flows, undiscounted, is less than the carrying amount of the asset, an impairment loss is recognized as the amount by which the carrying amount of the asset exceeds its fair value. Goodwill Goodwill and identifiable intangible assets that have indefinite useful lives are not amortized, but instead are tested annually for impairment and upon the occurrence of certain events or substantive changes in circumstances. The annual goodwill impairment test allows for the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An entity may choose to perform the qualitative assessment on none, some or all of its reporting units or an entity may bypass the qualitative assessment for any reporting unit and proceed directly to step one of the quantitative impairment test. If it is determined, on the basis of qualitative factors, that the fair value of a reporting unit is, more likely than not, less than its carrying value, the quantitative impairment test is required. The quantitative impairment test calculates any goodwill impairment as the difference between the carrying amount of a reporting unit and its fair value, but not to exceed the carrying amount of goodwill. It is our practice, at a minimum, to perform a qualitative or quantitative goodwill impairment test in the fourth quarter every year. Indefinite-Lived Intangible Assets Indefinite-lived intangible assets established in connection with business combinations consist of the brand name. The impairment test for identifiable indefinite-lived intangible assets consists of a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. Annual Impairment Tests At December 31, 2021, management determined that certain events and circumstances occurred, primarily the continued reduction in revenues partially as a result of COVID-19, that indicated that the carrying value of the Company’s brand name asset pertaining to Bailey44 may not be recoverable. As such, the Company compared the estimated fair value of the brand name with its carrying value and recorded an impairment loss of $3,400,000 in the consolidated statements of operations. At December 31, 2022, management determined that certain events and circumstances occurred that indicated that the carrying value of the Company’s brand name assets, and the carrying amount of the reporting units, pertaining to Bailey44 and Harper & Jones may not be recoverable. The qualitative assessment was primarily due to reduced or stagnant revenues of both entities as compared to the Company’s initial projections at the time of each respective acquisition, as well as the entities’ liabilities in excess of assets. As such, the Company compared the estimated fair value of the brand names with its carrying value and recorded an impairment loss of $3,667,000 in the consolidated statements of operations. Additionally, the Company compared the fair value of the reporting units to the carrying amounts and recorded an impairment loss of $11,872,332 Year Ended December 31, 2022 2021 Bailey brand name (intangibles) $ 2,182,000 $ 3,400,000 Bailey goodwill 3,321,095 — Total impairment $ 5,503,095 $ 3,400,000 In determining the fair value of the respective reporting units, management estimated the price that would be received to sell the reporting unit as a whole in an orderly transaction between market participants at the measurement date. This includes reviewing market comparables such as revenue multipliers and assigning certain assets and liabilities to the reporting units, such as the respective working capital deficits of each entity and debt obligations that would need to be assumed by a market participant buyer in an orderly transaction. The Company calculated the carrying amounts of each reporting unit by utilizing the entities’ assets and liabilities at December 31, 2022, including the carrying value of the identifiable intangible assets and goodwill assigned to the respective reporting units. Refer to Note 12 for the related developments with H&J. Convertible Instruments U.S. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional as that term is described under applicable U.S. GAAP. When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company also records, when necessary, deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares. Accounting for Preferred Stock ASC 480, Distinguishing Liabilities from Equity, includes standards for how an issuer of equity (including equity shares issued by consolidated entities) classifies and measures on its balance sheet certain financial instruments with characteristics of both liabilities and equity. Management is required to determine the presentation for the preferred stock as a result of the redemption and conversion provisions, among other provisions in the agreement. Specifically, management is required to determine whether the embedded conversion feature in the preferred stock is clearly and closely related to the host instrument, and whether the bifurcation of the conversion feature is required and whether the conversion feature should be accounted for as a derivative instrument. If the host instrument and conversion feature are determined to be clearly and closely related (both more akin to equity), derivative liability accounting under ASC 815, Derivatives and Hedging, is not required. Management determined that the host contract of the preferred stock is more akin to equity, and accordingly, liability accounting is not required by the Company. The Company has presented preferred stock within stockholders’ equity. Costs incurred directly for the issuance of the preferred stock are recorded as a reduction of gross proceeds received by the Company, resulting in a discount to the preferred stock. The discount is not amortized. Revenue Recognition Revenues are recognized when performance obligations are satisfied through the transfer of promised goods to the Company’s customers. Control transfers upon shipment of product and when the title has been passed to the customers. This includes the transfer of legal title, physical possession, the risks and rewards of ownership, and customer acceptance. The Company provides the customer the right of return on the product and revenue is adjusted based on an estimate of the expected returns based on historical rates. The Company considers the sale of products as a single performance obligation. Sales tax collected from customers and remitted to taxing authorities is excluded from revenue and is included in accrued expenses. Revenue is deferred for orders received for which associated shipments have not occurred. The reserve for returns totaled $307,725 and $33,933 as of December 31, 2022 and 2021, respectively, and is included in accrued expenses and other liabilities in the accompanying consolidated balance sheets. Cost of Revenues Cost of revenues consists primarily of inventory sold and related freight-in. Cost of revenues includes direct labor pertaining to our inventory production activities and an allocation of overhead costs including rent and insurance. Cost of revenues also includes inventory write-offs and reserves. Shipping and Handling The Company recognizes shipping and handling billed to customers as a component of net revenues, and the cost of shipping and handling as distribution costs. Total shipping and handling billed to customers as a component of net revenues was approximately $72,000 and $23,000 for the years ended December 31, 2022 and 2021, respectively. Total shipping and handling costs included in distribution costs were approximately $525,000 and $423,000, respectively. Advertising and Promotion Advertising and promotional costs are expensed as incurred. Advertising and promotional expense for the years ended December 31, 2022 and 2021 amounted to approximately $1,178,000 and $240,000, respectively. The amounts are included in sales and marketing expense. General and Administrative General and administrative expenses consist primarily of compensation and benefits costs, professional services and information technology. General and administrative expenses also include payment processing fees, design and warehousing fees. Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedging relationships and the types of relationships designated are based on the exposures hedged. At December 31, 2022 and 2021, the Company did not have any derivative instruments that were designated as hedges. Stock Option and Warrant Valuation Stock option and warrant valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option model. For warrants and stock options issued to non- employees, the Company accounts for the expected life based on the contractual life of the warrants and stock options. For employees, the Company accounts for the expected life of options in accordance with the “simplified” method, which is used for “plain-vanilla” options, as defined in the accounting standards codification. The simplified method is based on the average of the vesting tranches and the contractual life of each grant. For stock price volatility, the Company uses comparable public companies as a basis for its expected volatility to calculate the fair value of options grants. The risk-free interest rate was determined from the implied yields of U.S. Treasury zero-coupon bonds with a remaining life consistent with the expected term of the options. The number of stock award forfeitures are recognized as incurred. Stock-Based Compensation The Company accounts for stock-based compensation costs under the provisions of ASC 718, Compensation — Stock Compensation, which requires the measurement and recognition of compensation expense related to the fair value of stock-based compensation awards that are ultimately expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock-based payments granted to employees, officers, and directors based on the grant date fair value estimated in accordance with the provisions of ASC 718. ASC 718 is also applied to awards modified, repurchased, or cancelled during the periods reported. Stock-based compensation is recognized as an expense over the employee’s requisite vesting period and over the nonemployee’s period of providing goods or services. The Company measures employee stock-based awards at grant-date fair value and recognizes employee compensation expense on a straight-line basis over the vesting period of the award. Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions, including the fair value of the Company’s common stock, and for stock options, the expected life of the option, and expected stock price volatility. The Company used the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards. Deferred Offering Costs The Company complies with the requirements of ASC 340, Other Assets and Deferred Costs, with regards to offering costs. Prior to the completion of an offering, offering costs are capitalized. The deferred offering costs are charged to additional paid-in capital or as a discount to debt, as applicable, upon the completion of an offering or to expense if the offering is not completed. As of December 31, 2020, the Company had capitalized $214,647 in deferred offering costs. Upon completion of the IPO in May 2021, all capitalized deferred offering costs were charged to additional paid-in capital. As of December 31, 2021, the Company capitalized $367,696 in deferred offering costs pertaining to its equity line of credit agreement with Oasis (Note 8). In 2022, the Company wrote off these costs to general and administrative expenses in the consolidated statements of operations as the equity line of credit financing never occurred. Segment Information In accordance with ASC 280, Segment Reporting (“ASC 280”), we identify our operating segments according to how our business activities are managed and evaluated. As of December 31, 2022 our operating segments included: DSTLD, Bailey, H&J, Stateside and Sundry. Each operating segment currently reports to the Chief Executive Officer. Each of our brands serve or are expected to serve customers through our wholesale, in store and online channels, allowing us to execute on our omni-channel strategy. We have determined that each of our operating segments share similar economic and other qualitative characteristics, and therefore the results of our operating segments are aggregated into one reportable segment. All of the operating segments have met the aggregation criteria and have been aggregated and are presented as one reportable segment, as permitted by ASC 280. We continually monitor and review our segment reporting structure in accordance with authoritative guidance to determine whether any changes have occurred that would impact our reportable segments. Income Taxes The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is unlikely that the deferred tax assets will not be realized. We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, our policy will be to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions wher

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	6 Months Ended
DISCONTINUED OPERATIONS	Jun. 30, 2023
DISCONTINUED OPERATIONS
DISPOSITION	NOTE 4: DISCONTINUED OPERATIONS On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 78,103 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. This transaction is known as the “H&J Settlement”. The H&J Settlement was accounted for a business disposition in accordance with ASC 810-40-40-3A. As of June 21, 2023, the Company no longer consolidated the assets, liabilities, revenues and expenses of H&J. The components of the disposition are as follows: Cash payment due to H&J Seller $ (229,000) Common shares issued to H&J Seller* (1,357,043) Total fair value of consideration received (given) $ (1,586,043) Carrying amount of assets and liabilities Cash and cash equivalents 18,192 Accounts receivable, net 55,782 Prepaid expenses and other current assets 25,115 Goodwill 1,130,311 Intangible assets, net 1,246,915 Deposits 4,416 Accounts payable (40,028) Accrued expenses and other liabilities (734,068) Deferred revenue (18,347) Due to related parties (1,008) Contingent consideration (1,400,000) Loan payable (219,894) Note payable - related party (129,489) Total carrying amount of assets and liabilities (62,103) Loss on disposition of business $ (1,523,940) * Represents the fair value of 78,103 shares of common stock issued to D. Jones. Through June 30, 2023, the Company has made payments to D. Jones totaling $150,000. The remaining balance of $79,000 is included in accrued expenses and other liabilities on the consolidated balance sheet. The loss of disposition of business of $1,523,940 was included in income (loss) from discontinued operations, net of tax in the consolidated statements of operations. In accordance with the provisions of ASC 205-20, the Company has excluded the results of discontinued operations from its results of continuing operations in the accompanying consolidated statements of operations for the three and six months ended June 30, 2023 and 2022. The results of the discontinued operations of HJ for the three and six months ended June 30, 2023 and 2022 consist of the following: Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 Net revenues $ 686,627 $ 1,089,569 $ 1,405,482 $ 1,892,849 Cost of net revenues 292,107 328,915 565,621 605,413 Gross profit 394,520 760,654 839,861 1,287,436 Operating expenses: General and administrative 189,751 449,508 520,582 896,873 Sales and marketing 169,875 332,723 346,167 515,775 Distribution — — — — Change in fair value of contingent consideration — — — — Total operating expenses 359,626 782,231 866,749 1,412,648 Income (loss) from operations 34,894 (21,577) (26,888) (125,212) Other income (expense): Interest expense (3,003) (29,828) (11,675) (40,862) Loss on disposition of business (1,523,940) — (1,523,940) — Other non-operating income (expenses) — — — — Total other income (expense), net (1,526,944) (29,828) (1,535,615) (40,862) Income tax benefit (provision) — — — — Net income (loss) from discontinued operations $ (1,492,050) $ (51,404) $ (1,562,503) $ (166,074) Weighted average common shares outstanding - basic 246,809 14,329 236,824 9,836 Weighted average common shares outstanding - diluted 834,604 14,329 824,619 9,836 Net income (loss) from discontinued operations per common share - basic $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) from discontinued operations per common share - diluted $ (6.05) $ (3.59) $ (6.60) $ (16.88)

DUE FROM FACTOR

DUE FROM FACTOR	6 Months Ended	12 Months Ended
DUE FROM FACTOR	Jun. 30, 2023	Dec. 31, 2022
DUE FROM FACTOR
DUE FROM FACTOR	NOTE 5: DUE FROM FACTOR Due to/from factor consist of the following: June 30, December 31, 2023 2022 Outstanding receivables: Without recourse $ 787,542 $ 1,680,042 With recourse 50,979 65,411 Matured funds and deposits 88,516 81,055 Advances (478,753) (632,826) Credits due customers (10,142) (354,282) $ 438,142 $ 839,400	NOTE 5: DUE FROM FACTOR The Company, via its subsidiaries, Bailey, Stateside and Sundry, assigns a portion of its trade accounts receivable to third- party factoring companies, who assumes the credit risk with respect to the collection of non-recourse accounts receivable. The Company may request advances on the net sales factored at any time before their maturity date, and up to 50% of eligible finished goods inventories based on the terms of one of our agreements that terminated in 2021. The factor charges a commission on the net sales factored for credit and collection services. For one factoring company, interest on advances is charged as of the last day of each month at a rate equal to the LIBOR rate plus 2.5% for Bailey. For Stateside and Sundry, should total commission and fees payable be less than $30,000 in a single year, then the factor shall charge the difference between the actual fees in said year and $30,000 to the Company. Interest on advances is charged as of the last day of each month at a rate equal to the greater of either, (a) the Chase Prime Rate + (2.0)% or (b) (4.0)% per annum. For another factoring company, interest is charged at one-thirty- third Advances are collateralized by a security interest in substantially all of the companies’ assets. Due to/from factor consist of the following: December 31, 2022 2021 Outstanding receivables: Without recourse $ 564,548 $ 579,295 With recourse 352,379 361,584 Advances 118,521 121,617 Credits due customers (196,048) (77,208) $ 839,400 $ 985,288

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	6 Months Ended	12 Months Ended
GOODWILL AND INTANGIBLE ASSETS	Jun. 30, 2023	Dec. 31, 2022
GOODWILL AND INTANGIBLE ASSETS
GOODWILL AND INTANGIBLE ASSETS	NOTE 6: GOODWILL AND INTANGIBLE ASSETS The following is a summary of goodwill attributable to each business combination: June 30, December 31, 2023 2022 Bailey $ 3,158,123 $ 3,158,123 Stateside 2,104,056 2,104,056 Sundry 3,711,322 3,711,322 $ 8,973,501 $ 10,103,812 In connection with the H&J disposition, the Company derecognized $1,130,311 in goodwill. The following table summarizes information relating to the Company’s identifiable intangible assets as of June 30, 2023: Gross Accumulated Carrying Amount Amortization Value Amortized: Customer relationships $ 9,734,560 $ (4,155,129) $ 5,579,431 $ 9,734,560 $ (4,155,129) $ 5,579,431 Indefinite-lived: Brand name $ 5,841,880 — 5,841,880 $ 15,576,440 $ (4,155,129) $ 11,421,311 In connection with the H&J disposition, the Company derecognized $1,246,915 in intangible assets. The Company recorded amortization expense of $804,924 and $537,812 during the three months ended June 30, 2023 and 2022, and $1,759,277 and $1,075,625 during the six months ended June 30, 2023 and 2022, respectively, which is included in general and administrative expenses in the consolidated statements of operations.	NOTE 6: GOODWILL AND INTANGIBLE ASSETS Goodwill The Company recorded goodwill from each of its business combinations. The following is a summary of goodwill by entity for the years ended December 31, 2022 and 2021: Bailey Stateside Sundry Total Balances at December 31, 2020 $ 6,479,218 $ — $ — $ 6,479,218 Business combination — 2,104,056 — 2,104,056 Impairment — — — — Balances at December 31, 2021 6,479,218 2,104,056 — 8,583,274 Business combination — — 3,711,322 3,711,322 Impairment (3,321,095) — — (3,321,095) Balances at December 31, 2022 $ 3,158,123 $ 2,104,056 $ 3,711,322 $ 8,973,501 Refer to Note 3 for discussion on the goodwill impairment recorded in 2022. As of December 31, 2022, there was approximately $3.2 million for Bailey in goodwill that relates to liabilities in excess of assets. Intangible Assets The following table summarizes information relating to the Company’s identifiable intangible assets as of December 31, 2022 and 2021: Gross Accumulated Carrying December 31, 2022 Amount Amortization Value Amortized: Customer relationships $ 9,734,560 (2,670,202) $ 7,064,358 9,734,560 (2,670,202) 7,064,358 Indefinite-lived: Brand name $ 5,841,880 — 5,841,880 $ 15,576,440 $ (2,670,202) $ 12,906,238 Gross Accumulated Carrying December 31, 2021 Amount Amortization Value Amortized: Customer relationships $ 4,736,080 (1,091,509) $ 3,644,571 4,736,080 (1,091,509) 3,644,571 Indefinite-lived: Brand name $ 5,618,560 — 5,618,560 $ 10,354,640 $ (1,091,509) $ 9,263,131 Due to the effects of COVID-19 and revenue levels not recovering as quickly as anticipated and related uncertainty which affected Bailey’s results and near-term demand for its products, the Company determined that there were indications for further impairment analysis in both 2022 and 2021. Due to Harper’s revenue levels lower as compared to initial projects, the Company determined that there were indications for further impairment analysis in 2022. Refer to Note 3 for discussion on the intangible asset impairment recorded in 2022 and 2021. Management determined circumstances existed that indicated the carrying value may not be recoverable. The impairment analysis was based on the relief from royalty method using projected revenue estimates and discounts rates believed to be appropriate. Fair value determinations require considerable judgment and are sensitive to changes in underlying assumptions, estimates and market factors. The discount rate, revenue assumptions and terminal growth rate of our reporting unit were the material assumptions utilized in the model used to estimate the fair value of the Bailey unit. The analysis requires estimates, assumptions and judgments about future events. Our analysis uses our internally generated long-range plan. The long-range plan reflects management judgment, which includes observation of expected industry trends. The Company recorded amortization expense of $1,653,819 and $1,128,524 during the years ended December 31, 2022 and 2021, respectively, which is included in general and administrative expenses in the consolidated statements of operations. Future amortization expense at December 31, 2022 is as follows: Year Ending December 31, 2023 2,924,020 2024 2,474,178 2025 1,666,160 $ 7,064,358

LIABILITIES AND DEBT

LIABILITIES AND DEBT	6 Months Ended	12 Months Ended
LIABILITIES AND DEBT	Jun. 30, 2023	Dec. 31, 2022
LIABILITIES AND DEBT
LIABILITIES AND DEBT	NOTE 7: LIABILITIES AND DEBT Accrued Expenses and Other Liabilities The Company accrued expenses and other liabilities line in the consolidated balance sheets is comprised of the following as of June 30, 2023 and December 31,2022: June 30, December 31, 2023 2022 Accrued expenses $ 503,927 $ 668,714 Reserve for returns — 307,725 Payroll related liabilities 4,009,812 2,618,870 Sales tax liability 277,800 262,765 Other liabilities 247,398 78,845 $ 5,038,937 $ 3,936,920 As of June 30, 2023, payroll liabilities included an aggregate of $1,288,048 in payroll taxes due to remit to federal and state authorities. Of this amount, $620,400 pertained to DBG and $667,648 pertained to Bailey44. The amounts are subject to further penalties and interest. The amounts are subject to further penalties and interest. As of June 30, 2023 and December 31, 2022, accrued expenses included $535,000 in accrued common stock issuances pursuant to an advisory agreement for services performed in 2022. The 5,000 shares of common stock owed per the agreement are expected to be issued in the third quarter of 2023. At June 30, 2023, accrued expenses also includes owed to Sundry executives based on their employment agreements with the Company, which is expected to be issued in the third quarter of 2023. Convertible Debt 2020 Regulation D Offering As of June 30, 2023 and December 31, 2022, there was $100,000 remaining in outstanding principal that was not converted into equity. Convertible Promissory Note On December 29, 2022, the Company and various purchasers executed a Securities Purchase Agreement (“December Notes”) whereby the investors purchased from the Company convertible promissory notes in the aggregate principal amount of $4,000,000, consisting of original issue discount of $800,000. The Company received net proceeds of $3,000,000. The December Notes were due and payable on February 15, 2023. If the December Notes are not repaid in full by the maturity date or if any other event of default occurs, (1) the face value of the December Notes will be automatically increased to 120%; (2) the Notes will begin generating an annual interest rate of 20%, which will be paid in cash monthly until the default is cured; and (3) if such default continues for 14 or more calendar days, at the investors’ discretion, the December Notes shall become convertible at the option of the investors into shares of the Company’s common stock at a conversion price equal to the closing price of the Company’s common stock on the date of the note conversion. In connection with the December Notes, the Company issued to the investors an aggregate of 18,779 warrants to purchase common stock at an exercise price equal to $106.50, and 2,400 shares of common stock. The Company recognized $428,200 as a debt discount for the fair value of the warrants and common shares using the Black-Scholes option model, resulting in a total debt discount of $1,378,200. In February 2023, the principal of $4,000,000 of the December Notes were fully repaid. The Company amortized $689,100 of debt discount up until the repayment date, and then recognized a loss on extinguishment of debt of $689,100 which is included in other non-operating income (expenses) on the consolidated statements of operations. The following is a summary of the convertible notes for the six months ended June 30, 2023: Unamortized Convertible Note Principal Debt Discount Payable, Net Balance, December 31, 2022 $ 4,100,000 $ (1,378,200) $ 2,721,800 Repayments of notes (4,000,000) — (4,000,000) Amortization of debt discount — 689,100 689,100 Loss on extinguishment of debt — 689,100 689,100 Balance, June 30, 2023 $ 100,000 $ — $ 100,000 During the six months ended June 30, 2022, the Company converted an aggregate of $888,930 in outstanding principal into 350 shares of common stock. During the six months ended June 30, 2023 and 2022, the Company amortized $689,100 and $1,724,291, respectively of debt discount to interest expense pertaining to convertible notes. In January 2023, the Company issued 4,400 shares of common stock at a fair value of $322,300 to a former convertible noteholder pursuant to default provisions. The amount was included in interest expense in the consolidated statements of operations. Loan Payable — PPP and SBA Loan As of both June 30, 2023 and December 31, 2022, Bailey had an outstanding PPP Loan balance of $933,295 and matures in 2026. Merchant Advances In 2022, the Company obtained several merchant advances. These advances are, for the most part, secured by expected future sales transactions of the Company with expected payments on a weekly basis. As of December 31, 2022, $896,334 remained outstanding. During the six months ended June 30, 2023, the Company received additional proceeds totaling $1,692,748 and made repayments totaling $2,331,972. As of June 30, 2023, the remaining principal outstanding was $257,110. In connection with these advances, the Company granted 6,095 warrants to purchase common stock at an exercise price of $131.25 to the lender in connection with its merchant advances. In 2023, the Company obtained merchant advances totaling $502,051 from Shopify Capital, and made repayments totaling $208,416 . As of June 30, 2023, the remaining principal outstanding was Promissory Note Payable As of June 30, 2023 and December 31, 2022, the outstanding principal on the note to the sellers of Bailey was $3,500,000. The maturity date was December 31, 2022. On July 5, 2023, the parties agreed to extend the maturity date to June 30, 2024. Interest expense was $105,000 and $105,000 for the three months ended June 30, 2023 and 2022 and $210,000 and $210,000 for the six months ended June 30, 2023 and 2022, all respectively, which was accrued and unpaid as of June 30, 2023. The Company issued a promissory note in the principal amount of $5,500,000 to the Sundry Holders pursuant to the Sundry acquisition. The note bears interest at 8% per annum and matures on February 15, 2023. In February 2023, the parties verbally agreed to extend the maturity date to December 31, 2023. Interest expense was $149,177 and $259,177 for the three and six months ended June 30, 2023, respectively. On June 21, 2023, the Company and the Sundry Holders executed a Securities Purchase Agreement (the “Sundry SPA”) whereby the Company issued per share (see Note 7). The shares were issued pursuant to the cancellation of the Sundry Holders’ entire principal amount of In March 2023, the Company and various purchasers executed a Securities Purchase Agreement (“March 2023 Notes”) whereby the investors purchased from the Company promissory notes in the aggregate principal amount of $2,458,750, consisting of original issue discount of $608,750. The Company received net proceeds of $1,850,000 after additional fees. The March 2023 Notes are due and payable on September 30, 2023 (the “Maturity Date”). The Company will also have the option to prepay the Notes with no penalties at any time prior to the Maturity Date. If the Company completes a debt or equity financing of less than $7,500,000, the Company is required to repay 50% of the remaining balance of the March 2023 Notes. Following such 50% repayment, the Company must also use any proceeds from any subsequent debt or equity financing to repay the March 2023 Notes. Upon the closing of any debt or equity financing of $7,500,000 or greater, the Company is required to repay 100% of the Notes with no penalties. There is no additional interest after the 20% original interest discount. The Company recognized a debt discount of $608,750, of which $263,839 was amortized through June 30, 2023. The following is a summary of promissory notes payable, net: June 30, December 31, 2023 2022 Bailey Note $ 3,500,000 $ 3,500,000 Sundry Note — 5,500,000 March 2023 Notes - principal 2,458,750 — March 2023 Notes - unamortized debt discount (344,911) — Promissory note payable, net $ 5,613,839 $ 9,000,000	NOTE 7: LIABILITIES AND DEBT Accrued Expenses and Other Liabilities The Company accrued expenses and other liabilities line in the consolidated balance sheets is comprised of the following as of December 31, 2022 and 2021: December 31, 2022 2021 Accrued expenses $ 668,714 $ 178,819 Reserve for returns 307,725 33,933 Payroll related liabilities 2,618,870 1,183,598 Sales tax liability 262,765 225,804 Due to seller — 396,320 Other liabilities 78,845 59,613 $ 3,936,920 $ 2,078,087 As of December 31, 2022, payroll liabilities included an aggregate of $1,074,316 in payroll taxes due to remit to federal and state authorities. Of this amount, $539,839 pertained to DBG and $534,477 pertained to Bailey44. The amounts are subject to further penalties and interest. As of December 31, 2022, accrued expenses included $535,000 in accrued common stock issuances pursuant to an advisory agreement for services performed in 2022. The 200 shares of common stock owed per the agreement are expected to be issued in the second quarter of 2023. Due to seller represents amounts to the seller owed pursuant the Stateside Acquisition after certain purchase price adjustments were made in the fourth quarter of 2021, and repaid in 2022. Venture Debt As of December 31, 2021, the gross loan balance with Black Oak Capital (“Black Oak”) pertaining to its senior credit agreement was $6,001,755. In February 2022, the Company received $237,500 in proceeds, including loan fees of $12,500, from the existing venture debt lender under the same terms as the existing facility. On September 29, 2022, the Company and Black Oak executed a Securities Purchase Agreement (the “Black Oak SPA”) whereby the Company issued 6,300 shares of Series A Convertible Preferred Stock to Black Oak for $1,000 per share (see Note 7). The shares were issued pursuant to the conversion of Black Oak’s entire principal amount of $6,251,755, and the Company recorded $48,245 in interest as part of the conversion. Pursuant to the Black Oak SPA, all accrued interest remaining outstanding. Accrued interest was $269,880 as of December 31, 2022. For the year ended December 31, 2022 and 2021, $12,500 and $147,389 of loan fees and discounts from warrants were amortized to interest expense, leaving unamortized balance of $0 as of December 31 2022. Interest expense was $573,455 and $825,219 for the years ended December 31, 2022 and 2021, respectively. Convertible Debt 2020 Regulation CF Offering During the year ended December 31, 2020, the Company received gross proceeds of $450,308 from a Regulation CF convertible debt offering. In 2021, the Company received additional gross proceeds of $473,650. Interest was 6% per annum and the debt was due October 30, 2022. Upon closing of the IPO, the outstanding principal and accrued and unpaid interest of $16,942 was converted into 12,786 shares of common stock based on the terms of the notes. Total issuances costs were $69,627, which was recognized as a debt discount and was amortized in 2021 through the date of IPO when such debt converted. During the year ended December 31, 2021, $27,894 of the debt discount was amortized to interest expense. Concurrently with the offering above, in 2021 and 2020 the Company received gross proceeds of $55,000 and $800,000, respectively, from a Regulation D convertible debt offering. The debt accrued interest at a rate of 14% per annum with a maturity date of nine months from the date of issuance. In addition, the Company issued 0.2 warrants to purchase common stock in connection with the notes. The issuance costs and warrants are recognized as a debt discount and were amortized in 2021 through the date of IPO when such debt converted. The fair value of the warrants was determined to be negligible. Upon closing of the IPO, $755,000 in outstanding principal and approximately $185,000 of the accrued and unpaid interest was converted into 181 shares of common stock. As of December 31, 2022 and 2021, there was $100,000 remaining in outstanding principal that was not converted into equity (see table below). During the year ended December 31, 2021, $100,000 of the debt discount was amortized to interest expense. The Company recorded an additional $132,609 in default interest expense upon conversion of these notes. 2019 Regulation D Offering For the year ended December 31, 2019, the Company received gross proceeds of $799,280 from a Regulation D convertible debt offering. The debt accrued interest at a rate of 12% per annum with a maturity date of thirty-six months from the date of issuance. The debt was contingently convertible and contained both automatic and optional conversions. Upon closing of the IPO, the outstanding principal was converted into 145 shares of common stock. Convertible Promissory Notes 2021 Notes On August 27, 2021, the Company entered into a Securities Purchase Agreement with Oasis Capital, LLC (“Oasis Capital”) further to which Oasis Capital purchased a senior secured convertible note (the “Oasis Note”), with an interest rate of 6% per annum, having a face value of $5,265,000 for a total purchase price of $5,000,000, secured by all assets of the Company. The Oasis Note, in the principal amount of $5,265,000, bears interest at 6% per annum and is due and payable 18 months from the date of issuance, unless sooner converted. The Oasis Note is convertible at the option of Oasis Capital into shares of the Company’s common stock at a conversion price (the “ Oasis Conversion Price”) which is the lesser of (i) $90.601, and (ii) 90% of the average of the two lowest volumed weighted average prices (“VWAPs’) during the five consecutive trading day period preceding the delivery of the notice of conversion. Oasis Capital is not permitted to submit conversion notices in any thirty day period having conversion amounts equaling, in the aggregate, in excess of $500,000. If the Oasis Conversion Price set forth in any conversion notice is less than $7,500 per share, the Company, at its sole option, may elect to pay the applicable conversion amount in cash rather than issue shares of its common stock. On October 1, 2021, the Company entered into an Amended and Restated Securities Purchase Agreement with FirstFire Global Opportunities Fund, LLC (“FirstFire”) and Oasis Capital further to which FirstFire purchased a Senior Secured Convertible Promissory Note (the “First FirstFire Note”), with an interest rate of 6% per annum, having a face value of $1,575,000 for a total purchase price of $1,500,000, secured by all assets of the Company. The First FirstFire Note, in the principal amount of $1,575,000, bears interest at 6% per annum and is due and payable 18 months from the date of issuance, unless sooner converted. The First FirstFire Note is convertible at the option of FirstFire into shares of the Company’s common stock at a conversion price (the “First FirstFire Conversion Price”) which is the lesser of (i) $9,880, and (ii) 90% of the average of the two lowest volume-weighted average prices during the five consecutive trading day period preceding the delivery of the notice of conversion. On November 16, 2021, the Company entered into a Securities Purchase Agreement with FirstFire further to which FirstFire purchased a Senior Secured Convertible Promissory Note (the “Second FirstFire Note” and together with the First FirstFire Note, the “FirstFire Notes”), with an interest rate of 6% per annum, having a face value of $2,625,000 for a total purchase price of $2,500,000. The Second FirstFire Note is convertible at the option of FirstFire into shares of the Company’s common stock at a conversion price (the “Second FirstFire Conversion Price”) which is the lesser of (i) $10,700, and (ii) 90% of the average of the two lowest volume-weighted average prices during the five consecutive trading day period preceding the delivery of the notice of conversion. The Company evaluated the terms of the conversion features of the Oasis and FirstFire Notes as noted above in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock, and determined they are not indexed to the Company’s common stock and that the conversion features meet the definition of a liability. The notes contain an indeterminate number of shares to settle with conversion options outside of the Company’s control. Therefore, the Company bifurcated the conversion feature and accounted for it as a separate derivative liability. Upon issuance of the Oasis and FirstFire Notes, the Company recognized a derivative liability at an aggregate fair value of $3,204,924, which is recorded as a debt discount and was amortized over the life of the notes. The original issue discount and issuance costs for the Oasis and FirstFire Notes totaled $1,560,000, which were recognized as a debt discount and was amortized over the life of the notes. As of December 31, 2021, the outstanding principal of the FirstFire and Oasis Notes was $9,465,000. During the year ended December 31, 2022, the Company fully converted the outstanding principal of $9,465,000 and accrued interest of $533,242 into an aggregate of 79,807 shares of commons stock. The Company recorded an additional $484,904 in interest expense as a result of the conversions. As a result of the conversions, all terms and conditions under the notes were met and no further obligations exist. 2022 Notes On April 8, 2022, the Company and various purchasers executed a Securities Purchase Agreement (“April Notes”) whereby the investors purchased from the Company convertible promissory notes in the aggregate principal amount of $3,068,750, consisting of original issue discount of $613,750. The Company received net proceeds of $2,313,750 after the original issue discount and fees, resulting in a debt discount of $755,000. Upon the Company’s public offering in May 2022 (see below), the Company repaid $3,068,750 to the investors and the debt discount was fully amortized. In connection with the April Notes, the Company issued an aggregate of 503 warrants to purchase common stock at an exercise price of $3,050 per share. The Company recognized $98,241 as a debt discount for the fair value of the warrants using the Black-Scholes option model, which was fully amortized upon the notes’ repayment in May. On July 22 and July 28, 2022, the Company and various purchasers executed a Securities Purchase Agreement (“July Notes”) whereby the investors purchased from the Company convertible promissory notes in the aggregate principal amount of $1,875,000, consisting of original issue discount of $375,000. The Company received net proceeds of $1,450,000 after the original issue discount and fees. In connection with the July 22 and July 28 notes, the Company issued an aggregate of 1,645 and 1,106 warrants to purchase common stock at an exercise price of $380 and $282.50 per share, respectively. The Company recognized $692,299 as a debt discount for the fair value of the warrants using the Black-Scholes option model, which will be amortized to interest expense over the life of the notes. If the July Notes are not repaid in full by the maturity date or if any other event of default occurs, (1) the face value of the notes will be automatically increased to 120%; (2) the notes will begin generating an annual interest rate of 20%, which will be paid in cash monthly until the default is cured; and (3) if such default continues for 14 or more calendar days, at the Investors’ discretion, the notes shall become convertible at the option of the investors into shares of the Company’s common stock at a conversion price equal to the closing price of the Company’s common stock on the on the date of the note conversion. The Company evaluated the terms of the conversion features of the July notes as noted above in accordance with ASC Topic No. 815 — 40, Derivatives and Hedging — Contracts in Entity’s Own Stock In December 2022, the Company fully repaid the outstanding principal of $1,875,000 pertaining to the July 22 and 28 notes, as well as an additional $416,923 due to the default provisions noted above. This amount was included in interest expense in the consolidated statements of operations. On December 29, 2022, the Company and various purchasers executed a Securities Purchase Agreement (“December Notes”) whereby the investors purchased from the Company convertible promissory notes in the aggregate principal amount of $4,000,000, consisting of original issue discount of $800,000. The Company received net proceeds of $3,000,000. The December Notes were due and payable on February 15, 2023. If the December Notes are not repaid in full by the maturity date or if any other event of default occurs, (1) the face value of the December Notes will be automatically increased to 120%; (2) the Notes will begin generating an annual interest rate of 20%, which will be paid in cash monthly until the default is cured; and (3) if such default continues for 14 or more calendar days, at the investors’ discretion, the December Notes shall become convertible at the option of the investors into shares of the Company’s common stock at a conversion price equal to the closing price of the Company’s common stock on the date of the note conversion. The December Notes were fully repaid in February 2023. In connection with the December Notes, the Company issued to the investors an aggregate of 18,779 warrants to purchase common stock at an exercise price equal to $106.50, and 2,400 shares of common stock. The Company recognized $428,200 as a debt discount for the fair value of the warrants and common shares using the Black-Scholes option model, which will be amortized to interest expense over the life of the notes. The following is a summary of the convertible notes for the years ended December 31, 2022 and 2021: Unamortized Convertible Note Principal Debt Discount Payable, Net Balance, December 31, 2020 $ 100,000 $ — $ 100,000 Issuance of Oasis note, net of issuance costs 5,265,000 (715,000) 4,550,000 Issuance of FirstFire First note, net of issuance costs 1,575,000 (315,000) 1,260,000 Issuance of Second FirstFire note, net of issuance costs 2,625,000 (530,000) 2,095,000 Derivative liability in connection with notes — (3,204,924) (3,204,924) Amortization of debt discount — 801,538 801,538 Balance, December 31, 2021 9,565,000 (3,963,386) 5,601,614 Proceeds from issuance of notes 8,943,750 (1,992,500) 6,951,250 Repayments of notes (4,943,750) — (4,943,750) Conversion of notes into common stock (9,465,000) — (9,465,000) Warrant and common shares issued with convertible notes — (1,368,741) (1,368,741) Derivative liability in connection with notes — (559,957) (559,957) Amortization of debt discount — 6,506,384 6,506,384 Balance, December 31, 2022 $ 4,100,000 $ (1,378,200) $ 2,721,800 As of December 31, 2022, the December Notes remained outstanding with a principal of $4,000,000 and unamortized debt discount of $1,278,200, consisting of the original issue discount, $50,000 in other financing fees, and the fair value of warrants and shares. The December Notes were fully repaid in February 2023 (see Note 14). During the years ended December 31, 2022 and 2021, the Company amortized $6,506,384 and $801,538, respectively of debt discount to interest expense pertaining to all convertible notes. As of December 31, 2022, there was no remaining derivative liability outstanding pertaining to any convertible notes. Loan Payable — PPP and SBA Loan In December 2021, the Company received notification that both its PPP Loans of $203,994 and $204,000 were approved for full forgiveness. As such, $407,994 was recorded as other non-operating income in the consolidated financial statements. In April 2022, Bailey received notification of full forgiveness of its 2 nd st As of December 31, 2022, the Company and H&J had outstanding loans under the EIDL program of $150,000 and $147,438, respectively. The EIDL Loans mature in thirty years from the effective date of the Loan and has a fixed interest rate of 3.75% per annum. The H&J loan was classified in liabilities per discontinued operations. Loan Payable In May 2021, H&J entered into a loan payable with a bank and received proceeds of $75,000. The line bears interest at 7.76% and matures in December 2025. As of December 31, 2022 and 2021, the outstanding balance was $73,187 and $72,269, respectively. The H&J loan was classified in liabilities per discontinued operations. In December 2021, H&J entered into a merchant advance loan for a principal amount of $153,860 and received proceeds of $140,000. The loan bears interest at 9.9% and matures in June 2023. As of December 31, 2021, the outstanding balance was $149,962. The H&J loan was classified in liabilities per discontinued operations. Note Payable – Related Party As of December 31, 2022 and 2021, H&J had an outstanding note payable of $129,489 and $299,489, respectively owned by the H&J Seller. The note matured in July 2022 and bears interest at 12% per annum. The H&J loan was classified in liabilities per discontinued operations. Merchant Advances In 2022 and 2021, H&J entered into merchant advance loans for proceeds of $147,267 and $140,000, respectively. The loan bears interest at 9.9% per annum. As of December 31, 2022 and 2021, the outstanding principal of the loans was $63,433 and $149,962, respectively. The outstanding loan at December 31, 2022 matures in November 2023. In 2022, the Company obtained several merchant advances for net proceeds of $1,335,360 to fund operations. These advances are, for the most part, secured by expected future sales transactions of the Company with expected payments on a weekly basis. During 2022, the Company made repayments totaling $1,078,385 and $896,334 remained outstanding, which is expected to be repaid in 2023. As of the date of these financial statements, the Company was in compliance with these covenants. Promissory Note Payable As noted in Note 4, the Company issued a promissory note in the principal amount of $4,500,000 to the Bailey Holders pursuant to the Bailey acquisition. Upon the IPO closing in May 2021, the Company repaid $1,000,000 of the outstanding principal on this note in May 2021. In August 2021, the maturity date was further extended to December 31, 2022. The Company is required to make prepayments of $2,000,000 to $4,000,000 if the Company completes a secondary public offering. If a public offering is not consummated before October 31, 2021 and June 30, 2022, the Company shall repay 10% of the outstanding principal at each date. The Company did not make any payments in October 2021, and the Company and the lender agreed to defer these payments to the maturity date of the loan, December 31, 2022. As of the date of these financial statements, the parties are undergoing an extension of the maturity date, but is in technical default. The note incurs interest at 12% per annum. As of December 31, 2022 and 2021, $3,500,000 remained outstanding. Interest expense was $420,000 and $494,000 for the years ended December 31, 2022 and 2021, respectively, all of which was accrued and unpaid as of December 31, 2022. In April 2021, the Company entered into a promissory note in the principal amount of $1,000,000. The Company received $810,000 in proceeds, net of issuance costs and original issue discount. Additionally, the Company issued 48 warrants to the lender, which was recorded as a debt discount at the time of the loan. The fair value of the warrants and shares recorded as a debt discount was $73,958. Upon the closing of the IPO, the note was repaid in full. The entire debt discount of $263,958 was amortized to interest expense upon repayment of the note. As noted in Note 4, the Company issued a promissory note in the principal amount of $5,500,000 to the Sundry Holders pursuant to the Sundry acquisition. The note bears interest at 8% per annum and matures on February 15, 2023. In February 2023, the parties verbally agreed to extend the maturity date to December 31, 2023.

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	6 Months Ended	12 Months Ended
STOCKHOLDERS' DEFICIT	Jun. 30, 2023	Dec. 31, 2022
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT	NOTE 8: STOCKHOLDERS’ DEFICIT On January 11, 2023, the Company, entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a certain accredited investor (the “Investor”), pursuant to which the Company agreed to issue and sell, in a private placement (the “January Private Placement”), an aggregate of 19,000 shares (the “Shares”) of the Company’s common stock (“Common Stock”), and accompanying warrants (the “Common Warrants”) to purchase 19,000 shares of Common Stock, at a combined purchase price of $97.875 per share and Common Warrant, and (ii) 32,086 pre-funded warrants (the “Pre-Funded Warrants” and together with the Common Warrants, the “Warrants” and together with the Shares and the shares of Common Stock underlying the Warrants, the “Securities”) exercisable for 32,086 shares of Common Stock, and accompanying Common Warrants to purchase 32,086 shares of Common Stock, at a combined purchase price of $97.875 per Pre-Funded Warrant and accompanying Common Warrant, to the Investors, for aggregate gross proceeds from the Private Placement of approximately $5 million before deducting placement agent fees and related offering expenses. As a result of the transaction, the Company issued 50,890 shares of common stock, including the 19,000 shares and the immediate exercise of 32,086 pre-funded warrants, for gross proceeds of $5.0 million. The Company received net proceeds of $4.3 million after deducting placement agent fees and offering expenses. In January 2023, the Company issued 4,400 shares of common stock at a fair value of $322,300 to a former convertible noteholder pursuant to default provisions. The amount was included in interest expense in the consolidated statements of operations. In March 2023, the Company issued an aggregate of 4,756 shares of common stock to Sundry executives based on their employment agreements with the Company. The fair value of $499,338, or $4.20 per share as determined by the agreements, was included in general and administrative expenses in the consolidated statements of operations. In June 2023, the Company issued 78,103 shares of common stock to D. Jones at a fair value of $1,357,043 pursuant to the H&J Settlement Agreement. During the six months ended June 30, 2022, the Company converted an aggregate of $888,930 in outstanding principal into 350 shares of common stock. Series B Preferred Stock On May 30, 2023, the Company entered into a Subscription and Investment Representation Agreement (the “Subscription Agreement”) with John Hilburn Davis IV, its Chief Executive Officer pursuant to which the Company agreed to issue and sell 1 share of the Company’s Series B Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”) for $25,000. On May 30, 2023, the Company filed a certificate of designation (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the share of Series B Preferred Stock. The Certificate of Designation provides that the Series B Preferred Stock will have 250,000,000 votes per share of Series B Preferred Stock and will vote together with the outstanding shares of the Company’s common stock, par value 0.0001 per share (the “Common Stock”) and Series A Convertible Preferred Stock, par value 0.0001 per share (the “Series A Convertible Preferred Stock”) as a single class exclusively with respect to any proposal to amend the Company’s Sixth Amended and Restated Certificate of Incorporation (as may be amended and/or restated from time to time, the “Restated Certificate”) to effect a reverse stock split of the Company’s common stock. The Series B Preferred Stock will be voted, without action by the holder, on any such proposal in the same proportion as shares of Common Stock and Series A Convertible Preferred Stock are voted. The Series B Preferred Stock otherwise has no voting rights. The Series B Preferred Stock is not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company. The Series B Preferred Stock has no rights with respect to any distribution of assets of the Company, including upon a liquidation, bankruptcy, reorganization, merger, acquisition, sale, dissolution or winding up of the Company, whether voluntarily or involuntarily. The holder of the Series B Preferred Stock will not be entitled to receive dividends of any kind. The outstanding share of Series B Preferred Stock shall be redeemed in whole, but not in part, at any time (i) if such redemption is ordered by the Board of Directors in its sole discretion or (ii) automatically upon the effectiveness of the amendment to the Restated Certificate implementing a reverse stock split. Upon such redemption, the holder of the Series B Preferred Stock will receive consideration of $25,000 in cash. Series C Convertible Preferred Stock On June 21, 2023, the Company, on the one hand, and Moise Emquies, George Levy, Matthieu Leblan, Carol Ann Emquies, Jenny Murphy and Elodie Crichi (collectively, the “Sundry Investors”), on the other hand, executed a Securities Purchase Agreement (the “Sundry SPA”) whereby the Company issued 5,761 shares of Series C Convertible Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”) to the Sundry Investors at a purchase price of $1,000 per share. The Series C Preferred Stock is convertible into a number of shares of the Company’s Common Stock equal to $1,000 divided by an initial conversion price of $17.925 which represents the lower of (i) the closing price per share of the Common Stock as reported on the Nasdaq on June 20, 2023, and (ii) the average closing price per share of Common Stock as reported on the Nasdaq for the five trading days preceding June 21, 2023. The shares of Series C Preferred Stock were issued in consideration for the cancellation of certain promissory notes issued by the Company to the Sundry Investors dated December 30, 2022 (the “Sundry Loan Documents”). The following is a summary of the rights and preferences of the Series C Convertible Preferred Stock. On June 21, 2023, the Company filed the Certificate of Designation with the Secretary of State for the State of Delaware designating up to 5,761 shares out of the authorized but unissued shares of its preferred stock as Series C Convertible Preferred Stock. The following is a summary of the principal terms of the Series C Preferred Stock. Except for stock dividends or distributions for which adjustments are to be made pursuant to the Certificate of Designation, the holders of the Series C Preferred Stock (the “Series C Holders”) shall be entitled to receive, and the Company shall pay, dividends on shares of the Series C Preferred Stock equal (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of the Series C Preferred Stock. The Series C Holders are entitled to vote as a class as expressly provided in the Certificate of Designation. The Series C Holders are also entitled to vote with the holders of shares of Common Stock, voting together as one class, on all matters in which the Series C Holders are permitted to vote with the class of shares of Common Stock. With respect to any vote with the class of Common Stock, each share of the Series C Preferred Stock shall entitle the Holder thereof to cast that number of votes per share as is equal to the number of shares of Common Stock into which it is then convertible (subject to the ownership limitations specified in the Certificate of Designation) using the record date for determining the stockholders of the Company eligible to vote on such matters as the date as of which the conversion price is calculated. The Series C Preferred Stock shall rank (i) senior to all of the Common Stock; (ii) senior to Junior Securities; (iii) on parity with Parity Securities; and (iv) junior to Senior Securities, in each case, as to dividends or distributions of assets upon liquidation, dissolution or winding up of the Company, whether voluntarily or involuntarily. Subject to any superior liquidation rights of the holders of any Senior Securities of the Company and the rights of the Company’s existing and future creditors, upon a Liquidation, each Holder shall be entitled to be paid out of the assets of the Company legally available for distribution to stockholders, prior and in preference to any distribution of any of the assets or surplus funds of the Company to the holders of the Common Stock and Junior Securities and pari passu with any distribution to the holders of Parity Securities, an amount equal to the Stated Value (as defined in the Certificate of Designation) for each share of the Series C Preferred Stock held by such Holder and an amount equal to any accrued and unpaid dividends thereon, and thereafter the Series C Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Company the same amount that a holder of Common Stock would receive if the Series C Preferred Stock were fully converted (disregarding for such purposes any conversion limitations hereunder) to Common Stock which amounts shall be paid pari passu with all holders of Common Stock. Each share of the Series C Preferred Stock shall be convertible, at any time and from time to time from and after June 21, 2023 at the option of the Holder thereof, into that number of shares of Common Stock determined by dividing the Stated Value of such share of the Series C Preferred Stock ($1,000 as of June 21, 2023) by the Conversion Price. The conversion price for each share of the Series C Preferred Stock is $17.925, which is the lower of (a) the closing price per share of the Common Stock as reported on the Nasdaq Capital Market on June 20, 2023 (the trading day before the date of the Sundry SPA), and (b) the average closing price per share of Common Stock as reported on the Nasdaq Capital Market for the five The Company has the option to redeem any or all of the then outstanding Series C Preferred Stock at 112% of the then Stated Value any time after June 21, 2023 and so long as there is an effective Registration Statement covering the shares issuable upon conversion of the Series C Preferred Stock.	NOTE 8: STOCKHOLDERS’ DEFICIT Amendments to Articles of Incorporation On October 13, 2022, On October 21, 2022, the Board of Directors approved a one reverse stock split became effective as of November 3, 2022. Accordingly, all share and per share amounts for all periods presented in the accompanying consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect this reverse stock split and adjustment of the preferred stock conversion ratios. On May 18, 2021, the Company filed a Sixth Amended and Restated Certificate of Incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware in connection with the Company’s IPO. The Company’s board of directors and stockholders previously approved the Restated Certificate to be effective immediately prior to the closing of the IPO. The Restated Certificate amends and restates the Company’s amended and restated certificate of incorporation, as amended, in its entirety to, among other things: (i) increase the authorized number of shares of common stock to 200,000,000 shares; (ii) authorize 10,000,000 shares of preferred stock that may be issued from time to time by the Company’s board of directors in one or more series; (iii) provide that directors may be removed from office only for cause by the affirmative vote of the holders of at least 66⅔% The Restated Certificate also effected a 1-for-15.625 reverse stock split approved by the Company’s Board of Directors as described above. Series A Preferred Stock On August 31, 2022, the Company entered into a Subscription and Investment Representation Agreement with Hil Davis, its Chief Executive Officer, pursuant to which the Company agreed to issue 1 share of the Company’s Series A Preferred Stock to for $25,000. The issuance of the preferred stock reduced the due to related party balance. The share of Series A Preferred Stock had 250,000,000 votes per share and voted together with the outstanding shares of the Company’s common stock as a single class exclusively with respect to any proposals to amend the Certificate of Incorporation to effect a reverse stock split of the Company’s common stock and to increase the authorized number of shares of the Company’s common stock. The terms of the Series A Preferred Stock provided that the outstanding share of Series A Preferred Stock would be redeemed in whole, but not in part, at any time: (i) if such redemption is ordered by the Board of Directors in its sole discretion or (ii) automatically upon the approval of Proposals 2 and 6 presented at the Company’s 2022 annual shareholders meeting. Following conclusion of the shareholders meeting, such share of the Company’s Series A Preferred Stock was redeemed. On October 13, 2022, the outstanding share of the Company’s Series A Preferred Stock was redeemed for $25,000. Series A Convertible Preferred Stock On September 29, 2022, the Company filed the Certificate of Designation designating up to 6,800 shares out of the authorized but unissued shares of its preferred stock as Series A Convertible Preferred Stock. Except for stock dividends or distributions for which adjustments are to be made pursuant to the Certificate of Designation, the holders of the Series A Preferred Stock (the “Holders”) shall be entitled to receive, and the Company shall pay, dividends on shares of the Series A Preferred Stock equal (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of the Series A Preferred Stock. With respect to any vote with the class of Common Stock, each share of the Series A Preferred Stock shall entitle the Holder thereof to cast that number of votes per share as is equal to the number of shares of Common Stock into which it is then convertible. The Series A Preferred Stock shall rank (i) senior to all of the Common Stock; (ii) senior to any class or series of capital stock of the Company hereafter created specifically ranking by its terms junior to any Preferred Stock (“Junior Securities”); (iii) on parity with any class or series of capital stock of the Corporation created specifically ranking by its terms on parity with the Preferred Stock (“Parity Securities”); and (iv) junior to any class or series of capital stock of the Company hereafter created specifically ranking by its terms senior to any Preferred Stock (“Senior Securities”), in each case, as to dividends or distributions of assets upon liquidation, dissolution or winding up of the Company, whether voluntarily or involuntarily. Each share of the Series A Preferred Stock shall be convertible, at any time and from time to time from and after September 29, 2022 at the option of the Holder thereof, into that number of shares of Common Stock determined by dividing the Stated Value of such share of the Series A Preferred Stock ($1,000 as of September 29, 2022) by the Conversion Price. The conversion price for each share of the Series A Preferred Stock is the closing price of the Common Stock on September 29, 2022, which was $232.50. Common Stock The Company had 1,000,000,000 shares of common stock authorized with a par value of $0.0001 as of December 31, 2022. Common stockholders have voting rights of one vote per share. The voting, dividend, and liquidation rights of the holders of common stock are subject to and qualified by the rights, powers, and preferences of preferred stockholders. 2022 Transactions During the year ended December 31, 2022, the Company issued an aggregate of 79,807 shares of common stock pursuant to the conversion of the FirstFire and Oasis Notes (see Note 7). In September 2022, the Company issued 30 shares of common stock pursuant to a consultant agreement at a fair value of $123,000. As part of the Sundry acquisition (see Note 4), the Company issued 3,636 shares of common stock to the Sundry Sellers at a fair value of $1,000,000. In connection with the December Notes, the Company issued 2,400 shares of common stock with a fair value of $264,000. Underwriting Agreements and Public Offerings On May 5, 2022, the Company entered into an underwriting agreement (the “Alexander Underwriting Agreement”) with Alexander Capital, L.P., acting as representative of the several underwriters named in the Alexander Underwriting Agreement (the “ Alexander Underwriters”), relating to the Company’s underwritten the offering pursuant to which the Company agreed to issue and sell 14,956 shares of the Company’s common stock. The shares were sold to the public at a combined public offering price of $625 per share and were purchased by the Underwriters from the Company at a price of $575 per share. The Company also granted the Alexander Underwriters a 45-day option to purchase up to an additional 2,243 shares of Common Stock at the same price, which expired and were not purchased. The shares were sold in the Offering pursuant to a Registration Statement on Form S-1, as amended (File No. 333-264347) (the “Registration Statement”), a Registration Statement on Form S-1 pursuant to 462(b) of the Securities Act of 1933, as amended (File No. 333-264775), and a related prospectus filed with the Securities and Exchange Commission. The public offering closed on May 10, 2022 and the Company sold 14,956 shares of common stock for total gross proceeds of $9.3 million. The Company received net proceeds of $8.1 million after deducting underwriters’ discounts and commissions of $0.7 million and direct offering expenses of $0.5 million. On November 29, 2022, the Company, entered into a Securities Purchase Agreement with investors pursuant to which the Company agreed to issue and sell, in an offering (i) an aggregate of 6,720 shares (the “Shares”) of the Company’s common stock, and accompanying Class B Warrants (the “Class B Warrants”) to purchase 6,720 shares of common stock and accompanying Class C Warrants (the “Class C Warrants”) to purchase 6,720 shares of Common Stock, at a combined public offering price of $137.50 per share and Class B Warrant and Class C Warrant, and (ii) 66,007 pre-funded warrants (the “Pre-Funded Warrants” and together with the Class B Warrants and the Class C Warrants, the “Warrants” and together with the Shares and the shares of common stock underlying the Warrants, the “Securities”) exercisable for 66,007 shares of Common Stock, and accompanying Class B Warrants to purchase 66,007 shares of Common Stock and Class C Warrants to purchase 66,007 shares of Common Stock, at a combined public offering price of $137.50, less the exercise price of $0.0001, per Pre-Funded Warrant and accompanying Class B Warrant and Class C Warrant, to the Investors, for aggregate gross proceeds from the offering of approximately $10 million before deducting placement agent fees and related offering expenses. As a result of the transaction, the Company issued 72,727 shares of common stock, including the 6,720 shares and the immediate exercise of 66,007 pre-funded warrants, for gross proceeds of $10.0 million. The Company received net proceeds of $9.0 million after deducting placement agent fees and offering expenses. 2021 Transactions On May 13, 2021, the Company’s registration statement on Form S-1 relating to the IPO was declared effective by the SEC. In the IPO, which closed on May 18, 2021, the Company issued and sold 964 shares of common stock at a public offering price of $10,375 per share. Additionally, the Company issued warrants to purchase 1,111 shares, which includes 145 warrants sold upon the partial exercise of the over-allotment option. The aggregate net proceeds to the Company from the were $8.6 million after deducting underwriting discounts and commissions of $0.8 million and direct offering expenses of $0.6 million. Upon the closing of the Company’s IPO on May 18, 2021, all then-outstanding shares of Preferred Stock converted into an aggregate of 1,611 shares of common stock according to their terms. Upon closing of the Company’s IPO, the Company converted outstanding principal totaling $2,680,289 and certain accrued and unpaid interest of the Company’s convertible debt into an aggregate of 454 shares of common stock. See Note 7. Upon closing of the Company’s IPO, certain officers and directors converted balances due totaling $257,515 into 61 shares of common stock and recorded $233,184 in compensation expense for the shares issued in excess of accrued balances owed. In connection with the H&J and Stateside acquisitions, the Company issued 877 and 441 shares of common stock to the respective sellers. See Note 4. Pursuant to a consulting agreement, the Company issued 20 shares of common stock with a guaranteed equity value of $250,000. In connection with the agreement, the Company recorded a contingent consideration liability of $67,000. See Note 3. An additional 17 shares were issued upon settlement of the contingent liability. In May 2021, an aggregate of 13 warrants were exercised for shares of common stock for proceeds of $145,696. In July 2021, warrant holders exercised 142 warrants for proceeds of $1,622,350. On June 28, 2021, the Company’s underwriters purchased 145 shares of common stock at a public offering price of $10,375 per share pursuant to the exercise of the remaining portion of their over-allotment option. The Company received net proceeds of approximately $1.4 million after deducting underwriting discounts and commissions of $0.1 million. In connection with the execution of the Oasis Capital EPA, the Company issued Oasis Capital 51 shares of common stock (the “Commitment Shares”). Upon nine months from the Execution Date, Oasis may return a portion of the Commitment Shares. As of December 31, 2021, the Company recorded the fair value of the Commitment Shares of $367,696 as deferred offering costs as no financings under the related EPA have occurred. In connection with the Second FirstFire Note, in November 2021 the Company issued (a) 12 additional shares of common stock to FirstFire and (b) 40 additional shares of common stock to Oasis Capital, as set forth in the waivers and consents (the “Waivers”), dated November 16, 2021 executed by each of FirstFire and Oasis Capital (collectively, the “Waiver Shares”). The Company recorded interest expense of $427,700 pertaining to the fair value of the Waiver Shares issued. In December 2021, the Company issued 60 shares of common stock pursuant to a consulting agreement. The fair value of $339,000 was based on the value of the Company’s common stock on the date of grant and is included in general and administrative expenses in the consolidated statements of operations.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended	12 Months Ended
RELATED PARTY TRANSACTIONS	Jun. 30, 2023	Dec. 31, 2022
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 9: RELATED PARTY TRANSACTIONS During the six months ended June 30, 2023 and 2022, the Company made net repayments for amounts due to related parties totaling $57,427 and $172,036, respectively. As of June 30, 2023 and December 31, 2022, amounts due to related parties were $472,790 and $556,225 , respectively. The advances are unsecured, non-interest bearing and due on demand. Amounts due to related parties consist of current and former executives, and a board member. As of December 31, 2022, H&J had an outstanding note payable of $129,489 owned by the H&J Seller. The balance was $0 upon the H&J disposition in June 2023.	NOTE 9: RELATED PARTY TRANSACTIONS As of December 31, 2022 and 2021, due to related parties includes advances from the former officer, Mark Lynn, who also serves as a director, totaling $104,568 and $104,568 respectively, and accrued salary and expense reimbursements of $100,649 and $126,706, respectively, to current officers. Upon closing of the IPO, 1,003 shares of common stock were issued to directors as conversion of balances owed. In October 2022, the Company received advances from a director, Trevor Pettennude, totaling $325,000. The advances are unsecured, non-interest bearing and due on demand. As of December 31, 2022, the amounts were outstanding. The current CEO, Hil Davis, previously advanced funds to the Company for working capital. These prior advances were converted to a note payable totaling $115,000. Upon closing of the IPO, 5,091 shares of common stock were issued to the CEO as conversion of the outstanding note payable and related accrued interest, accrued compensation and other consideration. As of a result of the transaction, the Company recorded an additional $233,184 in stock compensation expense, which is included in general and administrative expenses in the consolidated statements of operations. As of December 31, 2022 and 2021, H&J had an outstanding note payable of $129,489 and $299,489, respectively, owned by the H&J Seller. The note matured on December 10, 2022 and bears interest at 12% per annum. The note is in technical default. The H&J note was classified in liabilities per discontinued operations.

SHARE-BASED PAYMENTS

SHARE-BASED PAYMENTS	6 Months Ended	12 Months Ended
SHARE-BASED PAYMENTS	Jun. 30, 2023	Dec. 31, 2022
SHARE-BASED PAYMENTS
SHARE-BASED PAYMENTS	NOTE 10: SHARE-BASED PAYMENTS Common Stock Warrants In connection with the January Private Placement, the Company granted 32,086 pre-funded warrants which were immediately exercised for shares of common stock. The Company also granted an additional 51,086 warrants as part of the offering. Each warrant has an exercise price of $95 per share, is immediately exercisable upon issuance and expires five years after issuance. The Company also granted the placement agent 3,831 warrants to purchase common stock at an exercise price of $3,050.35 per share, which is immediately exercisable upon issuance and expires five years In connection with merchant advances (Note 6), the Company granted 6,095 warrants to purchase common stock at an exercise price of $131.25. The warrants are immediately exercisable upon issuance and expire five years after issuance. The following is a summary of warrant activity: Common Weighted Stock Average Warrants Exercise Price Outstanding - December 31, 2022 176,733 $ 209 Granted 93,099 99.50 Exercised (32,086) 97.88 Forfeited — — Outstanding - June 30, 2023 237,746 $ 181.25 Exercisable at December 31, 2022 171,278 $ 210.50 Exercisable at June 30, 2023 237,745 $ 181.25 Stock Options As of June 30, 2023 and December 31, 2022, the Company had 1,558 stock options outstanding with a weighted average exercise price of $362.11 per share. As of June 30, 2023, there were 1,439 options exercisable. Stock-based compensation expense of $101,500 and $119,759 was recognized for the three months ended June 30, 2023 and 2022, respectively, and $207,094 and $258,852 was recognized for the six months June 30, 2023 and 2022, respectively. During the six months ended June 30, 2023 and 2022, $28,798 and $28,798 was recorded to sales and marketing expense, and all other stock compensation was included in general and administrative expense in the condensed consolidated statements of operations. Total unrecognized compensation cost related to non-vested stock option awards as of June 30, 2023 amounted to $370,907 and will be recognized over a weighted average period of 0.9 years.	NOTE 10: SHARE-BASED PAYMENTS Common Stock Warrants 2022 Transactions In connection with the April note agreement, the Company granted warrants to acquire 503 shares of common stock at an exercise price of $3,050.00 per share expiring in April 2027. On May 10, 2022, pursuant to the Underwriting Agreement, the Company issued the Underwriters’ Warrants to purchase up to an aggregate of 598 shares of common stock. The Underwriters’ Warrants may be exercised beginning on November 1, 2022 until May 5, 2027. The initial exercise price of each Underwriters’ Warrant is $812.50 per share, which represents 130% of the public offering price. In connection with the July 22 and July 28 notes, the Company issued an aggregate of 1,645 and 1,106 warrants to purchase common stock at an exercise price of $380 and $282.50 per share, respectively. The warrants expire in July 2027. In connection with the November public offering, the Company granted 66,007 pre-funded warrants which were immediately exercised for shares of common stock. The Company also granted an additional 72,727 Class B Warrants and 72,727 Class C Warrants as part of the offering. Each Class B Warrant has an exercise price of $131.25 per share, is immediately exercisable upon issuance and expires five years after issuance. Each Class C Warrant has an exercise price of $131.25 per share, is immediately exercisable upon issuance and expires thirteen months after issuance. The Company also granted the placement agent 5,455 warrants to purchase common stock at an exercise price of $172 per share, which are exercisable 180 days after issuance and expire in five years. In connection with the December Notes, the Company issued to the investors an aggregate of 18,779 warrants to purchase common stock at an exercise price equal to $106.50 for a fair value of $164,200. The warrants are immediately exercisable. The Company granted 1,760 warrants to purchase common stock at an exercise price of $125 to the lender in connection with its merchant advances. 2021 Transactions In connection with the IPO, the Company issued 964 warrants and an additional 145 warrants to purchase common stock per the over-allotment option. Each warrant will have an exercise price of $11,425 per share (equal to 110% of the offering price of the common stock), will be exercisable upon issuance and will expire five years from issuance. On May 13, 2021, pursuant to the IPO Underwriting Agreement, the Company issued warrants to the underwriters to purchase up to an aggregate of 48 shares of common stock with an exercise price of $12,975 per share. The warrants may be exercised beginning on November 13, 2021 and will expire five years from issuance. In connection with the Company’s April 2021 note financing, the Company issued warrants to the lender to purchase up to 48 shares of common stock. The warrants have an exercise price of $10,375 per share and are exercisable immediately after issuance. In May 2021, an aggregate of 13 warrants were exercised for shares of common stock for proceeds of $145,696. In July 2021, warrant holders exercised 142 warrants for proceeds of $1,622,350. A summary of information related to common stock warrants for the years ended December 31, 2022 and 2021 is as follows: Common Weighted Stock Average Warrants Exercise Price Outstanding - December 31, 2020 366 $ 6,650 Granted 1,205 11,450 Conversion of preferred stock warrants upon IPO 21 19,150 Exercised (155) 11,425 Forfeited (4) 19,150 Outstanding - December 31, 2021 1,432 $ 10,300 Granted 241,308 140.36 Exercised (66,007) 131.25 Forfeited — — Outstanding - December 31, 2022 176,733 $ 209.23 Exercisable at December 31, 2021 1,432 $ 10,300 Exercisable at December 31, 2022 171,278 $ 210.41 Preferred Stock Warrants Upon the IPO, all outstanding preferred stock warrants converted into common stock warrants at a ratio of 39,075:1. Stock Options 2020 Incentive Stock Plan The Company has adopted a 2020 Omnibus Incentive Stock Plan (the “2020 Plan”). An aggregate of 33,000 shares of the Company’s common stock is reserved for issuance and available for awards under the 2020 Plan, including incentive stock options granted under the 2020 Plan. The 2020 Plan administrator may grant awards to any employee, director, consultant or other person providing services to us or our affiliates. During 2021, 1,093 options were granted to executives and directors at an exercise price from $9,625 to $10,375 per share. As of December 31, 2022, 31,907 options were available for future issuance. 2013 Incentive Stock Plan The Company has adopted the 2013 Stock Plan, as amended and restated (the “Plan”), which provides for the grant of shares of stock options, stock appreciation rights, and stock awards (performance shares) to employees, non-employee directors, and non-employee consultants. The number of shares authorized by the Plan was 479 shares as December 31, 2022 and 2021. The option exercise price generally may not be less than the underlying stock’s fair market value at the date of the grant and generally have a term often years. The amounts granted each calendar year to an employee or non-employee is limited depending on the type of award. Stock options comprise all of the awards granted since the Plan’s inception. Shares available for grant under the Plan amounted to 13 and as of December 31, 2022. Vesting generally occurs over a period of immediately to four years. A summary of information related to stock options under our 2013 and 2020 Stock Plan for the years ended December 31, 2022 and 2021 is as follows: Weighted Average Options Exercise Price Outstanding - December 31, 2020 485 $ 5,850 Granted 1,093 10,375 Exercised — — Forfeited — — Outstanding - December 31, 2021 1,558 $ 9,053 Granted — — Exercised — — Forfeited — — Outstanding - December 31, 2022 1,558 $ 9,053 Exercisable at December 31, 2021 1,266 $ 8,975 Exercisable at December 31, 2022 1,389 $ 10,125 Weighted average duration (years) to expiration of outstanding options at December 31, 2022 7.00 The assumptions utilized for option grants during the years ended December 31, 2022 and 2021 are as follows: Year Ended December 31, 2022 2021 Risk Free Interest Rate n/a 0.34% - 0.85 % Expected Dividend Yield n/a 0.00 % Expected Volatility n/a 58.00 % Expected Life (years) n/a 5.18 The total grant-date fair value of the options granted during the years ended December 31, 2021 was $4,696,605. During the year ended December 31, 2022 and 2021, $421,442 and $3,325,897 was recorded to general and administrative expenses, and $57,596 and $551,948 was recorded to sales and marketing expense in the consolidated statements of operations, all respectively. Total unrecognized compensation cost related to non-vested stock option awards as of December 31, 2022 amounted to $577,999 and will be recognized over a weighted average period of 1.56 years.

LEASE OBLIGATIONS

LEASE OBLIGATIONS	6 Months Ended	12 Months Ended
LEASE OBLIGATIONS	Jun. 30, 2023	Dec. 31, 2022
LEASE OBLIGATIONS
LEASE OBLIGATIONS	NOTE 11: LEASE OBLIGATIONS In January 2023, the Company entered into a lease agreement extension for its corporate office and distribution center in Vernon, California that expires on December 31, 2023. The lease has monthly base rent payments of $38,105. As a result of the extension, the Company recognized a right of use asset and liability of $467,738 using a discount rate of 8.0%. As of June 30, 2023, the Company has $949,071 in accounts payable for past rents due to the landlord pertaining to this lease. In May 2023, the Company entered into a lease agreement extension for a showroom space in Los Angeles, California that commences in March 2023 and expires in January 2025. The original lease began in April 2018 and terminated in May 2020, at which point the lease was month to month. The lease has a monthly base rent of $6,520 until January 31, 2025, at which point the base rent increases to $6,781 until the end of the lease. As a result of the extension, the Company recognized a right of use asset and liability of $125,397 using a discount rate of 8.0%. As of June 30, 2023, the Company has $214,626 in accounts payable for past rents due to the landlord pertaining to this lease. Stateside and Sundry utilize a lease for a showroom in Los Angeles, California which is month to month. Total rent expense for the three months ended June 30, 2023 and 2022 was $37,580 and $195,060, and $210,265 and $469,482 for the six months end June 30, 2023 and 2022, respectively.	NOTE 11: LEASE OBLIGATIONS In April 2021, the Company entered into a lease agreement for operating space in Los Angeles, California. The lease expires in June 2023 and has monthly base rent payments of $17,257. The lease required a $19,500 deposit. The Company adopted ASC 842 on January 1, 2021 and recognized a right of use asset and liability of $250,244 using a discount rate of 6.0%. Under ASC 842, the lease was classified as an operating lease. Stateside leases office and showroom facilities in Los Angeles, California. The leases expire at various dates through November 2022 with base rents ranging from $3,100 to $9,000. Total rent expense for the years ended December 31, 2022 and 2021 was $945,216 and $816,790, respectively. Rent is classified by function on the consolidated statements of operations either as general and administrative, sales and marketing, or cost of revenue. The Company determines whether an arrangement is or contains a lease at inception by evaluating potential lease agreements including services and operating agreements to determine whether an identified asset exists that the Company controls over the term of the arrangement. Lease commencement is determined to be when the lessor provides access to, and the right to control, the identified asset. The rental payments for the Company’s leases are typically structured as either fixed or variable payments. Fixed rent payments include stated minimum rent and stated minimum rent with stated increases. The Company considers lease payments that cannot be predicted with reasonable certainty upon lease commencement to be variable lease payments, which are recorded as incurred each period and are excluded from the calculation of lease liabilities. Management uses judgment in determining lease classification, including determination of the economic life and the fair market value of the identified asset. The fair market value of the identified asset is generally estimated based on comparable market data provided by third-party sources.

CONTINGENCIES

CONTINGENCIES	6 Months Ended	12 Months Ended
CONTINGENCIES	Jun. 30, 2023	Dec. 31, 2022
CONTINGENCIES
CONTINGENCIES	NOTE 12: CONTINGENCIES On March 21, 2023, a vendor filed a lawsuit against Digital Brands Group related to trade payables totaling approximately $43,501. Such amounts include interest due, and are included in accounts payable, net of payments made to date, in the accompanying consolidated balance sheets. The Company does not believe it is probable that the losses in excess of such trade payables will be incurred. On February 7, 2023, a vendor filed a lawsuit against Digital Brands Group related to trade payables totaling approximately $182,400. Such amounts include interest due, and are included in accounts payable, net of payments made to date, in the accompanying consolidated balance sheets. The Company does not believe it is probable that the losses in excess of such trade payables will be incurred. On November 9, 2022, a vendor filed a lawsuit against Digital Brand’s Group related to prior services rendered. The claims (including fines, fees, and legal expenses) total an aggregate of $50,190. The matter was settled in January 2023 and are on payment plans which will be paid off in April 2023. In August 2020 and March 2021, two lawsuits were filed against Bailey by third-party’s related to prior services rendered. The claims (including fines, fees, and legal expenses) total an aggregate of $96,900. Both matters were settled in February 2022 and are on payment plans which will be paid off in July and September of 2023. On December 21, 2020, a Company investor filed a lawsuit against DBG for reimbursement of their investment totaling $100,000. Claimed amounts are included in short-term convertible note payable in the accompanying consolidated balance sheets and the Company does not believe it is probable that losses in excess of such short-term note payable will be incurred. The Company is actively working to resolve this matter. A vendor filed a lawsuit against Bailey related to a retail store lease in the amount of $1.5 million. The Company is disputing the claim for damages and the matter is ongoing. The vendor has recently updated the claim to now be $450,968 after signing a long-term lease with another brand for this location. The Company is disputing this new amount after review of the lease. All claims above, to the extent management believes it will be liable, have been included in accounts payable and accrued expenses and other liabilities in the accompanying consolidated balance sheet as of June 30, 2023. Except as may be set forth above the Company is not a party to any legal proceedings, and the Company is not aware of any claims or actions pending or threatened against us. In the future, the Company might from time to time become involved in litigation relating to claims arising from its ordinary course of business, the resolution of which the Company does not anticipate would have a material adverse impact on our financial position, results of operations or cash flows.	NOTE 12: CONTINGENCIES On March 21, 2023, a vendor filed a lawsuit against Digital Brands Group related to trade payables totaling approximately $43,501. Such amounts include interest due, and are included in accounts payable, net of payments made to date, in the accompanying consolidated balance sheets. The Company does not believe it is probable that the losses in excess of such trade payables will be incurred. On February 7, 2023, a vendor filed a lawsuit against Digital Brands Group related to trade payables totaling approximately $182,400. Such amounts include interest due, and are included in accounts payable, net of payments made to date, in the accompanying consolidated balance sheets. The Company does not believe it is probable that the losses in excess of such trade payables will be incurred. On November 9, 2022, a vendor filed a lawsuit against Digital Brand's Group related to prior services rendered. The claims (including fines, fees, and legal expenses) total an aggregate of $50,190. The matter was settled in January 2023 and are on payment plans which will be paid off in April 2023. In August 2020 and March 2021, two lawsuits were filed against Bailey by third-party’s related to prior services rendered. The claims (including fines, fees, and legal expenses) total an aggregate of $96,900. Both matters were settled in February 2022 and are on payment plans which will be paid off in July and September of 2023 On December 21, 2020, a Company investor filed a lawsuit against DBG for reimbursement of their investment totaling $100,000. Claimed amounts are included in short-term convertible note payable in the accompanying consolidated balance sheets and the Company does not believe it is probable that losses in excess of such short-term note payable will be incurred. The Company is actively working to resolve this matter. On September 24, 2020 a Bailey’s product vendor filed a lawsuit against Bailey for non-payment of trade payables totaling approximately $481,000 and additional damages of approximately $296,000. Claimed amounts for trade payables are included in accounts payable in the accompanying consolidated balance sheets, net of payments made. In December 2021, the Company reached a settlement; however, the settlement terms were not met and the Company received a judgement of $496,000. The amount due has been paid, the lawsuit dismissed and there is no claim or amount due. A vendor filed a lawsuit against Bailey related to a retail store lease in the amount of $1.5 million. The Company is disputing the claim for damages and the matter is ongoing. The Company has been involved in a dispute with the former owners of H&J regarding its obligation to “true up” their ownership interest in our Company further to that membership interest purchase agreement dated May 18, 2021 whereby we acquired all of the outstanding membership interests of H&J (the “H&J Purchase Agreement”). Further to the H&J Purchase Agreement, we agreed that if, at May 18, 2022, the one year anniversary of the closing date of our initial public offering, the product of the number of shares of our common stock issued at the closing of such acquisition multiplied by the average closing price per share of our shares of common stock as quoted on the NasdaqCM for the thirty (30) day trading period immediately preceding such date plus the gross proceeds, if any, of shares of our stock issued to such sellers and sold by them during the one year period from the closing date of the offering does not exceed the sum of $9.1 million, less the value of any shares of common stock cancelled further to any indemnification claims or post-closing adjustments under the H&J Purchase Agreement, then we shall issue to the subject sellers an additional aggregate number of shares of common stock equal to any such valuation shortfall at a per share price equal to the then closing price per share of our common stock as quoted on the NasdaqCM. We did not honor our obligation to issue such shares and the former owner of H&J have claimed that they were damaged as a result. As part of a proposed settlement with such holders, the Company has tentatively agreed to the following: (i) to transfer all membership interests of H&J back to the original owners, (ii) to pay such owners the sum of $229,000, (iii) issue the former owners of H&J an aggregate of $1,400,000 worth of our common stock to be issued on May 16, 2023 based on the lower of (a) the stock closing price per share on May 15, 2023, and (b) the average common stock closing price based on the average of the 5 trading days preceding May 16, 2023, with the closing price on May 9, 2023. Such tentative terms are to be memorialized in definitive purchase agreements and as such there is no assurance that such arrangements will be finalized. As of the issuance date of these financial statements, the above terms and continued negotiations have been verbally approved by the Board. All claims above, to the extent management believes it will be liable, have been included in accounts payable and accrued expenses and other liabilities in the accompanying consolidated balance sheet as of December 31, 2022. Except as may be set forth above the Company is not a party to any legal proceedings, and the Company is not aware of any claims or actions pending or threatened against us. In the future, the Company might from time to time become involved in litigation relating to claims arising from its ordinary course of business, the resolution of which the Company does not anticipate would have a material adverse impact on our financial position, results of operations or cash flows.

INCOME TAXES

INCOME TAXES	6 Months Ended	12 Months Ended
INCOME TAXES	Jun. 30, 2023	Dec. 31, 2022
INCOME TAXES
INCOME TAXES	NOTE 13: INCOME TAXES The Company has historically calculated the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full fiscal year to “ordinary” income or loss (pretax income or loss excluding unusual or infrequently occurring discrete items) for the reporting period. The Company has used a discrete effective tax rate method to calculate taxes for the fiscal three and six month periods ended June 30, 2023. The Company determined that since small changes in estimated “ordinary” income would result in significant changes in the estimated annual effective tax rate, the historical method would not provide a reliable estimate for the fiscal three and six-month periods ended June 30, 2023. The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. The Company assessed the need for a valuation allowance against its net deferred tax assets and determined a full valuation allowance is required due, cumulative losses through June 30, 2023, and no history of generating taxable income.	NOTE 13: INCOME TAXES Deferred taxes are recognized for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate primarily to depreciable assets using accelerated depreciation methods for income tax purposes, share-based compensation expense, and for net operating loss carryforwards. As of December 31, 2022, and 2021, the Company had net deferred tax assets before valuation allowance of $16,733,582 and $13,103,268, respectively. The following table presents the deferred tax assets and liabilities by source: December 31, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 16,733,582 $ 13,108,371 Deferred tax liabilities: Depreciation timing differences — (5,103) Valuation allowance (16,733,582) (13,103,268) Net deferred tax assets $ — $ — The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. The Company assessed the need for a valuation allowance against its net deferred tax assets and determined a full valuation allowance is required due, cumulative losses through December 31, 2022, and no history of generating taxable income. Therefore, valuation allowances of $16,733,582 and $13,103,268 were recorded as of December 31, 2022 and 2021, respectively. Valuation allowance increased by $3,630,314 and $3,081,497 during the years ended December 31, 2022 and 2021, respectively. Deferred tax assets were calculated using the Company’s combined effective tax rate, which it estimated to be approximately 28.0%. The effective rate is reduced to 0% for 2022 and 2021 due to the full valuation allowance on its net deferred tax assets. The Company has permanent differences, consisting of non-deductible impairments of goodwill and intangible assets of $17.7 million and amortization of non-cash debt issuance costs of $6.5 million. The Company’s ability to utilize net operating loss carryforwards will depend on its ability to generate adequate future taxable income. At December 31, 2022 and 2021, the Company had net operating loss carryforwards available to offset future taxable income in the amounts of approximately $59,865,000 and $46,896,000, for which losses from 2018 forward can be carried forward indefinitely. As a result of prior operating losses, the Company has net operating loss, or “NOL,” carryforwards for federal income tax purposes. The ability to utilize NOL carryforwards to reduce taxable income in future years could become subject to significant limitations under Section 382 of the Internal Revenue Code if the Company undergoes an ownership change. The Company would undergo an ownership change if, among other things, the stockholders who own, directly or indirectly, 5% or more of our common stock, or are otherwise treated as “5% shareholders” under Section 382 of the U.S. Internal Revenue Code and the regulations promulgated thereunder, increase their aggregate percentage ownership of the Company’s stock by more than 50 percentage points over the lowest percentage of the stock owned by these stockholders at any time during the testing period, which is generally the three-year period preceding the potential ownership change. The Company has evaluated its income tax positions and has determined that it does not have any uncertain tax positions. The Company will recognize interest and penalties related to any uncertain tax positions through its income tax expense. The Company is not presently subject to any income tax audit in any taxing jurisdiction, though all tax years from 2018 on remain open to examination. The Company recorded a tax benefit of $1,100,120 for the year ended December 31, 2021 related to a full release of its valuation allowance pertaining to the acquisition of H&J (see Note 4). The acquisition of H&J created a deferred tax liability position, and those deferred tax liabilities can be used as a source of income for the Company’s existing deferred tax assets.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended	12 Months Ended
SUBSEQUENT EVENTS	Jun. 30, 2023	Dec. 31, 2022
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 14: SUBSEQUENT EVENTS On July 5, 2023, the Company and the Bailey sellers agreed to extend the maturity date of the Bailey Note to June 30, 2024. On August 21, 2023, the Company filed a Certificate of Amendment to our Certificate of Incorporation, as amended, to effect a one-for-twenty-five (1-for- 25	NOTE 14: SUBSEQUENT EVENTS On January 11, 2023, the Company, entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a certain accredited investor (the “Investor”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Private Placement”), an aggregate of 19,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”), and accompanying warrants (the “Common Warrants”) to purchase 19,000 shares of Common Stock, at a combined purchase price of $97.875 per share and Common Warrant, and (ii) 32,086 pre-funded warrants (the “Pre-Funded Warrants” and together with the Common Warrants, the “Warrants” and together with the Shares and the shares of Common Stock underlying the Warrants, the “Securities”) exercisable for 32,086 shares of Common Stock, and accompanying Common Warrants to purchase 32,086 shares of Common Stock, at a combined purchase price of $97.875, less the exercise price of $0.0001, per Pre-Funded Warrant and accompanying Common Warrant, to the Investors, for aggregate gross proceeds from the Private Placement of approximately $5 million. Each Common Warrant has an exercise price of $95 per share, will be immediately exercisable upon issuance and will expire five years from the date of issuance. In February 2023, the Company fully repaid the December Notes for $4.0 million. In February 2023, the Company and the Sundry Sellers verbally agreed to extend the maturity date to December 31, 2023. On April 7, 2023, the Company and various purchasers executed a Securities Purchase Agreement (“April 2023 Notes”) whereby the investors purchased from the Company convertible promissory notes in the aggregate principal amount of $2,208,750, consisting of original issue discount of $408,750. The Company received net proceeds of $1,800,000. The April 2023 Notes are due and payable on September 30, 2023. If the April 2023 Notes are not repaid in full by the maturity date or if any other event of default occurs, (1) the face value of the April Notes will be automatically increased to 120%; (2) the April 2023 Notes will begin generating an annual interest rate of 20%, which will be paid in cash monthly until the default is cured; and (3) if such default continues for 14 or more calendar days, at the investors’ discretion, the April 2023 Notes shall become convertible at the option of the investors into shares of the Company’s common stock at a conversion price equal to the closing price of the Company’s common stock on the date of the note conversion. On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 78,103 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. The total estimated value of the common stock was approximately $1.4 million. We accounted for the disposition as discontinued operations in the accompanying consolidated financial statements, and as a result, we retrospectively reflected certain adjustments to the years ended December 31, 2022 and 2021 in accordance with Accounting Standard Codification (ASC) 205-20 for reporting Discounting Operations. On August 21, 2023, the Company filed a Certificate of Amendment to our Certificate of Incorporation, as amended, to effect a one-for-twenty-five (1-for- 25

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”).	Basis of Presentation The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”).
Reverse Stock Split	Reverse Stock Split On October 21, 2022, the Board of Directors approved a one
Unaudited Interim Financial Information	Unaudited Interim Financial Information The accompanying unaudited condensed consolidated balance sheet as of June 30, 2023, the unaudited condensed consolidated statements of operations for the six and six months ended June 30, 2023 and 2022 and of cash flows for the six months ended June 30, 2023 and 2022 have been prepared by the Company, pursuant to the rules and regulations of the SEC for the interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to rules and regulations. However, the Company believes that the disclosures are adequate to make the information presented not misleading. The unaudited interim consolidated financial statements have been prepared on a basis consistent with the audited consolidated financial statements and in the opinion of management, reflect all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the consolidated results for the interim periods presented and of the consolidated financial condition as of the date of the interim consolidated balance sheet. The results of operations are not necessarily indicative of the results expected for the year ended December 31, 2023. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2022 included in the Company’s Annual Form 10-K filed with SEC on April 17, 2023.
Principles of Consolidation	Principles of Consolidation These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Bailey, H&J and Stateside from the dates of acquisition. All inter-company transactions and balances have been eliminated on consolidation. As of June 21, 2023, the Company no longer consolidated the assets, liabilities, revenues and expenses of H&J (see Note 4).	H&J Disposition On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 78,103 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. This transaction is known as the “H&J Settlement”. The H&J Settlement was accounted for a business disposition in accordance with ASC 810-40-40-3A. In accordance with the provisions of ASC 205-20, the Company has excluded the results of discontinued operations from its results of continuing operations in the accompanying consolidated statements of operations for the three and six months ended June 30, 2023 and 2022 in it’s Form 10-Q Quarterly Report filed on August 21, 2023. Accordingly, the consolidated financial statements as of and for the years ended December 31, 2022 and 2021 have been adjusted retroactively to account for the discontinued operations classification of H&J. Principles of Consolidation These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Bailey, H&J, Stateside and Sundry from the dates of acquisition. All inter-company transactions and balances have been eliminated on consolidation. H&J has been retroactively adjusted to be presented as discontinued operations (see above).
Use of Estimates	Use of Estimates The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, inventory, impairment of long-lived assets, contingent consideration and derivative liabilities. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Reclassification of Previously Issued Financial Statements	Reclassification of Previously Issued Financial Statements Certain prior year accounts have been reclassified to conform with current year presentation pertaining to cost of net revenue and general and administrative expenses. The Company has reclassified $297,696 and $630,976 in general and administrative expenses per previously reported financial statements to cost of net revenues in the accompanying consolidated statements of operations for the three and six months ended June 30, 2022, respectively. The reclassified costs from general and administrative expense to cost of net revenues are primarily personnel and warehouse related costs. The reclassification had no effect on the reported results of operations. Certain prior year accounts have been reclassified to conform with current year presentation regarding income (loss) from discontinued operations. H&J’s assets and liabilities as of December 31, 2022 have also been reclassified on the consolidated balance sheet. See Note 4.	Restatement of Previously Issued Financial Statements Certain prior year accounts have been reclassified to conform with current year presentation pertaining to cost of net revenue and general and administrative expenses. The Company has reclassified The reclassified costs from general and administrative expense to cost of net revenues made in the fourth quarter of 2022 and 2021 are fixed in nature as they are personnel and warehouse related costs. The impact of the reclassification was approximately for each of the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022. The impact of the reclassification was approximately
Cash and Equivalents and Concentration of Credit Risk	Cash and Equivalents and Concentration of Credit Risk The Company considers all highly liquid securities with an original maturity of less than six months to be cash equivalents. As of June 30, 2023 and December 31, 2022, the Company did not hold any cash equivalents. The Company’s cash and cash equivalents in bank deposit accounts, at times, may exceed federally insured limits of $250,000.	Cash and Equivalents and Concentration of Credit Risk The Company considers all highly liquid securities with an original maturity of less than three months to be cash equivalents. As of December 31, 2022 and 2021, the Company did not hold any cash equivalents. The Company’s cash and cash equivalents in bank deposit accounts, at times, may exceed federally insured limits of $250,000.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued expenses, due to related parties, related party note payable, and convertible debt. The carrying value of these assets and liabilities is representative of their fair market value, due to the short maturity of these instruments. The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy used to determine such fair values: Fair Value Measurements as of June 30, 2023 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ — $ — $ — $ — $ — $ — Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ 12,098,475 $ 12,098,475 $ — $ — $ 12,098,475 $ 12,098,475 Contingent Consideration The Company recorded a contingent consideration liability relating to stock price guarantees included in its acquisitions of Bailey44 and H&J. The estimated fair value of the contingent consideration was recorded using significant unobservable measures and other fair value inputs and was therefore classified as a Level 3 financial instrument. The Company estimates and records the acquisition date fair value of contingent consideration as part of purchase price consideration for acquisitions. Additionally, each reporting period, the Company estimates changes in the fair value of contingent consideration and recognizes any change in fair in the consolidated statement of operations. The estimate of the fair value of contingent consideration requires very subjective assumptions to be made of future operating results, discount rates and probabilities assigned to various potential operating result scenarios. Future revisions to these assumptions could materially change the estimate of the fair value of contingent consideration and, therefore, materially affect the Company’s future financial results. The contingent consideration liability is to be settled with the issuance of shares of common stock once contingent provisions set forth in respective acquisition agreements have been achieved. Upon achievement of contingent provisions, respective liabilities are relieved and offset by increases to common stock and additional paid-in capital in the stockholders’ equity section of the Company’s consolidated balance sheets. Norwest Waiver On June 21, 2023, the Company, on the one hand, and Norwest Venture Partners XI, LP and Norwest Venture Partners XII, LP (together, the “Norwest Investors”), on the other hand, executed a Waiver and Amendment (the “Norwest Amendment”) whereby the Norwest Investors agreed to waive and terminate certain true up rights of the Norwest Investors under the Agreement and Plan of Merger, dated February 12, 2020 (the “Bailey Merger Agreement”), among the Company, Bailey 44, LLC, Norwest Venture Partners XI, LP, and Norwest Venture Partners XII, LP and Denim.LA Acquisition Corp. This transaction is known as the “Norwest Waiver”. As a result of the Norwest Waiver, the Company recorded a fair value of H&J Settlement Agreement On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby the Company transferred 100% of its membership interests in H&J to D. Jones (the “H&J Seller”). Pursuant to the Settlement Agreement, the Company agreed to make an aggregate cash payment of shares of common stock to the H&J Seller. In connection with the Settlement Agreement, the parties agreed that no further shares were owed to the H&J Seller resulting from the stock price guarantee pursuant to the May 2021 H&J acquisition. As a result, the Company recorded a fair value of The detail of contingent consideration by company is as follows: June 30, December 31, 2023 2022 Bailey $ — $ 10,698,475 Harper & Jones — 1,400,000 $ — $ 12,098,475	Fair Value of Financial Instruments FASB guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 3 — Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, due from factor, prepaid expenses, accounts payable, accrued expenses, deferred revenue, due to related parties, related party note payable, accrued interest, loan payable and convertible debt. The carrying value of these assets and liabilities is representative of their fair market value, due to the short maturity of these instruments. The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy used to determine such fair values: Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ — $ — $ — Contingent consideration — — 12,098,475 12,098,475 Derivative liability — — — — $ — $ — $ 12,098,475 $ 12,098,475 Fair Value Measurements as of December 31, 2021 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ 18,223 $ — $ 18,223 Contingent consideration — — 12,179,476 12,179,476 Derivative liability — — 2,294,720 2,294,720 $ — $ 18,223 $ 14,474,196 $ 14,492,419 Warrant Liability Certain of the Company’s common stock warrants are carried at fair value. As of December 31, 2020, the fair value of the Company’s common stock warrant liabilities was measured under the Level 3 hierarchy using the Black-Scholes pricing model as the Company’s underlying common stock had no observable market price (see Note 10). The warrant liability was valued using a market approach. Upon the IPO, the warrant liabilities were valued using quoted prices of identical assets in active markets, and was reclassified under the Level 2 hierarchy. Changes in common stock warrant liability during the years ended December 31, 2022 and 2021 are as follows: Warrant Liability Outstanding as of December 31, 2020 $ 6,265 Change in fair value 11,958 Outstanding as of December 31, 2021 18,223 Change in fair value (18,223) Outstanding as of December 31, 2022 $ — Contingent Consideration The Company records a contingent consideration liability relating to stock price guarantees included in its acquisition and consulting agreements. The estimated fair value of the contingent consideration is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument. The Company estimates and records the acquisition date fair value of contingent consideration as part of purchase price consideration for acquisitions. Additionally, each reporting period, the Company estimates changes in the fair value of contingent consideration and recognizes any change in fair in the consolidated statement of operations. The estimate of the fair value of contingent consideration requires very subjective assumptions to be made of future operating results, discount rates and probabilities assigned to various potential operating result scenarios. Future revisions to these assumptions could materially change the estimate of the fair value of contingent consideration and, therefore, materially affect the Company’s future financial results. The contingent consideration liability is to be settled with the issuance of shares of common stock once contingent provisions set forth in respective acquisition agreements have been achieved. Upon achievement of contingent provisions, respective liabilities are relieved and offset by increases to common stock and additional paid-in capital in the stockholders’ equity section of the Company’s consolidated balance sheets. The fair value of the contingent consideration liability related to the Company’s business combinations is valued using the Monte Carlo simulation model. The Monte Carlo simulation inputs include the stock price, volatility of common stock, timing of settlement and resale restrictions and limits. The fair value of the contingent consideration is then calculated based on guaranteed equity values at settlement as defined in the acquisition agreements. Changes in contingent consideration liability during the years ended December 31, 2022 and 2021 are as follows: Contingent Consideration Liability Balance as of December 31, 2020 $ — Initial recognition in connection with acquisition of Harper & Jones 3,421,516 Stock price guarantee per consulting agreement 67,000 Conversion into shares (73,500) Change in fair value 8,764,460 Outstanding as of December 31, 2021 12,179,476 Repayments to Harper & Jones seller (645,304) Change in fair value 564,303 Outstanding as of December 31, 2022 $ 12,098,475 During the year ended December 31, 2022, the Company utilized the following inputs for the fair value of the contingent consideration: volatilities of 79.3% and 88.9%, risk-free rate of 0.25%, expected share increase of 5% per annum, and the guaranteed stock price of $828 for Bailey and $10,375 for Harper & Jones. The detail of contingent consideration by company is as follows: December 31, 2022 2021 Bailey $ 10,698,475 7,935,016 Harper & Jones 1,400,000 4,244,460 $ 12,098,475 $ 12,179,476 The contingent consideration liabilities were revalued for a final time as of May 18, 2022, the anniversary date of the Company’s initial public offering. As of the date of the issuance of these financial statements, the contingent consideration liabilities were not yet settled with shares. In December 2022, the Company paid $645,304 to the H&J Seller to partially reduce the contingent consideration balance owed. The Company and the H&J Seller are in the process of amending the May 2021 purchase agreement to determine the ultimate settlement of the Company’s common stock to the H&J Seller by May 16, 2023. Refer to Note 12. Derivative Liability In connection with the Company’s convertible notes, the Company recorded a derivative liability (see Note 7). The estimated fair value of the derivative liability is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument. The fair value of the derivative liability is valued using a multinomial lattice model. The multinomial lattice inputs include the underlying stock price, volatility of common stock and remaining term of the convertible note. Changes in derivative liability during the years ended December 31, 2022 and 2021 are as follows: Derivative Liability Outstanding as of December 31, 2020 $ — Initial fair value on issuance of convertible note 3,204,924 Change in fair value (910,204) Outstanding as of December 31, 2021 2,294,720 Initial fair value on issuance of convertible note 559,957 Conversion of underlying notes into common stock (1,500,243) Change in fair value (1,354,434) Outstanding as of December 31, 2022 $ — During the year ended December 31, 2022, the Company utilized the following inputs for the fair value of the derivative liability: volatility of 70.9% - 96.7%, risk-free rate of 2.71% - 3.74%, and remaining term ranging from .08 years - 0.62 years. The change in fair value of the derivative liability is included in other non-operating income (expense), net in the consolidated statements of operations.
Inventory	Inventory Inventory is stated at the lower of cost or net realizable value and accounted for using the weighted average cost method for DSTLD and first-in, first-out method for Bailey, Stateside and Sundry. The inventory balances as of June 30, 2023 and December 31, 2022 consist substantially of finished good products purchased or produced for resale, as well as any raw materials the Company purchased to modify the products and work in progress. Inventory consisted of the following: June 30, December 31, 2023 2022 Raw materials $ 1,508,416 $ 1,611,134 Work in process 653,412 888,643 Finished goods 2,609,443 2,725,505 Inventory $ 4,771,271 $ 5,225,282	Inventory Inventory is stated at the lower of cost or net realizable value and accounted for using the weighted average cost method for DSTLD and H&J and first-in, first-out method for Bailey, Stateside and Sundry. The inventory balances as of December 31, 2022 and 2021 consist substantially of finished good products purchased or produced for resale, as well as any raw materials the Company purchased to modify the products and work in progress. Inventory consisted of the following: December 31, 2022 2021 Raw materials $ 1,508,416 $ 292,167 Work in process 888,643 242,673 Finished goods 2,725,505 2,220,519 Inventory $ 5,122,564 $ 2,660,203
Goodwill	Goodwill Goodwill and identifiable intangible assets that have indefinite useful lives are not amortized, but instead are tested annually for impairment and upon the occurrence of certain events or substantive changes in circumstances. The annual goodwill impairment test allows for the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An entity may choose to perform the qualitative assessment on none, some or all of its reporting units or an entity may bypass the qualitative assessment for any reporting unit and proceed directly to step one of the quantitative impairment test. If it is determined, on the basis of qualitative factors, that the fair value of a reporting unit is, more likely than not, less than its carrying value, the quantitative impairment test is required.	Goodwill Goodwill and identifiable intangible assets that have indefinite useful lives are not amortized, but instead are tested annually for impairment and upon the occurrence of certain events or substantive changes in circumstances. The annual goodwill impairment test allows for the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An entity may choose to perform the qualitative assessment on none, some or all of its reporting units or an entity may bypass the qualitative assessment for any reporting unit and proceed directly to step one of the quantitative impairment test. If it is determined, on the basis of qualitative factors, that the fair value of a reporting unit is, more likely than not, less than its carrying value, the quantitative impairment test is required. The quantitative impairment test calculates any goodwill impairment as the difference between the carrying amount of a reporting unit and its fair value, but not to exceed the carrying amount of goodwill. It is our practice, at a minimum, to perform a qualitative or quantitative goodwill impairment test in the fourth quarter every year.
Annual Impairment	Annual Impairment At December 31, 2022, management determined that certain events and circumstances occurred that indicated that the carrying value of the Company’s brand name assets, and the carrying amount of the reporting units, pertaining to Bailey44 and Harper & Jones may not be recoverable. The qualitative assessment was primarily due to reduced or stagnant revenues of both entities as compared to the Company’s initial projections at the time of each respective acquisition, as well as the entities’ liabilities in excess of assets. As such, the Company compared the estimated fair value of the brand names with its carrying value and recorded an impairment loss of $3,667,000 in the consolidated statements of operations. Additionally, the Company compared the fair value of the reporting units to the carrying amounts and recorded an impairment loss of $11,872,332	Annual Impairment Tests At December 31, 2021, management determined that certain events and circumstances occurred, primarily the continued reduction in revenues partially as a result of COVID-19, that indicated that the carrying value of the Company’s brand name asset pertaining to Bailey44 may not be recoverable. As such, the Company compared the estimated fair value of the brand name with its carrying value and recorded an impairment loss of $3,400,000 in the consolidated statements of operations. At December 31, 2022, management determined that certain events and circumstances occurred that indicated that the carrying value of the Company’s brand name assets, and the carrying amount of the reporting units, pertaining to Bailey44 and Harper & Jones may not be recoverable. The qualitative assessment was primarily due to reduced or stagnant revenues of both entities as compared to the Company’s initial projections at the time of each respective acquisition, as well as the entities’ liabilities in excess of assets. As such, the Company compared the estimated fair value of the brand names with its carrying value and recorded an impairment loss of $3,667,000 in the consolidated statements of operations. Additionally, the Company compared the fair value of the reporting units to the carrying amounts and recorded an impairment loss of $11,872,332 Year Ended December 31, 2022 2021 Bailey brand name (intangibles) $ 2,182,000 $ 3,400,000 Bailey goodwill 3,321,095 — Total impairment $ 5,503,095 $ 3,400,000 In determining the fair value of the respective reporting units, management estimated the price that would be received to sell the reporting unit as a whole in an orderly transaction between market participants at the measurement date. This includes reviewing market comparables such as revenue multipliers and assigning certain assets and liabilities to the reporting units, such as the respective working capital deficits of each entity and debt obligations that would need to be assumed by a market participant buyer in an orderly transaction. The Company calculated the carrying amounts of each reporting unit by utilizing the entities’ assets and liabilities at December 31, 2022, including the carrying value of the identifiable intangible assets and goodwill assigned to the respective reporting units. Refer to Note 12 for the related developments with H&J.
Net Loss per Share	Net Loss per Share Net earnings or loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period, excluding shares subject to redemption or forfeiture. The Company presents basic and diluted net earnings or loss per share. Diluted net earnings or loss per share reflect the actual weighted average of common shares issued and outstanding during the period, adjusted for potentially dilutive securities outstanding. Potentially dilutive securities are excluded from the computation of the diluted net loss per share if their inclusion would be anti-dilutive. The following table sets forth the computation of basic and diluted net income (loss) per share: Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 Numerator: Net income (loss) from continuing operations $ 6,536,310 $ (9,482,520) $ 470,415 $ (17,200,792) Income (loss) from discontinued operations, net of tax (1,492,050) (51,404) (1,562,503) (166,074) Net income (loss) $ 5,044,260 $ (9,533,924) $ (1,092,088) $ (17,366,866) Denominator: Weighted average common shares outstanding - basic 246,809 14,329 236,824 9,836 Weighted average common shares outstanding - diluted 834,604 14,329 824,619 9,836 Net income (loss) from continuing operations per share - basic $ 26.48 $ (661.78) $ 1.99 $ (1,748.68) Net income (loss) from continuing operations per share - diluted $ 7.83 $ (661.78) $ 0.57 $ (1,748.68) Net income (loss) from discontinued operations per common share – basic $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) from discontinued operations per common share – diluted $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) per share – $ 20.44 $ (665.36) $ (4.61) $ (1,765.57) Net income (loss) per share – $ 6.04 $ (665.36) $ (4.61) $ (1,765.57) The following table sets forth the a) the dilutive items included in the weighted average common shares – diluted amount above as of June 30, 2023 and b) the number of potential common shares excluded from the calculations of net loss per diluted share because their inclusion would be anti-dilutive as of June 30, 2022: June 30, 2023 2022 — 18,496 Convertible notes 27,097 — Series A convertible preferred stock 321,395 — Series C convertible preferred stock 237,746 2,533 Common stock warrants 1,558 1,558 Stock options 587,795 22,588 The stock options and warrants above are out-of-the-money as of June 30, 2023 and 2022.	Net Loss per Share Net earnings or loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period, excluding shares subject to redemption or forfeiture. The Company presents basic and diluted net earnings or loss per share. Diluted net earnings or loss per share reflect the actual weighted average of common shares issued and outstanding during the period, adjusted for potentially dilutive securities outstanding. Potentially dilutive securities are excluded from the computation of the diluted net loss per share if their inclusion would be anti-dilutive. As all potentially dilutive securities are anti-dilutive as of December 31, 2022 and 2021, diluted net loss per share is the same as basic net loss per share for each year. Potentially dilutive items outstanding as of December 31, 2022 and 2021 are as follows: December 31, 2022 2021 Convertible notes 37,915 1,916 Series A convertible preferred stock 4,320 — Common stock warrants 176,733 1,432 Stock options 1,558 1,558 Total potentially dilutive shares 220,526 4,907 The potentially dilutive shares pertaining to the Company’s outstanding convertible notes were calculated based on the assumed conversion abilities as of December 31, 2022 and 2021. The ultimate number of shares for which the notes can convert into is indeterminable. The stock options and warrants above are out-of-the-money as of December 31, 2022 and 2021.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which amends and clarifies several provisions of Topic 326. In May 2019, the FASB issued ASU 2019-05, Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief, which amends Topic 326 to allow the fair value option to be elected for certain financial instruments upon adoption. ASU 2019-10 extended the effective date of ASU 2016-13 until December 15, 2022. The Company adopted this new guidance, including the subsequent updates to Topic 326, on January 1, 2023 and the adoption did not have a material impact on the Company’s condensed consolidated financial statements and related disclosures. Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are	Recent Accounting Pronouncements In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02: Leases (Topic 842). Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable under the circumstances.
Unaudited Pro Forma Financial Information, Policy	Unaudited Pro Forma Financial Information The following unaudited pro forma financial information presents the Company’s financial results as if the Sundry acquisition had occurred as of January 1, 2022. The unaudited pro forma financial information is not necessarily indicative of what the financial results actually would have been had the acquisitions been completed on this date. In addition, the unaudited pro forma financial information is not indicative of, nor does it purport to project, the Company’s future financial results. The following unaudited pro forma financial information includes incremental property and equipment depreciation and intangible asset amortization as a result of the acquisitions. The pro forma information does not give effect to any estimated and potential cost savings or other operating efficiencies that could result from the acquisition: Six Months Ended June 30, 2022 Net revenues $ 14,728,296 Net loss $ (16,907,152) Net loss per common share $ (1,718.83)
Property, Equipment, and Software		Property, Equipment, and Software Property, equipment, and software are recorded at cost. Depreciation/amortization is recorded for property, equipment, and software using the straight-line method over the estimated useful lives of assets. The Company reviews the recoverability of all long-lived assets, including the related useful lives, whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset might not be recoverable. The balances at December 31, 2022 and 2021 consist of software with three (3) year lives, property and equipment with three (3) to ten (10) year lives, and leasehold improvements which are depreciated over the shorter of the lease life or expected life. Depreciation and amortization charges on property, equipment, and software are included in general and administrative expenses and amounted to $75,126 and $92,213 for the years ended December 31, 2022 and 2021, respectively.
Business Combinations		Business Combinations The Company accounts for acquisitions in which it obtains control of one or more businesses as a business combination. The purchase price of the acquired businesses is allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date. The excess of the purchase price over those fair values is recognized as goodwill. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments, in the period in which they are determined, to the assets acquired and liabilities assumed with the corresponding offset to goodwill. If the assets acquired are not a business, the Company accounts for the transaction or other event as an asset acquisition. Under both methods, the Company recognizes the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest in the acquired entity. In addition, for transactions that are business combinations, the Company evaluates the existence of goodwill or a gain from a bargain purchase. Goodwill represents the excess of the purchase price of an acquired entity over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed in a business combination. Intangible assets are established with business combinations and consist of brand names and customer relationships. Intangible assets with finite lives are recorded at their estimated fair value at the date of acquisition and are amortized over their estimated useful lives using the straight-line method. The estimated useful lives of amortizable intangible assets are as follows: Customer relationships 3 years
Impairment		Impairment Long-Lived Assets The Company reviews its long-lived assets (property and equipment and amortizable intangible assets) for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. If the sum of the expected cash flows, undiscounted, is less than the carrying amount of the asset, an impairment loss is recognized as the amount by which the carrying amount of the asset exceeds its fair value.
Indefinite-Lived Intangible Assets		Indefinite-Lived Intangible Assets Indefinite-lived intangible assets established in connection with business combinations consist of the brand name. The impairment test for identifiable indefinite-lived intangible assets consists of a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.
Convertible Instruments		Convertible Instruments U.S. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional as that term is described under applicable U.S. GAAP. When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company also records, when necessary, deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.
Accounting for Preferred Stock		Accounting for Preferred Stock ASC 480, Distinguishing Liabilities from Equity, includes standards for how an issuer of equity (including equity shares issued by consolidated entities) classifies and measures on its balance sheet certain financial instruments with characteristics of both liabilities and equity. Management is required to determine the presentation for the preferred stock as a result of the redemption and conversion provisions, among other provisions in the agreement. Specifically, management is required to determine whether the embedded conversion feature in the preferred stock is clearly and closely related to the host instrument, and whether the bifurcation of the conversion feature is required and whether the conversion feature should be accounted for as a derivative instrument. If the host instrument and conversion feature are determined to be clearly and closely related (both more akin to equity), derivative liability accounting under ASC 815, Derivatives and Hedging, is not required. Management determined that the host contract of the preferred stock is more akin to equity, and accordingly, liability accounting is not required by the Company. The Company has presented preferred stock within stockholders’ equity. Costs incurred directly for the issuance of the preferred stock are recorded as a reduction of gross proceeds received by the Company, resulting in a discount to the preferred stock. The discount is not amortized.
Revenue Recognition		Revenue Recognition Revenues are recognized when performance obligations are satisfied through the transfer of promised goods to the Company’s customers. Control transfers upon shipment of product and when the title has been passed to the customers. This includes the transfer of legal title, physical possession, the risks and rewards of ownership, and customer acceptance. The Company provides the customer the right of return on the product and revenue is adjusted based on an estimate of the expected returns based on historical rates. The Company considers the sale of products as a single performance obligation. Sales tax collected from customers and remitted to taxing authorities is excluded from revenue and is included in accrued expenses. Revenue is deferred for orders received for which associated shipments have not occurred. The reserve for returns totaled $307,725 and $33,933 as of December 31, 2022 and 2021, respectively, and is included in accrued expenses and other liabilities in the accompanying consolidated balance sheets.
Cost of Revenues		Cost of Revenues Cost of revenues consists primarily of inventory sold and related freight-in. Cost of revenues includes direct labor pertaining to our inventory production activities and an allocation of overhead costs including rent and insurance. Cost of revenues also includes inventory write-offs and reserves.
Shipping and Handling		Shipping and Handling The Company recognizes shipping and handling billed to customers as a component of net revenues, and the cost of shipping and handling as distribution costs. Total shipping and handling billed to customers as a component of net revenues was approximately $72,000 and $23,000 for the years ended December 31, 2022 and 2021, respectively. Total shipping and handling costs included in distribution costs were approximately $525,000 and $423,000, respectively.
Advertising and Promotion		Advertising and Promotion Advertising and promotional costs are expensed as incurred. Advertising and promotional expense for the years ended December 31, 2022 and 2021 amounted to approximately $1,178,000 and $240,000, respectively. The amounts are included in sales and marketing expense.
General and Administrative		General and Administrative General and administrative expenses consist primarily of compensation and benefits costs, professional services and information technology. General and administrative expenses also include payment processing fees, design and warehousing fees.
Common Stock Purchase Warrants and Other Derivative Financial Instruments		Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedging relationships and the types of relationships designated are based on the exposures hedged. At December 31, 2022 and 2021, the Company did not have any derivative instruments that were designated as hedges.
Stock Option and Warrant Valuation		Stock Option and Warrant Valuation Stock option and warrant valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option model. For warrants and stock options issued to non- employees, the Company accounts for the expected life based on the contractual life of the warrants and stock options. For employees, the Company accounts for the expected life of options in accordance with the “simplified” method, which is used for “plain-vanilla” options, as defined in the accounting standards codification. The simplified method is based on the average of the vesting tranches and the contractual life of each grant. For stock price volatility, the Company uses comparable public companies as a basis for its expected volatility to calculate the fair value of options grants. The risk-free interest rate was determined from the implied yields of U.S. Treasury zero-coupon bonds with a remaining life consistent with the expected term of the options. The number of stock award forfeitures are recognized as incurred.
Stock-Based Compensation		Stock-Based Compensation The Company accounts for stock-based compensation costs under the provisions of ASC 718, Compensation — Stock Compensation, which requires the measurement and recognition of compensation expense related to the fair value of stock-based compensation awards that are ultimately expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock-based payments granted to employees, officers, and directors based on the grant date fair value estimated in accordance with the provisions of ASC 718. ASC 718 is also applied to awards modified, repurchased, or cancelled during the periods reported. Stock-based compensation is recognized as an expense over the employee’s requisite vesting period and over the nonemployee’s period of providing goods or services. The Company measures employee stock-based awards at grant-date fair value and recognizes employee compensation expense on a straight-line basis over the vesting period of the award. Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions, including the fair value of the Company’s common stock, and for stock options, the expected life of the option, and expected stock price volatility. The Company used the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.
Deferred Offering Costs		Deferred Offering Costs The Company complies with the requirements of ASC 340, Other Assets and Deferred Costs, with regards to offering costs. Prior to the completion of an offering, offering costs are capitalized. The deferred offering costs are charged to additional paid-in capital or as a discount to debt, as applicable, upon the completion of an offering or to expense if the offering is not completed. As of December 31, 2020, the Company had capitalized $214,647 in deferred offering costs. Upon completion of the IPO in May 2021, all capitalized deferred offering costs were charged to additional paid-in capital. As of December 31, 2021, the Company capitalized $367,696 in deferred offering costs pertaining to its equity line of credit agreement with Oasis (Note 8). In 2022, the Company wrote off these costs to general and administrative expenses in the consolidated statements of operations as the equity line of credit financing never occurred.
Segment Information		Segment Information In accordance with ASC 280, Segment Reporting (“ASC 280”), we identify our operating segments according to how our business activities are managed and evaluated. As of December 31, 2022 our operating segments included: DSTLD, Bailey, H&J, Stateside and Sundry. Each operating segment currently reports to the Chief Executive Officer. Each of our brands serve or are expected to serve customers through our wholesale, in store and online channels, allowing us to execute on our omni-channel strategy. We have determined that each of our operating segments share similar economic and other qualitative characteristics, and therefore the results of our operating segments are aggregated into one reportable segment. All of the operating segments have met the aggregation criteria and have been aggregated and are presented as one reportable segment, as permitted by ASC 280. We continually monitor and review our segment reporting structure in accordance with authoritative guidance to determine whether any changes have occurred that would impact our reportable segments.
Income Taxes		Income Taxes The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is unlikely that the deferred tax assets will not be realized. We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, our policy will be to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit will be recognized in the financial statements.
Concentrations		Concentrations The Company utilized three and two vendors that made up 30% and 40%, respectively, of all inventory purchases during the years ended December 31, 2022 and 2021. The loss of one of these vendors, may have a negative short-term impact on the Company’s operations; however, we believe there are acceptable substitute vendors that can be utilized longer-term.
Leases		Leases On January 1, 2022, the Company adopted ASC 842, Leases The Company elected transitional practical expedients for existing leases which eliminated the requirements to reassess existing lease classification, initial direct costs, and whether contracts contain leases. Also, the Company elected to present the payments associated with short-term leases as an expense in statements of operations. Short-term leases are leases with a lease term of 12 months or less.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of financial assets and liabilities measured at fair value on recurring basis	Fair Value Measurements as of June 30, 2023 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ — $ — $ — $ — $ — $ — Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ 12,098,475 $ 12,098,475 $ — $ — $ 12,098,475 $ 12,098,475	Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ — $ — $ — Contingent consideration — — 12,098,475 12,098,475 Derivative liability — — — — $ — $ — $ 12,098,475 $ 12,098,475 Fair Value Measurements as of December 31, 2021 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ 18,223 $ — $ 18,223 Contingent consideration — — 12,179,476 12,179,476 Derivative liability — — 2,294,720 2,294,720 $ — $ 18,223 $ 14,474,196 $ 14,492,419
Summary of contingent consideration	June 30, December 31, 2023 2022 Bailey $ — $ 10,698,475 Harper & Jones — 1,400,000 $ — $ 12,098,475	December 31, 2022 2021 Bailey $ 10,698,475 7,935,016 Harper & Jones 1,400,000 4,244,460 $ 12,098,475 $ 12,179,476
Schedule of inventory	June 30, December 31, 2023 2022 Raw materials $ 1,508,416 $ 1,611,134 Work in process 653,412 888,643 Finished goods 2,609,443 2,725,505 Inventory $ 4,771,271 $ 5,225,282	December 31, 2022 2021 Raw materials $ 1,508,416 $ 292,167 Work in process 888,643 242,673 Finished goods 2,725,505 2,220,519 Inventory $ 5,122,564 $ 2,660,203
Schedule of the computation of basic and diluted net income (loss) per share	Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 Numerator: Net income (loss) from continuing operations $ 6,536,310 $ (9,482,520) $ 470,415 $ (17,200,792) Income (loss) from discontinued operations, net of tax (1,492,050) (51,404) (1,562,503) (166,074) Net income (loss) $ 5,044,260 $ (9,533,924) $ (1,092,088) $ (17,366,866) Denominator: Weighted average common shares outstanding - basic 246,809 14,329 236,824 9,836 Weighted average common shares outstanding - diluted 834,604 14,329 824,619 9,836 Net income (loss) from continuing operations per share - basic $ 26.48 $ (661.78) $ 1.99 $ (1,748.68) Net income (loss) from continuing operations per share - diluted $ 7.83 $ (661.78) $ 0.57 $ (1,748.68) Net income (loss) from discontinued operations per common share – basic $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) from discontinued operations per common share – diluted $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) per share – $ 20.44 $ (665.36) $ (4.61) $ (1,765.57) Net income (loss) per share – $ 6.04 $ (665.36) $ (4.61) $ (1,765.57)
Schedule of potentially dilutive items outstanding	June 30, 2023 2022 — 18,496 Convertible notes 27,097 — Series A convertible preferred stock 321,395 — Series C convertible preferred stock 237,746 2,533 Common stock warrants 1,558 1,558 Stock options 587,795 22,588	December 31, 2022 2021 Convertible notes 37,915 1,916 Series A convertible preferred stock 4,320 — Common stock warrants 176,733 1,432 Stock options 1,558 1,558 Total potentially dilutive shares 220,526 4,907
Schedule of business acquisition pro forma information		Year Ended December 31, 2022 2021 Net revenues $ 28,519,261 $ 34,635,426 Net loss $ (42,001,415) $ (33,171,473) Net loss per common share $ (1,361.50) $ (10,870.25)
Schedule of estimated useful lives of amortizable intangible assets		Customer relationships 3 years
Schedule of changes in common stock warrant liability		Warrant Liability Outstanding as of December 31, 2020 $ 6,265 Change in fair value 11,958 Outstanding as of December 31, 2021 18,223 Change in fair value (18,223) Outstanding as of December 31, 2022 $ —
Summary of goodwill and intangible impairment		Year Ended December 31, 2022 2021 Bailey brand name (intangibles) $ 2,182,000 $ 3,400,000 Bailey goodwill 3,321,095 — Total impairment $ 5,503,095 $ 3,400,000

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	6 Months Ended	12 Months Ended
DISCONTINUED OPERATIONS (Tables)	Jun. 30, 2023	Dec. 31, 2022
DISCONTINUED OPERATIONS
Schedule of components of disposition	Cash payment due to H&J Seller $ (229,000) Common shares issued to H&J Seller* (1,357,043) Total fair value of consideration received (given) $ (1,586,043) Carrying amount of assets and liabilities Cash and cash equivalents 18,192 Accounts receivable, net 55,782 Prepaid expenses and other current assets 25,115 Goodwill 1,130,311 Intangible assets, net 1,246,915 Deposits 4,416 Accounts payable (40,028) Accrued expenses and other liabilities (734,068) Deferred revenue (18,347) Due to related parties (1,008) Contingent consideration (1,400,000) Loan payable (219,894) Note payable - related party (129,489) Total carrying amount of assets and liabilities (62,103) Loss on disposition of business $ (1,523,940) * Represents the fair value of 78,103 shares of common stock issued to D. Jones. Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 Net revenues $ 686,627 $ 1,089,569 $ 1,405,482 $ 1,892,849 Cost of net revenues 292,107 328,915 565,621 605,413 Gross profit 394,520 760,654 839,861 1,287,436 Operating expenses: General and administrative 189,751 449,508 520,582 896,873 Sales and marketing 169,875 332,723 346,167 515,775 Distribution — — — — Change in fair value of contingent consideration — — — — Total operating expenses 359,626 782,231 866,749 1,412,648 Income (loss) from operations 34,894 (21,577) (26,888) (125,212) Other income (expense): Interest expense (3,003) (29,828) (11,675) (40,862) Loss on disposition of business (1,523,940) — (1,523,940) — Other non-operating income (expenses) — — — — Total other income (expense), net (1,526,944) (29,828) (1,535,615) (40,862) Income tax benefit (provision) — — — — Net income (loss) from discontinued operations $ (1,492,050) $ (51,404) $ (1,562,503) $ (166,074) Weighted average common shares outstanding - basic 246,809 14,329 236,824 9,836 Weighted average common shares outstanding - diluted 834,604 14,329 824,619 9,836 Net income (loss) from discontinued operations per common share - basic $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) from discontinued operations per common share - diluted $ (6.05) $ (3.59) $ (6.60) $ (16.88)
Schedule of due to/ from factor	June 30, December 31, 2023 2022 Outstanding receivables: Without recourse $ 787,542 $ 1,680,042 With recourse 50,979 65,411 Matured funds and deposits 88,516 81,055 Advances (478,753) (632,826) Credits due customers (10,142) (354,282) $ 438,142 $ 839,400	December 31, 2022 2021 Outstanding receivables: Without recourse $ 564,548 $ 579,295 With recourse 352,379 361,584 Advances 118,521 121,617 Credits due customers (196,048) (77,208) $ 839,400 $ 985,288

DUE FROM FACTOR (Tables)

DUE FROM FACTOR (Tables)	6 Months Ended	12 Months Ended
DUE FROM FACTOR (Tables)	Jun. 30, 2023	Dec. 31, 2022
DUE FROM FACTOR
Schedule of due to/ from factor	June 30, December 31, 2023 2022 Outstanding receivables: Without recourse $ 787,542 $ 1,680,042 With recourse 50,979 65,411 Matured funds and deposits 88,516 81,055 Advances (478,753) (632,826) Credits due customers (10,142) (354,282) $ 438,142 $ 839,400	December 31, 2022 2021 Outstanding receivables: Without recourse $ 564,548 $ 579,295 With recourse 352,379 361,584 Advances 118,521 121,617 Credits due customers (196,048) (77,208) $ 839,400 $ 985,288

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	6 Months Ended
GOODWILL AND INTANGIBLE ASSETS (Tables)	Jun. 30, 2023
GOODWILL AND INTANGIBLE ASSETS
Summary of amortized and indefinite-lived intangible assets	Gross Accumulated Carrying Amount Amortization Value Amortized: Customer relationships $ 9,734,560 $ (4,155,129) $ 5,579,431 $ 9,734,560 $ (4,155,129) $ 5,579,431 Indefinite-lived: Brand name $ 5,841,880 — 5,841,880 $ 15,576,440 $ (4,155,129) $ 11,421,311
Schedule of goodwill attributable to each business combination	June 30, December 31, 2023 2022 Bailey $ 3,158,123 $ 3,158,123 Stateside 2,104,056 2,104,056 Sundry 3,711,322 3,711,322 $ 8,973,501 $ 10,103,812

LIABILITIES AND DEBT (Tables)

LIABILITIES AND DEBT (Tables)	6 Months Ended	12 Months Ended
LIABILITIES AND DEBT (Tables)	Jun. 30, 2023	Dec. 31, 2022
LIABILITIES AND DEBT
Schedule of accrued expenses and other liabilities	June 30, December 31, 2023 2022 Accrued expenses $ 503,927 $ 668,714 Reserve for returns — 307,725 Payroll related liabilities 4,009,812 2,618,870 Sales tax liability 277,800 262,765 Other liabilities 247,398 78,845 $ 5,038,937 $ 3,936,920	December 31, 2022 2021 Accrued expenses $ 668,714 $ 178,819 Reserve for returns 307,725 33,933 Payroll related liabilities 2,618,870 1,183,598 Sales tax liability 262,765 225,804 Due to seller — 396,320 Other liabilities 78,845 59,613 $ 3,936,920 $ 2,078,087
Summary of the convertible notes	Unamortized Convertible Note Principal Debt Discount Payable, Net Balance, December 31, 2022 $ 4,100,000 $ (1,378,200) $ 2,721,800 Repayments of notes (4,000,000) — (4,000,000) Amortization of debt discount — 689,100 689,100 Loss on extinguishment of debt — 689,100 689,100 Balance, June 30, 2023 $ 100,000 $ — $ 100,000	Unamortized Convertible Note Principal Debt Discount Payable, Net Balance, December 31, 2020 $ 100,000 $ — $ 100,000 Issuance of Oasis note, net of issuance costs 5,265,000 (715,000) 4,550,000 Issuance of FirstFire First note, net of issuance costs 1,575,000 (315,000) 1,260,000 Issuance of Second FirstFire note, net of issuance costs 2,625,000 (530,000) 2,095,000 Derivative liability in connection with notes — (3,204,924) (3,204,924) Amortization of debt discount — 801,538 801,538 Balance, December 31, 2021 9,565,000 (3,963,386) 5,601,614 Proceeds from issuance of notes 8,943,750 (1,992,500) 6,951,250 Repayments of notes (4,943,750) — (4,943,750) Conversion of notes into common stock (9,465,000) — (9,465,000) Warrant and common shares issued with convertible notes — (1,368,741) (1,368,741) Derivative liability in connection with notes — (559,957) (559,957) Amortization of debt discount — 6,506,384 6,506,384 Balance, December 31, 2022 $ 4,100,000 $ (1,378,200) $ 2,721,800
summary of promissory notes payable, net	June 30, December 31, 2023 2022 Bailey Note $ 3,500,000 $ 3,500,000 Sundry Note — 5,500,000 March 2023 Notes - principal 2,458,750 — March 2023 Notes - unamortized debt discount (344,911) — Promissory note payable, net $ 5,613,839 $ 9,000,000

SHARE-BASED PAYMENTS (Tables)

SHARE-BASED PAYMENTS (Tables)	6 Months Ended	12 Months Ended
SHARE-BASED PAYMENTS (Tables)	Jun. 30, 2023	Dec. 31, 2022
SHARE-BASED PAYMENTS
Summary of information related to common stock and preferred stock warrants	Common Weighted Stock Average Warrants Exercise Price Outstanding - December 31, 2022 176,733 $ 209 Granted 93,099 99.50 Exercised (32,086) 97.88 Forfeited — — Outstanding - June 30, 2023 237,746 $ 181.25 Exercisable at December 31, 2022 171,278 $ 210.50 Exercisable at June 30, 2023 237,745 $ 181.25	Common Weighted Stock Average Warrants Exercise Price Outstanding - December 31, 2020 366 $ 6,650 Granted 1,205 11,450 Conversion of preferred stock warrants upon IPO 21 19,150 Exercised (155) 11,425 Forfeited (4) 19,150 Outstanding - December 31, 2021 1,432 $ 10,300 Granted 241,308 140.36 Exercised (66,007) 131.25 Forfeited — — Outstanding - December 31, 2022 176,733 $ 209.23 Exercisable at December 31, 2021 1,432 $ 10,300 Exercisable at December 31, 2022 171,278 $ 210.41
Summary of information related to stock options under stock plan		Weighted Average Options Exercise Price Outstanding - December 31, 2020 485 $ 5,850 Granted 1,093 10,375 Exercised — — Forfeited — — Outstanding - December 31, 2021 1,558 $ 9,053 Granted — — Exercised — — Forfeited — — Outstanding - December 31, 2022 1,558 $ 9,053 Exercisable at December 31, 2021 1,266 $ 8,975 Exercisable at December 31, 2022 1,389 $ 10,125 Weighted average duration (years) to expiration of outstanding options at December 31, 2022 7.00
Schedule of assumptions utilized for option grants		Year Ended December 31, 2022 2021 Risk Free Interest Rate n/a 0.34% - 0.85 % Expected Dividend Yield n/a 0.00 % Expected Volatility n/a 58.00 % Expected Life (years) n/a 5.18

NATURE OF OPERATIONS (Details)

NATURE OF OPERATIONS (Details) - USD ($)			6 Months Ended	12 Months Ended
NATURE OF OPERATIONS (Details) - USD ($)	Jun. 21, 2023	May 13, 2021	Jun. 30, 2023	Dec. 31, 2022	Dec. 30, 2022	Aug. 30, 2021	May 18, 2021
NATURE OF OPERATIONS
Aggregate net proceeds from the IPO, inclusive of the proceeds from the over-allotment exercise				$ 8,100,000
Aggregate cash payment agreed to pay	$ 229,000
D.Jones (H&J Seller) \| H&J Settlement Agreement
NATURE OF OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	78,103		78,103
Percentage of membership interest transferred	100%
D.Jones (H&J Seller) \| Harper & Jones, LLC \| H&J Settlement Agreement
NATURE OF OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	78,103
D.Jones (H&J Seller) \| Disposal group, Disposed by sale \| Harper & Jones, LLC \| H&J Settlement Agreement
NATURE OF OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	78,103
Percentage of membership interest transferred	100%
IPO
NATURE OF OPERATIONS
Underwriting discounts and commissions		$ 800,000
Estimated offering expenses		600,000
Additional offering costs		$ 600,000
Share issued price		$ 10,375		$ 625
Aggregate net proceeds from the IPO, inclusive of the proceeds from the over-allotment exercise		$ 8,600,000
Harper & Jones
NATURE OF OPERATIONS
Percentage of equity acquired							100%
Stateside
NATURE OF OPERATIONS
Percentage of equity acquired						100%
Sundry
NATURE OF OPERATIONS
Percentage of equity acquired					100%

GOING CONCERN (Details)

GOING CONCERN (Details) - USD ($)	6 Months Ended		12 Months Ended
GOING CONCERN (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
GOING CONCERN
Net loss	$ 1,092,088	$ 17,366,866	$ 38,043,362	$ 32,357,957
Working capital deficit	$ 16,037,518		$ 32,064,398

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)					3 Months Ended		6 Months Ended		12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	Jun. 21, 2023 USD ($) shares	Oct. 21, 2022	May 18, 2021	May 12, 2021	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) shares	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Reverse stock split conversion ratio		0.01	1	0.064
Reclassification adjustment						$ 297,696		$ 630,976
Cash and cash equivalents in bank deposit					$ 250,000		$ 250,000		$ 250,000
Fair value of contingent consideration									12,098,475	$ 12,179,476
Gain in the change in fair value of contingent consideration					$ (10,698,475)	$ 5,920,919	$ (10,698,475)	$ 7,121,240	564,303	8,764,460
Aggregate cash payment agreed to pay	$ 229,000
Bailey LLC
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Fair value of contingent consideration									10,698,475	7,935,016
Harper & Jones, LLC
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Fair value of contingent consideration									$ 1,400,000	$ 4,244,460
Norwest investors \| Norwest waiver \| Bailey LLC
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Fair value of contingent consideration	0
Gain in the change in fair value of contingent consideration	10,698,475
D.Jones (H&J Seller) \| H&J Settlement Agreement
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Fair value of contingent consideration	0
Gain in the change in fair value of contingent consideration	$ 1,400,000
Percentage of membership interest transferred	100%
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares) \| shares	78,103						78,103

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Financial Instruments (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Liabilities:
Fair value of contingent consideration	$ 12,098,475	$ 12,179,476
Total	12,098,475
Outstanding as of Opening balance	18,223	6,265
Warrant liability		14,492,419
Outstanding as of Ending balance		18,223
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Initial recognition in connection with acquisition of Harper & Jones		3,421,516
Stock price guarantee per consulting agreement		67,000
Conversion into shares		(73,500)
Repayments to Harper & Jones seller	(645,304)
Harper & Jones, LLC
Liabilities:
Fair value of contingent consideration	1,400,000	4,244,460
Bailey LLC
Liabilities:
Fair value of contingent consideration	$ 10,698,475	7,935,016
Expected Volatility \| Minimum
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the contingent consideration	0.793
Expected Volatility \| Maximum
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the contingent consideration	0.889
Risk Free Interest Rate
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the contingent consideration	0.0025
Expected share
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the contingent consideration	0.05
Stock price \| Harper & Jones, LLC
Liabilities:
Fair value of contingent consideration	$ 10,375,000
Stock price \| Bailey LLC
Liabilities:
Fair value of contingent consideration	828,000
Level 2
Liabilities:
Warrant liability		18,223
Level 3
Liabilities:
Fair value of contingent consideration	12,098,475	12,179,476
Total	$ 12,098,475
Warrant liability		$ 14,474,196

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Deferred Offering Costs (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2020
Restructuring Cost and Reserve
Deferred offering costs		$ 214,647
Harper & Jones, LLC
Restructuring Cost and Reserve
Repayments of notes	$ 645,304

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventory (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Raw materials	$ 1,508,416	$ 1,611,134	$ 292,167
Work in process	653,412	888,643	242,673
Finished goods	2,609,443	2,725,505	2,220,519
Inventory	$ 4,771,271	$ 5,225,282	$ 2,660,203

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Impairment (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)
Indefinite-lived Intangible Assets
Impairment loss of consolidated statements of operations	$ 3,667,000
Impairment of goodwill	3,321,095
Bailey Goodwill
Indefinite-lived Intangible Assets
Impairment of goodwill	$ 3,321,095

SUMMARY OF SIGNIFICANT ACCOUN_9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss per Share Computation (Details) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Numerator:
Net income (loss) from continuing operations	$ 6,536,310		$ (9,482,520)		$ 470,415	$ (17,200,792)	$ (27,114,719)	$ (31,334,084)
Income (loss) from discontinued operations, net of tax	(1,492,050)		(51,404)		(1,562,503)	(166,074)	(10,928,643)	(1,023,873)
Net income (loss)	$ 5,044,260	$ (6,136,349)	$ (9,533,924)	$ (7,832,942)	$ (1,092,088)	$ (17,366,866)	$ (38,043,362)	$ (32,357,957)
Denominator:
Weighted average common shares outstanding - basic	246,809		14,329		236,824	9,836	30,852	3,052
Weighted average common shares outstanding -diluted	834,604		14,329		824,619	9,836	30,852	3,052
Net income (loss) from continuing per common share - basic	$ 26.48		$ (661.78)		$ 1.99	$ (1,748.68)	$ (878.87)	$ (10,268.22)
Net income (loss) from continuing per common share - diluted	7.83		(661.78)		0.57	(1,748.68)	$ (878.87)	$ (10,268.22)
Net income (loss) from discontinued operations per common share - basic	(6.05)		(3.59)		(6.60)	(16.88)
Net income (loss) from discontinued operations per common share - diluted	(6.05)		(3.59)		(6.60)	(16.88)
Net income (loss) per share - basic	20.44		(665.36)		(4.61)	(1,765.57)
Net income (loss) per share - diluted	$ 6.04		$ (665.36)		$ (4.61)	$ (1,765.57)

SUMMARY OF SIGNIFICANT ACCOU_10

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss per Share (Details) - shares	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Potentially dilutive items outstanding
Total potentially dilutive shares	587,795	22,588	220,526	4,907
Stock options
Potentially dilutive items outstanding
Total potentially dilutive shares	1,558	1,558	1,558	1,558
Convertible notes
Potentially dilutive items outstanding
Total potentially dilutive shares		18,496	37,915	1,916
Series A convertible preferred stock
Potentially dilutive items outstanding
Total potentially dilutive shares	27,097		4,320
Series C convertible preferred stock
Potentially dilutive items outstanding
Total potentially dilutive shares	321,395
Common stock warrants
Potentially dilutive items outstanding
Total potentially dilutive shares	237,746	2,533	176,733	1,432

SUMMARY OF SIGNIFICANT ACCOU_11

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Unaudited Pro Forma Financial Information (Details) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Net revenues		$ 14,728,296	$ 28,519,261	$ 34,635,426
Net loss		$ (16,907,152)	$ (42,001,415)	$ (33,171,473)
Net loss per common share , Basic		$ (1,718.83)	$ (1,361.50)	$ (10,870.25)
Net loss per common share , Diluted	$ (1,718.83)

DISCONTINUED OPERATIONS - Busin

DISCONTINUED OPERATIONS - Business disposition (Details) - USD ($)		3 Months Ended	6 Months Ended
	Jun. 21, 2023	Jun. 30, 2023	Jun. 30, 2023
DISCONTINUED OPERATIONS
Cash payment due to H&J Seller	$ (229,000)
Common shares issued to H&J Seller*	(1,357,043)	$ (1,357,043)
Total fair value of consideration received (given)	(1,586,043)
Carrying amount of assets and liabilities
Cash and cash equivalents	18,192
Accounts receivable, net	55,782
Prepaid expenses and other current assets	25,115
Goodwill	1,130,311
Intangible assets, net	1,246,915
Deposits	4,416
Accounts payable	(40,028)
Accrued expenses and other liabilities	(734,068)
Deferred revenue	(18,347)
Due to related parties	(1,008)
Contingent consideration	(1,400,000)
Loan payable	(219,894)
Note payable - related party	(129,489)
Total carrying amount of assets and liabilities	62,103
Loss on disposition of business	(1,523,940)		$ (1,523,940)
Disposal group, Disposed by sale
Carrying amount of assets and liabilities
Loss on disposition of business	$ 1,523,940
Harper & Jones, LLC \| Disposal group, Disposed by sale
Carrying amount of assets and liabilities
Goodwill		1,130,311	1,130,311
Intangible assets, net		$ 1,246,915	$ 1,246,915

DISCONTINUED OPERATIONS - Addit

DISCONTINUED OPERATIONS - Additional information (Details) - USD ($)		6 Months Ended
	Jun. 21, 2023	Jun. 30, 2023
DISCONTINUED OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Loss on disposition of business	(1,523,940)	$ (1,523,940)
H&J Settlement Agreement \| D.Jones (H&J Seller)
DISCONTINUED OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Percentage of membership interest transferred	100%
Issuance of common stock pursuant to disposition (in shares)	78,103	78,103
Disposal group, Disposed by sale
DISCONTINUED OPERATIONS
Loss on disposition of business	$ 1,523,940
Harper & Jones, LLC \| H&J Settlement Agreement \| D.Jones (H&J Seller)
DISCONTINUED OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	78,103
Harper & Jones, LLC \| Disposal group, Disposed by sale \| H&J Settlement Agreement \| D.Jones (H&J Seller)
DISCONTINUED OPERATIONS
Aggregate cash payment agreed to pay	$ 229,000
Percentage of membership interest transferred	100%
Issuance of common stock pursuant to disposition (in shares)	78,103
Payments made		$ 150,000
Remaining consideration payable		$ 79,000

DISCONTINUED OPERATIONS - Conso

DISCONTINUED OPERATIONS - Consolidated statements of operations of discontinued operations of HJ (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
DISCONTINUED OPERATIONS
Net revenues	$ 4,493,424	$ 2,649,432	$ 8,869,803	$ 5,278,562	$ 10,333,558	$ 5,764,963
Cost of net revenues	2,157,349	1,536,703	4,540,488	3,552,396	6,789,314	3,828,496
Gross profit	2,336,075	1,112,729	4,329,315	1,726,166	3,544,244	1,936,467
Operating expenses:
General and administrative	4,074,051	4,243,031	8,380,063	8,073,621	14,067,681	16,149,510
Sales and marketing	1,097,326	1,372,568	2,036,677	2,230,087	4,018,985	3,269,710
Distribution	242,214	221,925	512,399	424,773	611,569	489,371
Change in fair value of contingent consideration	(10,698,475)	5,920,919	(10,698,475)	7,121,240	564,303	8,764,460
Total operating expenses	(5,284,884)	11,758,443	230,664	17,849,721	24,765,633	32,073,050
Income (loss) from operations	7,620,959	(10,645,714)	4,098,651	(16,123,555)	(21,221,389)	(30,136,583)
Other income (expense):
Interest expense	(1,086,889)	(2,173,769)	(2,951,487)	(3,730,612)	(8,961,410)	(3,619,093)
Other non-operating income (expenses)	2,240	3,336,963	(676,749)	2,653,375	3,068,080	1,321,472
Total other income (expense), net	(1,084,649)	1,163,194	(3,628,236)	(1,077,237)	(5,893,330)	(2,297,621)
Income tax benefit (provision)						1,100,120
Net income (loss) from discontinued operations	$ (1,492,050)	$ (51,404)	$ (1,562,503)	$ (166,074)	$ (10,928,643)	$ (1,023,873)
Weighted average common shares outstanding - basic	246,809	14,329	236,824	9,836	30,852	3,052
Weighted average common shares outstanding -diluted	834,604	14,329	824,619	9,836	30,852	3,052
Net income (loss) from discontinued operations per common share - basic	$ (6.05)	$ (3.59)	$ (6.60)	$ (16.88)
Net income (loss) from discontinued operations per common share - diluted	$ (6.05)	$ (3.59)	$ (6.60)	$ (16.88)
Harper & Jones, LLC
DISCONTINUED OPERATIONS
Net revenues	$ 686,627	$ 1,089,569	$ 1,405,482	$ 1,892,849
Cost of net revenues	292,107	328,915	565,621	605,413
Gross profit	394,520	760,654	839,861	1,287,436
Operating expenses:
General and administrative	189,751	449,508	520,582	896,873
Sales and marketing	169,875	332,723	346,167	515,775
Total operating expenses	359,626	782,231	866,749	1,412,648
Income (loss) from operations	34,894	(21,577)	(26,888)	(125,212)
Other income (expense):
Interest expense	(3,003)	(29,828)	(11,675)	(40,862)
Loss on disposition of business	(1,523,940)		(1,523,940)
Total other income (expense), net	(1,526,944)	(29,828)	(1,535,615)	(40,862)
Income tax benefit (provision)	0		0
Net income (loss) from discontinued operations	$ (1,492,050)	$ (51,404)	$ (1,562,503)	$ (166,074)
Weighted average common shares outstanding - basic	246,809	14,329	236,824	9,836
Weighted average common shares outstanding -diluted	834,604	14,329	824,619	9,836
Net income (loss) from discontinued operations per common share - basic	$ (6.05)	$ (3.59)	$ (6.60)	$ (16.88)
Net income (loss) from discontinued operations per common share - diluted	$ (6.05)	$ (3.59)	$ (6.60)	$ (16.88)

DUE FROM FACTOR (Details)

DUE FROM FACTOR (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Outstanding receivables:
Without recourse, Current	$ 787,542	$ 1,680,042	$ 579,295
With recourse, Current	50,979	65,411	361,584
Matured funds and deposits	88,516	81,055
Advances	478,753	632,826
Credits due customers, Current	(10,142)	(354,282)	(77,208)
Due from factor	$ 438,142	$ 839,400	$ 985,288

GOODWILL AND INTANGIBLE ASSET_2

GOODWILL AND INTANGIBLE ASSETS - Summary of goodwill by entity (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021	Aug. 30, 2021	Dec. 31, 2020
GOODWILL AND INTANGIBLE ASSETS
Goodwill	$ 8,973,501	$ 10,103,812	$ 8,583,274		$ 6,479,218
Bailey
GOODWILL AND INTANGIBLE ASSETS
Goodwill	3,158,123	3,158,123	6,479,218		$ 6,479,218
Stateside
GOODWILL AND INTANGIBLE ASSETS
Goodwill	2,104,056	2,104,056	$ 2,104,056	$ 2,104,056
Sundry
GOODWILL AND INTANGIBLE ASSETS
Goodwill	$ 3,711,322	$ 3,711,322

GOODWILL AND INTANGIBLE ASSET_3

GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Jun. 21, 2023
Indefinite-lived Intangible Assets
Gross Amount	$ 9,734,560		$ 9,734,560		$ 9,734,560	$ 4,736,080
Accumulated Amortization	(4,155,129)		(4,155,129)		(2,670,202)	(1,091,509)
Carrying Value	5,579,431		5,579,431		7,064,358	3,644,571
Indefinite-lived	15,576,440		15,576,440		15,576,440	10,354,640
Intangible assets, net	11,421,311		11,421,311		12,906,238	9,263,131
Amortization expense	804,924	$ 537,812	1,759,277	$ 1,075,625	1,653,819	1,128,524
Goodwill							$ 1,130,311
Intangible assets, net							$ 1,246,915
Harper & Jones, LLC \| Disposal group, Disposed by sale
Indefinite-lived Intangible Assets
Goodwill	1,130,311		1,130,311
Intangible assets, net	1,246,915		1,246,915
Customer relationships
Indefinite-lived Intangible Assets
Gross Amount	9,734,560		9,734,560		9,734,560	4,736,080
Accumulated Amortization	(4,155,129)		(4,155,129)		(2,670,202)	(1,091,509)
Carrying Value	5,579,431		5,579,431		7,064,358	3,644,571
Brand name
Indefinite-lived Intangible Assets
Indefinite-lived	$ 5,841,880		$ 5,841,880			5,618,560
Intangible assets, net					$ 5,841,880	$ 5,618,560

LIABILITIES AND DEBT - Accrued

LIABILITIES AND DEBT - Accrued Expenses and Other Liabilities (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
LIABILITIES AND DEBT
Accrued expenses	$ 503,927	$ 668,714	$ 178,819
Reserve for returns		307,725	33,933
Payroll related liabilities	4,009,812	2,618,870	1,183,598
Sales tax liability	277,800	262,765	225,804
Other liabilities	247,398	78,845	59,613
Accrued expenses and other liabilities, Total	5,038,937	3,936,920	2,078,087
Estimated penalties associated with accrued payroll taxes	1,288,048	1,074,316
Accrued expenses included in accrued common stock	535,000	$ 535,000
Accrued expenses included in accrued common stock issuances owned to sundry executives	$ 500,000
Number of common shares owed per the agreement	5,000	200
Due to seller			$ 396,320
DBG
LIABILITIES AND DEBT
Sales tax liability	$ 620,400	$ 539,839
Bailey
LIABILITIES AND DEBT
Sales tax liability	$ 667,648	$ 534,477

LIABILITIES AND DEBT - Converti

LIABILITIES AND DEBT - Convertible Debt (Details) - USD ($)	12 Months Ended
LIABILITIES AND DEBT - Convertible Debt (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2019	Jun. 30, 2023	Dec. 31, 2022
Convertible Debt 2020 Regulation CF Offering
LIABILITIES AND DEBT
Outstanding principal and accrued interest upon closing of IPO	$ 16,942
Conversion of shares	12,786
Convertible Debt 2020 Regulation CF Offering \| Convertible Debt
LIABILITIES AND DEBT
Issuance costs	$ 69,627
Convertible Debt 2020 Regulation D Offering
LIABILITIES AND DEBT
Outstanding principal and accrued interest upon closing of IPO	100,000		$ 100,000	$ 100,000
Default interest expense	132,609
Convertible Debt 2020 Regulation D Offering \| IPO
LIABILITIES AND DEBT
Outstanding principal and accrued interest upon closing of IPO	$ 185,000
Convertible Debt 2020 Regulation D Offering \| Convertible Debt
LIABILITIES AND DEBT
Debt instrument term	9 months
Convertible Debt 2019 Regulation D Offering \| Convertible Debt
LIABILITIES AND DEBT
Debt instrument term		36 months

LIABILITIES AND DEBT - Conver_2

LIABILITIES AND DEBT - Convertible Promissory Note (Details) - USD ($)				1 Months Ended						3 Months Ended	6 Months Ended		12 Months Ended
	May 30, 2023	Dec. 29, 2022	Apr. 08, 2022	Feb. 28, 2023	Jan. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	May 31, 2022	Nov. 30, 2021	Mar. 31, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Nov. 16, 2021	Oct. 01, 2021	Aug. 27, 2021
LIABILITIES AND DEBT
Repayments of debt											$ 6,604,552	$ 3,068,750	$ 7,350,276	$ 2,006,628
Exercise price of warrants											$ 95
Outstanding principal amount converted											$ 888,930
Number of shares issued							30				50,890
Value of shares issued	$ 25,000									$ 5,000,003
Loss on extinguishment of debt											$ (689,100)
Promissory note
LIABILITIES AND DEBT
Number of shares issued					4,400
Value of shares issued					$ 322,300
Promissory note
LIABILITIES AND DEBT
Principal, beginning balance					4,100,000					4,100,000	4,100,000	9,565,000	9,565,000	100,000
Unamortized Debt Discount, beginning balance					1,378,200					1,378,200	1,378,200	3,963,386	3,963,386
Convertible Note Payable, Net beginning balance					2,721,800					2,721,800	2,721,800	$ 5,601,614	5,601,614	100,000
Shares issued to notes payable holders												350
Outstanding principal amount converted												$ 888,930
Amortization of debt discount											689,100	1,724,291	6,506,384	801,538
Principal, ending balance						$ 4,100,000							4,100,000	9,565,000
Unamortized Debt Discount, ending balance						1,378,200							1,378,200	3,963,386
Convertible Note Payable, Net ending balance						2,721,800							2,721,800	5,601,614
Oasis Note
LIABILITIES AND DEBT
Aggregate principal amount						5,265,000							5,265,000				$ 5,265,000
Number of shares issued									40
Amortization of debt discount													6,506,384	801,538
Oasis Note \| Promissory note
LIABILITIES AND DEBT
Principal, beginning balance												5,265,000	5,265,000
Unamortized Debt Discount, beginning balance												715,000	715,000
Principal, ending balance														5,265,000
Unamortized Debt Discount, ending balance														715,000
First Fire First Note
LIABILITIES AND DEBT
Aggregate principal amount																$ 1,575,000
First Fire First Note \| Promissory note
LIABILITIES AND DEBT
Principal, beginning balance												1,575,000	1,575,000
Unamortized Debt Discount, beginning balance												315,000	315,000
Principal, ending balance														1,575,000
Unamortized Debt Discount, ending balance														315,000
Second First Fire Note
LIABILITIES AND DEBT
Aggregate principal amount															$ 2,625,000
Second First Fire Note \| Promissory note
LIABILITIES AND DEBT
Principal, beginning balance												2,625,000	2,625,000
Unamortized Debt Discount, beginning balance												530,000	530,000
Principal, ending balance														2,625,000
Unamortized Debt Discount, ending balance														530,000
Oasis and FirstFire Notes
LIABILITIES AND DEBT
Principal, beginning balance												9,465,000	$ 9,465,000
Shares issued to notes payable holders													79,807
Outstanding principal amount converted													$ 9,465,000
Principal, ending balance														9,465,000
Derivative liability \| Promissory note
LIABILITIES AND DEBT
Unamortized Debt Discount, beginning balance					559,957					559,957	559,957	$ 3,204,924	3,204,924
Unamortized Debt Discount, ending balance						559,957							559,957	3,204,924
Proceeds from issuance of notes \| Promissory note
LIABILITIES AND DEBT
Principal, beginning balance					8,943,750					8,943,750	8,943,750
Unamortized Debt Discount, beginning balance					1,992,500					1,992,500	1,992,500
Principal, ending balance						8,943,750							8,943,750
Unamortized Debt Discount, ending balance						1,992,500							1,992,500
Repayments of notes
LIABILITIES AND DEBT
Repayments of notes											(4,000,000)
Repayments of notes \| Promissory note
LIABILITIES AND DEBT
Repayments of notes													(4,943,750)
Warrant and common shares issued with convertible notes \| Promissory note
LIABILITIES AND DEBT
Unamortized Debt Discount, beginning balance					1,368,741					1,368,741	1,368,741
Unamortized Debt Discount, ending balance						1,368,741							1,368,741
PPP Loan
LIABILITIES AND DEBT
Aggregate principal amount														$ 203,994
April Notes \| Securities purchase agreement
LIABILITIES AND DEBT
Aggregate principal amount			$ 3,068,750
Original issue discount			613,750
Net proceeds			$ 2,313,750
Repayments of debt								$ 3,068,750
Number of warrants issued to purchase common stock			503
Exercise price of warrants			$ 3,050
Debt discount for the fair value of the warrants			$ 98,241
Unamortized Debt Discount, ending balance			$ 755,000
July Notes \| Securities purchase agreement
LIABILITIES AND DEBT
Aggregate principal amount						1,875,000							1,875,000
Original issue discount						375,000							375,000
Net proceeds													$ 1,450,000
Repayments of debt						$ 1,875,000
July 22 Notes \| Securities purchase agreement
LIABILITIES AND DEBT
Number of warrants issued to purchase common stock						1,645							1,645
Exercise price of warrants						$ 380							$ 380
July 28 Notes \| Securities purchase agreement
LIABILITIES AND DEBT
Number of warrants issued to purchase common stock						1,106							1,106
Exercise price of warrants						$ 282.50							$ 282.50
Debt discount for the fair value of the warrants						$ 692,299							$ 692,299
December Notes
LIABILITIES AND DEBT
Principal, beginning balance					4,000,000					4,000,000	4,000,000
Unamortized Debt Discount, beginning balance					1,278,200					1,278,200	$ 1,278,200
Number of shares issued													2,400
Principal, ending balance						4,000,000							$ 4,000,000
Unamortized Debt Discount, ending balance						$ 1,278,200							$ 1,278,200
December Notes \| Securities purchase agreement
LIABILITIES AND DEBT
Aggregate principal amount		$ 4,000,000
Original issue discount		800,000
Net proceeds		$ 3,000,000
Percentage of increase in face value		120%
Percentage of annual interest rate		20%
Repayments of debt				$ 4,000,000
Number of warrants issued to purchase common stock						18,779					18,779		18,779
Exercise price of warrants						$ 106.50					$ 106.50		$ 106.50
Debt discount for the fair value of the warrants						$ 428,200					$ 428,200		$ 428,200
Number of shares issued											2,400		2,400
Amortization of debt discount				689,100
Loss on extinguishment of debt				$ 689,100
Unamortized Debt Discount, ending balance											$ 1,378,200
Convertible Promissory Note
LIABILITIES AND DEBT
Principal, beginning balance					4,100,000					4,100,000	4,100,000
Unamortized Debt Discount, beginning balance					1,378,200					1,378,200	1,378,200
Convertible Note Payable, Net beginning balance					$ 2,721,800					$ 2,721,800	2,721,800
Amortization of debt discount											689,100
Loss on extinguishment of debt											689,100
Principal, ending balance						4,100,000					100,000		$ 4,100,000
Unamortized Debt Discount, ending balance						1,378,200							1,378,200
Convertible Note Payable, Net ending balance						$ 2,721,800					$ 100,000		$ 2,721,800
July 22 notes \| Securities purchase agreement
LIABILITIES AND DEBT
Exercise price of warrants						$ 380							$ 380
July 28 notes \| Securities purchase agreement
LIABILITIES AND DEBT
Exercise price of warrants						$ 282.50							$ 282.50

LIABILITIES AND DEBT - Loan Pay

LIABILITIES AND DEBT - Loan Payable - PPP and SBA Loan (Details) - USD ($)	1 Months Ended	12 Months Ended
	Apr. 30, 2022	Dec. 31, 2022	Jun. 30, 2023	Dec. 31, 2021
H&J
LIABILITIES AND DEBT
Note payable - related party		$ 129,489		$ 299,489
Aggregate of principal amount		73,187		$ 72,269
Proceeds from loan originations		$ 140,000
Interest rates of notes		12%
PPP Loan \| Bailey LLC
LIABILITIES AND DEBT
Convertible Note Payable, Net		$ 933,295	$ 933,295
1st PPP loan \| Bailey LLC
LIABILITIES AND DEBT
Loan forgiveness amount	$ 413,705
2nd PPP loan \| Bailey LLC
LIABILITIES AND DEBT
Loan forgiveness amount	$ 1,347,050

LIABILITIES AND DEBT- Merchant

LIABILITIES AND DEBT- Merchant Advances (Details) - USD ($)	6 Months Ended	12 Months Ended
LIABILITIES AND DEBT- Merchant Advances (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
LIABILITIES AND DEBT
Exercise price per share	$ 95
Merchant Advance from Shopify Capital
LIABILITIES AND DEBT
Secured Debt	$ 293,635
Proceeds from debt	502,051
Repayments	208,416
Merchant Advances
LIABILITIES AND DEBT
Secured Debt	257,110	$ 896,334
Net proceeds	1,692,748	1,335,360
Repayments of debt	$ 2,331,972	$ 1,078,385
Warrants issued	6,095
Exercise price per share	$ 131.25

LIABILITIES AND DEBT - Promisso

LIABILITIES AND DEBT - Promissory Note Payable (Details)		1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
LIABILITIES AND DEBT - Promissory Note Payable (Details)	Jun. 21, 2023 $ / shares shares	Mar. 31, 2023 USD ($) $ / shares	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) shares	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Feb. 15, 2023 USD ($)	Apr. 30, 2021 USD ($)	Feb. 28, 2021 USD ($)
Debt Instrument
Issue price per share \| $ / shares		$ 4.20
Debt Discount Cost							$ 263,958
Net proceeds							3,280,360	$ 2,779,910
Promissory note payable, net			$ 5,613,839		$ 5,613,839		9,000,000	3,500,000
Common Stock
Debt Instrument
Shares issued to notes payable holders \| shares					350
Bailey LLC
Debt Instrument
Aggregate principal amount									$ 5,500,000
Promissory note, annual interest rate (as a percent)									8%
Securities purchase agreement \| Series C convertible preferred stock
Debt Instrument
Shares issued to notes payable holders \| shares	5,761
Issue price per share \| $ / shares	$ 1,000
Promissory note payable
Debt Instrument
Aggregate principal amount							3,500,000			$ 1,000,000
Debt discount							$ 73,958
Promissory note payable \| Secondary Public Offering
Debt Instrument
Percentage of outstanding principal							10
Promissory note payable \| Secondary Public Offering \| Maximum
Debt Instrument
Aggregate principal amount							$ 4,000,000
Promissory note payable \| Secondary Public Offering \| Minimum
Debt Instrument
Aggregate principal amount							2,000,000
Promissory note payable \| Bailey LLC
Debt Instrument
Aggregate principal amount							4,500,000
Promissory note payable \| Notes Payable to Banks
Debt Instrument
Interest expense							$ 420,000	494,000
Promissory note, annual interest rate (as a percent)							12%
PPP Loan
Debt Instrument
Aggregate principal amount								203,994
PPP Loan \| Bailey LLC
Debt Instrument
Aggregate principal amount								$ 204,000			$ 407,994
Bailey Note
Debt Instrument
Aggregate principal amount			3,500,000		$ 3,500,000		$ 3,500,000
Interest expense			105,000	$ 105,000	210,000	$ 210,000
Promissory note payable, net			3,500,000		3,500,000		3,500,000
Sundry Note
Debt Instrument
Interest expense			149,177		259,177
Promissory note, annual interest rate (as a percent)									8%
Promissory note payable, net			5,500,000		5,500,000		$ 5,500,000
Sundry Note \| Securities purchase agreement
Debt Instrument
Cancellation of principal amount					5,500,000
Accrued interest converted					259,177
Sundry Note \| Securities purchase agreement \| Series C convertible preferred stock
Debt Instrument
Shares issued to notes payable holders \| shares	5,761
Issue price per share \| $ / shares	$ 1,000
March 2023 Notes
Debt Instrument
Debt discount			$ 608,750		$ 608,750
Original issue discount		$ 608,750
Net proceeds		1,850,000
Prepayment penalty			0%		0%
Percentage of notes to be repaid, if the Company completes a debt or equity financing of less than the threshold amount					$ 7,500,000
Percentage of notes to be repaid, if the Company completes a debt or equity financing of amount equal to or greater than the threshold amount			100%		100%
Penalty percentage on notes to be repaid, if the Company completes a debt or equity financing of amount equal to or greater than the threshold amount			0%		0%
Additional interest percentage			0%		0%
Original interest discount percentage			20%		20%
Amortization of debt discount					$ 263,839
Debt discount			$ (344,911)		(344,911)
Promissory note payable, net		$ 2,458,750	$ 2,458,750		$ 2,458,750
Percentage of notes to be repaid, if the Company completes a debt or equity financing of less than the threshold amount			50%		50%

STOCKHOLDERS' DEFICIT (Details)

STOCKHOLDERS' DEFICIT (Details) - USD ($)

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Jun. 21, 2023

May 30, 2023

Jan. 11, 2023

Nov. 29, 2022

Nov. 16, 2021

Jun. 28, 2021

May 18, 2021

May 13, 2021

Mar. 31, 2023

Jan. 31, 2023

Sep. 30, 2022

Dec. 31, 2021

Nov. 30, 2021

Jul. 31, 2021

May 31, 2021

Jun. 30, 2023

Mar. 31, 2023

Jun. 30, 2023

Dec. 31, 2022

Dec. 31, 2021

Class of Stock

Number of shares issued

50,890

Value of shares issued

$ 25,000

$ 5,000,003

Stock issued (in shares)

4,756

Stock issued

$ 499,338

Issue price (in dollars per share)

$ 4.20

Issuance of common stock pursuant to disposition

$ 1,357,043

Converted outstanding principal

$ 888,930

Percentage of affirmative votes required to remove directors from the Board

66.3333%

Reverse stock split approved

1-for-15.625

voting rights

one vote per share

Common stock issued pursuant to consulting agreement

$ 123,000

$ 595,500

Proceeds from issuance of common stock

8,100,000

Net proceeds of after deducting underwriting discounts and commissions

700,000

Direct offering expenses

500,000

Exercise of warrants

1,768,046

Deferred offering costs

$ 367,696

104,512

367,696

Interest expense

$ 427,700

$ 573,455

$ 825,219

Promissory note

Class of Stock

Number of shares issued

4,400

Value of shares issued

$ 322,300

Common Stock

Class of Stock

Number of shares issued

50,890

Value of shares issued

$ 5

Stock issued (in shares)

4,756

Number of shares resulting from conversion

350

Gross proceeds

$ 5,000,000

Net proceeds

$ 4,300,000

Issuance of common stock pursuant to disposition (in shares)

78,103

Issuance of common stock pursuant to disposition

$ 8

Warrants were exercised

142

Exercise of warrants

$ 1,622,350

$ 145,696

Common stock issued pursuant to consulting agreement (in shares)

Common Warrant

Class of Stock

Warrants issued

19,000

Volume-Weighted Average

$ 97.875

Number of shares resulting from conversion

32,086

Common Warrant | Common Stock

Class of Stock

Number of shares issued

19,000

Pre-funded warrants

Class of Stock

Number of shares issued

32,086

Warrants issued

32,086

Volume-Weighted Average

$ 97.875

Number of shares resulting from conversion

32,086

Securities purchase agreement

Class of Stock

Gross proceeds

$ 10,000,000

Securities purchase agreement | Common Stock

Class of Stock

Number of shares issued

72,727

Warrants issued

6,720

Proceeds from issuance of common stock

$ 9,000,000

Securities purchase agreement | Pre-funded warrants

Class of Stock

Warrants issued

66,007

H&J Settlement Agreement | D.Jones (H&J Seller)

Class of Stock

Issuance of common stock pursuant to disposition (in shares)

78,103

Issuance of common stock pursuant to disposition

$ 1,400,000

$ 1,357,043

FirstFire

Class of Stock

Number of shares issued

Oasis and FirstFire Notes

Class of Stock

Number of shares resulting from conversion

79,807

Converted outstanding principal

$ 9,465,000

Private Placement

Class of Stock

Number of shares issued

19,000

Aggregate amount issued to investor

$ 5,000,000

IPO

Class of Stock

Number of shares issued

964

14,956

Issue price (in dollars per share)

$ 575

Warrants issued

1,111

Converted outstanding principal

$ 2,680,289

Number of shares agreed to issued and sell

14,956

Number of option days granted to purchase an additional shares

45 days

Gross proceeds from the offering

$ 9,300,000

Proceeds from issuance of common stock

$ 8,600,000

Maximum number of additional shares allowed to purchase within 45 option days

2,243

Aggregate net proceeds

8,600,000

Underwriting commissions

800,000

Direct offering expenses

$ 600,000

Underwriting discounts and commissions

$ 800,000

Share issued price

$ 10,375

$ 625

IPO | Common Stock

Class of Stock

Number of shares issued

964

Issue price (in dollars per share)

$ 10,375

Number of shares resulting from conversion

454

Over-allotment option

Class of Stock

Warrants issued

145

Over-allotment option | Common Stock

Class of Stock

Number of shares issued

145

Issue price (in dollars per share)

$ 10,375

Aggregate net proceeds

$ 1,400,000

Underwriting discounts and commissions

$ 100,000

Consulting agreement

Class of Stock

Number of shares issued

Value of shares issued

$ 60

Guaranteed equity value of shares issued

$ 250,000

Issued upon settlement of contingent liability

STOCKHOLDERS' DEFICIT - Series

STOCKHOLDERS' DEFICIT - Series B Preferred Stock (Details) - USD ($)		1 Months Ended	3 Months Ended	6 Months Ended
	May 30, 2023	Sep. 30, 2022	Mar. 31, 2023	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Class of Stock
Number of shares issued		30		50,890
Value of shares issued	$ 25,000		$ 5,000,003
Common stock par value				$ 0.0001	$ 0.0001	$ 0.0001
Consideration upon redemption	$ 25,000
Series A preferred stock
Class of Stock
Preferred stock, par value (in dollars per share)	$ 0.0001			$ 0.0001	$ 0.0001	$ 0.0001
Series B Preferred Stock
Class of Stock
Preferred stock, par value (in dollars per share)	$ 0.0001
Number of votes per share	250,000,000
Series B Preferred Stock \| Subscription Agreement \| John Hilburn Davis IV
Class of Stock
Preferred stock, par value (in dollars per share)	$ 0.0001

STOCKHOLDERS' DEFICIT - Serie_2

STOCKHOLDERS' DEFICIT - Series C Convertible Preferred Stock (Details) - USD ($)	Jun. 21, 2023	Jun. 20, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Class of Stock
Issue price (in dollars per share)				$ 4.20
Series C convertible preferred stock
Class of Stock
Preferred stock, par value (in dollars per share)			$ 0.0001		$ 0.0001
Redemption percentage	112%
Series C convertible preferred stock \| Securities purchase agreement
Class of Stock
Number of shares resulting from conversion	5,761
Preferred stock, par value (in dollars per share)	$ 0.0001
Issue price (in dollars per share)	$ 1,000
Convertible preferred stock value	$ 1,000
Conversion price (in dollars per share)	$ 17.925
Number of trading days	5 days	5 days

RELATED PARTY TRANSACTIONS - (D

RELATED PARTY TRANSACTIONS - (Details) - USD ($)	6 Months Ended		12 Months Ended
RELATED PARTY TRANSACTIONS - (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 10, 2022
RELATED PARTY TRANSACTIONS
Repayments from related parties	$ 57,427	$ 172,036
Due to related parties	$ 472,790		$ 556,225
John Hilburn Davis IV
RELATED PARTY TRANSACTIONS
Additional stock compensation expense			233,184
Interest rate				12%
Notes Payable, Other Payables
RELATED PARTY TRANSACTIONS
Interest rate	0%
Notes Payable, Other Payables \| H&J
RELATED PARTY TRANSACTIONS
Aggregate principal amount			$ 129,489

SHARE-BASED PAYMENTS - Common S

SHARE-BASED PAYMENTS - Common Stock Warrants - General Information (Details) - USD ($)

1 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

May 10, 2022

May 13, 2021

Jul. 31, 2021

May 31, 2021

Apr. 30, 2021

Jun. 30, 2023

Sep. 30, 2021

Dec. 31, 2022

Dec. 31, 2021

Jan. 11, 2023

Nov. 29, 2022

Dec. 31, 2020

SHARE-BASED PAYMENTS

Exercise price per share

$ 95

Aggregate shares of stock options granted

51,086

1,093

Option outstanding exercise price (in dollars per share)

$ 362.11

$ 9,053

$ 5,850

Option outstanding exercise price

$ 362.11

$ 9,053

$ 5,850

Weighted average duration (Years)

5 years

7 years

Class of warrant or right, warrants issued

142

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

51,086

1,093

Warrants value

$ 1,622,350

$ 145,696

IPO

SHARE-BASED PAYMENTS

Warrants issued

1,111

Over-Allotment Option [Member]

SHARE-BASED PAYMENTS

Warrants issued

145

July 22 notes | Securities purchase agreement

SHARE-BASED PAYMENTS

Exercise price per share

$ 380

July 28 notes

SHARE-BASED PAYMENTS

Warrants issued

1,106

July 28 notes | Securities purchase agreement

SHARE-BASED PAYMENTS

Exercise price per share

$ 282.50

Underwriters Warrants

SHARE-BASED PAYMENTS

Warrants issued

598

Exercise price per share

$ 812.50

Percentage of initial exercise price representing the public offering price

130%

Pre-funded warrants

SHARE-BASED PAYMENTS

Warrants issued

32,086

Aggregate shares of stock options granted

32,086

66,007

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

32,086

66,007

Pre-funded warrants | Securities purchase agreement

SHARE-BASED PAYMENTS

Warrants issued

66,007

Class B Warrants

SHARE-BASED PAYMENTS

Aggregate shares of stock options granted

72,727

Option outstanding exercise price (in dollars per share)

$ 131.25

Option outstanding exercise price

$ 131.25

Weighted average duration (Years)

5 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

72,727

Class C Warrants

SHARE-BASED PAYMENTS

Aggregate shares of stock options granted

72,727

Option outstanding exercise price (in dollars per share)

$ 131.25

Option outstanding exercise price

$ 131.25

Weighted average duration (Years)

13 months

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

72,727

Placement Agent Warrant

SHARE-BASED PAYMENTS

Exercise price per share

$ 3,050.35

$ 172

Aggregate shares of stock options granted

3,831

5,455

Weighted average duration (Years)

5 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

3,831

5,455

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable Contractual Term

180 days

Aggregate Warrant

SHARE-BASED PAYMENTS

Warrants issued

6,095

18,779

Exercise price of additional units

$ 131.25

$ 106.50

Warrant to purchase common stock fair value

$ 164,200

Merchant Cash Advance

SHARE-BASED PAYMENTS

Warrants issued

1,760

Exercise price of additional units

$ 125

Common stock | July 22 notes | Securities purchase agreement

SHARE-BASED PAYMENTS

Warrants issued

1,645

Common stock warrants | IPO

SHARE-BASED PAYMENTS

Exercise price per share

$ 12,975

$ 11,425

Class of warrant or right, warrants issued

964

Percentage of warrants exercise price

110%

Warrants expiration term

5 years

Common stock warrants | Over-Allotment Option [Member]

SHARE-BASED PAYMENTS

Class of warrant or right, warrants issued

145

Common stock warrants | April notes

SHARE-BASED PAYMENTS

Warrants issued

503

Exercise price per share

$ 3,050

Common Stock Warrants, Venture Debt Lender

SHARE-BASED PAYMENTS

Exercise price per share

$ 10,375

Class of warrant or right, warrants issued

SHARE-BASED PAYMENTS - Warrants

SHARE-BASED PAYMENTS - Warrants Roll Forward (Details)	6 Months Ended	12 Months Ended
SHARE-BASED PAYMENTS - Warrants Roll Forward (Details)	Jun. 30, 2023 $ / shares shares	Dec. 31, 2022 $ / shares shares	Dec. 31, 2021 $ / shares shares
SHARE-BASED PAYMENTS
Debt Instrument, Convertible, Conversion Ratio		39,075
Common stock warrants
SHARE-BASED PAYMENTS
Warrant Outstanding Beginning Balance \| shares	176,733	1,432	366
Granted \| shares	93,099	241,308	1,205
Conversion of stock warrants upon IPO \| shares			21
Exercised \| shares	(32,086)	(66,007)	(155)
Forfeited \| shares			(4)
Warrant Outstanding Ending Balance \| shares	237,746	176,733	1,432
Common Stock Warrants Exercisable \| shares	237,745	171,278	1,432
Weighted Average Exercise Price Outstanding Beginning Balance	$ 209	$ 10,300	$ 6,650
Granted	99.50	140.36	$ 11,450
Conversion of stock warrants upon IPO			19,150
Weighted Average Exercise Price Outstanding Ending Balance	181.25	209	$ 10,300
Weighted Average Exercise Price Exercisable	181.25	210.50
Exercised	97.88	131.25	11,425
Forfeited			19,150
Weighted Average Exercise Price Outstanding Beginning Balance	$ 181.25	$ 209	$ 10,300

SHARE-BASED PAYMENTS - Stock Op

SHARE-BASED PAYMENTS - Stock Options - Activity (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
SHARE-BASED PAYMENTS
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance	1,558	1,558	485
Granted	51,086		1,093
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	1,558	1,558	1,558
SHARE-BASED PAYMENTS
Granted			$ 10,375
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance	$ 362.11	$ 362.11	$ 9,053
SHARE-BASED PAYMENTS
Share-based Compensation Arrangement by Share-based Option Exercisable	1,439	1,389	1,266
Share-based Compensation Arrangement by Weighted Average Exercise Price at December 31, 2021		$ 10,125	$ 8,975

SHARE-BASED PAYMENTS - Stock-ba

SHARE-BASED PAYMENTS - Stock-based Compensation - Stock options granted (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
SHARE-BASED PAYMENTS
Total grant-date fair value of the options granted					$ 4,696,605
Stock-based compensation expense	$ 101,500	$ 119,759	$ 207,094	$ 258,852
Unrecognized compensation cost related to non-vested stock option	370,907		$ 370,907		$ 577,999
Share-based arrangement, non-vested weighted average period			10 months 24 days		1 year 6 months 21 days
Sales and marketing expense
SHARE-BASED PAYMENTS
Stock-based compensation expense	$ 28,798	$ 28,798			$ 57,596	$ 551,948
General and administrative expenses
SHARE-BASED PAYMENTS
Stock-based compensation expense					$ 421,442	$ 3,325,897

LEASE OBLIGATIONS (Details)

LEASE OBLIGATIONS (Details) - USD ($)	1 Months Ended			3 Months Ended		6 Months Ended		12 Months Ended
LEASE OBLIGATIONS (Details) - USD ($)	May 31, 2023	Jan. 31, 2023	Apr. 30, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Operating lease agreements
Rent expense			$ 17,257	$ 37,580	$ 195,060	$ 210,265	$ 469,482	$ 945,216	$ 816,790
Right of use asset				339,085		339,085		102,349
Security deposit			19,500
Corporate office and distribution center
Operating lease agreements
Rent expense		$ 38,105
Right of use asset		$ 467,738
Discount rate		8%
Operating lease accounts payable past rent due to landlord				949,071		949,071
Showroom Space
Operating lease agreements
Rent expense	$ 6,520
Right of use asset	$ 125,397
Discount rate	8%
Operating lease accounts payable past rent due to landlord				$ 214,626		$ 214,626
Base rent increases	$ 6,781
Accounting Standards Update 2016-02
Operating lease agreements
Right of use asset			$ 250,244
Discount rate			6%
Stateside
Operating lease agreements
Maximum Rent base								9,000
Minimum Rent base								$ 3,100

CONTINGENCIES (Details)

1 Months Ended

3 Months Ended

6 Months Ended

May 30, 2023 USD ($)

May 16, 2023

Mar. 21, 2023 USD ($)

Feb. 07, 2023 USD ($)

May 18, 2022 USD ($)

May 18, 2021 USD ($)

Dec. 21, 2020 USD ($)

Sep. 24, 2020 USD ($)

Mar. 31, 2021 USD ($) item

Aug. 31, 2020 USD ($) item

Mar. 31, 2023 USD ($)

Jun. 30, 2023 USD ($)

Nov. 09, 2023 USD ($)

Nov. 09, 2022 USD ($)

Litigation Matters

Settlement amount payable to vendor

$ 50,190

Claims settled after signing long-term lease

$ 450,968

Trading day immediately preceding period

30 days

Gross proceeds from common stock indemnification claims

$ 9,100,000

Value of shares issued

$ 25,000

$ 5,000,003

Common Stock

Litigation Matters

Value of shares issued

$ 5

H&J Purchase Agreement

Litigation Matters

Trading day immediately preceding period

30 days

Gross proceeds from common stock indemnification claims

$ 9,100,000

Transfer of membership interests

229,000

Value of shares issued

$ 1,400,000

H&J Purchase Agreement | Common Stock | Subsequent events

Litigation Matters

Trading day immediately preceding period

5 days

Lawsuits filed related to prior services rendered

Litigation Matters

Damages sought

$ 100,000

$ 96,900

Number of lawsuit settled | item

lawsuit against Bailey 44 related to a retail store lease

Litigation Matters

Damages sought

$ 1,500,000

Non-payment of trade payables

Litigation Matters

Damages sought

$ 43,501

$ 182,400

Non-payment of trade payables | Subsequent events

Litigation Matters

Damages sought

$ 43,501

$ 182,400

Non-payment of trade payables | Lawsuits filed related to prior services rendered

Litigation Matters

Damages sought

481,000

Additional damages sought

$ 296,000

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details)	Aug. 21, 2023	Oct. 21, 2022	May 18, 2021	May 12, 2021
SUBSEQUENT EVENTS
Reverse stock split conversion ratio		0.01	1	0.064
Subsequent events
SUBSEQUENT EVENTS
Reverse stock split conversion ratio	0.04

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 335,470	$ 1,275,616	$ 515,796
Accounts receivable, net	196,919	583,368	67,384
Due from factor, net	438,142	839,400	985,288
Inventory	4,771,271	5,122,564	2,660,203
Prepaid expenses and other current assets	872,142	766,901	288,474
Total current assets	6,613,944	8,829,394	4,776,334
Deferred offering costs		104,512	367,696
Property, equipment and software, net	98,170	104,512	69,367
Goodwill	8,973,501	10,103,812	8,583,274
Intangible assets, net	11,421,311	12,906,238	9,263,131
Deposits	106,547	193,926	133,378
Right of use asset, net	339,085	102,349
Total assets	27,552,558	33,738,056	36,485,224
Current liabilities:
Accounts payable	8,143,991	8,016,173	6,507,709
Accrued expenses and other liabilities	5,038,937	3,936,920	2,078,087
Due to related parties	472,790	555,217	256,274
Contingent consideration liability		12,098,475	12,179,476
Convertible note payable, net	100,000	2,721,800	100,000
Accrued interest payable	1,779,274	1,561,795	1,110,679
Venture debt, net of discount			6,001,755
Loan payable, current	1,190,405	1,829,629	2,279,768
Promissory note payable	5,613,839	9,000,000	3,500,000
Right of use liability, current portion	312,226	40,893,791
Total current liabilities	22,651,462	40,893,792	35,047,266
Convertible note payable, net		150,000	5,723,846
Loans payable, net of current portion	443,635	150,000	342,050
Derivative liability		0	2,294,720
Warrant liability			18,223
Total liabilities	23,128,598	41,191,230	43,575,005
Commitments and contingencies
Stockholders' deficit:
Additional paid-in capital		96,294,123	58,614,160
Accumulated deficit	(104,839,404)	(103,747,316)	(65,703,954)
Total stockholders' deficit	4,423,960	(7,453,174)	(7,089,781)
Total liabilities and stockholders' deficit	27,552,558	33,738,056	36,485,224
Undesignated preferred stock
Stockholders' deficit:
Preferred stock
Series A preferred stock
Stockholders' deficit:
Preferred stock
Series A Convertible Preferred Stock
Stockholders' deficit:
Preferred stock	1	1
Common stock
Stockholders' deficit:
Common stock, $0.0001 par, 1,000,000,000 shares authorized, 4,468,939 and 130,018 shares issued and outstanding as of December 31, 2022 and 2021, respectively	31	18	$ 13
Additional paid-in capital	$ 109,263,332	$ 96,294,123

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Common stock par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, share authorized (in shares)	1,000,000,000	1,000,000,000	1,000,000,000
Common stock, share issued (in shares)	316,906	178,758	5,201
Common stock, shares outstanding (in shares)	316,906	178,758	5,201
Undesignated preferred stock
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0	0
Preferred stock, shares outstanding (in shares)	0	0	0
Series A preferred stock
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1	1	1
Preferred stock, shares issued (in shares)	0	0	0
Preferred stock, shares outstanding (in shares)	0	0	0
Series A Convertible Preferred Stock
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	6,800	6,800	0
Preferred stock, shares issued (in shares)	6,300	6,300
Preferred stock, shares outstanding (in shares)	6,300	6,300	0

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Net revenues	$ 4,493,424		$ 2,649,432		$ 8,869,803	$ 5,278,562	$ 10,333,558	$ 5,764,963
Cost of net revenues	2,157,349		1,536,703		4,540,488	3,552,396	6,789,314	3,828,496
Gross profit	2,336,075		1,112,729		4,329,315	1,726,166	3,544,244	1,936,467
Operating expenses:
General and administrative	4,074,051		4,243,031		8,380,063	8,073,621	14,067,681	16,149,510
Sales and marketing	1,097,326		1,372,568		2,036,677	2,230,087	4,018,985	3,269,710
Distribution	242,214		221,925		512,399	424,773	611,569	489,371
Impairment							5,503,095	3,400,000
Gain in the change in fair value of contingent consideration	(10,698,475)		5,920,919		(10,698,475)	7,121,240	564,303	8,764,460
Total operating expenses	(5,284,884)		11,758,443		230,664	17,849,721	24,765,633	32,073,050
Income (loss) from operations	7,620,959		(10,645,714)		4,098,651	(16,123,555)	(21,221,389)	(30,136,583)
Other income (expense):
Interest expense	(1,086,889)		(2,173,769)		(2,951,487)	(3,730,612)	(8,961,410)	(3,619,093)
Other non-operating income (expenses)	2,240		3,336,963		(676,749)	2,653,375	3,068,080	1,321,472
Total other income (expense), net	(1,084,649)		1,163,194		(3,628,236)	(1,077,237)	(5,893,330)	(2,297,621)
Income tax benefit (provision)								1,100,120
Net income (loss)	$ 5,044,260	$ (6,136,349)	$ (9,533,924)	$ (7,832,942)	$ (1,092,088)	$ (17,366,866)	$ (38,043,362)	$ (32,357,957)
Weighted average common shares outstanding - basic	246,809		14,329		236,824	9,836	30,852	3,052
Weighted average common shares outstanding - diluted	834,604		14,329		824,619	9,836	30,852	3,052
Net loss per common share - basic	$ 26.48		$ (661.78)		$ 1.99	$ (1,748.68)	$ (878.87)	$ (10,268.22)
Net loss per common share - diluted	$ 7.83		$ (661.78)		$ 0.57	$ (1,748.68)	$ (878.87)	$ (10,268.22)

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)	Preferred Stock Series Seed Preferred Stock [Member]	Preferred Stock Series A Preferred Stock [Member]	Preferred Stock Series A2 Convertible Preferred Stock [Member]	Preferred Stock Series A3 Convertible Preferred Stock [Member]	Preferred Stock Series CF Convertible Preferred Stock [Member]	Preferred Stock Series B Preferred Stock [Member]	Preferred Stock Series A Convertible Preferred Stock [Member]	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Beginning balance (in shares) at Dec. 31, 2020	20,714,518	5,654,072	5,932,742	9,032,330	836,331	20,754,717		266
Beginning balance at Dec. 31, 2020	$ 2,071	$ 565	$ 593	$ 904	$ 83	$ 2,075	$ 0	$ 0	$ 27,482,061	$ (33,345,997)	$ (5,857,645)
Conversion of preferred stock into common stock	$ (2,071)	$ (565)	$ (593)	$ (904)	$ (83)	$ (2,075)			6,291		6,291
Conversion of preferred stock into common stock (shares)	(20,714,518)	(5,654,072)	(5,932,742)	(9,032,330)	(836,331)	(20,754,717)		1,611
Issuance of common stock in public offering									10,000,002		10,000,002
Issuance of common stock in public offering (in shares)								964
Offering costs									(2,116,957)		(2,116,957)
Exercise of over-allotment option, net of offering costs									1,364,997		1,364,997
Exercise of over-allotment option, net of offering costs (in shares)								145
Conversion of debt into common stock									2,680,289		2,680,289
Conversion of debt into common stock (In shares)								454
Conversion of related party notes and payables into common stock									257,515		257,515
Conversion of related party notes and payables into common stock (in shares)								61
Common stock issued in connection with business combination									11,428,738		11,428,738
Common stock issued in connection with business combination (in shares)								1,318
Exercise of warrants									1,768,046		1,768,046
Exercise of warrants (in shares)								155
Common stock issued pursuant to consulting agreement									595,500		595,500
Common stock issued pursuant to consulting agreement (in shares)								97
Issuance of common stock pursuant to equity line of credit									367,696		367,696
Issuance of common stock pursuant to equity line of credit (in shares)								51
Common stock and warrants issued in connection with notes									501,658		501,658
Common stock and warrants issued in connection with notes (in shares)								52
Stock-based compensation									4,278,337		4,278,337
Stock-based compensation (Shares)								29
Net loss										(32,357,957)	(32,357,957)
Ending balance at Dec. 31, 2021								$ 0	58,614,173	(65,703,954)	(7,089,781)
Ending balance (in shares) at Dec. 31, 2021								521
Stock-based compensation									139,093		139,093
Net loss										(7,832,942)	(7,832,942)
Ending balance at Mar. 31, 2022								$ 0	59,954,848	(73,536,896)	(13,582,048)
Ending balance (in shares) at Mar. 31, 2022								870
Beginning balance (in shares) at Dec. 31, 2021								521
Beginning balance at Dec. 31, 2021								$ 0	58,614,173	(65,703,954)	(7,089,781)
Conversion of debt into common stock											1,802,372
Net loss											(17,366,866)
Ending balance at Jun. 30, 2022								$ 2	68,190,600	(83,070,820)	(14,880,218)
Ending balance (in shares) at Jun. 30, 2022								16,470
Beginning balance (in shares) at Dec. 31, 2021								521
Beginning balance at Dec. 31, 2021								$ 0	58,614,173	(65,703,954)	(7,089,781)
Issuance of common stock in public offering								$ 1	9,347,449		9,347,450
Issuance of common stock in public offering (in shares)								14,956
Issuance of common stock and exercise of pre-funded warrants in public offering (in shares)								72,727
Issuance of common stock and exercise of pre-funded warrants in public offering								$ 7	9,999,989		9,999,996
Offering costs									(2,921,646)		(2,921,646)
Conversion of debt into common stock											11,983,389
Common stock issued in connection with business combination									1,000,000		1,000,000
Common stock issued in connection with business combination (in shares)								3,636
Common stock issued pursuant to consulting agreement									123,000		123,000
Common stock issued pursuant to consulting agreement (in shares)								30
Stock-based compensation									479,038		479,038
Net loss										(38,043,362)	(38,043,362)
Conversion of notes and derivative liability into common stock								$ 8	11,983,381		11,983,389
Conversion of notes and derivative liability into common stock (in shares)								79,807
Warrant and common shares issued with notes									1,368,741		1,368,741
Warrant and common shares issued with notes (in shares)								2,400
Conversion of venture debt into Series A convertible preferred stock							$ 1		6,299,999		6,300,000
Conversion of venture debt into Series A convertible preferred stock (in shares)							6,300
Ending balance at Dec. 31, 2022							$ 1	$ 18	96,294,123	(103,747,316)	(7,453,174)
Ending balance (in shares) at Dec. 31, 2022							6,300	178,758
Beginning balance (in shares) at Mar. 31, 2022								870
Beginning balance at Mar. 31, 2022								$ 0	59,954,848	(73,536,896)	(13,582,048)
Issuance of common stock in public offering								$ 1	9,347,449		9,347,450
Issuance of common stock in public offering (in shares)								14,956
Offering costs									(1,930,486)		(1,930,486)
Common stock and warrants issued in connection with notes									98,241		98,241
Stock-based compensation									119,759		119,759
Net loss										(9,533,924)	(9,533,924)
Conversion of notes and derivative liability into common stock									600,790		600,790
Conversion of notes and derivative liability into common stock (in shares)								644
Ending balance at Jun. 30, 2022								$ 2	68,190,600	(83,070,820)	(14,880,218)
Ending balance (in shares) at Jun. 30, 2022								16,470
Beginning balance (in shares) at Dec. 31, 2022							6,300	178,758
Beginning balance at Dec. 31, 2022							$ 1	$ 18	96,294,123	(103,747,316)	(7,453,174)
Offering costs									(536,927)		(536,927)
Stock-based compensation									105,594		105,594
Net loss										(6,136,349)	(6,136,349)
Ending balance at Mar. 31, 2023							$ 1	$ 23	102,020,620	(109,883,665)	(7,863,022)
Ending balance (in shares) at Mar. 31, 2023							6,300	238,803
Beginning balance (in shares) at Dec. 31, 2022							6,300	178,758
Beginning balance at Dec. 31, 2022							$ 1	$ 18	96,294,123	(103,747,316)	(7,453,174)
Net loss											(1,092,088)
Ending balance at Jun. 30, 2023							$ 1	$ 31	109,263,332	(104,839,404)	4,423,960
Ending balance (in shares) at Jun. 30, 2023						1	6,300	316,906
Beginning balance (in shares) at Mar. 31, 2023							6,300	238,803
Beginning balance at Mar. 31, 2023							$ 1	$ 23	102,020,620	(109,883,665)	(7,863,022)
Stock-based compensation									101,500		101,500
Net loss										5,044,260	5,044,260
Ending balance at Jun. 30, 2023							$ 1	$ 31	$ 109,263,332	$ (104,839,404)	$ 4,423,960
Ending balance (in shares) at Jun. 30, 2023						1	6,300	316,906

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS	12 Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Cash flows from operating activities:
Net loss	$ (38,043,362)	$ (32,357,957)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,653,819	862,888
Amortization of loan discount and fees	6,506,384	1,382,222
Stock-based compensation	602,038	4,800,337
Fees incurred in connection with debt financings	568,149	560,309
Change in fair value of warrant liability	(18,223)	11,958
Change in fair value of derivative liability	(1,354,434)	(910,204)
Gain in the change in fair value of contingent consideration	564,303	8,764,460
Impairment of goodwill and intangible assets	5,503,095	3,400,000
Forgiveness of Payroll Protection Program	(1,760,755)	(407,994)
Change in credit reserve	(118,840)	36,893
Deferred offering costs	367,696
Loss from discontinued operations, net of tax	10,928,643	1,023,873
Deferred offering costs	104,512	367,696
Deferred income tax benefit		(1,100,120)
Changes in operating assets and liabilities:
Accounts receivable, net	(452,030)	150,288
Due from factor, net	655,708	(399,701)
Inventory	479,394	(911,293)
Prepaid expenses and other current assets	(445,798)	(151,917)
Accounts payable	892,120	456,690
Accrued expenses and other liabilities	1,631,512	834,489
Deferred revenue		4,882
Due to related parties	298,943	(63,550)
Accrued interest	984,358	461,113
Assets and liabilities of discontinued operations	(210,426)	(678,623)
Net cash used in operating activities	(10,767,706)	(14,230,957)
Cash flows from investing activities:
Cash acquired (consideration) pursuant to business combination	(7,247,303)	(5,936,757)
Net cash provided by (used in) investing activities	(7,369,137)	(6,011,053)
Cash flows from financing activities:
Advances (repayments) from factor	(3,096)	(41,200)
Repayment of contingent consideration	(645,304)
Proceeds from venture debt	237,500
Repayments of convertible notes and loans payable	(7,350,276)	(2,006,628)
Issuance of convertible notes payable	3,280,360	2,779,910
Proceeds from public offering	19,347,446	10,000,002
Proceeds from Issuance Initial Public Offering	19,347,446	10,000,002
Exercise of over-allotment option with public offering, net		(1,364,997)
Exercise of warrants		1,768,046
Offering costs	(2,921,216)	(2,116,957)
Net cash provided by financing activities	18,896,664	20,181,820
Net change in cash and cash equivalents	759,820	(60,190)
Cash and cash equivalents at beginning of period	515,796	575,986
Cash and cash equivalents at end of period	1,275,616	515,796
Supplemental disclosure of cash flow information:
Cash paid for interest	734,869	902,089
Supplemental disclosure of non-cash investing and financing activities:
Conversion of notes into common stock	11,983,389	2,680,289
Warrant and common shares issued with notes	1,368,741
Derivative liability in connection with convertible note	559,957	3,204,924
Conversion of venture debt into preferred stock	$ 6,300,000
Conversion of related party notes and payables into preferred and common stock		257,515
Conversion of preferred stock into common stock		6,291
Conversion of contingent consideration into common stock		73,500
Common shares issued pursuant to equity line of credit		$ 367,696

NATURE OF OPERATIONS_2

NATURE OF OPERATIONS	6 Months Ended	12 Months Ended
NATURE OF OPERATIONS	Jun. 30, 2023	Dec. 31, 2022
NATURE OF OPERATIONS
NATURE OF OPERATIONS	NOTE 1: NATURE OF OPERATIONS Digital Brands Group, Inc. (the “Company” or “DBG”), was organized on September 17, 2012 under the laws of Delaware as a limited liability company under the name Denim.LA LLC. The Company converted to a Delaware corporation on January 30, 2013 and changed its name to Denim.LA, Inc. Effective December 31, 2020, the Company changed its name to Digital Brands Group, Inc. (DBG). The Company is a curated collection of lifestyle brands, including Bailey, DSTLD, Harper & Jones, Stateside and ACE Studios, that offers a variety of apparel products through direct-to-consumer and wholesale distribution. On February 12, 2020, Denim.LA, Inc. entered into an Agreement and Plan of Merger with Bailey 44, LLC (“Bailey”), a Delaware limited liability company. On the acquisition date, Bailey, LLC became a wholly owned subsidiary of the Company. On May 18, 2021, the Company closed its acquisition of Harper & Jones, LLC (“H&J”) pursuant to its Membership Interest Stock Purchase Agreement with D. Jones Tailored Collection, Ltd. to purchase 100% of the issued and outstanding equity of Harper & Jones, LLC. On the acquisition date, H&J became a wholly owned subsidiary of the Company. On August 30, 2021, the Company closed its acquisition of Mosbest, LLC dba Stateside (“Stateside”) pursuant to its Membership Interest Purchase Agreement with Moise Emquies to purchase 100% of the issued and outstanding equity of Stateside. On the acquisition date, Stateside became a wholly owned subsidiary of the Company. On December 30, 2022, the Company closed its previously announced acquisition of Sunnyside, LLC dba Sundry (“Sundry”) pursuant to its Second Amended and Restated Membership Interest Purchase Agreement with Moise Emquies to purchase 100% of the issued and outstanding equity of Sundry. On the acquisition date, Sundry became a wholly owned subsidiary of the Company. On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 78,103 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. The H&J Settlement was accounted for a business disposition.	NOTE 1: NATURE OF OPERATIONS Digital Brands Group, Inc. (the “Company” or “DBG”), was organized on September 17, 2012 under the laws of Delaware as a limited liability company under the name Denim.LA LLC. The Company converted to a Delaware corporation on January 30, 2013 and changed its name to Denim.LA, Inc. Effective December 31, 2020, the Company changed its name to Digital Brands Group, Inc. (DBG). On February 12, 2020, Denim.LA, Inc. entered into an Agreement and Plan of Merger with Bailey 44, LLC (“Bailey”), a Delaware limited liability company. On the acquisition date, Bailey became a wholly owned subsidiary of the Company. See Note 4. On May 18, 2021, the Company closed its acquisition of Harper & Jones, LLC (“H&J”) pursuant to its Membership Interest Stock Purchase Agreement with D. Jones Tailored Collection, Ltd. to purchase 100% of the issued and outstanding equity of Harper & Jones, LLC. On the acquisition date, H&J became a wholly owned subsidiary of the Company. See Note 4. On August 30, 2021, the Company closed its acquisition of Mosbest, LLC dba Stateside (“Stateside”) pursuant to its Membership Interest Purchase Agreement with Moise Emquies to purchase 100% of the issued and outstanding equity of Stateside. On the acquisition date, Stateside became a wholly owned subsidiary of the Company. See Note 4. On December 30, 2022, the Company closed its previously announced acquisition of Sunnyside, LLC dba Sundry (“Sundry”) pursuant to its Second Amended and Restated Membership Interest Purchase Agreement with Moise Emquies to purchase 100% of the issued and outstanding equity of Sundry. On the acquisition date, Sundry became a wholly owned subsidiary of the Company. See Note 4. Reverse Stock Split On May 12, 2021, the Board of Directors approved a one On October 21, 2022, the Board of Directors approved a one Initial Public Offering On May 13, 2021, the Company’s registration statement on Form S-1 relating to its initial public offering of its common stock (the “IPO”) was declared effective by the Securities and Exchange Commission (“SEC”). Further to the IPO, which closed on May 18, 2021, the Company issued and sold 964 shares of common stock at a public offering price of $10,375 per share. Additionally, the Company issued warrants to purchase 1,111 shares, which includes 145 warrants sold upon the partial exercise of the over-allotment option. The aggregate net proceeds to the Company from the IPO, were $8.6 million after deducting underwriting discounts and commissions of $0.8 million and direct offering expenses of $0.6 million. Concurrent with this offering, the Company acquired H&J (see Note 4). The Company incurred an additional $0.6 million in offering costs related to the IPO that were not paid directly out of the proceeds from the offering.

GOING CONCERN_2

GOING CONCERN	6 Months Ended	12 Months Ended
GOING CONCERN	Jun. 30, 2023	Dec. 31, 2022
GOING CONCERN
GOING CONCERN	NOTE 2: GOING CONCERN The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not generated profits since inception, has sustained net losses of $1,092,088 and $17,366,866 for the six months ended June 30, 2023 and 2022, respectively, and has incurred negative cash flows from operations for the six months ended June 30, 2023 and 2022. The Company has historically lacked liquidity to satisfy obligations as they come due and as of June 30, 2023, and the Company had a working capital deficit of $16,037,518. These factors, among others, arise substantial doubt about the Company’s ability to continue as a going concern. The Company expects to continue to generate operating losses for the foreseeable future. The accompanying consolidated financial statements do not include any adjustments as a result of this uncertainty. The Company’s ability to continue as a going concern for the next 12 months from the date the financial statements were available to be issued is dependent upon its ability to generate sufficient cash flows from operations to meet its obligations, which it has not been able to accomplish to date, and/or to obtain additional capital financing. Through the date the financial statements were available to be issued, the Company has been primarily financed through the issuance of capital stock and debt. In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities. The issuance of additional equity would result in dilution to existing shareholders. If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations. No assurance can be given that the Company will be successful in these efforts.	NOTE 2: GOING CONCERN The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not generated profits since inception, has sustained net losses of $38,043,362 and $32,357,957 for the years ended December 31, 2022 and 2021, respectively, and has incurred negative cash flows from operations for the years ended December 31, 2022 and 2021. The Company has historically lacked liquidity to satisfy obligations as they come due and as of December 31, 2022, and the Company had a working capital deficit of $32,064,398. These factors, among others, arise substantial doubt about the Company’s ability to continue as a going concern. The Company expects to continue to generate operating losses for the foreseeable future. The accompanying consolidated financial statements do not include any adjustments as a result of this uncertainty. The Company’s ability to continue as a going concern for the next 12 months from the date the financial statements were available to be issued is dependent upon its ability to generate sufficient cash flows from operations to meet its obligations, which it has not been able to accomplish to date, and/or to obtain additional capital financing. Through the date the financial statements were available to be issued, the Company has been primarily financed through the issuance of capital stock and debt. In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities. The issuance of additional equity would result in dilution to existing shareholders. If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations. No assurance can be given that the Company will be successful in these efforts.

SUMMARY OF SIGNIFICANT ACCOU_12

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”). Reverse Stock Split On October 21, 2022, the Board of Directors approved a one Unaudited Interim Financial Information The accompanying unaudited condensed consolidated balance sheet as of June 30, 2023, the unaudited condensed consolidated statements of operations for the six and six months ended June 30, 2023 and 2022 and of cash flows for the six months ended June 30, 2023 and 2022 have been prepared by the Company, pursuant to the rules and regulations of the SEC for the interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to rules and regulations. However, the Company believes that the disclosures are adequate to make the information presented not misleading. The unaudited interim consolidated financial statements have been prepared on a basis consistent with the audited consolidated financial statements and in the opinion of management, reflect all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the consolidated results for the interim periods presented and of the consolidated financial condition as of the date of the interim consolidated balance sheet. The results of operations are not necessarily indicative of the results expected for the year ended December 31, 2023. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2022 included in the Company’s Annual Form 10-K filed with SEC on April 17, 2023. Principles of Consolidation These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Bailey, H&J and Stateside from the dates of acquisition. All inter-company transactions and balances have been eliminated on consolidation. As of June 21, 2023, the Company no longer consolidated the assets, liabilities, revenues and expenses of H&J (see Note 4). Use of Estimates The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, inventory, impairment of long-lived assets, contingent consideration and derivative liabilities. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates. Reclassification of Previously Issued Financial Statements Certain prior year accounts have been reclassified to conform with current year presentation pertaining to cost of net revenue and general and administrative expenses. The Company has reclassified $297,696 and $630,976 in general and administrative expenses per previously reported financial statements to cost of net revenues in the accompanying consolidated statements of operations for the three and six months ended June 30, 2022, respectively. The reclassified costs from general and administrative expense to cost of net revenues are primarily personnel and warehouse related costs. The reclassification had no effect on the reported results of operations. Certain prior year accounts have been reclassified to conform with current year presentation regarding income (loss) from discontinued operations. H&J’s assets and liabilities as of December 31, 2022 have also been reclassified on the consolidated balance sheet. See Note 4. Cash and Equivalents and Concentration of Credit Risk The Company considers all highly liquid securities with an original maturity of less than six months to be cash equivalents. As of June 30, 2023 and December 31, 2022, the Company did not hold any cash equivalents. The Company’s cash and cash equivalents in bank deposit accounts, at times, may exceed federally insured limits of $250,000. Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued expenses, due to related parties, related party note payable, and convertible debt. The carrying value of these assets and liabilities is representative of their fair market value, due to the short maturity of these instruments. The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy used to determine such fair values: Fair Value Measurements as of June 30, 2023 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ — $ — $ — $ — $ — $ — Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ 12,098,475 $ 12,098,475 $ — $ — $ 12,098,475 $ 12,098,475 Contingent Consideration The Company recorded a contingent consideration liability relating to stock price guarantees included in its acquisitions of Bailey44 and H&J. The estimated fair value of the contingent consideration was recorded using significant unobservable measures and other fair value inputs and was therefore classified as a Level 3 financial instrument. The Company estimates and records the acquisition date fair value of contingent consideration as part of purchase price consideration for acquisitions. Additionally, each reporting period, the Company estimates changes in the fair value of contingent consideration and recognizes any change in fair in the consolidated statement of operations. The estimate of the fair value of contingent consideration requires very subjective assumptions to be made of future operating results, discount rates and probabilities assigned to various potential operating result scenarios. Future revisions to these assumptions could materially change the estimate of the fair value of contingent consideration and, therefore, materially affect the Company’s future financial results. The contingent consideration liability is to be settled with the issuance of shares of common stock once contingent provisions set forth in respective acquisition agreements have been achieved. Upon achievement of contingent provisions, respective liabilities are relieved and offset by increases to common stock and additional paid-in capital in the stockholders’ equity section of the Company’s consolidated balance sheets. Norwest Waiver On June 21, 2023, the Company, on the one hand, and Norwest Venture Partners XI, LP and Norwest Venture Partners XII, LP (together, the “Norwest Investors”), on the other hand, executed a Waiver and Amendment (the “Norwest Amendment”) whereby the Norwest Investors agreed to waive and terminate certain true up rights of the Norwest Investors under the Agreement and Plan of Merger, dated February 12, 2020 (the “Bailey Merger Agreement”), among the Company, Bailey 44, LLC, Norwest Venture Partners XI, LP, and Norwest Venture Partners XII, LP and Denim.LA Acquisition Corp. This transaction is known as the “Norwest Waiver”. As a result of the Norwest Waiver, the Company recorded a fair value of H&J Settlement Agreement On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby the Company transferred 100% of its membership interests in H&J to D. Jones (the “H&J Seller”). Pursuant to the Settlement Agreement, the Company agreed to make an aggregate cash payment of shares of common stock to the H&J Seller. In connection with the Settlement Agreement, the parties agreed that no further shares were owed to the H&J Seller resulting from the stock price guarantee pursuant to the May 2021 H&J acquisition. As a result, the Company recorded a fair value of The detail of contingent consideration by company is as follows: June 30, December 31, 2023 2022 Bailey $ — $ 10,698,475 Harper & Jones — 1,400,000 $ — $ 12,098,475 Inventory Inventory is stated at the lower of cost or net realizable value and accounted for using the weighted average cost method for DSTLD and first-in, first-out method for Bailey, Stateside and Sundry. The inventory balances as of June 30, 2023 and December 31, 2022 consist substantially of finished good products purchased or produced for resale, as well as any raw materials the Company purchased to modify the products and work in progress. Inventory consisted of the following: June 30, December 31, 2023 2022 Raw materials $ 1,508,416 $ 1,611,134 Work in process 653,412 888,643 Finished goods 2,609,443 2,725,505 Inventory $ 4,771,271 $ 5,225,282 Goodwill Goodwill and identifiable intangible assets that have indefinite useful lives are not amortized, but instead are tested annually for impairment and upon the occurrence of certain events or substantive changes in circumstances. The annual goodwill impairment test allows for the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An entity may choose to perform the qualitative assessment on none, some or all of its reporting units or an entity may bypass the qualitative assessment for any reporting unit and proceed directly to step one of the quantitative impairment test. If it is determined, on the basis of qualitative factors, that the fair value of a reporting unit is, more likely than not, less than its carrying value, the quantitative impairment test is required. Annual Impairment At December 31, 2022, management determined that certain events and circumstances occurred that indicated that the carrying value of the Company’s brand name assets, and the carrying amount of the reporting units, pertaining to Bailey44 and Harper & Jones may not be recoverable. The qualitative assessment was primarily due to reduced or stagnant revenues of both entities as compared to the Company’s initial projections at the time of each respective acquisition, as well as the entities’ liabilities in excess of assets. As such, the Company compared the estimated fair value of the brand names with its carrying value and recorded an impairment loss of $3,667,000 in the consolidated statements of operations. Additionally, the Company compared the fair value of the reporting units to the carrying amounts and recorded an impairment loss of $11,872,332 Net Loss per Share Net earnings or loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period, excluding shares subject to redemption or forfeiture. The Company presents basic and diluted net earnings or loss per share. Diluted net earnings or loss per share reflect the actual weighted average of common shares issued and outstanding during the period, adjusted for potentially dilutive securities outstanding. Potentially dilutive securities are excluded from the computation of the diluted net loss per share if their inclusion would be anti-dilutive. The following table sets forth the computation of basic and diluted net income (loss) per share: Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 Numerator: Net income (loss) from continuing operations $ 6,536,310 $ (9,482,520) $ 470,415 $ (17,200,792) Income (loss) from discontinued operations, net of tax (1,492,050) (51,404) (1,562,503) (166,074) Net income (loss) $ 5,044,260 $ (9,533,924) $ (1,092,088) $ (17,366,866) Denominator: Weighted average common shares outstanding - basic 246,809 14,329 236,824 9,836 Weighted average common shares outstanding - diluted 834,604 14,329 824,619 9,836 Net income (loss) from continuing operations per share - basic $ 26.48 $ (661.78) $ 1.99 $ (1,748.68) Net income (loss) from continuing operations per share - diluted $ 7.83 $ (661.78) $ 0.57 $ (1,748.68) Net income (loss) from discontinued operations per common share – basic $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) from discontinued operations per common share – diluted $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) per share – $ 20.44 $ (665.36) $ (4.61) $ (1,765.57) Net income (loss) per share – $ 6.04 $ (665.36) $ (4.61) $ (1,765.57) The following table sets forth the a) the dilutive items included in the weighted average common shares – diluted amount above as of June 30, 2023 and b) the number of potential common shares excluded from the calculations of net loss per diluted share because their inclusion would be anti-dilutive as of June 30, 2022: June 30, 2023 2022 — 18,496 Convertible notes 27,097 — Series A convertible preferred stock 321,395 — Series C convertible preferred stock 237,746 2,533 Common stock warrants 1,558 1,558 Stock options 587,795 22,588 The stock options and warrants above are out-of-the-money as of June 30, 2023 and 2022. Recent Accounting Pronouncements In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which amends and clarifies several provisions of Topic 326. In May 2019, the FASB issued ASU 2019-05, Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief, which amends Topic 326 to allow the fair value option to be elected for certain financial instruments upon adoption. ASU 2019-10 extended the effective date of ASU 2016-13 until December 15, 2022. The Company adopted this new guidance, including the subsequent updates to Topic 326, on January 1, 2023 and the adoption did not have a material impact on the Company’s condensed consolidated financial statements and related disclosures. Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are Unaudited Pro Forma Financial Information The following unaudited pro forma financial information presents the Company’s financial results as if the Sundry acquisition had occurred as of January 1, 2022. The unaudited pro forma financial information is not necessarily indicative of what the financial results actually would have been had the acquisitions been completed on this date. In addition, the unaudited pro forma financial information is not indicative of, nor does it purport to project, the Company’s future financial results. The following unaudited pro forma financial information includes incremental property and equipment depreciation and intangible asset amortization as a result of the acquisitions. The pro forma information does not give effect to any estimated and potential cost savings or other operating efficiencies that could result from the acquisition: Six Months Ended June 30, 2022 Net revenues $ 14,728,296 Net loss $ (16,907,152) Net loss per common share $ (1,718.83)	NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”). H&J Disposition On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 78,103 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. This transaction is known as the “H&J Settlement”. The H&J Settlement was accounted for a business disposition in accordance with ASC 810-40-40-3A. In accordance with the provisions of ASC 205-20, the Company has excluded the results of discontinued operations from its results of continuing operations in the accompanying consolidated statements of operations for the three and six months ended June 30, 2023 and 2022 in it’s Form 10-Q Quarterly Report filed on August 21, 2023. Accordingly, the consolidated financial statements as of and for the years ended December 31, 2022 and 2021 have been adjusted retroactively to account for the discontinued operations classification of H&J. Principles of Consolidation These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Bailey, H&J, Stateside and Sundry from the dates of acquisition. All inter-company transactions and balances have been eliminated on consolidation. H&J has been retroactively adjusted to be presented as discontinued operations (see above). Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Restatement of Previously Issued Financial Statements Certain prior year accounts have been reclassified to conform with current year presentation pertaining to cost of net revenue and general and administrative expenses. The Company has reclassified The reclassified costs from general and administrative expense to cost of net revenues made in the fourth quarter of 2022 and 2021 are fixed in nature as they are personnel and warehouse related costs. The impact of the reclassification was approximately for each of the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022. The impact of the reclassification was approximately Cash and Equivalents and Concentration of Credit Risk The Company considers all highly liquid securities with an original maturity of less than three months to be cash equivalents. As of December 31, 2022 and 2021, the Company did not hold any cash equivalents. The Company’s cash and cash equivalents in bank deposit accounts, at times, may exceed federally insured limits of $250,000. Fair Value of Financial Instruments FASB guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 3 — Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, due from factor, prepaid expenses, accounts payable, accrued expenses, deferred revenue, due to related parties, related party note payable, accrued interest, loan payable and convertible debt. The carrying value of these assets and liabilities is representative of their fair market value, due to the short maturity of these instruments. The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy used to determine such fair values: Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ — $ — $ — Contingent consideration — — 12,098,475 12,098,475 Derivative liability — — — — $ — $ — $ 12,098,475 $ 12,098,475 Fair Value Measurements as of December 31, 2021 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ 18,223 $ — $ 18,223 Contingent consideration — — 12,179,476 12,179,476 Derivative liability — — 2,294,720 2,294,720 $ — $ 18,223 $ 14,474,196 $ 14,492,419 Warrant Liability Certain of the Company’s common stock warrants are carried at fair value. As of December 31, 2020, the fair value of the Company’s common stock warrant liabilities was measured under the Level 3 hierarchy using the Black-Scholes pricing model as the Company’s underlying common stock had no observable market price (see Note 10). The warrant liability was valued using a market approach. Upon the IPO, the warrant liabilities were valued using quoted prices of identical assets in active markets, and was reclassified under the Level 2 hierarchy. Changes in common stock warrant liability during the years ended December 31, 2022 and 2021 are as follows: Warrant Liability Outstanding as of December 31, 2020 $ 6,265 Change in fair value 11,958 Outstanding as of December 31, 2021 18,223 Change in fair value (18,223) Outstanding as of December 31, 2022 $ — Contingent Consideration The Company records a contingent consideration liability relating to stock price guarantees included in its acquisition and consulting agreements. The estimated fair value of the contingent consideration is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument. The Company estimates and records the acquisition date fair value of contingent consideration as part of purchase price consideration for acquisitions. Additionally, each reporting period, the Company estimates changes in the fair value of contingent consideration and recognizes any change in fair in the consolidated statement of operations. The estimate of the fair value of contingent consideration requires very subjective assumptions to be made of future operating results, discount rates and probabilities assigned to various potential operating result scenarios. Future revisions to these assumptions could materially change the estimate of the fair value of contingent consideration and, therefore, materially affect the Company’s future financial results. The contingent consideration liability is to be settled with the issuance of shares of common stock once contingent provisions set forth in respective acquisition agreements have been achieved. Upon achievement of contingent provisions, respective liabilities are relieved and offset by increases to common stock and additional paid-in capital in the stockholders’ equity section of the Company’s consolidated balance sheets. The fair value of the contingent consideration liability related to the Company’s business combinations is valued using the Monte Carlo simulation model. The Monte Carlo simulation inputs include the stock price, volatility of common stock, timing of settlement and resale restrictions and limits. The fair value of the contingent consideration is then calculated based on guaranteed equity values at settlement as defined in the acquisition agreements. Changes in contingent consideration liability during the years ended December 31, 2022 and 2021 are as follows: Contingent Consideration Liability Balance as of December 31, 2020 $ — Initial recognition in connection with acquisition of Harper & Jones 3,421,516 Stock price guarantee per consulting agreement 67,000 Conversion into shares (73,500) Change in fair value 8,764,460 Outstanding as of December 31, 2021 12,179,476 Repayments to Harper & Jones seller (645,304) Change in fair value 564,303 Outstanding as of December 31, 2022 $ 12,098,475 During the year ended December 31, 2022, the Company utilized the following inputs for the fair value of the contingent consideration: volatilities of 79.3% and 88.9%, risk-free rate of 0.25%, expected share increase of 5% per annum, and the guaranteed stock price of $828 for Bailey and $10,375 for Harper & Jones. The detail of contingent consideration by company is as follows: December 31, 2022 2021 Bailey $ 10,698,475 7,935,016 Harper & Jones 1,400,000 4,244,460 $ 12,098,475 $ 12,179,476 The contingent consideration liabilities were revalued for a final time as of May 18, 2022, the anniversary date of the Company’s initial public offering. As of the date of the issuance of these financial statements, the contingent consideration liabilities were not yet settled with shares. In December 2022, the Company paid $645,304 to the H&J Seller to partially reduce the contingent consideration balance owed. The Company and the H&J Seller are in the process of amending the May 2021 purchase agreement to determine the ultimate settlement of the Company’s common stock to the H&J Seller by May 16, 2023. Refer to Note 12. Derivative Liability In connection with the Company’s convertible notes, the Company recorded a derivative liability (see Note 7). The estimated fair value of the derivative liability is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument. The fair value of the derivative liability is valued using a multinomial lattice model. The multinomial lattice inputs include the underlying stock price, volatility of common stock and remaining term of the convertible note. Changes in derivative liability during the years ended December 31, 2022 and 2021 are as follows: Derivative Liability Outstanding as of December 31, 2020 $ — Initial fair value on issuance of convertible note 3,204,924 Change in fair value (910,204) Outstanding as of December 31, 2021 2,294,720 Initial fair value on issuance of convertible note 559,957 Conversion of underlying notes into common stock (1,500,243) Change in fair value (1,354,434) Outstanding as of December 31, 2022 $ — During the year ended December 31, 2022, the Company utilized the following inputs for the fair value of the derivative liability: volatility of 70.9% - 96.7%, risk-free rate of 2.71% - 3.74%, and remaining term ranging from .08 years - 0.62 years. The change in fair value of the derivative liability is included in other non-operating income (expense), net in the consolidated statements of operations. Inventory Inventory is stated at the lower of cost or net realizable value and accounted for using the weighted average cost method for DSTLD and H&J and first-in, first-out method for Bailey, Stateside and Sundry. The inventory balances as of December 31, 2022 and 2021 consist substantially of finished good products purchased or produced for resale, as well as any raw materials the Company purchased to modify the products and work in progress. Inventory consisted of the following: December 31, 2022 2021 Raw materials $ 1,508,416 $ 292,167 Work in process 888,643 242,673 Finished goods 2,725,505 2,220,519 Inventory $ 5,122,564 $ 2,660,203 Property, Equipment, and Software Property, equipment, and software are recorded at cost. Depreciation/amortization is recorded for property, equipment, and software using the straight-line method over the estimated useful lives of assets. The Company reviews the recoverability of all long-lived assets, including the related useful lives, whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset might not be recoverable. The balances at December 31, 2022 and 2021 consist of software with three (3) year lives, property and equipment with three (3) to ten (10) year lives, and leasehold improvements which are depreciated over the shorter of the lease life or expected life. Depreciation and amortization charges on property, equipment, and software are included in general and administrative expenses and amounted to $75,126 and $92,213 for the years ended December 31, 2022 and 2021, respectively. Business Combinations The Company accounts for acquisitions in which it obtains control of one or more businesses as a business combination. The purchase price of the acquired businesses is allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date. The excess of the purchase price over those fair values is recognized as goodwill. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments, in the period in which they are determined, to the assets acquired and liabilities assumed with the corresponding offset to goodwill. If the assets acquired are not a business, the Company accounts for the transaction or other event as an asset acquisition. Under both methods, the Company recognizes the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest in the acquired entity. In addition, for transactions that are business combinations, the Company evaluates the existence of goodwill or a gain from a bargain purchase. Goodwill represents the excess of the purchase price of an acquired entity over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed in a business combination. Intangible assets are established with business combinations and consist of brand names and customer relationships. Intangible assets with finite lives are recorded at their estimated fair value at the date of acquisition and are amortized over their estimated useful lives using the straight-line method. The estimated useful lives of amortizable intangible assets are as follows: Customer relationships 3 years Impairment Long-Lived Assets The Company reviews its long-lived assets (property and equipment and amortizable intangible assets) for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. If the sum of the expected cash flows, undiscounted, is less than the carrying amount of the asset, an impairment loss is recognized as the amount by which the carrying amount of the asset exceeds its fair value. Goodwill Goodwill and identifiable intangible assets that have indefinite useful lives are not amortized, but instead are tested annually for impairment and upon the occurrence of certain events or substantive changes in circumstances. The annual goodwill impairment test allows for the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An entity may choose to perform the qualitative assessment on none, some or all of its reporting units or an entity may bypass the qualitative assessment for any reporting unit and proceed directly to step one of the quantitative impairment test. If it is determined, on the basis of qualitative factors, that the fair value of a reporting unit is, more likely than not, less than its carrying value, the quantitative impairment test is required. The quantitative impairment test calculates any goodwill impairment as the difference between the carrying amount of a reporting unit and its fair value, but not to exceed the carrying amount of goodwill. It is our practice, at a minimum, to perform a qualitative or quantitative goodwill impairment test in the fourth quarter every year. Indefinite-Lived Intangible Assets Indefinite-lived intangible assets established in connection with business combinations consist of the brand name. The impairment test for identifiable indefinite-lived intangible assets consists of a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. Annual Impairment Tests At December 31, 2021, management determined that certain events and circumstances occurred, primarily the continued reduction in revenues partially as a result of COVID-19, that indicated that the carrying value of the Company’s brand name asset pertaining to Bailey44 may not be recoverable. As such, the Company compared the estimated fair value of the brand name with its carrying value and recorded an impairment loss of $3,400,000 in the consolidated statements of operations. At December 31, 2022, management determined that certain events and circumstances occurred that indicated that the carrying value of the Company’s brand name assets, and the carrying amount of the reporting units, pertaining to Bailey44 and Harper & Jones may not be recoverable. The qualitative assessment was primarily due to reduced or stagnant revenues of both entities as compared to the Company’s initial projections at the time of each respective acquisition, as well as the entities’ liabilities in excess of assets. As such, the Company compared the estimated fair value of the brand names with its carrying value and recorded an impairment loss of $3,667,000 in the consolidated statements of operations. Additionally, the Company compared the fair value of the reporting units to the carrying amounts and recorded an impairment loss of $11,872,332 Year Ended December 31, 2022 2021 Bailey brand name (intangibles) $ 2,182,000 $ 3,400,000 Bailey goodwill 3,321,095 — Total impairment $ 5,503,095 $ 3,400,000 In determining the fair value of the respective reporting units, management estimated the price that would be received to sell the reporting unit as a whole in an orderly transaction between market participants at the measurement date. This includes reviewing market comparables such as revenue multipliers and assigning certain assets and liabilities to the reporting units, such as the respective working capital deficits of each entity and debt obligations that would need to be assumed by a market participant buyer in an orderly transaction. The Company calculated the carrying amounts of each reporting unit by utilizing the entities’ assets and liabilities at December 31, 2022, including the carrying value of the identifiable intangible assets and goodwill assigned to the respective reporting units. Refer to Note 12 for the related developments with H&J. Convertible Instruments U.S. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional as that term is described under applicable U.S. GAAP. When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company also records, when necessary, deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares. Accounting for Preferred Stock ASC 480, Distinguishing Liabilities from Equity, includes standards for how an issuer of equity (including equity shares issued by consolidated entities) classifies and measures on its balance sheet certain financial instruments with characteristics of both liabilities and equity. Management is required to determine the presentation for the preferred stock as a result of the redemption and conversion provisions, among other provisions in the agreement. Specifically, management is required to determine whether the embedded conversion feature in the preferred stock is clearly and closely related to the host instrument, and whether the bifurcation of the conversion feature is required and whether the conversion feature should be accounted for as a derivative instrument. If the host instrument and conversion feature are determined to be clearly and closely related (both more akin to equity), derivative liability accounting under ASC 815, Derivatives and Hedging, is not required. Management determined that the host contract of the preferred stock is more akin to equity, and accordingly, liability accounting is not required by the Company. The Company has presented preferred stock within stockholders’ equity. Costs incurred directly for the issuance of the preferred stock are recorded as a reduction of gross proceeds received by the Company, resulting in a discount to the preferred stock. The discount is not amortized. Revenue Recognition Revenues are recognized when performance obligations are satisfied through the transfer of promised goods to the Company’s customers. Control transfers upon shipment of product and when the title has been passed to the customers. This includes the transfer of legal title, physical possession, the risks and rewards of ownership, and customer acceptance. The Company provides the customer the right of return on the product and revenue is adjusted based on an estimate of the expected returns based on historical rates. The Company considers the sale of products as a single performance obligation. Sales tax collected from customers and remitted to taxing authorities is excluded from revenue and is included in accrued expenses. Revenue is deferred for orders received for which associated shipments have not occurred. The reserve for returns totaled $307,725 and $33,933 as of December 31, 2022 and 2021, respectively, and is included in accrued expenses and other liabilities in the accompanying consolidated balance sheets. Cost of Revenues Cost of revenues consists primarily of inventory sold and related freight-in. Cost of revenues includes direct labor pertaining to our inventory production activities and an allocation of overhead costs including rent and insurance. Cost of revenues also includes inventory write-offs and reserves. Shipping and Handling The Company recognizes shipping and handling billed to customers as a component of net revenues, and the cost of shipping and handling as distribution costs. Total shipping and handling billed to customers as a component of net revenues was approximately $72,000 and $23,000 for the years ended December 31, 2022 and 2021, respectively. Total shipping and handling costs included in distribution costs were approximately $525,000 and $423,000, respectively. Advertising and Promotion Advertising and promotional costs are expensed as incurred. Advertising and promotional expense for the years ended December 31, 2022 and 2021 amounted to approximately $1,178,000 and $240,000, respectively. The amounts are included in sales and marketing expense. General and Administrative General and administrative expenses consist primarily of compensation and benefits costs, professional services and information technology. General and administrative expenses also include payment processing fees, design and warehousing fees. Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedging relationships and the types of relationships designated are based on the exposures hedged. At December 31, 2022 and 2021, the Company did not have any derivative instruments that were designated as hedges. Stock Option and Warrant Valuation Stock option and warrant valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option model. For warrants and stock options issued to non- employees, the Company accounts for the expected life based on the contractual life of the warrants and stock options. For employees, the Company accounts for the expected life of options in accordance with the “simplified” method, which is used for “plain-vanilla” options, as defined in the accounting standards codification. The simplified method is based on the average of the vesting tranches and the contractual life of each grant. For stock price volatility, the Company uses comparable public companies as a basis for its expected volatility to calculate the fair value of options grants. The risk-free interest rate was determined from the implied yields of U.S. Treasury zero-coupon bonds with a remaining life consistent with the expected term of the options. The number of stock award forfeitures are recognized as incurred. Stock-Based Compensation The Company accounts for stock-based compensation costs under the provisions of ASC 718, Compensation — Stock Compensation, which requires the measurement and recognition of compensation expense related to the fair value of stock-based compensation awards that are ultimately expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock-based payments granted to employees, officers, and directors based on the grant date fair value estimated in accordance with the provisions of ASC 718. ASC 718 is also applied to awards modified, repurchased, or cancelled during the periods reported. Stock-based compensation is recognized as an expense over the employee’s requisite vesting period and over the nonemployee’s period of providing goods or services. The Company measures employee stock-based awards at grant-date fair value and recognizes employee compensation expense on a straight-line basis over the vesting period of the award. Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions, including the fair value of the Company’s common stock, and for stock options, the expected life of the option, and expected stock price volatility. The Company used the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards. Deferred Offering Costs The Company complies with the requirements of ASC 340, Other Assets and Deferred Costs, with regards to offering costs. Prior to the completion of an offering, offering costs are capitalized. The deferred offering costs are charged to additional paid-in capital or as a discount to debt, as applicable, upon the completion of an offering or to expense if the offering is not completed. As of December 31, 2020, the Company had capitalized $214,647 in deferred offering costs. Upon completion of the IPO in May 2021, all capitalized deferred offering costs were charged to additional paid-in capital. As of December 31, 2021, the Company capitalized $367,696 in deferred offering costs pertaining to its equity line of credit agreement with Oasis (Note 8). In 2022, the Company wrote off these costs to general and administrative expenses in the consolidated statements of operations as the equity line of credit financing never occurred. Segment Information In accordance with ASC 280, Segment Reporting (“ASC 280”), we identify our operating segments according to how our business activities are managed and evaluated. As of December 31, 2022 our operating segments included: DSTLD, Bailey, H&J, Stateside and Sundry. Each operating segment currently reports to the Chief Executive Officer. Each of our brands serve or are expected to serve customers through our wholesale, in store and online channels, allowing us to execute on our omni-channel strategy. We have determined that each of our operating segments share similar economic and other qualitative characteristics, and therefore the results of our operating segments are aggregated into one reportable segment. All of the operating segments have met the aggregation criteria and have been aggregated and are presented as one reportable segment, as permitted by ASC 280. We continually monitor and review our segment reporting structure in accordance with authoritative guidance to determine whether any changes have occurred that would impact our reportable segments. Income Taxes The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is unlikely that the deferred tax assets will not be realized. We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, our policy will be to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions wher

BUSINESS COMBINATIONS

BUSINESS COMBINATIONS	12 Months Ended
BUSINESS COMBINATIONS	Dec. 31, 2022
BUSINESS COMBINATIONS
BUSINESS COMBINATIONS	NOTE 4: BUSINESS COMBINATIONS AND DISPOSITION 2022 Acquisition Sundry On December 30, 2022, the Company completed its previously announced acquisition (the “ Sundry Acquisition”) of all of the issued and outstanding membership interests of Sunnyside, LLC, a California limited liability company (“Sundry”), pursuant to that certain Second Amended and Restated Membership Interest Purchase Agreement (the “ Sundry Agreement”), dated October 13, 2022, by and among Moise Emquies, George Levy, Matthieu Leblan and Carol Ann Emquies (“ Sundry Sellers”), George Levy as the Sundry Sellers’ representative, the Company as Buyer, and Sundry. Pursuant to the Agreement, Sellers, as the holders of all of the outstanding membership interests of Sundry, exchanged all of such membership interests for (i) $7.5 million in cash, (ii) $5.5 million in promissory notes of the Company (the “Sundry Notes”), and (iii) a number of shares of common stock of the Company equal to $1.0 million (the “Sundry Shares”), calculated in accordance with the terms of the Agreement, which consideration was paid or delivered to the Sellers, Jenny Murphy and Elodie Crichi. Each Sundry Note bears interest at eight percent (8%) per annum and matured on February 15, 2023 (see Note 7). The Company issued 3,636 shares of common stock to the Sundry Sellers on December 30, 2022 at a fair value of $1,000,000. The Company evaluated the acquisition of Sundry pursuant to ASC 805 and ASU 2017-01, Topic 805, Business Combinations. The acquisition method of accounting requires, among other things, that the assets acquired and liabilities assumed in a business combination be measured at their estimated respective fair values as of the closing date of the acquisition. Goodwill recognized in connection with this transaction represents primarily the potential economic benefits that the Company believes may arise from the acquisition. Total fair value of the purchase price consideration was determined as follows: Cash $ 7,500,000 Promissory notes payable 5,500,000 Common stock 1,000,000 Purchase price consideration $ 14,000,000 The Company has made an allocation of the purchase price in regard to the acquisition related to the assets acquired and the liabilities assumed as of the purchase date. The following table summarizes the purchase price allocation: Purchase Price Allocation Cash and cash equivalents $ 252,697 Accounts receivable, net 63,956 Due from factor, net 387,884 Inventory 2,941,755 Prepaid expenses and other current assets 32,629 Property, equipment and software, net 48,985 Goodwill 3,711,322 Intangible assets 7,403,800 Accounts payable (615,706) Accrued expenses and other liabilities (227,321) Purchase price consideration $ 14,000,000 The customer relationships and will be amortized on a straight-line basis over their estimated useful lives of three years. The brand name is indefinite-lived. The Company used the relief of royalty and income approach to estimate the fair value of intangible assets acquired. Goodwill is primarily attributable to the go-to-market synergies that are expected to arise as a result of the acquisition and other intangible assets that do not qualify for separate recognition. The goodwill is not deductible for tax purposes. The results of Sundry have been included in the consolidated financial statements since the date of acquisition. Previous Acquisitions Bailey On February 12, 2020, the Company acquired 100% of the membership interests of Bailey. The purchase price consideration included (i) an aggregate of 20,754,717 shares of Series B Preferred Stock of the Company (the “Parent Stock”) and (ii) a promissory note in the principal amount of $4,500,000. The total purchase price consideration was $15,500,000. DBG agreed that if at that date which is one year from the closing date of the IPO, the product of the number of shares of Parent Stock issued under the Merger multiplied by the sum of the closing price per share of the common stock of the Company on such date, plus Sold Parent Stock Gross Proceeds (as that term is defined in the Merger Agreement), does not exceed the sum of $11,000,000 less the value of any Holdback Shares cancelled further to the indemnification provisions of the Merger Agreement, then the Company shall issue to the Holders pro rata an additional aggregate number of shares of common stock of the Company equal to the valuation shortfall at a per share price equal to the then closing price per share of the common stock of the Company. As of December 31, 2022 and 2021, the Company has a contingent consideration liability of $10,698,475 and $7,935,016, respectively, based on the valuation shortfall as noted above. See Note 3. Harper & Jones On May 18, 2021, the Company closed its acquisition of H&J pursuant to its previously disclosed Membership Interest Stock Purchase Agreement (as amended, the “Purchase Agreement”) with D. Jones Tailored Collection, Ltd. (the “Seller”), to purchase 100% of the issued and outstanding equity of Harper & Jones LLC. The purchase price consideration included (i) an aggregate of 87,711 shares of the Company’s common stock and (ii) $500,000 financed from the proceeds of the IPO. Pursuant to the H&J Purchase Agreement, the Seller, as the holder of all of the outstanding membership interests of H&J, exchanged all of such membership interests for a number of common stock of the Company equal to the lesser of (i) $9.1 million at a per share price equal to the initial public offering price of the Company’s shares offered pursuant to its initial public offering or (ii) the number of Subject Acquisition Shares; “Subject Acquisition Shares” means the percentage of the aggregate number of shares of the Company’s common stock issued pursuant to the Agreement, which is the percentage that Subject Seller Dollar Value is in relation to Total Dollar Value. “Subject Seller Dollar Value” means $9.1 million. If, at the one year anniversary of the closing date of the Company’s IPO, the product of the number of shares of the Company’s common stock issued at the closing of the acquisition multiplied by the average closing price per share of the shares of the Company’s common stock as quoted on the NasdaqCM for the thirty (30) day trading period immediately preceding such date does not exceed the sum of $9.1 million less the value of any shares of the Company’s common stock cancelled further to any indemnification claims made against the Seller then the Company shall issue to Seller an additional aggregate number of shares of the Company’s common stock equal to the valuation shortfall at a per share price equal to the then closing price per share of the Company’s common stock as quoted on the NasdaqCM. The Company evaluated the acquisition of H&J pursuant to ASC 805 and ASU 2017-01, Topic 805, Business Combinations. The acquisition method of accounting requires, among other things, that the assets acquired and liabilities assumed in a business combination be measured at their estimated respective fair values as of the closing date of the acquisition. Goodwill recognized in connection with this transaction represents primarily the potential economic benefits that the Company believes may arise from the acquisition. Total fair value of the purchase price consideration was determined as follows: Cash $ 500,000 Common stock 8,025,542 Contingent consideration 3,421,516 Purchase price consideration $ 11,947,058 The Company has made an allocation of the purchase price in regard to the acquisition related to the assets acquired and the liabilities assumed as of the purchase date. The following table summarizes the purchase price allocation: Purchase Price Allocation Cash and cash equivalents $ 24,335 Accounts receivable, net 49,472 Due from factor, net — Inventory 77,159 Prepaid expenses and other current assets 69,715 Property, equipment and software, net 83,986 Goodwill 9,681,548 Intangible assets 3,936,030 Accounts payable (51,927) Accrued expenses and other liabilities (107,957) Purchase price consideration $ 11,947,058 The customer relationships and will be amortized on a straight-line basis over their estimated useful lives of three years. The brand name is indefinite-lived. The Company used the relief of royalty approach to estimate the fair value of intangible assets acquired. Goodwill is primarily attributable to the go-to-market synergies that are expected to arise as a result of the acquisition and other intangible assets that do not qualify for separate recognition. The goodwill is not deductible for tax purposes. The Company recorded an initial contingent consideration liability at a fair value of $3,421,516 based on the valuation shortfall noted above. As of December 31, 2022 and 2021, the H&J contingent consideration was valued at $1,400,000 and $4,244,460, respectively. See Note 3. The results of H&J have been included in the consolidated financial statements since the date of acquisition. H&J’s 2021 net revenue and net loss included in the consolidated financial statements since the acquisition date were approximately $1,860,000 and $390,000, respectively. June 2023 Disposition On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 78,103 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. This transaction is known as the “H&J Settlement”. The H&J Settlement was accounted for a business disposition in accordance with ASC 810-40-40-3A. In accordance with the provisions of ASC 205-20, the Company has excluded the results of discontinued operations from its results of continuing operations in the accompanying consolidated statements of operations for the three and six months ended June 30, 2023 and 2022 in its Form 10-Q Quarterly Report filed on August 21, 2023. Accordingly, the consolidated financial statements as of and for the years ended December 31, 2022 and 2021 have been adjusted retroactively to account for the discontinued operations classification of H&J. Significant components of H&J’s assets and liabilities consist of the following: December 31, 2022 2021 Cash and cash equivalents $ 7,666 $ 12,598 Inventory 102,718 95,155 Accounts receivable, net 45,018 22,010 Goodwill 1,130,310 9,681,548 Intangible assets, net 1,521,265 3,578,182 Other current and non-current assets 62,703 161,740 Accounts payable 81,991 54,981 Accrued expenses and other liabilities 520,195 381,290 Deferred revenue 202,129 276,397 Due to related parties 1,008 21,361 Note payable - related party 129,489 299,489 Loan payable 284,059 148,900 The results of the discontinued operations of H&J for the years ended December 31, 2022 and 2021 consist of the following: Year Ended December 31, 2022 2021 Net revenues $ 3,637,620 $ 1,819,896 Cost of net revenues 1,241,594 1,888,091 Gross profit (loss) 2,396,026 (68,195) Operating expenses: General and administrative 2,303,854 603,007 Sales and marketing 931,650 540,873 Impairment 10,036,238 — Total operating expenses 13,271,742 1,143,880 Loss from operations (10,875,716) (1,212,075) Other income (expense): Interest expense (52,927) (44,828) Other non-operating income (expenses) — 233,030 Total other income (expense), net (52,927) 188,202 Income tax benefit (provision) — — Net loss from discontinued operations $ (10,928,643) $ (1,023,873) Weighted average common shares outstanding - basic and diluted 30,852 3,052 Net loss from discontinued operations per common share - basic $ (354.23) $ (335.52) Stateside On August 30, 2021, the Company entered into a Membership Interest Purchase Agreement (the “MIPA”) with Moise Emquies pursuant to which the Company acquired all of the issued and outstanding membership interests of MOSBEST, LLC, a California limited liability company (“Stateside” and such transaction, the “Stateside Acquisition”). Pursuant to the MIPA, Moise Emquies, as the holder of all of the outstanding membership interests of Stateside, exchanged all of such membership interests for $5.0 million in cash and 44,062 shares of the Company’s common stock (the “Shares”), which number of Shares was calculated in accordance with the terms of the MIPA. Of such amount, $375,000 in cash and a number of Shares equal to $375,000, or 3,305 shares (calculated in accordance with the terms of the MIPA), is held in escrow to secure any working capital adjustments and indemnification claims. The MIPA contains customary representations, warranties and covenants by Moise Emquies. The Company evaluated the acquisition of Stateside pursuant to ASC 805 and ASU 2017-01, Topic 805, Business Combinations. The acquisition method of accounting requires, among other things, that the assets acquired and liabilities assumed in a business combination be measured at their estimated respective fair values as of the closing date of the acquisition. Goodwill recognized in connection with this transaction represents primarily the potential economic benefits that the Company believes may arise from the acquisition. Total fair value of the purchase price consideration was determined as follows: Cash $ 5,000,000 Common stock 3,403,196 Purchase price consideration $ 8,403,196 The Company has made an allocation of the purchase price in regard to the acquisition related to the assets acquired and the liabilities assumed as of the purchase date. The following table summarizes the purchase price allocation: Purchase Price Allocation Cash and cash equivalents 32,700 Accounts receivable, net 154,678 Due from factor, net 371,247 Inventory 603,625 Prepaid expenses and other current assets 7,970 Deposits 9,595 Property, equipment and software, net — Goodwill 2,104,056 Intangible assets 5,939,140 Accounts payable (374,443) Accrued expenses and other liabilities (445,372) $ 8,403,196 The customer relationships and will be amortized on a straight-line basis over their estimated useful lives of three years. The brand name is indefinite-lived. The Company used the relief of royalty and income approach to estimate the fair value of intangible assets acquired. Goodwill is primarily attributable to the go-to-market synergies that are expected to arise as a result of the acquisition and other intangible assets that do not qualify for separate recognition. The goodwill is not deductible for tax purposes. Per the terms of the MIPA, a working capital adjustment of $493,791 was recorded during the fourth quarter. Net amounts due to the seller are $396,320 at December 31, 2021 (Note 7). The results of Stateside have been included in the consolidated financial statements since the date of acquisition. Stateside’s 2021 net revenue and net loss included in the consolidated financial statements since the acquisition date were approximately $1,695,000 and $285,000, respectively. Unaudited Pro Forma Financial Information The following unaudited pro forma financial information presents the Company’s financial results as if the Bailey, H&J, Stateside and Sundry acquisitions had occurred as of January 1, 2021. The unaudited pro forma financial information is not necessarily indicative of what the financial results actually would have been had the acquisitions been completed on this date. In addition, the unaudited pro forma financial information is not indicative of, nor does it purport to project, the Company’s future financial results. The following unaudited pro forma financial information includes incremental property and equipment depreciation and intangible asset amortization as a result of the acquisitions. The unaudited pro forma information does not give effect to any estimated and potential cost savings or other operating efficiencies that could result from the acquisition: Year Ended December 31, 2022 2021 Net revenues $ 28,519,261 $ 34,635,426 Net loss $ (42,001,415) $ (33,171,473) Net loss per common share $ (1,361.50) $ (10,870.25)

DUE FROM FACTOR_2

DUE FROM FACTOR	6 Months Ended	12 Months Ended
DUE FROM FACTOR	Jun. 30, 2023	Dec. 31, 2022
DUE FROM FACTOR
DUE FROM FACTOR	NOTE 5: DUE FROM FACTOR Due to/from factor consist of the following: June 30, December 31, 2023 2022 Outstanding receivables: Without recourse $ 787,542 $ 1,680,042 With recourse 50,979 65,411 Matured funds and deposits 88,516 81,055 Advances (478,753) (632,826) Credits due customers (10,142) (354,282) $ 438,142 $ 839,400	NOTE 5: DUE FROM FACTOR The Company, via its subsidiaries, Bailey, Stateside and Sundry, assigns a portion of its trade accounts receivable to third- party factoring companies, who assumes the credit risk with respect to the collection of non-recourse accounts receivable. The Company may request advances on the net sales factored at any time before their maturity date, and up to 50% of eligible finished goods inventories based on the terms of one of our agreements that terminated in 2021. The factor charges a commission on the net sales factored for credit and collection services. For one factoring company, interest on advances is charged as of the last day of each month at a rate equal to the LIBOR rate plus 2.5% for Bailey. For Stateside and Sundry, should total commission and fees payable be less than $30,000 in a single year, then the factor shall charge the difference between the actual fees in said year and $30,000 to the Company. Interest on advances is charged as of the last day of each month at a rate equal to the greater of either, (a) the Chase Prime Rate + (2.0)% or (b) (4.0)% per annum. For another factoring company, interest is charged at one-thirty- third Advances are collateralized by a security interest in substantially all of the companies’ assets. Due to/from factor consist of the following: December 31, 2022 2021 Outstanding receivables: Without recourse $ 564,548 $ 579,295 With recourse 352,379 361,584 Advances 118,521 121,617 Credits due customers (196,048) (77,208) $ 839,400 $ 985,288

GOODWILL AND INTANGIBLE ASSET_4

GOODWILL AND INTANGIBLE ASSETS	6 Months Ended	12 Months Ended
GOODWILL AND INTANGIBLE ASSETS	Jun. 30, 2023	Dec. 31, 2022
GOODWILL AND INTANGIBLE ASSETS
GOODWILL AND INTANGIBLE ASSETS	NOTE 6: GOODWILL AND INTANGIBLE ASSETS The following is a summary of goodwill attributable to each business combination: June 30, December 31, 2023 2022 Bailey $ 3,158,123 $ 3,158,123 Stateside 2,104,056 2,104,056 Sundry 3,711,322 3,711,322 $ 8,973,501 $ 10,103,812 In connection with the H&J disposition, the Company derecognized $1,130,311 in goodwill. The following table summarizes information relating to the Company’s identifiable intangible assets as of June 30, 2023: Gross Accumulated Carrying Amount Amortization Value Amortized: Customer relationships $ 9,734,560 $ (4,155,129) $ 5,579,431 $ 9,734,560 $ (4,155,129) $ 5,579,431 Indefinite-lived: Brand name $ 5,841,880 — 5,841,880 $ 15,576,440 $ (4,155,129) $ 11,421,311 In connection with the H&J disposition, the Company derecognized $1,246,915 in intangible assets. The Company recorded amortization expense of $804,924 and $537,812 during the three months ended June 30, 2023 and 2022, and $1,759,277 and $1,075,625 during the six months ended June 30, 2023 and 2022, respectively, which is included in general and administrative expenses in the consolidated statements of operations.	NOTE 6: GOODWILL AND INTANGIBLE ASSETS Goodwill The Company recorded goodwill from each of its business combinations. The following is a summary of goodwill by entity for the years ended December 31, 2022 and 2021: Bailey Stateside Sundry Total Balances at December 31, 2020 $ 6,479,218 $ — $ — $ 6,479,218 Business combination — 2,104,056 — 2,104,056 Impairment — — — — Balances at December 31, 2021 6,479,218 2,104,056 — 8,583,274 Business combination — — 3,711,322 3,711,322 Impairment (3,321,095) — — (3,321,095) Balances at December 31, 2022 $ 3,158,123 $ 2,104,056 $ 3,711,322 $ 8,973,501 Refer to Note 3 for discussion on the goodwill impairment recorded in 2022. As of December 31, 2022, there was approximately $3.2 million for Bailey in goodwill that relates to liabilities in excess of assets. Intangible Assets The following table summarizes information relating to the Company’s identifiable intangible assets as of December 31, 2022 and 2021: Gross Accumulated Carrying December 31, 2022 Amount Amortization Value Amortized: Customer relationships $ 9,734,560 (2,670,202) $ 7,064,358 9,734,560 (2,670,202) 7,064,358 Indefinite-lived: Brand name $ 5,841,880 — 5,841,880 $ 15,576,440 $ (2,670,202) $ 12,906,238 Gross Accumulated Carrying December 31, 2021 Amount Amortization Value Amortized: Customer relationships $ 4,736,080 (1,091,509) $ 3,644,571 4,736,080 (1,091,509) 3,644,571 Indefinite-lived: Brand name $ 5,618,560 — 5,618,560 $ 10,354,640 $ (1,091,509) $ 9,263,131 Due to the effects of COVID-19 and revenue levels not recovering as quickly as anticipated and related uncertainty which affected Bailey’s results and near-term demand for its products, the Company determined that there were indications for further impairment analysis in both 2022 and 2021. Due to Harper’s revenue levels lower as compared to initial projects, the Company determined that there were indications for further impairment analysis in 2022. Refer to Note 3 for discussion on the intangible asset impairment recorded in 2022 and 2021. Management determined circumstances existed that indicated the carrying value may not be recoverable. The impairment analysis was based on the relief from royalty method using projected revenue estimates and discounts rates believed to be appropriate. Fair value determinations require considerable judgment and are sensitive to changes in underlying assumptions, estimates and market factors. The discount rate, revenue assumptions and terminal growth rate of our reporting unit were the material assumptions utilized in the model used to estimate the fair value of the Bailey unit. The analysis requires estimates, assumptions and judgments about future events. Our analysis uses our internally generated long-range plan. The long-range plan reflects management judgment, which includes observation of expected industry trends. The Company recorded amortization expense of $1,653,819 and $1,128,524 during the years ended December 31, 2022 and 2021, respectively, which is included in general and administrative expenses in the consolidated statements of operations. Future amortization expense at December 31, 2022 is as follows: Year Ending December 31, 2023 2,924,020 2024 2,474,178 2025 1,666,160 $ 7,064,358

LIABILITIES AND DEBT_2

LIABILITIES AND DEBT	6 Months Ended	12 Months Ended
LIABILITIES AND DEBT	Jun. 30, 2023	Dec. 31, 2022
LIABILITIES AND DEBT
LIABILITIES AND DEBT	NOTE 7: LIABILITIES AND DEBT Accrued Expenses and Other Liabilities The Company accrued expenses and other liabilities line in the consolidated balance sheets is comprised of the following as of June 30, 2023 and December 31,2022: June 30, December 31, 2023 2022 Accrued expenses $ 503,927 $ 668,714 Reserve for returns — 307,725 Payroll related liabilities 4,009,812 2,618,870 Sales tax liability 277,800 262,765 Other liabilities 247,398 78,845 $ 5,038,937 $ 3,936,920 As of June 30, 2023, payroll liabilities included an aggregate of $1,288,048 in payroll taxes due to remit to federal and state authorities. Of this amount, $620,400 pertained to DBG and $667,648 pertained to Bailey44. The amounts are subject to further penalties and interest. The amounts are subject to further penalties and interest. As of June 30, 2023 and December 31, 2022, accrued expenses included $535,000 in accrued common stock issuances pursuant to an advisory agreement for services performed in 2022. The 5,000 shares of common stock owed per the agreement are expected to be issued in the third quarter of 2023. At June 30, 2023, accrued expenses also includes owed to Sundry executives based on their employment agreements with the Company, which is expected to be issued in the third quarter of 2023. Convertible Debt 2020 Regulation D Offering As of June 30, 2023 and December 31, 2022, there was $100,000 remaining in outstanding principal that was not converted into equity. Convertible Promissory Note On December 29, 2022, the Company and various purchasers executed a Securities Purchase Agreement (“December Notes”) whereby the investors purchased from the Company convertible promissory notes in the aggregate principal amount of $4,000,000, consisting of original issue discount of $800,000. The Company received net proceeds of $3,000,000. The December Notes were due and payable on February 15, 2023. If the December Notes are not repaid in full by the maturity date or if any other event of default occurs, (1) the face value of the December Notes will be automatically increased to 120%; (2) the Notes will begin generating an annual interest rate of 20%, which will be paid in cash monthly until the default is cured; and (3) if such default continues for 14 or more calendar days, at the investors’ discretion, the December Notes shall become convertible at the option of the investors into shares of the Company’s common stock at a conversion price equal to the closing price of the Company’s common stock on the date of the note conversion. In connection with the December Notes, the Company issued to the investors an aggregate of 18,779 warrants to purchase common stock at an exercise price equal to $106.50, and 2,400 shares of common stock. The Company recognized $428,200 as a debt discount for the fair value of the warrants and common shares using the Black-Scholes option model, resulting in a total debt discount of $1,378,200. In February 2023, the principal of $4,000,000 of the December Notes were fully repaid. The Company amortized $689,100 of debt discount up until the repayment date, and then recognized a loss on extinguishment of debt of $689,100 which is included in other non-operating income (expenses) on the consolidated statements of operations. The following is a summary of the convertible notes for the six months ended June 30, 2023: Unamortized Convertible Note Principal Debt Discount Payable, Net Balance, December 31, 2022 $ 4,100,000 $ (1,378,200) $ 2,721,800 Repayments of notes (4,000,000) — (4,000,000) Amortization of debt discount — 689,100 689,100 Loss on extinguishment of debt — 689,100 689,100 Balance, June 30, 2023 $ 100,000 $ — $ 100,000 During the six months ended June 30, 2022, the Company converted an aggregate of $888,930 in outstanding principal into 350 shares of common stock. During the six months ended June 30, 2023 and 2022, the Company amortized $689,100 and $1,724,291, respectively of debt discount to interest expense pertaining to convertible notes. In January 2023, the Company issued 4,400 shares of common stock at a fair value of $322,300 to a former convertible noteholder pursuant to default provisions. The amount was included in interest expense in the consolidated statements of operations. Loan Payable — PPP and SBA Loan As of both June 30, 2023 and December 31, 2022, Bailey had an outstanding PPP Loan balance of $933,295 and matures in 2026. Merchant Advances In 2022, the Company obtained several merchant advances. These advances are, for the most part, secured by expected future sales transactions of the Company with expected payments on a weekly basis. As of December 31, 2022, $896,334 remained outstanding. During the six months ended June 30, 2023, the Company received additional proceeds totaling $1,692,748 and made repayments totaling $2,331,972. As of June 30, 2023, the remaining principal outstanding was $257,110. In connection with these advances, the Company granted 6,095 warrants to purchase common stock at an exercise price of $131.25 to the lender in connection with its merchant advances. In 2023, the Company obtained merchant advances totaling $502,051 from Shopify Capital, and made repayments totaling $208,416 . As of June 30, 2023, the remaining principal outstanding was Promissory Note Payable As of June 30, 2023 and December 31, 2022, the outstanding principal on the note to the sellers of Bailey was $3,500,000. The maturity date was December 31, 2022. On July 5, 2023, the parties agreed to extend the maturity date to June 30, 2024. Interest expense was $105,000 and $105,000 for the three months ended June 30, 2023 and 2022 and $210,000 and $210,000 for the six months ended June 30, 2023 and 2022, all respectively, which was accrued and unpaid as of June 30, 2023. The Company issued a promissory note in the principal amount of $5,500,000 to the Sundry Holders pursuant to the Sundry acquisition. The note bears interest at 8% per annum and matures on February 15, 2023. In February 2023, the parties verbally agreed to extend the maturity date to December 31, 2023. Interest expense was $149,177 and $259,177 for the three and six months ended June 30, 2023, respectively. On June 21, 2023, the Company and the Sundry Holders executed a Securities Purchase Agreement (the “Sundry SPA”) whereby the Company issued per share (see Note 7). The shares were issued pursuant to the cancellation of the Sundry Holders’ entire principal amount of In March 2023, the Company and various purchasers executed a Securities Purchase Agreement (“March 2023 Notes”) whereby the investors purchased from the Company promissory notes in the aggregate principal amount of $2,458,750, consisting of original issue discount of $608,750. The Company received net proceeds of $1,850,000 after additional fees. The March 2023 Notes are due and payable on September 30, 2023 (the “Maturity Date”). The Company will also have the option to prepay the Notes with no penalties at any time prior to the Maturity Date. If the Company completes a debt or equity financing of less than $7,500,000, the Company is required to repay 50% of the remaining balance of the March 2023 Notes. Following such 50% repayment, the Company must also use any proceeds from any subsequent debt or equity financing to repay the March 2023 Notes. Upon the closing of any debt or equity financing of $7,500,000 or greater, the Company is required to repay 100% of the Notes with no penalties. There is no additional interest after the 20% original interest discount. The Company recognized a debt discount of $608,750, of which $263,839 was amortized through June 30, 2023. The following is a summary of promissory notes payable, net: June 30, December 31, 2023 2022 Bailey Note $ 3,500,000 $ 3,500,000 Sundry Note — 5,500,000 March 2023 Notes - principal 2,458,750 — March 2023 Notes - unamortized debt discount (344,911) — Promissory note payable, net $ 5,613,839 $ 9,000,000	NOTE 7: LIABILITIES AND DEBT Accrued Expenses and Other Liabilities The Company accrued expenses and other liabilities line in the consolidated balance sheets is comprised of the following as of December 31, 2022 and 2021: December 31, 2022 2021 Accrued expenses $ 668,714 $ 178,819 Reserve for returns 307,725 33,933 Payroll related liabilities 2,618,870 1,183,598 Sales tax liability 262,765 225,804 Due to seller — 396,320 Other liabilities 78,845 59,613 $ 3,936,920 $ 2,078,087 As of December 31, 2022, payroll liabilities included an aggregate of $1,074,316 in payroll taxes due to remit to federal and state authorities. Of this amount, $539,839 pertained to DBG and $534,477 pertained to Bailey44. The amounts are subject to further penalties and interest. As of December 31, 2022, accrued expenses included $535,000 in accrued common stock issuances pursuant to an advisory agreement for services performed in 2022. The 200 shares of common stock owed per the agreement are expected to be issued in the second quarter of 2023. Due to seller represents amounts to the seller owed pursuant the Stateside Acquisition after certain purchase price adjustments were made in the fourth quarter of 2021, and repaid in 2022. Venture Debt As of December 31, 2021, the gross loan balance with Black Oak Capital (“Black Oak”) pertaining to its senior credit agreement was $6,001,755. In February 2022, the Company received $237,500 in proceeds, including loan fees of $12,500, from the existing venture debt lender under the same terms as the existing facility. On September 29, 2022, the Company and Black Oak executed a Securities Purchase Agreement (the “Black Oak SPA”) whereby the Company issued 6,300 shares of Series A Convertible Preferred Stock to Black Oak for $1,000 per share (see Note 7). The shares were issued pursuant to the conversion of Black Oak’s entire principal amount of $6,251,755, and the Company recorded $48,245 in interest as part of the conversion. Pursuant to the Black Oak SPA, all accrued interest remaining outstanding. Accrued interest was $269,880 as of December 31, 2022. For the year ended December 31, 2022 and 2021, $12,500 and $147,389 of loan fees and discounts from warrants were amortized to interest expense, leaving unamortized balance of $0 as of December 31 2022. Interest expense was $573,455 and $825,219 for the years ended December 31, 2022 and 2021, respectively. Convertible Debt 2020 Regulation CF Offering During the year ended December 31, 2020, the Company received gross proceeds of $450,308 from a Regulation CF convertible debt offering. In 2021, the Company received additional gross proceeds of $473,650. Interest was 6% per annum and the debt was due October 30, 2022. Upon closing of the IPO, the outstanding principal and accrued and unpaid interest of $16,942 was converted into 12,786 shares of common stock based on the terms of the notes. Total issuances costs were $69,627, which was recognized as a debt discount and was amortized in 2021 through the date of IPO when such debt converted. During the year ended December 31, 2021, $27,894 of the debt discount was amortized to interest expense. Concurrently with the offering above, in 2021 and 2020 the Company received gross proceeds of $55,000 and $800,000, respectively, from a Regulation D convertible debt offering. The debt accrued interest at a rate of 14% per annum with a maturity date of nine months from the date of issuance. In addition, the Company issued 0.2 warrants to purchase common stock in connection with the notes. The issuance costs and warrants are recognized as a debt discount and were amortized in 2021 through the date of IPO when such debt converted. The fair value of the warrants was determined to be negligible. Upon closing of the IPO, $755,000 in outstanding principal and approximately $185,000 of the accrued and unpaid interest was converted into 181 shares of common stock. As of December 31, 2022 and 2021, there was $100,000 remaining in outstanding principal that was not converted into equity (see table below). During the year ended December 31, 2021, $100,000 of the debt discount was amortized to interest expense. The Company recorded an additional $132,609 in default interest expense upon conversion of these notes. 2019 Regulation D Offering For the year ended December 31, 2019, the Company received gross proceeds of $799,280 from a Regulation D convertible debt offering. The debt accrued interest at a rate of 12% per annum with a maturity date of thirty-six months from the date of issuance. The debt was contingently convertible and contained both automatic and optional conversions. Upon closing of the IPO, the outstanding principal was converted into 145 shares of common stock. Convertible Promissory Notes 2021 Notes On August 27, 2021, the Company entered into a Securities Purchase Agreement with Oasis Capital, LLC (“Oasis Capital”) further to which Oasis Capital purchased a senior secured convertible note (the “Oasis Note”), with an interest rate of 6% per annum, having a face value of $5,265,000 for a total purchase price of $5,000,000, secured by all assets of the Company. The Oasis Note, in the principal amount of $5,265,000, bears interest at 6% per annum and is due and payable 18 months from the date of issuance, unless sooner converted. The Oasis Note is convertible at the option of Oasis Capital into shares of the Company’s common stock at a conversion price (the “ Oasis Conversion Price”) which is the lesser of (i) $90.601, and (ii) 90% of the average of the two lowest volumed weighted average prices (“VWAPs’) during the five consecutive trading day period preceding the delivery of the notice of conversion. Oasis Capital is not permitted to submit conversion notices in any thirty day period having conversion amounts equaling, in the aggregate, in excess of $500,000. If the Oasis Conversion Price set forth in any conversion notice is less than $7,500 per share, the Company, at its sole option, may elect to pay the applicable conversion amount in cash rather than issue shares of its common stock. On October 1, 2021, the Company entered into an Amended and Restated Securities Purchase Agreement with FirstFire Global Opportunities Fund, LLC (“FirstFire”) and Oasis Capital further to which FirstFire purchased a Senior Secured Convertible Promissory Note (the “First FirstFire Note”), with an interest rate of 6% per annum, having a face value of $1,575,000 for a total purchase price of $1,500,000, secured by all assets of the Company. The First FirstFire Note, in the principal amount of $1,575,000, bears interest at 6% per annum and is due and payable 18 months from the date of issuance, unless sooner converted. The First FirstFire Note is convertible at the option of FirstFire into shares of the Company’s common stock at a conversion price (the “First FirstFire Conversion Price”) which is the lesser of (i) $9,880, and (ii) 90% of the average of the two lowest volume-weighted average prices during the five consecutive trading day period preceding the delivery of the notice of conversion. On November 16, 2021, the Company entered into a Securities Purchase Agreement with FirstFire further to which FirstFire purchased a Senior Secured Convertible Promissory Note (the “Second FirstFire Note” and together with the First FirstFire Note, the “FirstFire Notes”), with an interest rate of 6% per annum, having a face value of $2,625,000 for a total purchase price of $2,500,000. The Second FirstFire Note is convertible at the option of FirstFire into shares of the Company’s common stock at a conversion price (the “Second FirstFire Conversion Price”) which is the lesser of (i) $10,700, and (ii) 90% of the average of the two lowest volume-weighted average prices during the five consecutive trading day period preceding the delivery of the notice of conversion. The Company evaluated the terms of the conversion features of the Oasis and FirstFire Notes as noted above in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock, and determined they are not indexed to the Company’s common stock and that the conversion features meet the definition of a liability. The notes contain an indeterminate number of shares to settle with conversion options outside of the Company’s control. Therefore, the Company bifurcated the conversion feature and accounted for it as a separate derivative liability. Upon issuance of the Oasis and FirstFire Notes, the Company recognized a derivative liability at an aggregate fair value of $3,204,924, which is recorded as a debt discount and was amortized over the life of the notes. The original issue discount and issuance costs for the Oasis and FirstFire Notes totaled $1,560,000, which were recognized as a debt discount and was amortized over the life of the notes. As of December 31, 2021, the outstanding principal of the FirstFire and Oasis Notes was $9,465,000. During the year ended December 31, 2022, the Company fully converted the outstanding principal of $9,465,000 and accrued interest of $533,242 into an aggregate of 79,807 shares of commons stock. The Company recorded an additional $484,904 in interest expense as a result of the conversions. As a result of the conversions, all terms and conditions under the notes were met and no further obligations exist. 2022 Notes On April 8, 2022, the Company and various purchasers executed a Securities Purchase Agreement (“April Notes”) whereby the investors purchased from the Company convertible promissory notes in the aggregate principal amount of $3,068,750, consisting of original issue discount of $613,750. The Company received net proceeds of $2,313,750 after the original issue discount and fees, resulting in a debt discount of $755,000. Upon the Company’s public offering in May 2022 (see below), the Company repaid $3,068,750 to the investors and the debt discount was fully amortized. In connection with the April Notes, the Company issued an aggregate of 503 warrants to purchase common stock at an exercise price of $3,050 per share. The Company recognized $98,241 as a debt discount for the fair value of the warrants using the Black-Scholes option model, which was fully amortized upon the notes’ repayment in May. On July 22 and July 28, 2022, the Company and various purchasers executed a Securities Purchase Agreement (“July Notes”) whereby the investors purchased from the Company convertible promissory notes in the aggregate principal amount of $1,875,000, consisting of original issue discount of $375,000. The Company received net proceeds of $1,450,000 after the original issue discount and fees. In connection with the July 22 and July 28 notes, the Company issued an aggregate of 1,645 and 1,106 warrants to purchase common stock at an exercise price of $380 and $282.50 per share, respectively. The Company recognized $692,299 as a debt discount for the fair value of the warrants using the Black-Scholes option model, which will be amortized to interest expense over the life of the notes. If the July Notes are not repaid in full by the maturity date or if any other event of default occurs, (1) the face value of the notes will be automatically increased to 120%; (2) the notes will begin generating an annual interest rate of 20%, which will be paid in cash monthly until the default is cured; and (3) if such default continues for 14 or more calendar days, at the Investors’ discretion, the notes shall become convertible at the option of the investors into shares of the Company’s common stock at a conversion price equal to the closing price of the Company’s common stock on the on the date of the note conversion. The Company evaluated the terms of the conversion features of the July notes as noted above in accordance with ASC Topic No. 815 — 40, Derivatives and Hedging — Contracts in Entity’s Own Stock In December 2022, the Company fully repaid the outstanding principal of $1,875,000 pertaining to the July 22 and 28 notes, as well as an additional $416,923 due to the default provisions noted above. This amount was included in interest expense in the consolidated statements of operations. On December 29, 2022, the Company and various purchasers executed a Securities Purchase Agreement (“December Notes”) whereby the investors purchased from the Company convertible promissory notes in the aggregate principal amount of $4,000,000, consisting of original issue discount of $800,000. The Company received net proceeds of $3,000,000. The December Notes were due and payable on February 15, 2023. If the December Notes are not repaid in full by the maturity date or if any other event of default occurs, (1) the face value of the December Notes will be automatically increased to 120%; (2) the Notes will begin generating an annual interest rate of 20%, which will be paid in cash monthly until the default is cured; and (3) if such default continues for 14 or more calendar days, at the investors’ discretion, the December Notes shall become convertible at the option of the investors into shares of the Company’s common stock at a conversion price equal to the closing price of the Company’s common stock on the date of the note conversion. The December Notes were fully repaid in February 2023. In connection with the December Notes, the Company issued to the investors an aggregate of 18,779 warrants to purchase common stock at an exercise price equal to $106.50, and 2,400 shares of common stock. The Company recognized $428,200 as a debt discount for the fair value of the warrants and common shares using the Black-Scholes option model, which will be amortized to interest expense over the life of the notes. The following is a summary of the convertible notes for the years ended December 31, 2022 and 2021: Unamortized Convertible Note Principal Debt Discount Payable, Net Balance, December 31, 2020 $ 100,000 $ — $ 100,000 Issuance of Oasis note, net of issuance costs 5,265,000 (715,000) 4,550,000 Issuance of FirstFire First note, net of issuance costs 1,575,000 (315,000) 1,260,000 Issuance of Second FirstFire note, net of issuance costs 2,625,000 (530,000) 2,095,000 Derivative liability in connection with notes — (3,204,924) (3,204,924) Amortization of debt discount — 801,538 801,538 Balance, December 31, 2021 9,565,000 (3,963,386) 5,601,614 Proceeds from issuance of notes 8,943,750 (1,992,500) 6,951,250 Repayments of notes (4,943,750) — (4,943,750) Conversion of notes into common stock (9,465,000) — (9,465,000) Warrant and common shares issued with convertible notes — (1,368,741) (1,368,741) Derivative liability in connection with notes — (559,957) (559,957) Amortization of debt discount — 6,506,384 6,506,384 Balance, December 31, 2022 $ 4,100,000 $ (1,378,200) $ 2,721,800 As of December 31, 2022, the December Notes remained outstanding with a principal of $4,000,000 and unamortized debt discount of $1,278,200, consisting of the original issue discount, $50,000 in other financing fees, and the fair value of warrants and shares. The December Notes were fully repaid in February 2023 (see Note 14). During the years ended December 31, 2022 and 2021, the Company amortized $6,506,384 and $801,538, respectively of debt discount to interest expense pertaining to all convertible notes. As of December 31, 2022, there was no remaining derivative liability outstanding pertaining to any convertible notes. Loan Payable — PPP and SBA Loan In December 2021, the Company received notification that both its PPP Loans of $203,994 and $204,000 were approved for full forgiveness. As such, $407,994 was recorded as other non-operating income in the consolidated financial statements. In April 2022, Bailey received notification of full forgiveness of its 2 nd st As of December 31, 2022, the Company and H&J had outstanding loans under the EIDL program of $150,000 and $147,438, respectively. The EIDL Loans mature in thirty years from the effective date of the Loan and has a fixed interest rate of 3.75% per annum. The H&J loan was classified in liabilities per discontinued operations. Loan Payable In May 2021, H&J entered into a loan payable with a bank and received proceeds of $75,000. The line bears interest at 7.76% and matures in December 2025. As of December 31, 2022 and 2021, the outstanding balance was $73,187 and $72,269, respectively. The H&J loan was classified in liabilities per discontinued operations. In December 2021, H&J entered into a merchant advance loan for a principal amount of $153,860 and received proceeds of $140,000. The loan bears interest at 9.9% and matures in June 2023. As of December 31, 2021, the outstanding balance was $149,962. The H&J loan was classified in liabilities per discontinued operations. Note Payable – Related Party As of December 31, 2022 and 2021, H&J had an outstanding note payable of $129,489 and $299,489, respectively owned by the H&J Seller. The note matured in July 2022 and bears interest at 12% per annum. The H&J loan was classified in liabilities per discontinued operations. Merchant Advances In 2022 and 2021, H&J entered into merchant advance loans for proceeds of $147,267 and $140,000, respectively. The loan bears interest at 9.9% per annum. As of December 31, 2022 and 2021, the outstanding principal of the loans was $63,433 and $149,962, respectively. The outstanding loan at December 31, 2022 matures in November 2023. In 2022, the Company obtained several merchant advances for net proceeds of $1,335,360 to fund operations. These advances are, for the most part, secured by expected future sales transactions of the Company with expected payments on a weekly basis. During 2022, the Company made repayments totaling $1,078,385 and $896,334 remained outstanding, which is expected to be repaid in 2023. As of the date of these financial statements, the Company was in compliance with these covenants. Promissory Note Payable As noted in Note 4, the Company issued a promissory note in the principal amount of $4,500,000 to the Bailey Holders pursuant to the Bailey acquisition. Upon the IPO closing in May 2021, the Company repaid $1,000,000 of the outstanding principal on this note in May 2021. In August 2021, the maturity date was further extended to December 31, 2022. The Company is required to make prepayments of $2,000,000 to $4,000,000 if the Company completes a secondary public offering. If a public offering is not consummated before October 31, 2021 and June 30, 2022, the Company shall repay 10% of the outstanding principal at each date. The Company did not make any payments in October 2021, and the Company and the lender agreed to defer these payments to the maturity date of the loan, December 31, 2022. As of the date of these financial statements, the parties are undergoing an extension of the maturity date, but is in technical default. The note incurs interest at 12% per annum. As of December 31, 2022 and 2021, $3,500,000 remained outstanding. Interest expense was $420,000 and $494,000 for the years ended December 31, 2022 and 2021, respectively, all of which was accrued and unpaid as of December 31, 2022. In April 2021, the Company entered into a promissory note in the principal amount of $1,000,000. The Company received $810,000 in proceeds, net of issuance costs and original issue discount. Additionally, the Company issued 48 warrants to the lender, which was recorded as a debt discount at the time of the loan. The fair value of the warrants and shares recorded as a debt discount was $73,958. Upon the closing of the IPO, the note was repaid in full. The entire debt discount of $263,958 was amortized to interest expense upon repayment of the note. As noted in Note 4, the Company issued a promissory note in the principal amount of $5,500,000 to the Sundry Holders pursuant to the Sundry acquisition. The note bears interest at 8% per annum and matures on February 15, 2023. In February 2023, the parties verbally agreed to extend the maturity date to December 31, 2023.

STOCKHOLDERS' DEFICIT_2

STOCKHOLDERS' DEFICIT	6 Months Ended	12 Months Ended
STOCKHOLDERS' DEFICIT	Jun. 30, 2023	Dec. 31, 2022
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT	NOTE 8: STOCKHOLDERS’ DEFICIT On January 11, 2023, the Company, entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a certain accredited investor (the “Investor”), pursuant to which the Company agreed to issue and sell, in a private placement (the “January Private Placement”), an aggregate of 19,000 shares (the “Shares”) of the Company’s common stock (“Common Stock”), and accompanying warrants (the “Common Warrants”) to purchase 19,000 shares of Common Stock, at a combined purchase price of $97.875 per share and Common Warrant, and (ii) 32,086 pre-funded warrants (the “Pre-Funded Warrants” and together with the Common Warrants, the “Warrants” and together with the Shares and the shares of Common Stock underlying the Warrants, the “Securities”) exercisable for 32,086 shares of Common Stock, and accompanying Common Warrants to purchase 32,086 shares of Common Stock, at a combined purchase price of $97.875 per Pre-Funded Warrant and accompanying Common Warrant, to the Investors, for aggregate gross proceeds from the Private Placement of approximately $5 million before deducting placement agent fees and related offering expenses. As a result of the transaction, the Company issued 50,890 shares of common stock, including the 19,000 shares and the immediate exercise of 32,086 pre-funded warrants, for gross proceeds of $5.0 million. The Company received net proceeds of $4.3 million after deducting placement agent fees and offering expenses. In January 2023, the Company issued 4,400 shares of common stock at a fair value of $322,300 to a former convertible noteholder pursuant to default provisions. The amount was included in interest expense in the consolidated statements of operations. In March 2023, the Company issued an aggregate of 4,756 shares of common stock to Sundry executives based on their employment agreements with the Company. The fair value of $499,338, or $4.20 per share as determined by the agreements, was included in general and administrative expenses in the consolidated statements of operations. In June 2023, the Company issued 78,103 shares of common stock to D. Jones at a fair value of $1,357,043 pursuant to the H&J Settlement Agreement. During the six months ended June 30, 2022, the Company converted an aggregate of $888,930 in outstanding principal into 350 shares of common stock. Series B Preferred Stock On May 30, 2023, the Company entered into a Subscription and Investment Representation Agreement (the “Subscription Agreement”) with John Hilburn Davis IV, its Chief Executive Officer pursuant to which the Company agreed to issue and sell 1 share of the Company’s Series B Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”) for $25,000. On May 30, 2023, the Company filed a certificate of designation (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the share of Series B Preferred Stock. The Certificate of Designation provides that the Series B Preferred Stock will have 250,000,000 votes per share of Series B Preferred Stock and will vote together with the outstanding shares of the Company’s common stock, par value 0.0001 per share (the “Common Stock”) and Series A Convertible Preferred Stock, par value 0.0001 per share (the “Series A Convertible Preferred Stock”) as a single class exclusively with respect to any proposal to amend the Company’s Sixth Amended and Restated Certificate of Incorporation (as may be amended and/or restated from time to time, the “Restated Certificate”) to effect a reverse stock split of the Company’s common stock. The Series B Preferred Stock will be voted, without action by the holder, on any such proposal in the same proportion as shares of Common Stock and Series A Convertible Preferred Stock are voted. The Series B Preferred Stock otherwise has no voting rights. The Series B Preferred Stock is not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company. The Series B Preferred Stock has no rights with respect to any distribution of assets of the Company, including upon a liquidation, bankruptcy, reorganization, merger, acquisition, sale, dissolution or winding up of the Company, whether voluntarily or involuntarily. The holder of the Series B Preferred Stock will not be entitled to receive dividends of any kind. The outstanding share of Series B Preferred Stock shall be redeemed in whole, but not in part, at any time (i) if such redemption is ordered by the Board of Directors in its sole discretion or (ii) automatically upon the effectiveness of the amendment to the Restated Certificate implementing a reverse stock split. Upon such redemption, the holder of the Series B Preferred Stock will receive consideration of $25,000 in cash. Series C Convertible Preferred Stock On June 21, 2023, the Company, on the one hand, and Moise Emquies, George Levy, Matthieu Leblan, Carol Ann Emquies, Jenny Murphy and Elodie Crichi (collectively, the “Sundry Investors”), on the other hand, executed a Securities Purchase Agreement (the “Sundry SPA”) whereby the Company issued 5,761 shares of Series C Convertible Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”) to the Sundry Investors at a purchase price of $1,000 per share. The Series C Preferred Stock is convertible into a number of shares of the Company’s Common Stock equal to $1,000 divided by an initial conversion price of $17.925 which represents the lower of (i) the closing price per share of the Common Stock as reported on the Nasdaq on June 20, 2023, and (ii) the average closing price per share of Common Stock as reported on the Nasdaq for the five trading days preceding June 21, 2023. The shares of Series C Preferred Stock were issued in consideration for the cancellation of certain promissory notes issued by the Company to the Sundry Investors dated December 30, 2022 (the “Sundry Loan Documents”). The following is a summary of the rights and preferences of the Series C Convertible Preferred Stock. On June 21, 2023, the Company filed the Certificate of Designation with the Secretary of State for the State of Delaware designating up to 5,761 shares out of the authorized but unissued shares of its preferred stock as Series C Convertible Preferred Stock. The following is a summary of the principal terms of the Series C Preferred Stock. Except for stock dividends or distributions for which adjustments are to be made pursuant to the Certificate of Designation, the holders of the Series C Preferred Stock (the “Series C Holders”) shall be entitled to receive, and the Company shall pay, dividends on shares of the Series C Preferred Stock equal (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of the Series C Preferred Stock. The Series C Holders are entitled to vote as a class as expressly provided in the Certificate of Designation. The Series C Holders are also entitled to vote with the holders of shares of Common Stock, voting together as one class, on all matters in which the Series C Holders are permitted to vote with the class of shares of Common Stock. With respect to any vote with the class of Common Stock, each share of the Series C Preferred Stock shall entitle the Holder thereof to cast that number of votes per share as is equal to the number of shares of Common Stock into which it is then convertible (subject to the ownership limitations specified in the Certificate of Designation) using the record date for determining the stockholders of the Company eligible to vote on such matters as the date as of which the conversion price is calculated. The Series C Preferred Stock shall rank (i) senior to all of the Common Stock; (ii) senior to Junior Securities; (iii) on parity with Parity Securities; and (iv) junior to Senior Securities, in each case, as to dividends or distributions of assets upon liquidation, dissolution or winding up of the Company, whether voluntarily or involuntarily. Subject to any superior liquidation rights of the holders of any Senior Securities of the Company and the rights of the Company’s existing and future creditors, upon a Liquidation, each Holder shall be entitled to be paid out of the assets of the Company legally available for distribution to stockholders, prior and in preference to any distribution of any of the assets or surplus funds of the Company to the holders of the Common Stock and Junior Securities and pari passu with any distribution to the holders of Parity Securities, an amount equal to the Stated Value (as defined in the Certificate of Designation) for each share of the Series C Preferred Stock held by such Holder and an amount equal to any accrued and unpaid dividends thereon, and thereafter the Series C Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Company the same amount that a holder of Common Stock would receive if the Series C Preferred Stock were fully converted (disregarding for such purposes any conversion limitations hereunder) to Common Stock which amounts shall be paid pari passu with all holders of Common Stock. Each share of the Series C Preferred Stock shall be convertible, at any time and from time to time from and after June 21, 2023 at the option of the Holder thereof, into that number of shares of Common Stock determined by dividing the Stated Value of such share of the Series C Preferred Stock ($1,000 as of June 21, 2023) by the Conversion Price. The conversion price for each share of the Series C Preferred Stock is $17.925, which is the lower of (a) the closing price per share of the Common Stock as reported on the Nasdaq Capital Market on June 20, 2023 (the trading day before the date of the Sundry SPA), and (b) the average closing price per share of Common Stock as reported on the Nasdaq Capital Market for the five The Company has the option to redeem any or all of the then outstanding Series C Preferred Stock at 112% of the then Stated Value any time after June 21, 2023 and so long as there is an effective Registration Statement covering the shares issuable upon conversion of the Series C Preferred Stock.	NOTE 8: STOCKHOLDERS’ DEFICIT Amendments to Articles of Incorporation On October 13, 2022, On October 21, 2022, the Board of Directors approved a one reverse stock split became effective as of November 3, 2022. Accordingly, all share and per share amounts for all periods presented in the accompanying consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect this reverse stock split and adjustment of the preferred stock conversion ratios. On May 18, 2021, the Company filed a Sixth Amended and Restated Certificate of Incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware in connection with the Company’s IPO. The Company’s board of directors and stockholders previously approved the Restated Certificate to be effective immediately prior to the closing of the IPO. The Restated Certificate amends and restates the Company’s amended and restated certificate of incorporation, as amended, in its entirety to, among other things: (i) increase the authorized number of shares of common stock to 200,000,000 shares; (ii) authorize 10,000,000 shares of preferred stock that may be issued from time to time by the Company’s board of directors in one or more series; (iii) provide that directors may be removed from office only for cause by the affirmative vote of the holders of at least 66⅔% The Restated Certificate also effected a 1-for-15.625 reverse stock split approved by the Company’s Board of Directors as described above. Series A Preferred Stock On August 31, 2022, the Company entered into a Subscription and Investment Representation Agreement with Hil Davis, its Chief Executive Officer, pursuant to which the Company agreed to issue 1 share of the Company’s Series A Preferred Stock to for $25,000. The issuance of the preferred stock reduced the due to related party balance. The share of Series A Preferred Stock had 250,000,000 votes per share and voted together with the outstanding shares of the Company’s common stock as a single class exclusively with respect to any proposals to amend the Certificate of Incorporation to effect a reverse stock split of the Company’s common stock and to increase the authorized number of shares of the Company’s common stock. The terms of the Series A Preferred Stock provided that the outstanding share of Series A Preferred Stock would be redeemed in whole, but not in part, at any time: (i) if such redemption is ordered by the Board of Directors in its sole discretion or (ii) automatically upon the approval of Proposals 2 and 6 presented at the Company’s 2022 annual shareholders meeting. Following conclusion of the shareholders meeting, such share of the Company’s Series A Preferred Stock was redeemed. On October 13, 2022, the outstanding share of the Company’s Series A Preferred Stock was redeemed for $25,000. Series A Convertible Preferred Stock On September 29, 2022, the Company filed the Certificate of Designation designating up to 6,800 shares out of the authorized but unissued shares of its preferred stock as Series A Convertible Preferred Stock. Except for stock dividends or distributions for which adjustments are to be made pursuant to the Certificate of Designation, the holders of the Series A Preferred Stock (the “Holders”) shall be entitled to receive, and the Company shall pay, dividends on shares of the Series A Preferred Stock equal (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of the Series A Preferred Stock. With respect to any vote with the class of Common Stock, each share of the Series A Preferred Stock shall entitle the Holder thereof to cast that number of votes per share as is equal to the number of shares of Common Stock into which it is then convertible. The Series A Preferred Stock shall rank (i) senior to all of the Common Stock; (ii) senior to any class or series of capital stock of the Company hereafter created specifically ranking by its terms junior to any Preferred Stock (“Junior Securities”); (iii) on parity with any class or series of capital stock of the Corporation created specifically ranking by its terms on parity with the Preferred Stock (“Parity Securities”); and (iv) junior to any class or series of capital stock of the Company hereafter created specifically ranking by its terms senior to any Preferred Stock (“Senior Securities”), in each case, as to dividends or distributions of assets upon liquidation, dissolution or winding up of the Company, whether voluntarily or involuntarily. Each share of the Series A Preferred Stock shall be convertible, at any time and from time to time from and after September 29, 2022 at the option of the Holder thereof, into that number of shares of Common Stock determined by dividing the Stated Value of such share of the Series A Preferred Stock ($1,000 as of September 29, 2022) by the Conversion Price. The conversion price for each share of the Series A Preferred Stock is the closing price of the Common Stock on September 29, 2022, which was $232.50. Common Stock The Company had 1,000,000,000 shares of common stock authorized with a par value of $0.0001 as of December 31, 2022. Common stockholders have voting rights of one vote per share. The voting, dividend, and liquidation rights of the holders of common stock are subject to and qualified by the rights, powers, and preferences of preferred stockholders. 2022 Transactions During the year ended December 31, 2022, the Company issued an aggregate of 79,807 shares of common stock pursuant to the conversion of the FirstFire and Oasis Notes (see Note 7). In September 2022, the Company issued 30 shares of common stock pursuant to a consultant agreement at a fair value of $123,000. As part of the Sundry acquisition (see Note 4), the Company issued 3,636 shares of common stock to the Sundry Sellers at a fair value of $1,000,000. In connection with the December Notes, the Company issued 2,400 shares of common stock with a fair value of $264,000. Underwriting Agreements and Public Offerings On May 5, 2022, the Company entered into an underwriting agreement (the “Alexander Underwriting Agreement”) with Alexander Capital, L.P., acting as representative of the several underwriters named in the Alexander Underwriting Agreement (the “ Alexander Underwriters”), relating to the Company’s underwritten the offering pursuant to which the Company agreed to issue and sell 14,956 shares of the Company’s common stock. The shares were sold to the public at a combined public offering price of $625 per share and were purchased by the Underwriters from the Company at a price of $575 per share. The Company also granted the Alexander Underwriters a 45-day option to purchase up to an additional 2,243 shares of Common Stock at the same price, which expired and were not purchased. The shares were sold in the Offering pursuant to a Registration Statement on Form S-1, as amended (File No. 333-264347) (the “Registration Statement”), a Registration Statement on Form S-1 pursuant to 462(b) of the Securities Act of 1933, as amended (File No. 333-264775), and a related prospectus filed with the Securities and Exchange Commission. The public offering closed on May 10, 2022 and the Company sold 14,956 shares of common stock for total gross proceeds of $9.3 million. The Company received net proceeds of $8.1 million after deducting underwriters’ discounts and commissions of $0.7 million and direct offering expenses of $0.5 million. On November 29, 2022, the Company, entered into a Securities Purchase Agreement with investors pursuant to which the Company agreed to issue and sell, in an offering (i) an aggregate of 6,720 shares (the “Shares”) of the Company’s common stock, and accompanying Class B Warrants (the “Class B Warrants”) to purchase 6,720 shares of common stock and accompanying Class C Warrants (the “Class C Warrants”) to purchase 6,720 shares of Common Stock, at a combined public offering price of $137.50 per share and Class B Warrant and Class C Warrant, and (ii) 66,007 pre-funded warrants (the “Pre-Funded Warrants” and together with the Class B Warrants and the Class C Warrants, the “Warrants” and together with the Shares and the shares of common stock underlying the Warrants, the “Securities”) exercisable for 66,007 shares of Common Stock, and accompanying Class B Warrants to purchase 66,007 shares of Common Stock and Class C Warrants to purchase 66,007 shares of Common Stock, at a combined public offering price of $137.50, less the exercise price of $0.0001, per Pre-Funded Warrant and accompanying Class B Warrant and Class C Warrant, to the Investors, for aggregate gross proceeds from the offering of approximately $10 million before deducting placement agent fees and related offering expenses. As a result of the transaction, the Company issued 72,727 shares of common stock, including the 6,720 shares and the immediate exercise of 66,007 pre-funded warrants, for gross proceeds of $10.0 million. The Company received net proceeds of $9.0 million after deducting placement agent fees and offering expenses. 2021 Transactions On May 13, 2021, the Company’s registration statement on Form S-1 relating to the IPO was declared effective by the SEC. In the IPO, which closed on May 18, 2021, the Company issued and sold 964 shares of common stock at a public offering price of $10,375 per share. Additionally, the Company issued warrants to purchase 1,111 shares, which includes 145 warrants sold upon the partial exercise of the over-allotment option. The aggregate net proceeds to the Company from the were $8.6 million after deducting underwriting discounts and commissions of $0.8 million and direct offering expenses of $0.6 million. Upon the closing of the Company’s IPO on May 18, 2021, all then-outstanding shares of Preferred Stock converted into an aggregate of 1,611 shares of common stock according to their terms. Upon closing of the Company’s IPO, the Company converted outstanding principal totaling $2,680,289 and certain accrued and unpaid interest of the Company’s convertible debt into an aggregate of 454 shares of common stock. See Note 7. Upon closing of the Company’s IPO, certain officers and directors converted balances due totaling $257,515 into 61 shares of common stock and recorded $233,184 in compensation expense for the shares issued in excess of accrued balances owed. In connection with the H&J and Stateside acquisitions, the Company issued 877 and 441 shares of common stock to the respective sellers. See Note 4. Pursuant to a consulting agreement, the Company issued 20 shares of common stock with a guaranteed equity value of $250,000. In connection with the agreement, the Company recorded a contingent consideration liability of $67,000. See Note 3. An additional 17 shares were issued upon settlement of the contingent liability. In May 2021, an aggregate of 13 warrants were exercised for shares of common stock for proceeds of $145,696. In July 2021, warrant holders exercised 142 warrants for proceeds of $1,622,350. On June 28, 2021, the Company’s underwriters purchased 145 shares of common stock at a public offering price of $10,375 per share pursuant to the exercise of the remaining portion of their over-allotment option. The Company received net proceeds of approximately $1.4 million after deducting underwriting discounts and commissions of $0.1 million. In connection with the execution of the Oasis Capital EPA, the Company issued Oasis Capital 51 shares of common stock (the “Commitment Shares”). Upon nine months from the Execution Date, Oasis may return a portion of the Commitment Shares. As of December 31, 2021, the Company recorded the fair value of the Commitment Shares of $367,696 as deferred offering costs as no financings under the related EPA have occurred. In connection with the Second FirstFire Note, in November 2021 the Company issued (a) 12 additional shares of common stock to FirstFire and (b) 40 additional shares of common stock to Oasis Capital, as set forth in the waivers and consents (the “Waivers”), dated November 16, 2021 executed by each of FirstFire and Oasis Capital (collectively, the “Waiver Shares”). The Company recorded interest expense of $427,700 pertaining to the fair value of the Waiver Shares issued. In December 2021, the Company issued 60 shares of common stock pursuant to a consulting agreement. The fair value of $339,000 was based on the value of the Company’s common stock on the date of grant and is included in general and administrative expenses in the consolidated statements of operations.

RELATED PARTY TRANSACTIONS_2

RELATED PARTY TRANSACTIONS	6 Months Ended	12 Months Ended
RELATED PARTY TRANSACTIONS	Jun. 30, 2023	Dec. 31, 2022
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 9: RELATED PARTY TRANSACTIONS During the six months ended June 30, 2023 and 2022, the Company made net repayments for amounts due to related parties totaling $57,427 and $172,036, respectively. As of June 30, 2023 and December 31, 2022, amounts due to related parties were $472,790 and $556,225 , respectively. The advances are unsecured, non-interest bearing and due on demand. Amounts due to related parties consist of current and former executives, and a board member. As of December 31, 2022, H&J had an outstanding note payable of $129,489 owned by the H&J Seller. The balance was $0 upon the H&J disposition in June 2023.	NOTE 9: RELATED PARTY TRANSACTIONS As of December 31, 2022 and 2021, due to related parties includes advances from the former officer, Mark Lynn, who also serves as a director, totaling $104,568 and $104,568 respectively, and accrued salary and expense reimbursements of $100,649 and $126,706, respectively, to current officers. Upon closing of the IPO, 1,003 shares of common stock were issued to directors as conversion of balances owed. In October 2022, the Company received advances from a director, Trevor Pettennude, totaling $325,000. The advances are unsecured, non-interest bearing and due on demand. As of December 31, 2022, the amounts were outstanding. The current CEO, Hil Davis, previously advanced funds to the Company for working capital. These prior advances were converted to a note payable totaling $115,000. Upon closing of the IPO, 5,091 shares of common stock were issued to the CEO as conversion of the outstanding note payable and related accrued interest, accrued compensation and other consideration. As of a result of the transaction, the Company recorded an additional $233,184 in stock compensation expense, which is included in general and administrative expenses in the consolidated statements of operations. As of December 31, 2022 and 2021, H&J had an outstanding note payable of $129,489 and $299,489, respectively, owned by the H&J Seller. The note matured on December 10, 2022 and bears interest at 12% per annum. The note is in technical default. The H&J note was classified in liabilities per discontinued operations.

SHARE-BASED PAYMENTS_2

SHARE-BASED PAYMENTS	6 Months Ended	12 Months Ended
SHARE-BASED PAYMENTS	Jun. 30, 2023	Dec. 31, 2022
SHARE-BASED PAYMENTS
SHARE-BASED PAYMENTS	NOTE 10: SHARE-BASED PAYMENTS Common Stock Warrants In connection with the January Private Placement, the Company granted 32,086 pre-funded warrants which were immediately exercised for shares of common stock. The Company also granted an additional 51,086 warrants as part of the offering. Each warrant has an exercise price of $95 per share, is immediately exercisable upon issuance and expires five years after issuance. The Company also granted the placement agent 3,831 warrants to purchase common stock at an exercise price of $3,050.35 per share, which is immediately exercisable upon issuance and expires five years In connection with merchant advances (Note 6), the Company granted 6,095 warrants to purchase common stock at an exercise price of $131.25. The warrants are immediately exercisable upon issuance and expire five years after issuance. The following is a summary of warrant activity: Common Weighted Stock Average Warrants Exercise Price Outstanding - December 31, 2022 176,733 $ 209 Granted 93,099 99.50 Exercised (32,086) 97.88 Forfeited — — Outstanding - June 30, 2023 237,746 $ 181.25 Exercisable at December 31, 2022 171,278 $ 210.50 Exercisable at June 30, 2023 237,745 $ 181.25 Stock Options As of June 30, 2023 and December 31, 2022, the Company had 1,558 stock options outstanding with a weighted average exercise price of $362.11 per share. As of June 30, 2023, there were 1,439 options exercisable. Stock-based compensation expense of $101,500 and $119,759 was recognized for the three months ended June 30, 2023 and 2022, respectively, and $207,094 and $258,852 was recognized for the six months June 30, 2023 and 2022, respectively. During the six months ended June 30, 2023 and 2022, $28,798 and $28,798 was recorded to sales and marketing expense, and all other stock compensation was included in general and administrative expense in the condensed consolidated statements of operations. Total unrecognized compensation cost related to non-vested stock option awards as of June 30, 2023 amounted to $370,907 and will be recognized over a weighted average period of 0.9 years.	NOTE 10: SHARE-BASED PAYMENTS Common Stock Warrants 2022 Transactions In connection with the April note agreement, the Company granted warrants to acquire 503 shares of common stock at an exercise price of $3,050.00 per share expiring in April 2027. On May 10, 2022, pursuant to the Underwriting Agreement, the Company issued the Underwriters’ Warrants to purchase up to an aggregate of 598 shares of common stock. The Underwriters’ Warrants may be exercised beginning on November 1, 2022 until May 5, 2027. The initial exercise price of each Underwriters’ Warrant is $812.50 per share, which represents 130% of the public offering price. In connection with the July 22 and July 28 notes, the Company issued an aggregate of 1,645 and 1,106 warrants to purchase common stock at an exercise price of $380 and $282.50 per share, respectively. The warrants expire in July 2027. In connection with the November public offering, the Company granted 66,007 pre-funded warrants which were immediately exercised for shares of common stock. The Company also granted an additional 72,727 Class B Warrants and 72,727 Class C Warrants as part of the offering. Each Class B Warrant has an exercise price of $131.25 per share, is immediately exercisable upon issuance and expires five years after issuance. Each Class C Warrant has an exercise price of $131.25 per share, is immediately exercisable upon issuance and expires thirteen months after issuance. The Company also granted the placement agent 5,455 warrants to purchase common stock at an exercise price of $172 per share, which are exercisable 180 days after issuance and expire in five years. In connection with the December Notes, the Company issued to the investors an aggregate of 18,779 warrants to purchase common stock at an exercise price equal to $106.50 for a fair value of $164,200. The warrants are immediately exercisable. The Company granted 1,760 warrants to purchase common stock at an exercise price of $125 to the lender in connection with its merchant advances. 2021 Transactions In connection with the IPO, the Company issued 964 warrants and an additional 145 warrants to purchase common stock per the over-allotment option. Each warrant will have an exercise price of $11,425 per share (equal to 110% of the offering price of the common stock), will be exercisable upon issuance and will expire five years from issuance. On May 13, 2021, pursuant to the IPO Underwriting Agreement, the Company issued warrants to the underwriters to purchase up to an aggregate of 48 shares of common stock with an exercise price of $12,975 per share. The warrants may be exercised beginning on November 13, 2021 and will expire five years from issuance. In connection with the Company’s April 2021 note financing, the Company issued warrants to the lender to purchase up to 48 shares of common stock. The warrants have an exercise price of $10,375 per share and are exercisable immediately after issuance. In May 2021, an aggregate of 13 warrants were exercised for shares of common stock for proceeds of $145,696. In July 2021, warrant holders exercised 142 warrants for proceeds of $1,622,350. A summary of information related to common stock warrants for the years ended December 31, 2022 and 2021 is as follows: Common Weighted Stock Average Warrants Exercise Price Outstanding - December 31, 2020 366 $ 6,650 Granted 1,205 11,450 Conversion of preferred stock warrants upon IPO 21 19,150 Exercised (155) 11,425 Forfeited (4) 19,150 Outstanding - December 31, 2021 1,432 $ 10,300 Granted 241,308 140.36 Exercised (66,007) 131.25 Forfeited — — Outstanding - December 31, 2022 176,733 $ 209.23 Exercisable at December 31, 2021 1,432 $ 10,300 Exercisable at December 31, 2022 171,278 $ 210.41 Preferred Stock Warrants Upon the IPO, all outstanding preferred stock warrants converted into common stock warrants at a ratio of 39,075:1. Stock Options 2020 Incentive Stock Plan The Company has adopted a 2020 Omnibus Incentive Stock Plan (the “2020 Plan”). An aggregate of 33,000 shares of the Company’s common stock is reserved for issuance and available for awards under the 2020 Plan, including incentive stock options granted under the 2020 Plan. The 2020 Plan administrator may grant awards to any employee, director, consultant or other person providing services to us or our affiliates. During 2021, 1,093 options were granted to executives and directors at an exercise price from $9,625 to $10,375 per share. As of December 31, 2022, 31,907 options were available for future issuance. 2013 Incentive Stock Plan The Company has adopted the 2013 Stock Plan, as amended and restated (the “Plan”), which provides for the grant of shares of stock options, stock appreciation rights, and stock awards (performance shares) to employees, non-employee directors, and non-employee consultants. The number of shares authorized by the Plan was 479 shares as December 31, 2022 and 2021. The option exercise price generally may not be less than the underlying stock’s fair market value at the date of the grant and generally have a term often years. The amounts granted each calendar year to an employee or non-employee is limited depending on the type of award. Stock options comprise all of the awards granted since the Plan’s inception. Shares available for grant under the Plan amounted to 13 and as of December 31, 2022. Vesting generally occurs over a period of immediately to four years. A summary of information related to stock options under our 2013 and 2020 Stock Plan for the years ended December 31, 2022 and 2021 is as follows: Weighted Average Options Exercise Price Outstanding - December 31, 2020 485 $ 5,850 Granted 1,093 10,375 Exercised — — Forfeited — — Outstanding - December 31, 2021 1,558 $ 9,053 Granted — — Exercised — — Forfeited — — Outstanding - December 31, 2022 1,558 $ 9,053 Exercisable at December 31, 2021 1,266 $ 8,975 Exercisable at December 31, 2022 1,389 $ 10,125 Weighted average duration (years) to expiration of outstanding options at December 31, 2022 7.00 The assumptions utilized for option grants during the years ended December 31, 2022 and 2021 are as follows: Year Ended December 31, 2022 2021 Risk Free Interest Rate n/a 0.34% - 0.85 % Expected Dividend Yield n/a 0.00 % Expected Volatility n/a 58.00 % Expected Life (years) n/a 5.18 The total grant-date fair value of the options granted during the years ended December 31, 2021 was $4,696,605. During the year ended December 31, 2022 and 2021, $421,442 and $3,325,897 was recorded to general and administrative expenses, and $57,596 and $551,948 was recorded to sales and marketing expense in the consolidated statements of operations, all respectively. Total unrecognized compensation cost related to non-vested stock option awards as of December 31, 2022 amounted to $577,999 and will be recognized over a weighted average period of 1.56 years.

LEASE OBLIGATIONS_2

LEASE OBLIGATIONS	6 Months Ended	12 Months Ended
LEASE OBLIGATIONS	Jun. 30, 2023	Dec. 31, 2022
LEASE OBLIGATIONS
LEASE OBLIGATIONS	NOTE 11: LEASE OBLIGATIONS In January 2023, the Company entered into a lease agreement extension for its corporate office and distribution center in Vernon, California that expires on December 31, 2023. The lease has monthly base rent payments of $38,105. As a result of the extension, the Company recognized a right of use asset and liability of $467,738 using a discount rate of 8.0%. As of June 30, 2023, the Company has $949,071 in accounts payable for past rents due to the landlord pertaining to this lease. In May 2023, the Company entered into a lease agreement extension for a showroom space in Los Angeles, California that commences in March 2023 and expires in January 2025. The original lease began in April 2018 and terminated in May 2020, at which point the lease was month to month. The lease has a monthly base rent of $6,520 until January 31, 2025, at which point the base rent increases to $6,781 until the end of the lease. As a result of the extension, the Company recognized a right of use asset and liability of $125,397 using a discount rate of 8.0%. As of June 30, 2023, the Company has $214,626 in accounts payable for past rents due to the landlord pertaining to this lease. Stateside and Sundry utilize a lease for a showroom in Los Angeles, California which is month to month. Total rent expense for the three months ended June 30, 2023 and 2022 was $37,580 and $195,060, and $210,265 and $469,482 for the six months end June 30, 2023 and 2022, respectively.	NOTE 11: LEASE OBLIGATIONS In April 2021, the Company entered into a lease agreement for operating space in Los Angeles, California. The lease expires in June 2023 and has monthly base rent payments of $17,257. The lease required a $19,500 deposit. The Company adopted ASC 842 on January 1, 2021 and recognized a right of use asset and liability of $250,244 using a discount rate of 6.0%. Under ASC 842, the lease was classified as an operating lease. Stateside leases office and showroom facilities in Los Angeles, California. The leases expire at various dates through November 2022 with base rents ranging from $3,100 to $9,000. Total rent expense for the years ended December 31, 2022 and 2021 was $945,216 and $816,790, respectively. Rent is classified by function on the consolidated statements of operations either as general and administrative, sales and marketing, or cost of revenue. The Company determines whether an arrangement is or contains a lease at inception by evaluating potential lease agreements including services and operating agreements to determine whether an identified asset exists that the Company controls over the term of the arrangement. Lease commencement is determined to be when the lessor provides access to, and the right to control, the identified asset. The rental payments for the Company’s leases are typically structured as either fixed or variable payments. Fixed rent payments include stated minimum rent and stated minimum rent with stated increases. The Company considers lease payments that cannot be predicted with reasonable certainty upon lease commencement to be variable lease payments, which are recorded as incurred each period and are excluded from the calculation of lease liabilities. Management uses judgment in determining lease classification, including determination of the economic life and the fair market value of the identified asset. The fair market value of the identified asset is generally estimated based on comparable market data provided by third-party sources.

CONTINGENCIES_2

CONTINGENCIES	6 Months Ended	12 Months Ended
CONTINGENCIES	Jun. 30, 2023	Dec. 31, 2022
CONTINGENCIES
CONTINGENCIES	NOTE 12: CONTINGENCIES On March 21, 2023, a vendor filed a lawsuit against Digital Brands Group related to trade payables totaling approximately $43,501. Such amounts include interest due, and are included in accounts payable, net of payments made to date, in the accompanying consolidated balance sheets. The Company does not believe it is probable that the losses in excess of such trade payables will be incurred. On February 7, 2023, a vendor filed a lawsuit against Digital Brands Group related to trade payables totaling approximately $182,400. Such amounts include interest due, and are included in accounts payable, net of payments made to date, in the accompanying consolidated balance sheets. The Company does not believe it is probable that the losses in excess of such trade payables will be incurred. On November 9, 2022, a vendor filed a lawsuit against Digital Brand’s Group related to prior services rendered. The claims (including fines, fees, and legal expenses) total an aggregate of $50,190. The matter was settled in January 2023 and are on payment plans which will be paid off in April 2023. In August 2020 and March 2021, two lawsuits were filed against Bailey by third-party’s related to prior services rendered. The claims (including fines, fees, and legal expenses) total an aggregate of $96,900. Both matters were settled in February 2022 and are on payment plans which will be paid off in July and September of 2023. On December 21, 2020, a Company investor filed a lawsuit against DBG for reimbursement of their investment totaling $100,000. Claimed amounts are included in short-term convertible note payable in the accompanying consolidated balance sheets and the Company does not believe it is probable that losses in excess of such short-term note payable will be incurred. The Company is actively working to resolve this matter. A vendor filed a lawsuit against Bailey related to a retail store lease in the amount of $1.5 million. The Company is disputing the claim for damages and the matter is ongoing. The vendor has recently updated the claim to now be $450,968 after signing a long-term lease with another brand for this location. The Company is disputing this new amount after review of the lease. All claims above, to the extent management believes it will be liable, have been included in accounts payable and accrued expenses and other liabilities in the accompanying consolidated balance sheet as of June 30, 2023. Except as may be set forth above the Company is not a party to any legal proceedings, and the Company is not aware of any claims or actions pending or threatened against us. In the future, the Company might from time to time become involved in litigation relating to claims arising from its ordinary course of business, the resolution of which the Company does not anticipate would have a material adverse impact on our financial position, results of operations or cash flows.	NOTE 12: CONTINGENCIES On March 21, 2023, a vendor filed a lawsuit against Digital Brands Group related to trade payables totaling approximately $43,501. Such amounts include interest due, and are included in accounts payable, net of payments made to date, in the accompanying consolidated balance sheets. The Company does not believe it is probable that the losses in excess of such trade payables will be incurred. On February 7, 2023, a vendor filed a lawsuit against Digital Brands Group related to trade payables totaling approximately $182,400. Such amounts include interest due, and are included in accounts payable, net of payments made to date, in the accompanying consolidated balance sheets. The Company does not believe it is probable that the losses in excess of such trade payables will be incurred. On November 9, 2022, a vendor filed a lawsuit against Digital Brand's Group related to prior services rendered. The claims (including fines, fees, and legal expenses) total an aggregate of $50,190. The matter was settled in January 2023 and are on payment plans which will be paid off in April 2023. In August 2020 and March 2021, two lawsuits were filed against Bailey by third-party’s related to prior services rendered. The claims (including fines, fees, and legal expenses) total an aggregate of $96,900. Both matters were settled in February 2022 and are on payment plans which will be paid off in July and September of 2023 On December 21, 2020, a Company investor filed a lawsuit against DBG for reimbursement of their investment totaling $100,000. Claimed amounts are included in short-term convertible note payable in the accompanying consolidated balance sheets and the Company does not believe it is probable that losses in excess of such short-term note payable will be incurred. The Company is actively working to resolve this matter. On September 24, 2020 a Bailey’s product vendor filed a lawsuit against Bailey for non-payment of trade payables totaling approximately $481,000 and additional damages of approximately $296,000. Claimed amounts for trade payables are included in accounts payable in the accompanying consolidated balance sheets, net of payments made. In December 2021, the Company reached a settlement; however, the settlement terms were not met and the Company received a judgement of $496,000. The amount due has been paid, the lawsuit dismissed and there is no claim or amount due. A vendor filed a lawsuit against Bailey related to a retail store lease in the amount of $1.5 million. The Company is disputing the claim for damages and the matter is ongoing. The Company has been involved in a dispute with the former owners of H&J regarding its obligation to “true up” their ownership interest in our Company further to that membership interest purchase agreement dated May 18, 2021 whereby we acquired all of the outstanding membership interests of H&J (the “H&J Purchase Agreement”). Further to the H&J Purchase Agreement, we agreed that if, at May 18, 2022, the one year anniversary of the closing date of our initial public offering, the product of the number of shares of our common stock issued at the closing of such acquisition multiplied by the average closing price per share of our shares of common stock as quoted on the NasdaqCM for the thirty (30) day trading period immediately preceding such date plus the gross proceeds, if any, of shares of our stock issued to such sellers and sold by them during the one year period from the closing date of the offering does not exceed the sum of $9.1 million, less the value of any shares of common stock cancelled further to any indemnification claims or post-closing adjustments under the H&J Purchase Agreement, then we shall issue to the subject sellers an additional aggregate number of shares of common stock equal to any such valuation shortfall at a per share price equal to the then closing price per share of our common stock as quoted on the NasdaqCM. We did not honor our obligation to issue such shares and the former owner of H&J have claimed that they were damaged as a result. As part of a proposed settlement with such holders, the Company has tentatively agreed to the following: (i) to transfer all membership interests of H&J back to the original owners, (ii) to pay such owners the sum of $229,000, (iii) issue the former owners of H&J an aggregate of $1,400,000 worth of our common stock to be issued on May 16, 2023 based on the lower of (a) the stock closing price per share on May 15, 2023, and (b) the average common stock closing price based on the average of the 5 trading days preceding May 16, 2023, with the closing price on May 9, 2023. Such tentative terms are to be memorialized in definitive purchase agreements and as such there is no assurance that such arrangements will be finalized. As of the issuance date of these financial statements, the above terms and continued negotiations have been verbally approved by the Board. All claims above, to the extent management believes it will be liable, have been included in accounts payable and accrued expenses and other liabilities in the accompanying consolidated balance sheet as of December 31, 2022. Except as may be set forth above the Company is not a party to any legal proceedings, and the Company is not aware of any claims or actions pending or threatened against us. In the future, the Company might from time to time become involved in litigation relating to claims arising from its ordinary course of business, the resolution of which the Company does not anticipate would have a material adverse impact on our financial position, results of operations or cash flows.

INCOME TAXES_2

INCOME TAXES	6 Months Ended	12 Months Ended
INCOME TAXES	Jun. 30, 2023	Dec. 31, 2022
INCOME TAXES
INCOME TAXES	NOTE 13: INCOME TAXES The Company has historically calculated the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full fiscal year to “ordinary” income or loss (pretax income or loss excluding unusual or infrequently occurring discrete items) for the reporting period. The Company has used a discrete effective tax rate method to calculate taxes for the fiscal three and six month periods ended June 30, 2023. The Company determined that since small changes in estimated “ordinary” income would result in significant changes in the estimated annual effective tax rate, the historical method would not provide a reliable estimate for the fiscal three and six-month periods ended June 30, 2023. The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. The Company assessed the need for a valuation allowance against its net deferred tax assets and determined a full valuation allowance is required due, cumulative losses through June 30, 2023, and no history of generating taxable income.	NOTE 13: INCOME TAXES Deferred taxes are recognized for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate primarily to depreciable assets using accelerated depreciation methods for income tax purposes, share-based compensation expense, and for net operating loss carryforwards. As of December 31, 2022, and 2021, the Company had net deferred tax assets before valuation allowance of $16,733,582 and $13,103,268, respectively. The following table presents the deferred tax assets and liabilities by source: December 31, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 16,733,582 $ 13,108,371 Deferred tax liabilities: Depreciation timing differences — (5,103) Valuation allowance (16,733,582) (13,103,268) Net deferred tax assets $ — $ — The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. The Company assessed the need for a valuation allowance against its net deferred tax assets and determined a full valuation allowance is required due, cumulative losses through December 31, 2022, and no history of generating taxable income. Therefore, valuation allowances of $16,733,582 and $13,103,268 were recorded as of December 31, 2022 and 2021, respectively. Valuation allowance increased by $3,630,314 and $3,081,497 during the years ended December 31, 2022 and 2021, respectively. Deferred tax assets were calculated using the Company’s combined effective tax rate, which it estimated to be approximately 28.0%. The effective rate is reduced to 0% for 2022 and 2021 due to the full valuation allowance on its net deferred tax assets. The Company has permanent differences, consisting of non-deductible impairments of goodwill and intangible assets of $17.7 million and amortization of non-cash debt issuance costs of $6.5 million. The Company’s ability to utilize net operating loss carryforwards will depend on its ability to generate adequate future taxable income. At December 31, 2022 and 2021, the Company had net operating loss carryforwards available to offset future taxable income in the amounts of approximately $59,865,000 and $46,896,000, for which losses from 2018 forward can be carried forward indefinitely. As a result of prior operating losses, the Company has net operating loss, or “NOL,” carryforwards for federal income tax purposes. The ability to utilize NOL carryforwards to reduce taxable income in future years could become subject to significant limitations under Section 382 of the Internal Revenue Code if the Company undergoes an ownership change. The Company would undergo an ownership change if, among other things, the stockholders who own, directly or indirectly, 5% or more of our common stock, or are otherwise treated as “5% shareholders” under Section 382 of the U.S. Internal Revenue Code and the regulations promulgated thereunder, increase their aggregate percentage ownership of the Company’s stock by more than 50 percentage points over the lowest percentage of the stock owned by these stockholders at any time during the testing period, which is generally the three-year period preceding the potential ownership change. The Company has evaluated its income tax positions and has determined that it does not have any uncertain tax positions. The Company will recognize interest and penalties related to any uncertain tax positions through its income tax expense. The Company is not presently subject to any income tax audit in any taxing jurisdiction, though all tax years from 2018 on remain open to examination. The Company recorded a tax benefit of $1,100,120 for the year ended December 31, 2021 related to a full release of its valuation allowance pertaining to the acquisition of H&J (see Note 4). The acquisition of H&J created a deferred tax liability position, and those deferred tax liabilities can be used as a source of income for the Company’s existing deferred tax assets.

SUBSEQUENT EVENTS_2

SUBSEQUENT EVENTS	6 Months Ended	12 Months Ended
SUBSEQUENT EVENTS	Jun. 30, 2023	Dec. 31, 2022
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 14: SUBSEQUENT EVENTS On July 5, 2023, the Company and the Bailey sellers agreed to extend the maturity date of the Bailey Note to June 30, 2024. On August 21, 2023, the Company filed a Certificate of Amendment to our Certificate of Incorporation, as amended, to effect a one-for-twenty-five (1-for- 25	NOTE 14: SUBSEQUENT EVENTS On January 11, 2023, the Company, entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a certain accredited investor (the “Investor”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Private Placement”), an aggregate of 19,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”), and accompanying warrants (the “Common Warrants”) to purchase 19,000 shares of Common Stock, at a combined purchase price of $97.875 per share and Common Warrant, and (ii) 32,086 pre-funded warrants (the “Pre-Funded Warrants” and together with the Common Warrants, the “Warrants” and together with the Shares and the shares of Common Stock underlying the Warrants, the “Securities”) exercisable for 32,086 shares of Common Stock, and accompanying Common Warrants to purchase 32,086 shares of Common Stock, at a combined purchase price of $97.875, less the exercise price of $0.0001, per Pre-Funded Warrant and accompanying Common Warrant, to the Investors, for aggregate gross proceeds from the Private Placement of approximately $5 million. Each Common Warrant has an exercise price of $95 per share, will be immediately exercisable upon issuance and will expire five years from the date of issuance. In February 2023, the Company fully repaid the December Notes for $4.0 million. In February 2023, the Company and the Sundry Sellers verbally agreed to extend the maturity date to December 31, 2023. On April 7, 2023, the Company and various purchasers executed a Securities Purchase Agreement (“April 2023 Notes”) whereby the investors purchased from the Company convertible promissory notes in the aggregate principal amount of $2,208,750, consisting of original issue discount of $408,750. The Company received net proceeds of $1,800,000. The April 2023 Notes are due and payable on September 30, 2023. If the April 2023 Notes are not repaid in full by the maturity date or if any other event of default occurs, (1) the face value of the April Notes will be automatically increased to 120%; (2) the April 2023 Notes will begin generating an annual interest rate of 20%, which will be paid in cash monthly until the default is cured; and (3) if such default continues for 14 or more calendar days, at the investors’ discretion, the April 2023 Notes shall become convertible at the option of the investors into shares of the Company’s common stock at a conversion price equal to the closing price of the Company’s common stock on the date of the note conversion. On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 78,103 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. The total estimated value of the common stock was approximately $1.4 million. We accounted for the disposition as discontinued operations in the accompanying consolidated financial statements, and as a result, we retrospectively reflected certain adjustments to the years ended December 31, 2022 and 2021 in accordance with Accounting Standard Codification (ASC) 205-20 for reporting Discounting Operations. On August 21, 2023, the Company filed a Certificate of Amendment to our Certificate of Incorporation, as amended, to effect a one-for-twenty-five (1-for- 25

SUMMARY OF SIGNIFICANT ACCOU_13

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”).	Basis of Presentation The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”).
Principles of Consolidation	Principles of Consolidation These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Bailey, H&J and Stateside from the dates of acquisition. All inter-company transactions and balances have been eliminated on consolidation. As of June 21, 2023, the Company no longer consolidated the assets, liabilities, revenues and expenses of H&J (see Note 4).	H&J Disposition On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby contemporaneously with the parties’ execution of the Settlement Agreement (i) the Company agreed to make an aggregate cash payment of $229,000 to D. Jones Tailored Collection, Ltd. (“D. Jones”), (ii) the Company issued 78,103 shares of common stock to D. Jones, and (iii) the Company assigned and transferred one hundred percent (100%) of the Company’s membership interest in H&J to D. Jones. This transaction is known as the “H&J Settlement”. The H&J Settlement was accounted for a business disposition in accordance with ASC 810-40-40-3A. In accordance with the provisions of ASC 205-20, the Company has excluded the results of discontinued operations from its results of continuing operations in the accompanying consolidated statements of operations for the three and six months ended June 30, 2023 and 2022 in it’s Form 10-Q Quarterly Report filed on August 21, 2023. Accordingly, the consolidated financial statements as of and for the years ended December 31, 2022 and 2021 have been adjusted retroactively to account for the discontinued operations classification of H&J. Principles of Consolidation These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Bailey, H&J, Stateside and Sundry from the dates of acquisition. All inter-company transactions and balances have been eliminated on consolidation. H&J has been retroactively adjusted to be presented as discontinued operations (see above).
Use of Estimates	Use of Estimates The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, inventory, impairment of long-lived assets, contingent consideration and derivative liabilities. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Restatement of Previously Issued Financial Statements	Reclassification of Previously Issued Financial Statements Certain prior year accounts have been reclassified to conform with current year presentation pertaining to cost of net revenue and general and administrative expenses. The Company has reclassified $297,696 and $630,976 in general and administrative expenses per previously reported financial statements to cost of net revenues in the accompanying consolidated statements of operations for the three and six months ended June 30, 2022, respectively. The reclassified costs from general and administrative expense to cost of net revenues are primarily personnel and warehouse related costs. The reclassification had no effect on the reported results of operations. Certain prior year accounts have been reclassified to conform with current year presentation regarding income (loss) from discontinued operations. H&J’s assets and liabilities as of December 31, 2022 have also been reclassified on the consolidated balance sheet. See Note 4.	Restatement of Previously Issued Financial Statements Certain prior year accounts have been reclassified to conform with current year presentation pertaining to cost of net revenue and general and administrative expenses. The Company has reclassified The reclassified costs from general and administrative expense to cost of net revenues made in the fourth quarter of 2022 and 2021 are fixed in nature as they are personnel and warehouse related costs. The impact of the reclassification was approximately for each of the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022. The impact of the reclassification was approximately
Cash and Equivalents and Concentration of Credit Risk	Cash and Equivalents and Concentration of Credit Risk The Company considers all highly liquid securities with an original maturity of less than six months to be cash equivalents. As of June 30, 2023 and December 31, 2022, the Company did not hold any cash equivalents. The Company’s cash and cash equivalents in bank deposit accounts, at times, may exceed federally insured limits of $250,000.	Cash and Equivalents and Concentration of Credit Risk The Company considers all highly liquid securities with an original maturity of less than three months to be cash equivalents. As of December 31, 2022 and 2021, the Company did not hold any cash equivalents. The Company’s cash and cash equivalents in bank deposit accounts, at times, may exceed federally insured limits of $250,000.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued expenses, due to related parties, related party note payable, and convertible debt. The carrying value of these assets and liabilities is representative of their fair market value, due to the short maturity of these instruments. The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy used to determine such fair values: Fair Value Measurements as of June 30, 2023 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ — $ — $ — $ — $ — $ — Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ 12,098,475 $ 12,098,475 $ — $ — $ 12,098,475 $ 12,098,475 Contingent Consideration The Company recorded a contingent consideration liability relating to stock price guarantees included in its acquisitions of Bailey44 and H&J. The estimated fair value of the contingent consideration was recorded using significant unobservable measures and other fair value inputs and was therefore classified as a Level 3 financial instrument. The Company estimates and records the acquisition date fair value of contingent consideration as part of purchase price consideration for acquisitions. Additionally, each reporting period, the Company estimates changes in the fair value of contingent consideration and recognizes any change in fair in the consolidated statement of operations. The estimate of the fair value of contingent consideration requires very subjective assumptions to be made of future operating results, discount rates and probabilities assigned to various potential operating result scenarios. Future revisions to these assumptions could materially change the estimate of the fair value of contingent consideration and, therefore, materially affect the Company’s future financial results. The contingent consideration liability is to be settled with the issuance of shares of common stock once contingent provisions set forth in respective acquisition agreements have been achieved. Upon achievement of contingent provisions, respective liabilities are relieved and offset by increases to common stock and additional paid-in capital in the stockholders’ equity section of the Company’s consolidated balance sheets. Norwest Waiver On June 21, 2023, the Company, on the one hand, and Norwest Venture Partners XI, LP and Norwest Venture Partners XII, LP (together, the “Norwest Investors”), on the other hand, executed a Waiver and Amendment (the “Norwest Amendment”) whereby the Norwest Investors agreed to waive and terminate certain true up rights of the Norwest Investors under the Agreement and Plan of Merger, dated February 12, 2020 (the “Bailey Merger Agreement”), among the Company, Bailey 44, LLC, Norwest Venture Partners XI, LP, and Norwest Venture Partners XII, LP and Denim.LA Acquisition Corp. This transaction is known as the “Norwest Waiver”. As a result of the Norwest Waiver, the Company recorded a fair value of H&J Settlement Agreement On June 21, 2023, the Company and the former owners of H&J executed a Settlement Agreement and Release (the “Settlement Agreement”) whereby the Company transferred 100% of its membership interests in H&J to D. Jones (the “H&J Seller”). Pursuant to the Settlement Agreement, the Company agreed to make an aggregate cash payment of shares of common stock to the H&J Seller. In connection with the Settlement Agreement, the parties agreed that no further shares were owed to the H&J Seller resulting from the stock price guarantee pursuant to the May 2021 H&J acquisition. As a result, the Company recorded a fair value of The detail of contingent consideration by company is as follows: June 30, December 31, 2023 2022 Bailey $ — $ 10,698,475 Harper & Jones — 1,400,000 $ — $ 12,098,475	Fair Value of Financial Instruments FASB guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1 — Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 3 — Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when their fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, due from factor, prepaid expenses, accounts payable, accrued expenses, deferred revenue, due to related parties, related party note payable, accrued interest, loan payable and convertible debt. The carrying value of these assets and liabilities is representative of their fair market value, due to the short maturity of these instruments. The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy used to determine such fair values: Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ — $ — $ — Contingent consideration — — 12,098,475 12,098,475 Derivative liability — — — — $ — $ — $ 12,098,475 $ 12,098,475 Fair Value Measurements as of December 31, 2021 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ 18,223 $ — $ 18,223 Contingent consideration — — 12,179,476 12,179,476 Derivative liability — — 2,294,720 2,294,720 $ — $ 18,223 $ 14,474,196 $ 14,492,419 Warrant Liability Certain of the Company’s common stock warrants are carried at fair value. As of December 31, 2020, the fair value of the Company’s common stock warrant liabilities was measured under the Level 3 hierarchy using the Black-Scholes pricing model as the Company’s underlying common stock had no observable market price (see Note 10). The warrant liability was valued using a market approach. Upon the IPO, the warrant liabilities were valued using quoted prices of identical assets in active markets, and was reclassified under the Level 2 hierarchy. Changes in common stock warrant liability during the years ended December 31, 2022 and 2021 are as follows: Warrant Liability Outstanding as of December 31, 2020 $ 6,265 Change in fair value 11,958 Outstanding as of December 31, 2021 18,223 Change in fair value (18,223) Outstanding as of December 31, 2022 $ — Contingent Consideration The Company records a contingent consideration liability relating to stock price guarantees included in its acquisition and consulting agreements. The estimated fair value of the contingent consideration is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument. The Company estimates and records the acquisition date fair value of contingent consideration as part of purchase price consideration for acquisitions. Additionally, each reporting period, the Company estimates changes in the fair value of contingent consideration and recognizes any change in fair in the consolidated statement of operations. The estimate of the fair value of contingent consideration requires very subjective assumptions to be made of future operating results, discount rates and probabilities assigned to various potential operating result scenarios. Future revisions to these assumptions could materially change the estimate of the fair value of contingent consideration and, therefore, materially affect the Company’s future financial results. The contingent consideration liability is to be settled with the issuance of shares of common stock once contingent provisions set forth in respective acquisition agreements have been achieved. Upon achievement of contingent provisions, respective liabilities are relieved and offset by increases to common stock and additional paid-in capital in the stockholders’ equity section of the Company’s consolidated balance sheets. The fair value of the contingent consideration liability related to the Company’s business combinations is valued using the Monte Carlo simulation model. The Monte Carlo simulation inputs include the stock price, volatility of common stock, timing of settlement and resale restrictions and limits. The fair value of the contingent consideration is then calculated based on guaranteed equity values at settlement as defined in the acquisition agreements. Changes in contingent consideration liability during the years ended December 31, 2022 and 2021 are as follows: Contingent Consideration Liability Balance as of December 31, 2020 $ — Initial recognition in connection with acquisition of Harper & Jones 3,421,516 Stock price guarantee per consulting agreement 67,000 Conversion into shares (73,500) Change in fair value 8,764,460 Outstanding as of December 31, 2021 12,179,476 Repayments to Harper & Jones seller (645,304) Change in fair value 564,303 Outstanding as of December 31, 2022 $ 12,098,475 During the year ended December 31, 2022, the Company utilized the following inputs for the fair value of the contingent consideration: volatilities of 79.3% and 88.9%, risk-free rate of 0.25%, expected share increase of 5% per annum, and the guaranteed stock price of $828 for Bailey and $10,375 for Harper & Jones. The detail of contingent consideration by company is as follows: December 31, 2022 2021 Bailey $ 10,698,475 7,935,016 Harper & Jones 1,400,000 4,244,460 $ 12,098,475 $ 12,179,476 The contingent consideration liabilities were revalued for a final time as of May 18, 2022, the anniversary date of the Company’s initial public offering. As of the date of the issuance of these financial statements, the contingent consideration liabilities were not yet settled with shares. In December 2022, the Company paid $645,304 to the H&J Seller to partially reduce the contingent consideration balance owed. The Company and the H&J Seller are in the process of amending the May 2021 purchase agreement to determine the ultimate settlement of the Company’s common stock to the H&J Seller by May 16, 2023. Refer to Note 12. Derivative Liability In connection with the Company’s convertible notes, the Company recorded a derivative liability (see Note 7). The estimated fair value of the derivative liability is recorded using significant unobservable measures and other fair value inputs and is therefore classified as a Level 3 financial instrument. The fair value of the derivative liability is valued using a multinomial lattice model. The multinomial lattice inputs include the underlying stock price, volatility of common stock and remaining term of the convertible note. Changes in derivative liability during the years ended December 31, 2022 and 2021 are as follows: Derivative Liability Outstanding as of December 31, 2020 $ — Initial fair value on issuance of convertible note 3,204,924 Change in fair value (910,204) Outstanding as of December 31, 2021 2,294,720 Initial fair value on issuance of convertible note 559,957 Conversion of underlying notes into common stock (1,500,243) Change in fair value (1,354,434) Outstanding as of December 31, 2022 $ — During the year ended December 31, 2022, the Company utilized the following inputs for the fair value of the derivative liability: volatility of 70.9% - 96.7%, risk-free rate of 2.71% - 3.74%, and remaining term ranging from .08 years - 0.62 years. The change in fair value of the derivative liability is included in other non-operating income (expense), net in the consolidated statements of operations.
Inventory	Inventory Inventory is stated at the lower of cost or net realizable value and accounted for using the weighted average cost method for DSTLD and first-in, first-out method for Bailey, Stateside and Sundry. The inventory balances as of June 30, 2023 and December 31, 2022 consist substantially of finished good products purchased or produced for resale, as well as any raw materials the Company purchased to modify the products and work in progress. Inventory consisted of the following: June 30, December 31, 2023 2022 Raw materials $ 1,508,416 $ 1,611,134 Work in process 653,412 888,643 Finished goods 2,609,443 2,725,505 Inventory $ 4,771,271 $ 5,225,282	Inventory Inventory is stated at the lower of cost or net realizable value and accounted for using the weighted average cost method for DSTLD and H&J and first-in, first-out method for Bailey, Stateside and Sundry. The inventory balances as of December 31, 2022 and 2021 consist substantially of finished good products purchased or produced for resale, as well as any raw materials the Company purchased to modify the products and work in progress. Inventory consisted of the following: December 31, 2022 2021 Raw materials $ 1,508,416 $ 292,167 Work in process 888,643 242,673 Finished goods 2,725,505 2,220,519 Inventory $ 5,122,564 $ 2,660,203
Property, Equipment, and Software		Property, Equipment, and Software Property, equipment, and software are recorded at cost. Depreciation/amortization is recorded for property, equipment, and software using the straight-line method over the estimated useful lives of assets. The Company reviews the recoverability of all long-lived assets, including the related useful lives, whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset might not be recoverable. The balances at December 31, 2022 and 2021 consist of software with three (3) year lives, property and equipment with three (3) to ten (10) year lives, and leasehold improvements which are depreciated over the shorter of the lease life or expected life. Depreciation and amortization charges on property, equipment, and software are included in general and administrative expenses and amounted to $75,126 and $92,213 for the years ended December 31, 2022 and 2021, respectively.
Business Combinations		Business Combinations The Company accounts for acquisitions in which it obtains control of one or more businesses as a business combination. The purchase price of the acquired businesses is allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date. The excess of the purchase price over those fair values is recognized as goodwill. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments, in the period in which they are determined, to the assets acquired and liabilities assumed with the corresponding offset to goodwill. If the assets acquired are not a business, the Company accounts for the transaction or other event as an asset acquisition. Under both methods, the Company recognizes the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest in the acquired entity. In addition, for transactions that are business combinations, the Company evaluates the existence of goodwill or a gain from a bargain purchase. Goodwill represents the excess of the purchase price of an acquired entity over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed in a business combination. Intangible assets are established with business combinations and consist of brand names and customer relationships. Intangible assets with finite lives are recorded at their estimated fair value at the date of acquisition and are amortized over their estimated useful lives using the straight-line method. The estimated useful lives of amortizable intangible assets are as follows: Customer relationships 3 years
Impairment		Impairment Long-Lived Assets The Company reviews its long-lived assets (property and equipment and amortizable intangible assets) for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. If the sum of the expected cash flows, undiscounted, is less than the carrying amount of the asset, an impairment loss is recognized as the amount by which the carrying amount of the asset exceeds its fair value.
Goodwill	Goodwill Goodwill and identifiable intangible assets that have indefinite useful lives are not amortized, but instead are tested annually for impairment and upon the occurrence of certain events or substantive changes in circumstances. The annual goodwill impairment test allows for the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An entity may choose to perform the qualitative assessment on none, some or all of its reporting units or an entity may bypass the qualitative assessment for any reporting unit and proceed directly to step one of the quantitative impairment test. If it is determined, on the basis of qualitative factors, that the fair value of a reporting unit is, more likely than not, less than its carrying value, the quantitative impairment test is required.	Goodwill Goodwill and identifiable intangible assets that have indefinite useful lives are not amortized, but instead are tested annually for impairment and upon the occurrence of certain events or substantive changes in circumstances. The annual goodwill impairment test allows for the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. An entity may choose to perform the qualitative assessment on none, some or all of its reporting units or an entity may bypass the qualitative assessment for any reporting unit and proceed directly to step one of the quantitative impairment test. If it is determined, on the basis of qualitative factors, that the fair value of a reporting unit is, more likely than not, less than its carrying value, the quantitative impairment test is required. The quantitative impairment test calculates any goodwill impairment as the difference between the carrying amount of a reporting unit and its fair value, but not to exceed the carrying amount of goodwill. It is our practice, at a minimum, to perform a qualitative or quantitative goodwill impairment test in the fourth quarter every year.
Indefinite-Lived Intangible Assets		Indefinite-Lived Intangible Assets Indefinite-lived intangible assets established in connection with business combinations consist of the brand name. The impairment test for identifiable indefinite-lived intangible assets consists of a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.
Annual Impairment Tests	Annual Impairment At December 31, 2022, management determined that certain events and circumstances occurred that indicated that the carrying value of the Company’s brand name assets, and the carrying amount of the reporting units, pertaining to Bailey44 and Harper & Jones may not be recoverable. The qualitative assessment was primarily due to reduced or stagnant revenues of both entities as compared to the Company’s initial projections at the time of each respective acquisition, as well as the entities’ liabilities in excess of assets. As such, the Company compared the estimated fair value of the brand names with its carrying value and recorded an impairment loss of $3,667,000 in the consolidated statements of operations. Additionally, the Company compared the fair value of the reporting units to the carrying amounts and recorded an impairment loss of $11,872,332	Annual Impairment Tests At December 31, 2021, management determined that certain events and circumstances occurred, primarily the continued reduction in revenues partially as a result of COVID-19, that indicated that the carrying value of the Company’s brand name asset pertaining to Bailey44 may not be recoverable. As such, the Company compared the estimated fair value of the brand name with its carrying value and recorded an impairment loss of $3,400,000 in the consolidated statements of operations. At December 31, 2022, management determined that certain events and circumstances occurred that indicated that the carrying value of the Company’s brand name assets, and the carrying amount of the reporting units, pertaining to Bailey44 and Harper & Jones may not be recoverable. The qualitative assessment was primarily due to reduced or stagnant revenues of both entities as compared to the Company’s initial projections at the time of each respective acquisition, as well as the entities’ liabilities in excess of assets. As such, the Company compared the estimated fair value of the brand names with its carrying value and recorded an impairment loss of $3,667,000 in the consolidated statements of operations. Additionally, the Company compared the fair value of the reporting units to the carrying amounts and recorded an impairment loss of $11,872,332 Year Ended December 31, 2022 2021 Bailey brand name (intangibles) $ 2,182,000 $ 3,400,000 Bailey goodwill 3,321,095 — Total impairment $ 5,503,095 $ 3,400,000 In determining the fair value of the respective reporting units, management estimated the price that would be received to sell the reporting unit as a whole in an orderly transaction between market participants at the measurement date. This includes reviewing market comparables such as revenue multipliers and assigning certain assets and liabilities to the reporting units, such as the respective working capital deficits of each entity and debt obligations that would need to be assumed by a market participant buyer in an orderly transaction. The Company calculated the carrying amounts of each reporting unit by utilizing the entities’ assets and liabilities at December 31, 2022, including the carrying value of the identifiable intangible assets and goodwill assigned to the respective reporting units. Refer to Note 12 for the related developments with H&J.
Convertible Instruments		Convertible Instruments U.S. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional as that term is described under applicable U.S. GAAP. When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company also records, when necessary, deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.
Accounting for Preferred Stock		Accounting for Preferred Stock ASC 480, Distinguishing Liabilities from Equity, includes standards for how an issuer of equity (including equity shares issued by consolidated entities) classifies and measures on its balance sheet certain financial instruments with characteristics of both liabilities and equity. Management is required to determine the presentation for the preferred stock as a result of the redemption and conversion provisions, among other provisions in the agreement. Specifically, management is required to determine whether the embedded conversion feature in the preferred stock is clearly and closely related to the host instrument, and whether the bifurcation of the conversion feature is required and whether the conversion feature should be accounted for as a derivative instrument. If the host instrument and conversion feature are determined to be clearly and closely related (both more akin to equity), derivative liability accounting under ASC 815, Derivatives and Hedging, is not required. Management determined that the host contract of the preferred stock is more akin to equity, and accordingly, liability accounting is not required by the Company. The Company has presented preferred stock within stockholders’ equity. Costs incurred directly for the issuance of the preferred stock are recorded as a reduction of gross proceeds received by the Company, resulting in a discount to the preferred stock. The discount is not amortized.
Revenue Recognition		Revenue Recognition Revenues are recognized when performance obligations are satisfied through the transfer of promised goods to the Company’s customers. Control transfers upon shipment of product and when the title has been passed to the customers. This includes the transfer of legal title, physical possession, the risks and rewards of ownership, and customer acceptance. The Company provides the customer the right of return on the product and revenue is adjusted based on an estimate of the expected returns based on historical rates. The Company considers the sale of products as a single performance obligation. Sales tax collected from customers and remitted to taxing authorities is excluded from revenue and is included in accrued expenses. Revenue is deferred for orders received for which associated shipments have not occurred. The reserve for returns totaled $307,725 and $33,933 as of December 31, 2022 and 2021, respectively, and is included in accrued expenses and other liabilities in the accompanying consolidated balance sheets.
Cost of Revenues		Cost of Revenues Cost of revenues consists primarily of inventory sold and related freight-in. Cost of revenues includes direct labor pertaining to our inventory production activities and an allocation of overhead costs including rent and insurance. Cost of revenues also includes inventory write-offs and reserves.
Shipping and Handling		Shipping and Handling The Company recognizes shipping and handling billed to customers as a component of net revenues, and the cost of shipping and handling as distribution costs. Total shipping and handling billed to customers as a component of net revenues was approximately $72,000 and $23,000 for the years ended December 31, 2022 and 2021, respectively. Total shipping and handling costs included in distribution costs were approximately $525,000 and $423,000, respectively.
Advertising and Promotion		Advertising and Promotion Advertising and promotional costs are expensed as incurred. Advertising and promotional expense for the years ended December 31, 2022 and 2021 amounted to approximately $1,178,000 and $240,000, respectively. The amounts are included in sales and marketing expense.
General and Administrative		General and Administrative General and administrative expenses consist primarily of compensation and benefits costs, professional services and information technology. General and administrative expenses also include payment processing fees, design and warehousing fees.
Common Stock Purchase Warrants and Other Derivative Financial Instruments		Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedging relationships and the types of relationships designated are based on the exposures hedged. At December 31, 2022 and 2021, the Company did not have any derivative instruments that were designated as hedges.
Stock Option and Warrant Valuation		Stock Option and Warrant Valuation Stock option and warrant valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option model. For warrants and stock options issued to non- employees, the Company accounts for the expected life based on the contractual life of the warrants and stock options. For employees, the Company accounts for the expected life of options in accordance with the “simplified” method, which is used for “plain-vanilla” options, as defined in the accounting standards codification. The simplified method is based on the average of the vesting tranches and the contractual life of each grant. For stock price volatility, the Company uses comparable public companies as a basis for its expected volatility to calculate the fair value of options grants. The risk-free interest rate was determined from the implied yields of U.S. Treasury zero-coupon bonds with a remaining life consistent with the expected term of the options. The number of stock award forfeitures are recognized as incurred.
Stock-Based Compensation		Stock-Based Compensation The Company accounts for stock-based compensation costs under the provisions of ASC 718, Compensation — Stock Compensation, which requires the measurement and recognition of compensation expense related to the fair value of stock-based compensation awards that are ultimately expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock-based payments granted to employees, officers, and directors based on the grant date fair value estimated in accordance with the provisions of ASC 718. ASC 718 is also applied to awards modified, repurchased, or cancelled during the periods reported. Stock-based compensation is recognized as an expense over the employee’s requisite vesting period and over the nonemployee’s period of providing goods or services. The Company measures employee stock-based awards at grant-date fair value and recognizes employee compensation expense on a straight-line basis over the vesting period of the award. Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions, including the fair value of the Company’s common stock, and for stock options, the expected life of the option, and expected stock price volatility. The Company used the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.
Deferred Offering Costs		Deferred Offering Costs The Company complies with the requirements of ASC 340, Other Assets and Deferred Costs, with regards to offering costs. Prior to the completion of an offering, offering costs are capitalized. The deferred offering costs are charged to additional paid-in capital or as a discount to debt, as applicable, upon the completion of an offering or to expense if the offering is not completed. As of December 31, 2020, the Company had capitalized $214,647 in deferred offering costs. Upon completion of the IPO in May 2021, all capitalized deferred offering costs were charged to additional paid-in capital. As of December 31, 2021, the Company capitalized $367,696 in deferred offering costs pertaining to its equity line of credit agreement with Oasis (Note 8). In 2022, the Company wrote off these costs to general and administrative expenses in the consolidated statements of operations as the equity line of credit financing never occurred.
Segment Information		Segment Information In accordance with ASC 280, Segment Reporting (“ASC 280”), we identify our operating segments according to how our business activities are managed and evaluated. As of December 31, 2022 our operating segments included: DSTLD, Bailey, H&J, Stateside and Sundry. Each operating segment currently reports to the Chief Executive Officer. Each of our brands serve or are expected to serve customers through our wholesale, in store and online channels, allowing us to execute on our omni-channel strategy. We have determined that each of our operating segments share similar economic and other qualitative characteristics, and therefore the results of our operating segments are aggregated into one reportable segment. All of the operating segments have met the aggregation criteria and have been aggregated and are presented as one reportable segment, as permitted by ASC 280. We continually monitor and review our segment reporting structure in accordance with authoritative guidance to determine whether any changes have occurred that would impact our reportable segments.
Income Taxes		Income Taxes The Company uses the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is unlikely that the deferred tax assets will not be realized. We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. In accordance with ASC 740-10, for those tax positions where there is a greater than 50% likelihood that a tax benefit will be sustained, our policy will be to record the largest amount of tax benefit that is more likely than not to be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit will be recognized in the financial statements.
Net Loss per Share	Net Loss per Share Net earnings or loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period, excluding shares subject to redemption or forfeiture. The Company presents basic and diluted net earnings or loss per share. Diluted net earnings or loss per share reflect the actual weighted average of common shares issued and outstanding during the period, adjusted for potentially dilutive securities outstanding. Potentially dilutive securities are excluded from the computation of the diluted net loss per share if their inclusion would be anti-dilutive. The following table sets forth the computation of basic and diluted net income (loss) per share: Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 Numerator: Net income (loss) from continuing operations $ 6,536,310 $ (9,482,520) $ 470,415 $ (17,200,792) Income (loss) from discontinued operations, net of tax (1,492,050) (51,404) (1,562,503) (166,074) Net income (loss) $ 5,044,260 $ (9,533,924) $ (1,092,088) $ (17,366,866) Denominator: Weighted average common shares outstanding - basic 246,809 14,329 236,824 9,836 Weighted average common shares outstanding - diluted 834,604 14,329 824,619 9,836 Net income (loss) from continuing operations per share - basic $ 26.48 $ (661.78) $ 1.99 $ (1,748.68) Net income (loss) from continuing operations per share - diluted $ 7.83 $ (661.78) $ 0.57 $ (1,748.68) Net income (loss) from discontinued operations per common share – basic $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) from discontinued operations per common share – diluted $ (6.05) $ (3.59) $ (6.60) $ (16.88) Net income (loss) per share – $ 20.44 $ (665.36) $ (4.61) $ (1,765.57) Net income (loss) per share – $ 6.04 $ (665.36) $ (4.61) $ (1,765.57) The following table sets forth the a) the dilutive items included in the weighted average common shares – diluted amount above as of June 30, 2023 and b) the number of potential common shares excluded from the calculations of net loss per diluted share because their inclusion would be anti-dilutive as of June 30, 2022: June 30, 2023 2022 — 18,496 Convertible notes 27,097 — Series A convertible preferred stock 321,395 — Series C convertible preferred stock 237,746 2,533 Common stock warrants 1,558 1,558 Stock options 587,795 22,588 The stock options and warrants above are out-of-the-money as of June 30, 2023 and 2022.	Net Loss per Share Net earnings or loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period, excluding shares subject to redemption or forfeiture. The Company presents basic and diluted net earnings or loss per share. Diluted net earnings or loss per share reflect the actual weighted average of common shares issued and outstanding during the period, adjusted for potentially dilutive securities outstanding. Potentially dilutive securities are excluded from the computation of the diluted net loss per share if their inclusion would be anti-dilutive. As all potentially dilutive securities are anti-dilutive as of December 31, 2022 and 2021, diluted net loss per share is the same as basic net loss per share for each year. Potentially dilutive items outstanding as of December 31, 2022 and 2021 are as follows: December 31, 2022 2021 Convertible notes 37,915 1,916 Series A convertible preferred stock 4,320 — Common stock warrants 176,733 1,432 Stock options 1,558 1,558 Total potentially dilutive shares 220,526 4,907 The potentially dilutive shares pertaining to the Company’s outstanding convertible notes were calculated based on the assumed conversion abilities as of December 31, 2022 and 2021. The ultimate number of shares for which the notes can convert into is indeterminable. The stock options and warrants above are out-of-the-money as of December 31, 2022 and 2021.
Concentrations		Concentrations The Company utilized three and two vendors that made up 30% and 40%, respectively, of all inventory purchases during the years ended December 31, 2022 and 2021. The loss of one of these vendors, may have a negative short-term impact on the Company’s operations; however, we believe there are acceptable substitute vendors that can be utilized longer-term.
Leases		Leases On January 1, 2022, the Company adopted ASC 842, Leases The Company elected transitional practical expedients for existing leases which eliminated the requirements to reassess existing lease classification, initial direct costs, and whether contracts contain leases. Also, the Company elected to present the payments associated with short-term leases as an expense in statements of operations. Short-term leases are leases with a lease term of 12 months or less.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which amends and clarifies several provisions of Topic 326. In May 2019, the FASB issued ASU 2019-05, Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief, which amends Topic 326 to allow the fair value option to be elected for certain financial instruments upon adoption. ASU 2019-10 extended the effective date of ASU 2016-13 until December 15, 2022. The Company adopted this new guidance, including the subsequent updates to Topic 326, on January 1, 2023 and the adoption did not have a material impact on the Company’s condensed consolidated financial statements and related disclosures. Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are	Recent Accounting Pronouncements In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02: Leases (Topic 842). Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable under the circumstances.

SUMMARY OF SIGNIFICANT ACCOU_14

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Jun. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of financial assets and liabilities measured at fair value on recurring basis	Fair Value Measurements as of June 30, 2023 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ — $ — $ — $ — $ — $ — Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Contingent consideration $ — $ — $ 12,098,475 $ 12,098,475 $ — $ — $ 12,098,475 $ 12,098,475	Fair Value Measurements as of December 31, 2022 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ — $ — $ — Contingent consideration — — 12,098,475 12,098,475 Derivative liability — — — — $ — $ — $ 12,098,475 $ 12,098,475 Fair Value Measurements as of December 31, 2021 Using: Level 1 Level 2 Level 3 Total Liabilities: Warrant liability $ — $ 18,223 $ — $ 18,223 Contingent consideration — — 12,179,476 12,179,476 Derivative liability — — 2,294,720 2,294,720 $ — $ 18,223 $ 14,474,196 $ 14,492,419
Schedule of changes in acquisition-related contingent consideration		Contingent Consideration Liability Balance as of December 31, 2020 $ — Initial recognition in connection with acquisition of Harper & Jones 3,421,516 Stock price guarantee per consulting agreement 67,000 Conversion into shares (73,500) Change in fair value 8,764,460 Outstanding as of December 31, 2021 12,179,476 Repayments to Harper & Jones seller (645,304) Change in fair value 564,303 Outstanding as of December 31, 2022 $ 12,098,475
Schedule of changes in derivative liability		Derivative Liability Outstanding as of December 31, 2020 $ — Initial fair value on issuance of convertible note 3,204,924 Change in fair value (910,204) Outstanding as of December 31, 2021 2,294,720 Initial fair value on issuance of convertible note 559,957 Conversion of underlying notes into common stock (1,500,243) Change in fair value (1,354,434) Outstanding as of December 31, 2022 $ —
Schedule of inventory	June 30, December 31, 2023 2022 Raw materials $ 1,508,416 $ 1,611,134 Work in process 653,412 888,643 Finished goods 2,609,443 2,725,505 Inventory $ 4,771,271 $ 5,225,282	December 31, 2022 2021 Raw materials $ 1,508,416 $ 292,167 Work in process 888,643 242,673 Finished goods 2,725,505 2,220,519 Inventory $ 5,122,564 $ 2,660,203
Schedule of potentially dilutive items outstanding	June 30, 2023 2022 — 18,496 Convertible notes 27,097 — Series A convertible preferred stock 321,395 — Series C convertible preferred stock 237,746 2,533 Common stock warrants 1,558 1,558 Stock options 587,795 22,588	December 31, 2022 2021 Convertible notes 37,915 1,916 Series A convertible preferred stock 4,320 — Common stock warrants 176,733 1,432 Stock options 1,558 1,558 Total potentially dilutive shares 220,526 4,907
Schedule of estimated useful lives of amortizable intangible assets		Customer relationships 3 years
Schedule of changes in common stock warrant liability		Warrant Liability Outstanding as of December 31, 2020 $ 6,265 Change in fair value 11,958 Outstanding as of December 31, 2021 18,223 Change in fair value (18,223) Outstanding as of December 31, 2022 $ —
Summary of goodwill and intangible impairment		Year Ended December 31, 2022 2021 Bailey brand name (intangibles) $ 2,182,000 $ 3,400,000 Bailey goodwill 3,321,095 — Total impairment $ 5,503,095 $ 3,400,000
Summary of contingent consideration	June 30, December 31, 2023 2022 Bailey $ — $ 10,698,475 Harper & Jones — 1,400,000 $ — $ 12,098,475	December 31, 2022 2021 Bailey $ 10,698,475 7,935,016 Harper & Jones 1,400,000 4,244,460 $ 12,098,475 $ 12,179,476

BUSINESS COMBINATIONS AND DISPO

BUSINESS COMBINATIONS AND DISPOSITION (Tables)	12 Months Ended
BUSINESS COMBINATIONS AND DISPOSITION (Tables)	Dec. 31, 2022
BUSINESS COMBINATIONS AND DISPOSITION
Schedule of components of purchase price consideration	Cash $ 7,500,000 Promissory notes payable 5,500,000 Common stock 1,000,000 Purchase price consideration $ 14,000,000
Schedule of assets and liabilities acquired in business combination	Purchase Price Allocation Cash and cash equivalents $ 252,697 Accounts receivable, net 63,956 Due from factor, net 387,884 Inventory 2,941,755 Prepaid expenses and other current assets 32,629 Property, equipment and software, net 48,985 Goodwill 3,711,322 Intangible assets 7,403,800 Accounts payable (615,706) Accrued expenses and other liabilities (227,321) Purchase price consideration $ 14,000,000
Schedule of fair value of purchase price consideration	Cash $ 500,000 Common stock 8,025,542 Contingent consideration 3,421,516 Purchase price consideration $ 11,947,058
Schedule of allocation of purchase price in regard to acquisition	Purchase Price Allocation Cash and cash equivalents $ 24,335 Accounts receivable, net 49,472 Due from factor, net — Inventory 77,159 Prepaid expenses and other current assets 69,715 Property, equipment and software, net 83,986 Goodwill 9,681,548 Intangible assets 3,936,030 Accounts payable (51,927) Accrued expenses and other liabilities (107,957) Purchase price consideration $ 11,947,058
Schedule of business acquisition pro forma information	Year Ended December 31, 2022 2021 Net revenues $ 28,519,261 $ 34,635,426 Net loss $ (42,001,415) $ (33,171,473) Net loss per common share $ (1,361.50) $ (10,870.25)
June 2023 Disposition
BUSINESS COMBINATIONS AND DISPOSITION
Schedule of assets and liabilities acquired in business combination	December 31, 2022 2021 Cash and cash equivalents $ 7,666 $ 12,598 Inventory 102,718 95,155 Accounts receivable, net 45,018 22,010 Goodwill 1,130,310 9,681,548 Intangible assets, net 1,521,265 3,578,182 Other current and non-current assets 62,703 161,740 Accounts payable 81,991 54,981 Accrued expenses and other liabilities 520,195 381,290 Deferred revenue 202,129 276,397 Due to related parties 1,008 21,361 Note payable - related party 129,489 299,489 Loan payable 284,059 148,900
June 2023 Disposition \| Discontinued operations
BUSINESS COMBINATIONS AND DISPOSITION
Schedule of assets and liabilities acquired in business combination	Year Ended December 31, 2022 2021 Net revenues $ 3,637,620 $ 1,819,896 Cost of net revenues 1,241,594 1,888,091 Gross profit (loss) 2,396,026 (68,195) Operating expenses: General and administrative 2,303,854 603,007 Sales and marketing 931,650 540,873 Impairment 10,036,238 — Total operating expenses 13,271,742 1,143,880 Loss from operations (10,875,716) (1,212,075) Other income (expense): Interest expense (52,927) (44,828) Other non-operating income (expenses) — 233,030 Total other income (expense), net (52,927) 188,202 Income tax benefit (provision) — — Net loss from discontinued operations $ (10,928,643) $ (1,023,873) Weighted average common shares outstanding - basic and diluted 30,852 3,052 Net loss from discontinued operations per common share - basic $ (354.23) $ (335.52)
Stateside
BUSINESS COMBINATIONS AND DISPOSITION
Schedule of fair value of purchase price consideration	Cash $ 5,000,000 Common stock 3,403,196 Purchase price consideration $ 8,403,196
Schedule of allocation of purchase price in regard to acquisition	Purchase Price Allocation Cash and cash equivalents 32,700 Accounts receivable, net 154,678 Due from factor, net 371,247 Inventory 603,625 Prepaid expenses and other current assets 7,970 Deposits 9,595 Property, equipment and software, net — Goodwill 2,104,056 Intangible assets 5,939,140 Accounts payable (374,443) Accrued expenses and other liabilities (445,372) $ 8,403,196

DUE FROM FACTOR (Tables)_2

DUE FROM FACTOR (Tables)	6 Months Ended	12 Months Ended
DUE FROM FACTOR (Tables)	Jun. 30, 2023	Dec. 31, 2022
DUE FROM FACTOR
Schedule of due to/ from factor	June 30, December 31, 2023 2022 Outstanding receivables: Without recourse $ 787,542 $ 1,680,042 With recourse 50,979 65,411 Matured funds and deposits 88,516 81,055 Advances (478,753) (632,826) Credits due customers (10,142) (354,282) $ 438,142 $ 839,400	December 31, 2022 2021 Outstanding receivables: Without recourse $ 564,548 $ 579,295 With recourse 352,379 361,584 Advances 118,521 121,617 Credits due customers (196,048) (77,208) $ 839,400 $ 985,288

GOODWILL AND INTANGIBLE ASSET_5

GOODWILL AND INTANGIBLE ASSETS (Tables)	12 Months Ended
GOODWILL AND INTANGIBLE ASSETS (Tables)	Dec. 31, 2022
GOODWILL AND INTANGIBLE ASSETS
Summary of future amortization expense	Year Ending December 31, 2023 2,924,020 2024 2,474,178 2025 1,666,160 $ 7,064,358
Summary of goodwill by entity	Bailey Stateside Sundry Total Balances at December 31, 2020 $ 6,479,218 $ — $ — $ 6,479,218 Business combination — 2,104,056 — 2,104,056 Impairment — — — — Balances at December 31, 2021 6,479,218 2,104,056 — 8,583,274 Business combination — — 3,711,322 3,711,322 Impairment (3,321,095) — — (3,321,095) Balances at December 31, 2022 $ 3,158,123 $ 2,104,056 $ 3,711,322 $ 8,973,501
Summary of information relating to the Company's identifiable intangible assets	Gross Accumulated Carrying December 31, 2022 Amount Amortization Value Amortized: Customer relationships $ 9,734,560 (2,670,202) $ 7,064,358 9,734,560 (2,670,202) 7,064,358 Indefinite-lived: Brand name $ 5,841,880 — 5,841,880 $ 15,576,440 $ (2,670,202) $ 12,906,238 Gross Accumulated Carrying December 31, 2021 Amount Amortization Value Amortized: Customer relationships $ 4,736,080 (1,091,509) $ 3,644,571 4,736,080 (1,091,509) 3,644,571 Indefinite-lived: Brand name $ 5,618,560 — 5,618,560 $ 10,354,640 $ (1,091,509) $ 9,263,131

LIABILITIES AND DEBT (Tables)_2

LIABILITIES AND DEBT (Tables)	6 Months Ended	12 Months Ended
LIABILITIES AND DEBT (Tables)	Jun. 30, 2023	Dec. 31, 2022
LIABILITIES AND DEBT
Schedule of accrued expenses and other liabilities	June 30, December 31, 2023 2022 Accrued expenses $ 503,927 $ 668,714 Reserve for returns — 307,725 Payroll related liabilities 4,009,812 2,618,870 Sales tax liability 277,800 262,765 Other liabilities 247,398 78,845 $ 5,038,937 $ 3,936,920	December 31, 2022 2021 Accrued expenses $ 668,714 $ 178,819 Reserve for returns 307,725 33,933 Payroll related liabilities 2,618,870 1,183,598 Sales tax liability 262,765 225,804 Due to seller — 396,320 Other liabilities 78,845 59,613 $ 3,936,920 $ 2,078,087
Summary of the convertible notes	Unamortized Convertible Note Principal Debt Discount Payable, Net Balance, December 31, 2022 $ 4,100,000 $ (1,378,200) $ 2,721,800 Repayments of notes (4,000,000) — (4,000,000) Amortization of debt discount — 689,100 689,100 Loss on extinguishment of debt — 689,100 689,100 Balance, June 30, 2023 $ 100,000 $ — $ 100,000	Unamortized Convertible Note Principal Debt Discount Payable, Net Balance, December 31, 2020 $ 100,000 $ — $ 100,000 Issuance of Oasis note, net of issuance costs 5,265,000 (715,000) 4,550,000 Issuance of FirstFire First note, net of issuance costs 1,575,000 (315,000) 1,260,000 Issuance of Second FirstFire note, net of issuance costs 2,625,000 (530,000) 2,095,000 Derivative liability in connection with notes — (3,204,924) (3,204,924) Amortization of debt discount — 801,538 801,538 Balance, December 31, 2021 9,565,000 (3,963,386) 5,601,614 Proceeds from issuance of notes 8,943,750 (1,992,500) 6,951,250 Repayments of notes (4,943,750) — (4,943,750) Conversion of notes into common stock (9,465,000) — (9,465,000) Warrant and common shares issued with convertible notes — (1,368,741) (1,368,741) Derivative liability in connection with notes — (559,957) (559,957) Amortization of debt discount — 6,506,384 6,506,384 Balance, December 31, 2022 $ 4,100,000 $ (1,378,200) $ 2,721,800

SHARE-BASED PAYMENTS (Tables)_2

SHARE-BASED PAYMENTS (Tables)	6 Months Ended	12 Months Ended
SHARE-BASED PAYMENTS (Tables)	Jun. 30, 2023	Dec. 31, 2022
SHARE-BASED PAYMENTS
Summary of information related to common stock and preferred stock warrants	Common Weighted Stock Average Warrants Exercise Price Outstanding - December 31, 2022 176,733 $ 209 Granted 93,099 99.50 Exercised (32,086) 97.88 Forfeited — — Outstanding - June 30, 2023 237,746 $ 181.25 Exercisable at December 31, 2022 171,278 $ 210.50 Exercisable at June 30, 2023 237,745 $ 181.25	Common Weighted Stock Average Warrants Exercise Price Outstanding - December 31, 2020 366 $ 6,650 Granted 1,205 11,450 Conversion of preferred stock warrants upon IPO 21 19,150 Exercised (155) 11,425 Forfeited (4) 19,150 Outstanding - December 31, 2021 1,432 $ 10,300 Granted 241,308 140.36 Exercised (66,007) 131.25 Forfeited — — Outstanding - December 31, 2022 176,733 $ 209.23 Exercisable at December 31, 2021 1,432 $ 10,300 Exercisable at December 31, 2022 171,278 $ 210.41
Summary of information related to stock options under stock plan		Weighted Average Options Exercise Price Outstanding - December 31, 2020 485 $ 5,850 Granted 1,093 10,375 Exercised — — Forfeited — — Outstanding - December 31, 2021 1,558 $ 9,053 Granted — — Exercised — — Forfeited — — Outstanding - December 31, 2022 1,558 $ 9,053 Exercisable at December 31, 2021 1,266 $ 8,975 Exercisable at December 31, 2022 1,389 $ 10,125 Weighted average duration (years) to expiration of outstanding options at December 31, 2022 7.00
Schedule of assumptions utilized for option grants		Year Ended December 31, 2022 2021 Risk Free Interest Rate n/a 0.34% - 0.85 % Expected Dividend Yield n/a 0.00 % Expected Volatility n/a 58.00 % Expected Life (years) n/a 5.18

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
INCOME TAXES (Tables)	Dec. 31, 2022
INCOME TAXES
Schedule of deferred tax assets and liabilities	December 31, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 16,733,582 $ 13,108,371 Deferred tax liabilities: Depreciation timing differences — (5,103) Valuation allowance (16,733,582) (13,103,268) Net deferred tax assets $ — $ —

NATURE OF OPERATIONS (Details_2

NATURE OF OPERATIONS (Details)					1 Months Ended	6 Months Ended	12 Months Ended
NATURE OF OPERATIONS (Details)	Oct. 21, 2022	May 18, 2021	May 13, 2021 USD ($) $ / shares shares	May 12, 2021	Sep. 30, 2022 shares	Jun. 30, 2023 shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 30, 2022	Aug. 30, 2021
NATURE OF OPERATIONS
Number of shares issued \| shares					30	50,890
Aggregate net proceeds from the IPO, inclusive of the proceeds from the over-allotment exercise							$ 8,100,000
Reverse stock split conversion ratio	0.01	1		0.064
IPO [Member]
NATURE OF OPERATIONS
Warrants issued to purchase common stock \| shares			1,111
Underwriting discounts and commissions			$ 800,000
Estimated offering expenses			600,000
Additional offering costs			$ 600,000
Share issued price \| $ / shares			$ 10,375				$ 625
Number of shares issued \| shares			964				14,956
Aggregate net proceeds from the IPO, inclusive of the proceeds from the over-allotment exercise			$ 8,600,000
Over-Allotment Option [Member]
NATURE OF OPERATIONS
Warrants issued to purchase common stock \| shares			145
Harper & Jones
NATURE OF OPERATIONS
Percentage of equity acquired		100%
Stateside
NATURE OF OPERATIONS
Percentage of equity acquired									100%
Sundry
NATURE OF OPERATIONS
Percentage of equity acquired								100%

GOING CONCERN (Details)_2

GOING CONCERN (Details) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
GOING CONCERN (Details) - USD ($)	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
GOING CONCERN
Net loss	$ 5,044,260	$ (6,136,349)	$ (9,533,924)	$ (7,832,942)	$ (1,092,088)	$ (17,366,866)	$ (38,043,362)	$ (32,357,957)
Working capital deficit	$ 16,037,518				$ 16,037,518		$ 32,064,398

SUMMARY OF SIGNIFICANT ACCOU_15

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

3 Months Ended

12 Months Ended

Oct. 21, 2022

May 18, 2021

May 12, 2021

Sep. 30, 2022 USD ($)

Jun. 30, 2022 USD ($)

Mar. 31, 2022 USD ($)

Sep. 30, 2021 USD ($)

Jun. 30, 2021 USD ($)

Mar. 31, 2021 USD ($)

Dec. 31, 2021 USD ($)

Jun. 30, 2023 USD ($)

Dec. 31, 2022 USD ($)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Reverse stock split conversion ratio

0.01

0.064

Cash and cash equivalents in bank deposit

$ 250,000

Reclassification adjustment

$ 290,000

$ 255,000

$ 1,027,387

SUMMARY OF SIGNIFICANT ACCOU_16

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Financial Instruments (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Liabilities:
Outstanding as of Opening balance	$ 18,223	$ 18,223	$ 6,265
Warrant liability			14,492,419
Outstanding as of Ending balance			18,223
Fair value of contingent consideration		12,098,475	12,179,476
Change in fair value	(18,223)	(18,223)	11,958
Total		12,098,475
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Outstanding as of beginning balance	$ 12,179,476	12,179,476	0
Initial recognition in connection with acquisition of Harper & Jones			3,421,516
Stock price guarantee per consulting agreement			67,000
Conversion into shares			(73,500)
Change in fair value		564,303	8,764,460
Repayments to Harper & Jones seller		(645,304)
Outstanding as of ending balance		12,098,475	12,179,476
Harper & Jones, LLC
Liabilities:
Fair value of contingent consideration		1,400,000	4,244,460
Bailey LLC
Liabilities:
Fair value of contingent consideration		$ 10,698,475	7,935,016
Expected Volatility \| Minimum
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the contingent consideration		0.793
Expected Volatility \| Maximum [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the contingent consideration		0.889
Risk Free Interest Rate
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the contingent consideration		0.0025
Expected share
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the contingent consideration		0.05
Stock price \| Harper & Jones, LLC
Liabilities:
Fair value of contingent consideration		$ 10,375,000
Stock price \| Bailey LLC
Liabilities:
Fair value of contingent consideration		828,000
Level 2
Liabilities:
Warrant liability			18,223
Level 3
Liabilities:
Warrant liability			14,474,196
Fair value of contingent consideration		12,098,475	12,179,476
Derivative liability			$ 2,294,720
Total		$ 12,098,475

SUMMARY OF SIGNIFICANT ACCOU_17

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivative Liability (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Outstanding as of beginning balance	$ 12,179,476	$ 0
Change in fair value	564,303	8,764,460
Outstanding as of ending balance	$ 12,098,475	12,179,476
Maximum \| Expected Volatility
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the derivative liability	0.967
Maximum \| Risk Free Interest Rate
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the derivative liability	0.0374
Maximum \| Expected Life (years)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the derivative liability	0.62
Minimum \| Expected Volatility
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the derivative liability	0.709
Minimum \| Risk Free Interest Rate
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the derivative liability	0.0271
Minimum \| Expected Life (years)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value of the derivative liability	0.08
Derivative Liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Outstanding as of beginning balance	$ 2,294,720
Initial fair value on issuance of convertible note	559,957	3,204,924
Conversion of underlying notes into common stock	(1,500,243)
Change in fair value	$ (1,354,434)	(910,204)
Outstanding as of ending balance		$ 2,294,720

SUMMARY OF SIGNIFICANT ACCOU_18

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Equipment, and Software (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Property, Equipment, and Software
General and administrative expenses	$ 75,126	$ 92,213
Property and equipment \| Minimum
Property, Equipment, and Software
Lease life or expected life	3 years	3 years
Property and equipment \| Maximum
Property, Equipment, and Software
Lease life or expected life	10 years	10 years
Software
Property, Equipment, and Software
Lease life or expected life	3 years	3 years

SUMMARY OF SIGNIFICANT ACCOU_19

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Deferred Offering Costs (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restructuring Cost and Reserve
Deferred offering costs			$ 214,647
Deferred offering costs capitalized	$ 104,512	$ 367,696
Harper & Jones, LLC
Restructuring Cost and Reserve
Repayments of Notes Payable	$ 645,304

SUMMARY OF SIGNIFICANT ACCOU_20

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Impairment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Indefinite-lived Intangible Assets
Total impairment of intangibles	$ 3,667,000
Total impairment of goodwill	3,321,095
Total impairment	5,503,095	$ 3,400,000
Bailey Goodwill
Indefinite-lived Intangible Assets
Total impairment of goodwill	3,321,095
Bailey brand name
Indefinite-lived Intangible Assets
Total impairment of intangibles	$ 2,182,000	$ 3,400,000

SUMMARY OF SIGNIFICANT ACCOU_21

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentrations (Details) - item	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of vendors	3	2
Inventory, percentage	30%	40%

SUMMARY OF SIGNIFICANT ACCOU_22

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Indefinite-Lived Intangible Assets (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)
Brand name
Indefinite-lived Intangible Assets [Line Items]
Impairment loss of indefinite-lived intangible assets	$ 3,400,000

SUMMARY OF SIGNIFICANT ACCOU_23

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventory (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Raw materials	$ 1,508,416	$ 1,611,134	$ 292,167
Work in process	653,412	888,643	242,673
Finished goods	2,609,443	2,725,505	2,220,519
Inventory	$ 4,771,271	$ 5,225,282	$ 2,660,203

SUMMARY OF SIGNIFICANT ACCOU_24

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss per Share (Details) - shares	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total potentially dilutive shares	587,795	22,588	220,526	4,907
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total potentially dilutive shares	1,558	1,558	1,558	1,558
Convertible notes
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total potentially dilutive shares		18,496	37,915	1,916
Series A convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total potentially dilutive shares	27,097		4,320
Common stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total potentially dilutive shares	237,746	2,533	176,733	1,432

SUMMARY OF SIGNIFICANT ACCOU_25

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Advertising and Promotion (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Advertising and promotional expense	$ 1,178,000	$ 240,000

SUMMARY OF SIGNIFICANT ACCOU_26

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Total shipping and handling	$ 72,000	$ 23,000
Total shipping and handling costs included in distribution costs	$ 525,000	$ 423,000

SUMMARY OF SIGNIFICANT ACCOU_27

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Leases (Details)	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Lease term	12 months

BUSINESS COMBINATIONS AND DIS_2

BUSINESS COMBINATIONS AND DISPOSITION - 2022 Acquisition (Details) - USD ($)			12 Months Ended
	Dec. 30, 2022	Feb. 12, 2020	Dec. 31, 2022	Dec. 31, 2021	Feb. 15, 2023	Apr. 30, 2021
BUSINESS COMBINATIONS AND DISPOSITION
Contingent consideration liability			$ 12,098,475	$ 12,179,476
Promissory note payable
BUSINESS COMBINATIONS AND DISPOSITION
Aggregate principal amount			3,500,000			$ 1,000,000
Bailey LLC
BUSINESS COMBINATIONS AND DISPOSITION
Aggregate principal amount					$ 5,500,000
Bailey LLC \| Promissory note payable
BUSINESS COMBINATIONS AND DISPOSITION
Aggregate principal amount			4,500,000
Preferred Stock \| Series B Preferred Stock
BUSINESS COMBINATIONS AND DISPOSITION
Conversion of preferred stock into common stock (shares)				(20,754,717)
2022 Acquisition
BUSINESS COMBINATIONS AND DISPOSITION
Cash	$ 7,500,000		7,500,000
Consideration in promissory notes	5,500,000
Common stock	$ 1,000,000		1,000,000
Percentage of equity acquired	8%
Number of shares of common stock issued	3,636
Business acquisition, equity interest fair value	$ 1,000,000
Previous Acquisitions
BUSINESS COMBINATIONS AND DISPOSITION
Business acquisition, equity interest rate		100%
Sale parent stock gross proceeds does not exceed		$ 11,000,000
Previous Acquisitions \| Bailey LLC
BUSINESS COMBINATIONS AND DISPOSITION
Total purchase price consideration		15,500,000
Contingent consideration liability			$ 10,698,475	$ 7,935,016
Previous Acquisitions \| Bailey LLC \| Promissory note payable
BUSINESS COMBINATIONS AND DISPOSITION
Aggregate principal amount		$ 4,500,000
Previous Acquisitions \| Preferred Stock \| Series B Preferred Stock
BUSINESS COMBINATIONS AND DISPOSITION
Conversion of preferred stock into common stock (shares)		20,754,717

BUSINESS COMBINATIONS AND DIS_3

BUSINESS COMBINATIONS AND DISPOSITION (Details)	May 18, 2021 USD ($) shares
BUSINESS COMBINATIONS AND DISPOSITION
Trading day immediately preceding period	30 days
Gross proceeds from common stock indemnification claims	$ 9,100,000
Harper & Jones
BUSINESS COMBINATIONS AND DISPOSITION
Business acquisition interest acquired	100%
Number of shares connection with merger \| shares	87,711
Harper & Jones \| IPO
BUSINESS COMBINATIONS AND DISPOSITION
Cash payments	$ 500,000
Business acquisition issuable amount	$ 9,100,000

BUSINESS COMBINATIONS AND DIS_4

BUSINESS COMBINATIONS AND DISPOSITION - Purchase price consideration (Details) - USD ($)			12 Months Ended
	Dec. 30, 2022	May 18, 2021	Dec. 31, 2022
Harper & Jones
BUSINESS COMBINATIONS AND DISPOSITION
Cash		$ 500,000
Common stock		8,025,542
Contingent consideration		3,421,516
Purchase price consideration		$ 11,947,058
2022 Acquisition
BUSINESS COMBINATIONS AND DISPOSITION
Cash	$ 7,500,000		$ 7,500,000
Common stock	1,000,000		1,000,000
Contingent consideration	5,500,000
Purchase price consideration	$ 14,000,000		14,000,000
Promissory note payable \| 2022 Acquisition
BUSINESS COMBINATIONS AND DISPOSITION
Contingent consideration			$ 5,500,000

BUSINESS COMBINATIONS AND DIS_5

BUSINESS COMBINATIONS AND DISPOSITION - Assets acquired and Liabilities assumed (Details) - USD ($)			12 Months Ended
	Dec. 30, 2022	May 18, 2021	Dec. 31, 2022	Jun. 30, 2023	Dec. 31, 2021	Dec. 31, 2020
BUSINESS COMBINATIONS AND DISPOSITION
Goodwill			$ 10,103,812	$ 8,973,501	$ 8,583,274	$ 6,479,218
Harper & Jones
BUSINESS COMBINATIONS AND DISPOSITION
Cash and cash equivalents		$ 24,335
Accounts receivable, net		49,472
Inventory		77,159
Prepaid expenses and other current assets		69,715
Property, equipment and software, net		83,986
Goodwill		9,681,548
Intangible assets		3,936,030
Accounts payable		(51,927)
Accrued expenses and other liabilities		(107,957)
Purchase price consideration		$ 11,947,058
2022 Acquisition
BUSINESS COMBINATIONS AND DISPOSITION
Cash and cash equivalents	$ 252,697
Accounts receivable, net	63,956
Due from factor, net	387,884
Inventory	2,941,755
Prepaid expenses and other current assets	32,629
Property, equipment and software, net	48,985
Goodwill	3,711,322
Intangible assets	7,403,800
Accounts payable	(615,706)
Accrued expenses and other liabilities	(227,321)
Purchase price consideration	$ 14,000,000		$ 14,000,000

BUSINESS COMBINATIONS AND DIS_6

BUSINESS COMBINATIONS AND DISPOSITION - Stateside (Details) - Stateside	Aug. 30, 2021 USD ($) shares
BUSINESS COMBINATIONS AND DISPOSITION
Membership interests acquired in cash	$ 5,000,000
Value of shares of common stock transferred \| shares	44,062
Cash held in escrow	$ 375,000
Value of shares held in escrow	$ 375,000
Number of shares held in escrow \| shares	3,305

BUSINESS COMBINATIONS AND DIS_7

BUSINESS COMBINATIONS AND DISPOSITION - Stateside purchase price consideration (Details) - Stateside	Aug. 30, 2021 USD ($)
Fair value of the purchase price consideration
Cash	$ 5,000,000
Common stock	3,403,196
Purchase price consideration	$ 8,403,196

BUSINESS COMBINATIONS AND DIS_8

BUSINESS COMBINATIONS AND DISPOSITION - Stateside Assets acquired and Liabilities assumed (Details) - USD ($)	Aug. 30, 2021	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
BUSINESS COMBINATIONS AND DISPOSITION
Goodwill		$ 8,973,501	$ 10,103,812	$ 8,583,274	$ 6,479,218
Stateside
BUSINESS COMBINATIONS AND DISPOSITION
Cash and cash equivalents	$ 32,700
Accounts receivable, net	154,678
Due from factor, net	371,247
Inventory	603,625
Prepaid expenses and other current assets	7,970
Deposits	9,595
Goodwill	2,104,056	$ 2,104,056	$ 2,104,056	$ 2,104,056
Intangible assets	5,939,140
Accounts payable	(374,443)
Accrued expenses and other liabilities	(445,372)
Purchase price consideration	$ 8,403,196

BUSINESS COMBINATIONS AND DIS_9

BUSINESS COMBINATIONS AND DISPOSITION - Stateside Additional information (Details) - USD ($)			12 Months Ended
	Dec. 30, 2022	Aug. 30, 2021	Dec. 31, 2022	Dec. 31, 2021
BUSINESS COMBINATIONS AND DISPOSITION
Estimated useful lives	3 years
Customer relationships
BUSINESS COMBINATIONS AND DISPOSITION
Estimated useful lives			3 years
Stateside
BUSINESS COMBINATIONS AND DISPOSITION
Working capital adjustments			$ 493,791
Net amount due to seller				$ 396,320
Net revenue since the acquisition date		$ 1,695,000
Net income since the acquisition date		$ 285,000
Stateside \| Customer relationships
BUSINESS COMBINATIONS AND DISPOSITION
Estimated useful lives		3 years

BUSINESS COMBINATIONS AND DI_10

BUSINESS COMBINATIONS AND DISPOSITION - Unaudited Pro Forma Financial Information (Details) - USD ($)			6 Months Ended		12 Months Ended
	Dec. 30, 2022	May 18, 2021	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
BUSINESS COMBINATIONS AND DISPOSITION
Estimated useful lives	3 years
Fair value of contingent consideration					$ 12,098,475	$ 12,179,476
Net revenues				$ 14,728,296	28,519,261	34,635,426
Net loss				$ (16,907,152)	$ (42,001,415)	$ (33,171,473)
Net loss per common share - basic				$ (1,718.83)	$ (1,361.50)	$ (10,870.25)
Net loss per common share - diluted			$ (1,718.83)
Harper & Jones
BUSINESS COMBINATIONS AND DISPOSITION
Contingent consideration liability, valuation shortfall		$ 3,421,516
Fair value of contingent consideration					$ 1,400,000	$ 4,244,460
Net revenues						1,860,000
Net loss						$ 390,000
Customer relationships
BUSINESS COMBINATIONS AND DISPOSITION
Estimated useful lives					3 years
Customer relationships \| Harper & Jones
BUSINESS COMBINATIONS AND DISPOSITION
Estimated useful lives		3 years

BUSINESS COMBINATIONS AND DI_11

BUSINESS COMBINATIONS AND DISPOSITION - June 2023 Disposition (Details) - USD ($)		6 Months Ended
	Jun. 21, 2023	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
BUSINESS COMBINATIONS AND DISPOSITION
Goodwill		$ 8,973,501	$ 10,103,812	$ 8,583,274	$ 6,479,218
Aggregate cash payment agreed to pay	$ 229,000
H&J Settlement Agreement \| D.Jones (H&J Seller)
BUSINESS COMBINATIONS AND DISPOSITION
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	78,103	78,103
Percentage of membership interest transferred	100%
June 2023 Disposition
BUSINESS COMBINATIONS AND DISPOSITION
Cash and cash equivalents			7,666	12,598
Inventory			102,718	95,155
Accounts receivable, net			45,018	22,010
Goodwill			1,130,310	9,681,548
Intangible assets, net			1,521,265	3,578,182
Other current and non-current assets			62,703	161,740
Accounts payable			81,991	54,981
Accrued expenses and other liabilities			520,195	381,290
Deferred revenue			202,129	276,397
Due to related parties			1,008	21,361
Note payable - related party			129,489	299,489
Loan payable			$ 284,059	$ 148,900
June 2023 Disposition \| H&J Settlement Agreement \| D.Jones (H&J Seller)
BUSINESS COMBINATIONS AND DISPOSITION
Aggregate cash payment agreed to pay	$ 229,000
Issuance of common stock pursuant to disposition (in shares)	78,103
Percentage of membership interest transferred	100%

BUSINESS COMBINATIONS AND DI_12

BUSINESS COMBINATIONS AND DISPOSITION - Discontinued operations of H&J (Details) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
BUSINESS COMBINATIONS AND DISPOSITION
Net revenues	$ 4,493,424		$ 2,649,432		$ 8,869,803	$ 5,278,562	$ 10,333,558	$ 5,764,963
Cost of net revenues	2,157,349		1,536,703		4,540,488	3,552,396	6,789,314	3,828,496
Gross profit (loss)	2,336,075		1,112,729		4,329,315	1,726,166	3,544,244	1,936,467
Operating expenses:
General and administrative	4,074,051		4,243,031		8,380,063	8,073,621	14,067,681	16,149,510
Sales and marketing	1,097,326		1,372,568		2,036,677	2,230,087	4,018,985	3,269,710
Impairment							5,503,095	3,400,000
Total operating expenses	(5,284,884)		11,758,443		230,664	17,849,721	24,765,633	32,073,050
Income (loss) from operations	7,620,959		(10,645,714)		4,098,651	(16,123,555)	(21,221,389)	(30,136,583)
Other income (expense):
Interest expense	(1,086,889)		(2,173,769)		(2,951,487)	(3,730,612)	(8,961,410)	(3,619,093)
Other non-operating income (expenses)	2,240		3,336,963		(676,749)	2,653,375	3,068,080	1,321,472
Total other income (expense), net	(1,084,649)		1,163,194		(3,628,236)	(1,077,237)	(5,893,330)	(2,297,621)
Income tax benefit (provision)								1,100,120
Net income (loss)	$ 5,044,260	$ (6,136,349)	$ (9,533,924)	$ (7,832,942)	$ (1,092,088)	$ (17,366,866)	$ (38,043,362)	$ (32,357,957)
Weighted average common shares outstanding - basic	246,809		14,329		236,824	9,836	30,852	3,052
Weighted average common shares outstanding - diluted	834,604		14,329		824,619	9,836	30,852	3,052
Net loss per common share - basic	$ 26.48		$ (661.78)		$ 1.99	$ (1,748.68)	$ (878.87)	$ (10,268.22)
Net loss per common share - diluted	$ 7.83		$ (661.78)		$ 0.57	$ (1,748.68)	$ (878.87)	$ (10,268.22)
Harper & Jones \| Discontinued Operations [Member]
BUSINESS COMBINATIONS AND DISPOSITION
Net revenues							$ 3,637,620	$ 1,819,896
Cost of net revenues							1,241,594	1,888,091
Gross profit (loss)							2,396,026	(68,195)
Operating expenses:
General and administrative							2,303,854	603,007
Sales and marketing							931,650	540,873
Impairment							10,036,238
Total operating expenses							13,271,742	1,143,880
Income (loss) from operations							(10,875,716)	(1,212,075)
Other income (expense):
Interest expense							(52,927)	(44,828)
Other non-operating income (expenses)								233,030
Total other income (expense), net							(52,927)	188,202
Net income (loss)							$ (10,928,643)	$ (1,023,873)
Weighted average common shares outstanding - basic							30,852	3,052
Weighted average common shares outstanding - diluted							30,852	3,052
Net loss per common share - basic							$ (354.23)	$ (335.52)
Net loss per common share - diluted							$ (354.23)	$ (335.52)

DUE FROM FACTOR (Details)_2

DUE FROM FACTOR (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Outstanding receivables:
Without recourse, Current	$ 787,542	$ 1,680,042	$ 579,295
With recourse, Current	50,979	65,411	361,584
Advances		118,521	121,617
Credits due customers, Current	(10,142)	(354,282)	(77,208)
Due from factor	$ 438,142	$ 839,400	$ 985,288

DUE FROM FACTOR - Additional in

DUE FROM FACTOR - Additional information (Details).	12 Months Ended
DUE FROM FACTOR - Additional information (Details).	Dec. 31, 2022 USD ($)
Debt Instrument
Maximum advances on net sales can be requested, percentage	50%
LIBOR
Debt Instrument
Debt instrument variable rate	2.50%
Prime Rate
Debt Instrument
Increase (Decrease) in interest rate	0.03%
Stateside
Debt Instrument
Maximum commission and fees payable	$ 30,000
Promissory note, annual interest rate (as a percent)	4%
Stateside \| Prime Rate
Debt Instrument
Debt instrument variable rate	2%
Maximum commission and fees payable	$ 30,000
Bailey \| Prime Rate
Debt Instrument
Promissory note, annual interest rate (as a percent)	4.25%

GOODWILL AND INTANGIBLE ASSET_6

GOODWILL AND INTANGIBLE ASSETS - Summary of goodwill by entity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Business Combination Segment Allocation
Balance	$ 8,583,274	$ 6,479,218
Business combinations	3,711,322	2,104,056
Impairment	(3,321,095)
Balance	10,103,812	8,583,274
Bailey LLC
Business Combination Segment Allocation
Balance	6,479,218	6,479,218
Impairment	(3,321,095)
Balance	3,158,123	6,479,218
Stateside
Business Combination Segment Allocation
Balance	2,104,056
Business combinations		2,104,056
Balance	2,104,056	$ 2,104,056
Sundry
Business Combination Segment Allocation
Business combinations	3,711,322
Balance	$ 3,711,322

GOODWILL AND INTANGIBLE ASSET_7

GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Aug. 30, 2021	May 18, 2021	Dec. 31, 2020
Indefinite-lived Intangible Assets
Business combinations					$ 3,711,322	$ 2,104,056
Gross Amount	$ 9,734,560		$ 9,734,560		9,734,560	4,736,080
Accumulated Amortization	(4,155,129)		(4,155,129)		(2,670,202)	(1,091,509)
Carrying Value	5,579,431		5,579,431		7,064,358	3,644,571
Indefinite-lived	15,576,440		15,576,440		15,576,440	10,354,640
Total-Gross					12,906,238
Intangible assets, net	11,421,311		11,421,311		12,906,238	9,263,131
Amortization expense	804,924	$ 537,812	1,759,277	$ 1,075,625	1,653,819	1,128,524
Goodwill	8,973,501		8,973,501		10,103,812	8,583,274			$ 6,479,218
Stateside
Indefinite-lived Intangible Assets
Business combinations						2,104,056
Goodwill	2,104,056		2,104,056		2,104,056	2,104,056	$ 2,104,056
Bailey LLC
Indefinite-lived Intangible Assets
Goodwill	3,158,123		3,158,123		3,158,123	6,479,218			$ 6,479,218
Harper & Jones
Indefinite-lived Intangible Assets
Goodwill								$ 9,681,548
Customer relationships
Indefinite-lived Intangible Assets
Gross Amount	9,734,560		9,734,560		9,734,560	4,736,080
Accumulated Amortization	(4,155,129)		(4,155,129)		(2,670,202)	(1,091,509)
Carrying Value	5,579,431		5,579,431		7,064,358	3,644,571
Brand name
Indefinite-lived Intangible Assets
Indefinite-lived	$ 5,841,880		$ 5,841,880			5,618,560
Total-Gross					5,841,880
Intangible assets, net					$ 5,841,880	$ 5,618,560

GOODWILL AND INTANGIBLE ASSET_8

GOODWILL AND INTANGIBLE ASSETS - Future amortization expense (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
GOODWILL AND INTANGIBLE ASSETS
2023		$ 2,924,020
2024		2,474,178
2025		1,666,160
Carrying Value	$ 5,579,431	$ 7,064,358	$ 3,644,571

LIABILITIES AND DEBT - Accrue_2

LIABILITIES AND DEBT - Accrued Expenses and Other Liabilities (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
LIABILITIES AND DEBT
Accrued expenses	$ 503,927	$ 668,714	$ 178,819
Reserve for returns		307,725	33,933
Payroll related liabilities	4,009,812	2,618,870	1,183,598
Sales tax liability	277,800	262,765	225,804
Due to seller			396,320
Other liabilities	247,398	78,845	59,613
Accrued expenses and other liabilities, Total	5,038,937	3,936,920	$ 2,078,087
Estimated penalties associated with accrued payroll taxes	1,288,048	1,074,316
Accrued expenses included in accrued common stock	$ 535,000	$ 535,000
Number of common shares owed per the agreement	5,000	200
DBG
LIABILITIES AND DEBT
Sales tax liability	$ 620,400	$ 539,839
Bailey
LIABILITIES AND DEBT
Sales tax liability	$ 667,648	$ 534,477

LIABILITIES AND DEBT - Venture

LIABILITIES AND DEBT - Venture Debt (Details) - USD ($)				1 Months Ended				12 Months Ended
LIABILITIES AND DEBT - Venture Debt (Details) - USD ($)	Sep. 29, 2022	Nov. 16, 2021	May 13, 2021	Feb. 28, 2022	Jul. 31, 2021	May 31, 2021	Mar. 31, 2017	Dec. 31, 2022	Dec. 31, 2021
Line of Credit Facility
Gross proceeds received								$ 237,500
Warrants granted					142	13
Warrants value					$ 1,622,350	$ 145,696
Interest expense		$ 427,700						573,455	$ 825,219
Note Warrant
Line of Credit Facility
Loan fees and discounts from warrants were amortized to interest expense								12,500	147,389
Loan fees and discounts from warrants unamortized balance								$ 0
IPO \| Common stock warrants
Line of Credit Facility
Warrants granted			48					964
Venture Debt \| Series A Convertible Preferred Stock \| Black Oak SPA
Line of Credit Facility
Compounded monthly fees	$ 6,300
Venture Debt \| Secured Debt
Line of Credit Facility
Loan fees				$ 12,500
Maximum borrowing capacity				$ 237,500					$ 6,001,755
Venture Debt \| Secured Debt \| Follow-On Public Offering \| Series A Convertible Preferred Stock
Line of Credit Facility
Line of credit facility, frequency of payments	$1,000
Amended Venture Debt \| Secured Debt \| Secondary Follow-On Public Offering Prior To September 30 2021
Line of Credit Facility
Loan payment							$ 6,251,755
Accrued interest	$ 48,245
Amended Venture Debt \| Secured Debt \| Secondary Follow-On Public Offering After September 30 2021
Line of Credit Facility
Loan payment								$ 269,880

LIABILITIES AND DEBT - Conver_3

LIABILITIES AND DEBT - Convertible Debt (Details) - USD ($)		6 Months Ended		12 Months Ended
LIABILITIES AND DEBT - Convertible Debt (Details) - USD ($)	Apr. 01, 2021	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
LIABILITIES AND DEBT
Amortization of debt issuance costs				$ 6,500,000
Issuance of convertible notes payable				3,280,360	$ 2,779,910
Derivative liability in connection with convertible note				559,957	3,204,924
Proceeds from Issuance of Debt				237,500
Convertible Debt
LIABILITIES AND DEBT
Amortization of debt discount		$ 689,100	$ 1,724,291	6,506,384	801,538
Principal				4,100,000	9,565,000	$ 100,000
Unamortized debt discount				1,378,200	3,963,386
Debt Conversion, Converted Instrument, Shares Issued			350
Convertible Debt 2020 Regulation CF Offering
LIABILITIES AND DEBT
Outstanding principal and accrued interest upon closing of IPO					$ 16,942
Conversion of shares					12,786
Convertible Debt 2020 Regulation CF Offering \| Convertible Debt
LIABILITIES AND DEBT
Issuance costs					$ 69,627
Amortization of debt issuance costs					27,894
Proceeds from Issuance of Debt					$ 473,650	450,308
Debt Instrument, Interest Rate, Stated Percentage					6%
Convertible Debt 2020 Regulation D Offering
LIABILITIES AND DEBT
Outstanding principal and accrued interest upon closing of IPO		$ 100,000		100,000	$ 100,000
Amortization of debt issuance costs					100,000
Default interest expense					132,609
Proceeds from Issuance of Debt					755,000
Convertible Debt 2020 Regulation D Offering \| IPO
LIABILITIES AND DEBT
Outstanding principal and accrued interest upon closing of IPO					$ 185,000
Convertible Debt 2020 Regulation D Offering \| Convertible Debt
LIABILITIES AND DEBT
Debt instrument term					9 months
Proceeds from Issuance of Debt					$ 55,000	$ 800,000
Debt Instrument, Interest Rate, Stated Percentage					14%
Convertible Debt 2020 Regulation D Offering \| Debt Converted Into Common Stock \| Convertible Debt
LIABILITIES AND DEBT
Debt Conversion, Converted Instrument, Shares Issued	181
Convertible Debt 2019 Regulation D Offering \| Convertible Debt
LIABILITIES AND DEBT
Debt instrument term							36 months
Proceeds from Issuance of Debt							$ 799,280
Debt Instrument, Interest Rate, Stated Percentage							12%
Convertible Debt 2019 Regulation D Offering \| Debt Converted Into Common Stock \| Convertible Debt
LIABILITIES AND DEBT
Debt Conversion, Converted Instrument, Shares Issued	145
December Notes
LIABILITIES AND DEBT
Principal				4,000,000
Unamortized debt discount				1,278,200
Other financing fees				$ 50,000

LIABILITIES AND DEBT - Conver_4

LIABILITIES AND DEBT - Convertible Promissory Note (Details)					1 Months Ended					6 Months Ended		12 Months Ended
	Dec. 29, 2022 USD ($)	Apr. 08, 2022 USD ($) $ / shares shares	Nov. 16, 2021 USD ($) item D $ / shares	Oct. 01, 2021 USD ($) item D $ / shares	Feb. 28, 2023 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares	Sep. 30, 2022 shares	May 31, 2022 USD ($)	Nov. 30, 2021 shares	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) shares	Dec. 31, 2022 USD ($) D $ / shares shares	Dec. 31, 2021 USD ($)	Aug. 27, 2021 USD ($)	Dec. 31, 2020 USD ($)
Debt Instrument
Repayments of debt										$ 6,604,552	$ 3,068,750	$ 7,350,276	$ 2,006,628
Exercise price of warrants \| $ / shares										$ 95
Outstanding principal amount converted										$ 888,930
Amortization of debt issuance costs												6,500,000
Number of shares issued \| shares							30			50,890
Issuance of convertible notes payable												3,280,360	2,779,910
Derivative liability in connection with convertible note												559,957	3,204,924
Convertible Debt
Debt Instrument
Principal						$ 4,100,000						4,100,000	9,565,000		$ 100,000
Unamortized debt discount						(1,378,200)						(1,378,200)	(3,963,386)
Convertible Note Payable, Net						2,721,800						2,721,800	5,601,614		$ 100,000
Amortization of debt discount										$ 689,100	$ 1,724,291	6,506,384	801,538
Shares issued to notes payable holders \| shares											350
Outstanding principal amount converted											$ 888,930
Oasis Note
Debt Instrument
Principal														$ 5,000,000
Amortization of debt discount												6,506,384	801,538
Aggregate principal amount						5,265,000						5,265,000		$ 5,265,000
Derivative liability at fair value						3,204,924						$ 3,204,924
Term of debt												18 months
Threshold percentage of stock price												90%
Number of lowest vwaps \| D												2
Number of consecutive trading days \| D												5
Period not to submit notice												30 days
Minimum conversion amount						$ 500,000						$ 500,000
Minimum conversion price \| $ / shares						$ 7,500						$ 7,500
Number of shares issued \| shares									40
Debt Instrument, Convertible, Conversion Price \| $ / shares						$ 90.601						$ 90.601
Debt Instrument, Interest Rate, Stated Percentage						6%						6%		6%
Oasis Note \| Convertible Debt
Debt Instrument
Principal													5,265,000
Unamortized debt discount													(715,000)
Issuance of convertible notes payable													4,550,000
First Fire First Note
Debt Instrument
Principal				$ 1,500,000
Aggregate principal amount				$ 1,575,000
Term of debt				18 months
Threshold percentage of stock price				90%
Number of lowest vwaps \| item				2
Number of consecutive trading days \| D				5
Debt Instrument, Convertible, Conversion Price \| $ / shares				$ 9,880
Debt Instrument, Interest Rate, Stated Percentage				6%
First Fire First Note \| Convertible Debt
Debt Instrument
Principal													1,575,000
Unamortized debt discount													(315,000)
Issuance of convertible notes payable													1,260,000
Second First Fire Note
Debt Instrument
Principal			$ 2,500,000
Aggregate principal amount			$ 2,625,000
Threshold percentage of stock price			90%
Number of lowest vwaps \| item			2
Number of consecutive trading days \| D			5
Debt Instrument, Convertible, Conversion Price \| $ / shares			$ 10,700
Debt Instrument, Interest Rate, Stated Percentage			6%
Second First Fire Note \| Convertible Debt
Debt Instrument
Principal													2,625,000
Unamortized debt discount													(530,000)
Issuance of convertible notes payable													2,095,000
Oasis and FirstFire Notes
Debt Instrument
Principal													9,465,000
Interest Expense, Debt												$ 484,904
Accrued interest amount converted												$ 533,242
Shares issued to notes payable holders \| shares												79,807
Outstanding principal amount converted												$ 9,465,000
Debt discount which will be amortized over the life of the note												1,560,000
Derivative liability \| Convertible Debt
Debt Instrument
Unamortized debt discount						$ (559,957)						(559,957)	(3,204,924)
Derivative liability in connection with convertible note												(559,957)	(3,204,924)
Proceeds from issuance of notes \| Convertible Debt
Debt Instrument
Principal						8,943,750						8,943,750
Unamortized debt discount						(1,992,500)						(1,992,500)
Issuance of convertible notes payable												6,951,250
Repayments of notes
Debt Instrument
Repayments of notes										(4,000,000)
Repayments of notes \| Convertible Debt
Debt Instrument
Repayments of notes												(4,943,750)
Conversion of notes into common stock \| Convertible Debt
Debt Instrument
Conversion of notes into common stock												(9,465,000)
Warrant and common shares issued with convertible notes \| Convertible Debt
Debt Instrument
Unamortized debt discount						(1,368,741)						(1,368,741)
Warrant and common shares issued with convertible notes												(1,368,741)
Paycheck Protection Program, Cares Act [Member]
Debt Instrument
Aggregate principal amount													$ 203,994
April Notes \| Securities purchase agreement
Debt Instrument
Unamortized debt discount		$ (755,000)
Aggregate principal amount		3,068,750
Original issue discount		613,750
Net proceeds		$ 2,313,750
Repayments of debt								$ 3,068,750
Number of warrants issued to purchase common stock \| shares		503
Exercise price of warrants \| $ / shares		$ 3,050
Debt discount for the fair value of the warrants		$ 98,241
July Notes \| Securities purchase agreement
Debt Instrument
Aggregate principal amount						1,875,000						1,875,000
Original issue discount						375,000						375,000
Net proceeds												$ 1,450,000
Repayments of debt						$ 1,875,000
Percentage of annual interest rate for notes, if notes are not repaid in full by the maturity date or if any other event of default occurs						20%						20%
Derivative liability at fair value						$ 559,957						$ 559,957
July 22 Notes \| Securities purchase agreement
Debt Instrument
Number of warrants issued to purchase common stock \| shares						1,645						1,645
Exercise price of warrants \| $ / shares						$ 380						$ 380
July 28 Notes \| Securities purchase agreement
Debt Instrument
Number of warrants issued to purchase common stock \| shares						1,106						1,106
Exercise price of warrants \| $ / shares						$ 282.50						$ 282.50
Debt discount for the fair value of the warrants						$ 692,299						$ 692,299
December Notes
Debt Instrument
Principal						4,000,000						4,000,000
Unamortized debt discount						$ (1,278,200)						$ (1,278,200)
Number of shares issued \| shares												2,400
December Notes \| Securities purchase agreement
Debt Instrument
Unamortized debt discount										$ (1,378,200)
Amortization of debt discount					$ 689,100
Aggregate principal amount	$ 4,000,000
Original issue discount	800,000
Net proceeds	$ 3,000,000
Repayments of debt					$ 4,000,000
Number of warrants issued to purchase common stock \| shares						18,779				18,779		18,779
Exercise price of warrants \| $ / shares						$ 106.50				$ 106.50		$ 106.50
Debt discount for the fair value of the warrants						$ 428,200				$ 428,200		$ 428,200
Increased percentage of face value of the notes, if notes are not repaid in full by the maturity date or if any other event of default occurs						120%						120%
Percentage of annual interest rate for notes, if notes are not repaid in full by the maturity date or if any other event of default occurs						20%						20%
Repayments of additional amount of debt						$ 416,923
Number of shares issued \| shares										2,400		2,400
July 22 notes \| Securities purchase agreement
Debt Instrument
Exercise price of warrants \| $ / shares						$ 380						$ 380
July 28 notes
Debt Instrument
Warrants issued to purchase common stock \| shares						1,106						1,106
July 28 notes \| Securities purchase agreement
Debt Instrument
Exercise price of warrants \| $ / shares						$ 282.50						$ 282.50

LIABILITIES AND DEBT - Loan P_2

LIABILITIES AND DEBT - Loan Payable - PPP and SBA Loan (Details) - USD ($)	1 Months Ended	6 Months Ended	12 Months Ended
	Apr. 30, 2022	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021	Feb. 15, 2023	May 31, 2021	Feb. 28, 2021	Jun. 25, 2020
LIABILITIES AND DEBT
Loans payable, net of current portion		$ 443,635	$ 150,000	$ 342,050
Bailey LLC
LIABILITIES AND DEBT
Aggregate principal amount					$ 5,500,000
Promissory note, annual interest rate (as a percent)					8%
Interest rate					8%
H&J
LIABILITIES AND DEBT
Note payable - related party			$ 129,489	299,489
Aggregate principal amount				153,860		$ 75,000
Promissory note, annual interest rate (as a percent)			9.90%			7.76%
Aggregate of principal amount			$ 73,187	72,269
Proceeds from loan originations			$ 140,000
Interest rates of notes			12%
Interest rate			9.90%			7.76%
Loans payable, net of current portion				149,962
PPP Loan
LIABILITIES AND DEBT
Aggregate principal amount				203,994
PPP Loan \| Bailey LLC
LIABILITIES AND DEBT
Aggregate principal amount				204,000			$ 407,994
Convertible Note Payable, Net		933,295	$ 933,295
Economic Injury Disaster Loan
LIABILITIES AND DEBT
Promissory note, annual interest rate (as a percent)								3.75%
Convertible Note Payable, Net			147,438
Interest rate								3.75%
Economic Injury Disaster Loan \| H&J
LIABILITIES AND DEBT
Convertible Note Payable, Net			150,000
1st PPP loan \| Bailey LLC
LIABILITIES AND DEBT
Loan forgiveness amount	$ 413,705
2nd PPP loan \| Bailey LLC
LIABILITIES AND DEBT
Loan forgiveness amount	$ 1,347,050
Merchant Advances
LIABILITIES AND DEBT
Net proceeds		1,692,748	1,335,360
Repayments of debt		$ 2,331,972	1,078,385
Outstanding amount			$ 896,334
Merchant Advances \| H&J
LIABILITIES AND DEBT
Promissory note, annual interest rate (as a percent)			9.90%
Proceeds from debt			$ 147,267	140,000
Interest rate			9.90%
Loans payable, net of current portion			$ 63,433	$ 149,962

LIABILITIES AND DEBT - Promis_2

LIABILITIES AND DEBT - Promissory Note Payable (Details)	1 Months Ended		12 Months Ended
LIABILITIES AND DEBT - Promissory Note Payable (Details)	May 31, 2021 USD ($)	Apr. 30, 2021 USD ($) shares	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jun. 30, 2023 USD ($)	Feb. 15, 2023 USD ($)	Feb. 28, 2021 USD ($)
Debt Instrument
Gross proceeds received			$ 237,500
Outstanding balance			1,829,629	$ 2,279,768	$ 1,190,405
Debt Discount Cost			263,958
Bailey LLC
Debt Instrument
Aggregate principal amount						$ 5,500,000
Promissory note, annual interest rate (as a percent)						8%
Promissory note payable
Debt Instrument
Aggregate principal amount		$ 1,000,000	3,500,000
Gross proceeds received		$ 810,000
Warrants issued \| shares		48
Debt discount			$ 73,958
Promissory note payable \| Secondary Public Offering
Debt Instrument
Percentage of outstanding principal			10
Promissory note payable \| Secondary Public Offering \| Maximum
Debt Instrument
Aggregate principal amount			$ 4,000,000
Promissory note payable \| Secondary Public Offering \| Minimum
Debt Instrument
Aggregate principal amount			2,000,000
Promissory note payable \| Bailey LLC
Debt Instrument
Aggregate principal amount			4,500,000
Repayment of outstanding principal amount	$ 1,000,000
Promissory note payable \| Notes Payable to Banks
Debt Instrument
Interest expense			$ 420,000	494,000
Promissory note, annual interest rate (as a percent)			12%
PPP Loan
Debt Instrument
Aggregate principal amount				203,994
PPP Loan \| Bailey LLC
Debt Instrument
Aggregate principal amount				$ 204,000			$ 407,994

STOCKHOLDERS' DEFICIT (Detail_2

STOCKHOLDERS' DEFICIT (Details)													1 Months Ended					3 Months Ended			6 Months Ended		12 Months Ended
STOCKHOLDERS' DEFICIT (Details)	Aug. 21, 2023	May 30, 2023 USD ($)	Jan. 11, 2023 $ / shares shares	Nov. 29, 2022 USD ($) $ / shares shares	Oct. 21, 2022	Oct. 13, 2022 USD ($) shares	Nov. 16, 2021 USD ($)	Aug. 30, 2021 USD ($) shares	Jun. 28, 2021 USD ($) $ / shares shares	May 18, 2021 USD ($) $ / shares shares	May 13, 2021 USD ($) $ / shares shares	May 12, 2021	Sep. 30, 2022 USD ($) shares	Dec. 31, 2021 USD ($) $ / shares shares	Nov. 30, 2021 shares	Jul. 31, 2021 USD ($) shares	May 31, 2021 USD ($) shares	Jun. 30, 2023 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Oct. 12, 2022 shares	Sep. 29, 2022 USD ($) $ / shares shares	Aug. 31, 2022 USD ($) shares
Class of Stock
Common stock, Shares authorized (in shares)						1,000,000,000								1,000,000,000				1,000,000,000			1,000,000,000		1,000,000,000	1,000,000,000	200,000,000
Aggregate number of authorized shares (in shares)						1,010,000,000
Reverse stock split conversion ratio					0.01					1		0.064
Percentage of affirmative votes required to remove directors from the Board										66.3333%
Reverse stock split approved										1-for-15.625
voting rights																							one vote per share
Common stock issued pursuant to consulting agreement \| $													$ 123,000										$ 123,000	$ 595,500
Number of shares issued													30								50,890
Issue price (in dollars per share) \| $ / shares																			$ 4.20
Proceeds from issuance of common stock \| $																							8,100,000
Net proceeds of after deducting underwriting discounts and commissions \| $																							700,000
Direct offering expenses \| $																							500,000
Value of shares issued \| $		$ 25,000																	$ 5,000,003
Converted outstanding principal \| $																					$ 888,930
Stock-based compensation expense \| $																		$ 101,500		$ 119,759	$ 207,094	$ 258,852
Contingent consideration liability \| $														$ 12,179,476									12,098,475	12,179,476
Exercise of warrants \| $																								1,768,046
Deferred offering costs \| $														$ 367,696									104,512	367,696
Interest expense \| $							$ 427,700																$ 573,455	$ 825,219
Exercise price of warrants \| $ / shares																		$ 95			$ 95
Common stock par value (in dollars per share) \| $ / shares														$ 0.0001				0.0001			$ 0.0001		$ 0.0001	$ 0.0001
Pre-funded warrants
Class of Stock
Shares issued to notes payable holders			32,086
Number of shares issued																					32,086
Warrants issued			32,086
Number of shares resulting from conversion			32,086
General and administrative expenses
Class of Stock
Value of shares issued \| $														$ 339,000
Stock-based compensation expense \| $																							$ 421,442	$ 3,325,897
Stateside
Class of Stock
Fair value of shares issued \| $								$ 3,403,196
Number of shares of common stock issued								44,062
Sundry
Class of Stock
Fair value of shares issued \| $																							$ 1,000,000
Number of shares of common stock issued																							3,636
Common Stock
Class of Stock
Common stock, Shares authorized (in shares)										200,000,000													1,000,000,000
Shares issued to notes payable holders																					350
Number of shares issued																			50,890
Value of shares issued \| $																			$ 5
Warrants were exercised																142	13
Exercise of warrants \| $																$ 1,622,350	$ 145,696
Number of shares resulting from conversion																					350
Common stock par value (in dollars per share) \| $ / shares																							$ 0.0001
Common Stock \| Stateside
Class of Stock
Stock to the respective sellers										441
Common Stock \| H&J and Stateside acquisitions
Class of Stock
Stock to the respective sellers										877
Preferred Stock
Class of Stock
Preferred stock, shares authorized (in shares)										10,000,000
Subsequent events
Class of Stock
Reverse stock split conversion ratio	0.04
Subsequent events \| Pre-funded warrants
Class of Stock
Shares issued to notes payable holders			32,086
Warrants issued			32,086
Number of shares resulting from conversion			32,086
Common stock par value (in dollars per share) \| $ / shares			$ 0.0001
Equity purchase agreement
Class of Stock
Number of shares issued																							51
Deferred offering costs \| $														367,696										367,696
Securities purchase agreement
Class of Stock
Gross proceeds \| $				$ 10,000,000
Securities purchase agreement \| Pre-funded warrants
Class of Stock
Warrants issued				66,007
Securities purchase agreement \| Statement scenario one
Class of Stock
Share issued price \| $ / shares				$ 137.50
Securities purchase agreement \| Statement scenario one \| Class B Warrants
Class of Stock
Warrants issued				6,720
Securities purchase agreement \| Statement scenario one \| Class C Warrants
Class of Stock
Warrants issued				6,720
Securities purchase agreement \| Statement scenario Two
Class of Stock
Warrants issued				66,007
Share issued price \| $ / shares				$ 137.50
Exercise price of warrants \| $ / shares				$ 0.0001
Aggregate gross proceeds from Offering \| $				$ 10,000,000
Securities purchase agreement \| Statement scenario Two \| Class B Warrants
Class of Stock
Warrants issued				66,007
Securities purchase agreement \| Statement scenario Two \| Class C Warrants
Class of Stock
Warrants issued				66,007
Securities purchase agreement \| Statement scenario Two \| Pre-funded warrants
Class of Stock
Warrants exercisable				66,007
Securities purchase agreement \| Common Stock
Class of Stock
Aggregate number of authorized shares (in shares)				6,720
Number of shares issued				72,727
Proceeds from issuance of common stock \| $				$ 9,000,000
Warrants issued				6,720
FirstFire
Class of Stock
Number of shares issued															12
Oasis Capital
Class of Stock
Number of shares issued															40
Debt conversion price (in dollars per share) \| $ / shares																							$ 90.601
Oasis and FirstFire Notes
Class of Stock
Shares issued to notes payable holders																							79,807
Converted outstanding principal \| $																							$ 9,465,000
Number of shares resulting from conversion																							79,807
Oasis and FirstFire Notes \| Equity purchase agreement
Class of Stock
Shares issued to notes payable holders																							79,807
Number of shares resulting from conversion																							79,807
December Notes
Class of Stock
Number of shares issued																							2,400
Fair value of shares issued \| $																							$ 264,000
December Notes \| Securities purchase agreement
Class of Stock
Number of shares issued																					2,400		2,400
Exercise price of warrants \| $ / shares																		$ 106.50			$ 106.50		$ 106.50
Series A preferred stock
Class of Stock
Stated Value \| $
Preferred stock, shares outstanding														0				0			0		0	0
Redemption of shares \| $						$ 25,000
Preferred stock, shares authorized (in shares)														1				1			1		1	1
Preferred stock \| $
Series A preferred stock \| Chief Executive Officer
Class of Stock
Stated Value \| $																											$ 25,000
Preferred stock, shares outstanding																											250,000,000
Preferred stock \| $																											$ 25,000
Series A Convertible Preferred Stock
Class of Stock
Stated Value \| $																		$ 1			$ 1		$ 1			$ 1,000
Conversion price (in dollars per share) \| $ / shares																										$ 232.50
Preferred stock, shares outstanding														0				6,300			6,300		6,300	0
Preferred stock, shares authorized (in shares)														0				6,800			6,800		6,800	0		6,800
Preferred stock \| $																		$ 1			$ 1		$ 1			$ 1,000
IPO
Class of Stock
Number of shares issued											964												14,956
Number of shares agreed to issued and sell																							14,956
Issue price (in dollars per share) \| $ / shares																							$ 575
Number of option days granted to purchase an additional shares																							45 days
Gross proceeds from the offering \| $																							$ 9,300,000
Proceeds from issuance of common stock \| $											$ 8,600,000
Maximum number of additional shares allowed to purchase within 45 option days																							2,243
Warrants issued											1,111
Aggregate net proceeds \| $										$ 8,600,000
Underwriting commissions \| $										800,000
Direct offering expenses \| $										600,000
Converted outstanding principal \| $										$ 2,680,289
Underwriting discounts and commissions \| $											$ 800,000
Share issued price \| $ / shares											$ 10,375												$ 625
IPO \| Common Stock
Class of Stock
Shares issued to notes payable holders										454
Number of shares issued										964
Issue price (in dollars per share) \| $ / shares										$ 10,375
Number of shares resulting from conversion										454
IPO \| Management
Class of Stock
Shares issued to notes payable holders										61
Converted outstanding principal \| $										$ 257,515
Stock-based compensation expense \| $										$ 233,184
Number of shares resulting from conversion										61
IPO \| Series A preferred stock \| Preferred Stock
Class of Stock
Preferred Stock converted										1,611
Over-allotment option
Class of Stock
Warrants issued											145
Over-allotment option \| Common Stock
Class of Stock
Number of shares issued									145
Issue price (in dollars per share) \| $ / shares									$ 10,375
Aggregate net proceeds \| $									$ 1,400,000
Underwriting discounts and commissions \| $									$ 100,000
Consulting agreement
Class of Stock
Number of shares issued																							20
Value of shares issued \| $														$ 60
Guaranteed equity value of shares issued \| $																							$ 250,000
Contingent consideration liability \| $																							$ 67,000
Issued upon settlement of contingent liability																								17

RELATED PARTY TRANSACTIONS - Du

RELATED PARTY TRANSACTIONS - Due to related parties (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Oct. 31, 2022	Dec. 31, 2021
Due to related parties
Conversion of stock, shares converted	1,003
Advances
Due to related parties
Advance due to related parties	$ 104,568		$ 104,568
Advances \| Director
Due to related parties
Advance due to related parties		$ 325,000
Accrued Salary
Due to related parties
Advance due to related parties	100,649		100,649
Expense Reimbursements
Due to related parties
Advance due to related parties	$ 126,706		$ 126,706

RELATED PARTY TRANSACTIONS - No

RELATED PARTY TRANSACTIONS - Note Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Jun. 30, 2023	Dec. 10, 2022	Dec. 31, 2021
RELATED PARTY TRANSACTIONS
Common stock, share issued (in shares)	178,758	316,906		5,201
Chief Executive Officer
RELATED PARTY TRANSACTIONS
Common stock, share issued (in shares)	5,091
Additional stock compensation expense	$ 233,184
Interest rate			12%
Notes Payable, Other Payables
RELATED PARTY TRANSACTIONS
Interest rate		0%
Notes Payable, Other Payables \| Chief Executive Officer \| Note Payable, Chief Executive Officer
RELATED PARTY TRANSACTIONS
Increase (decrease) in notes receivables	115,000
Aggregate principal amount	$ 129,489			$ 299,489

SHARE-BASED PAYMENTS - Common_2

SHARE-BASED PAYMENTS - Common Stock Warrants - General Information (Details) - USD ($)

1 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

May 10, 2022

May 13, 2021

Jul. 31, 2021

May 31, 2021

Apr. 30, 2021

Jun. 30, 2023

Sep. 30, 2021

Dec. 31, 2022

Dec. 31, 2021

Jan. 11, 2023

Nov. 29, 2022

Dec. 31, 2020

SHARE-BASED PAYMENTS

Exercise price per share

$ 95

Aggregate shares of stock options granted

51,086

1,093

Option outstanding exercise price (in dollars per share)

$ 362.11

$ 9,053

$ 5,850

Option outstanding exercise price

$ 362.11

$ 9,053

$ 5,850

Weighted average duration (Years)

5 years

7 years

Class of warrant or right, warrants issued

142

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

51,086

1,093

Warrants value

$ 1,622,350

$ 145,696

IPO

SHARE-BASED PAYMENTS

Warrants issued

1,111

Over-Allotment Option [Member]

SHARE-BASED PAYMENTS

Warrants issued

145

July 22 notes | Securities purchase agreement

SHARE-BASED PAYMENTS

Exercise price per share

$ 380

July 28 notes

SHARE-BASED PAYMENTS

Warrants issued

1,106

July 28 notes | Securities purchase agreement

SHARE-BASED PAYMENTS

Exercise price per share

$ 282.50

Underwriters Warrants

SHARE-BASED PAYMENTS

Warrants issued

598

Exercise price per share

$ 812.50

Percentage of initial exercise price representing the public offering price

130%

Pre-funded warrants

SHARE-BASED PAYMENTS

Warrants issued

32,086

Aggregate shares of stock options granted

32,086

66,007

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

32,086

66,007

Pre-funded warrants | Securities purchase agreement

SHARE-BASED PAYMENTS

Warrants issued

66,007

Class B Warrants

SHARE-BASED PAYMENTS

Aggregate shares of stock options granted

72,727

Option outstanding exercise price (in dollars per share)

$ 131.25

Option outstanding exercise price

$ 131.25

Weighted average duration (Years)

5 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

72,727

Class C Warrants

SHARE-BASED PAYMENTS

Aggregate shares of stock options granted

72,727

Option outstanding exercise price (in dollars per share)

$ 131.25

Option outstanding exercise price

$ 131.25

Weighted average duration (Years)

13 months

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

72,727

Placement Agent Warrant

SHARE-BASED PAYMENTS

Exercise price per share

$ 3,050.35

$ 172

Aggregate shares of stock options granted

3,831

5,455

Weighted average duration (Years)

5 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

3,831

5,455

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable Contractual Term

180 days

Aggregate Warrant

SHARE-BASED PAYMENTS

Warrants issued

6,095

18,779

Exercise price of additional units

$ 131.25

$ 106.50

Warrant to purchase common stock fair value

$ 164,200

Merchant Cash Advance

SHARE-BASED PAYMENTS

Warrants issued

1,760

Exercise price of additional units

$ 125

Common stock | July 22 notes | Securities purchase agreement

SHARE-BASED PAYMENTS

Warrants issued

1,645

Common stock warrants | IPO

SHARE-BASED PAYMENTS

Exercise price per share

$ 12,975

$ 11,425

Class of warrant or right, warrants issued

964

Percentage of warrants exercise price

110%

Warrants expiration term

5 years

Common stock warrants | Over-Allotment Option [Member]

SHARE-BASED PAYMENTS

Class of warrant or right, warrants issued

145

Common stock warrants | April notes

SHARE-BASED PAYMENTS

Warrants issued

503

Exercise price per share

$ 3,050

Common Stock Warrants, Venture Debt Lender

SHARE-BASED PAYMENTS

Exercise price per share

$ 10,375

Class of warrant or right, warrants issued

SHARE-BASED PAYMENTS - Warran_2

SHARE-BASED PAYMENTS - Warrants Roll Forward (Details)	6 Months Ended	12 Months Ended
SHARE-BASED PAYMENTS - Warrants Roll Forward (Details)	Jun. 30, 2023 $ / shares shares	Dec. 31, 2022 $ / shares shares	Dec. 31, 2021 $ / shares shares
SHARE-BASED PAYMENTS
Debt Instrument, Convertible, Conversion Ratio		39,075
Common stock warrants
SHARE-BASED PAYMENTS
Warrant Outstanding Beginning Balance \| shares	176,733	1,432	366
Granted \| shares	93,099	241,308	1,205
Conversion of stock warrants upon IPO \| shares			21
Exercised \| shares	(32,086)	(66,007)	(155)
Forfeited \| shares			(4)
Warrant Outstanding Ending Balance \| shares	237,746	176,733	1,432
Common Stock Warrants Exercisable \| shares	237,745	171,278	1,432
Weighted Average Exercise Price Outstanding Beginning Balance	$ 209	$ 10,300	$ 6,650
Class Of Warrant Or Right Warrants Outstanding Weighted Average Exercise Price Exercisable	181.25	210.50
Granted	99.50	140.36	$ 11,450
Conversion of stock warrants upon IPO			19,150
Weighted Average Exercise Price Outstanding Ending Balance	181.25	209	$ 10,300
Weighted Average Exercise Price Exercisable	181.25	210.50
Exercised	97.88	131.25	11,425
Forfeited			19,150
Weighted Average Exercise Price Outstanding Beginning Balance	$ 181.25	$ 209	$ 10,300

SHARE-BASED PAYMENTS - Stock _2

SHARE-BASED PAYMENTS - Stock Options - Activity (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
SHARE-BASED PAYMENTS
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance	1,558	1,558	485
Granted	51,086		1,093
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	1,558	1,558	1,558
SHARE-BASED PAYMENTS
Granted			$ 10,375
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance	$ 362.11	$ 362.11	$ 9,053
SHARE-BASED PAYMENTS
Share-based Compensation Arrangement by Share-based Option Exercisable	1,439	1,389	1,266
Share-based Compensation Arrangement by Weighted Average Exercise Price at December 31, 2021		$ 10,125	$ 8,975
Weighted average duration (years) to expiration of outstanding options at December 31, 2021	5 years	7 years

SHARE-BASED PAYMENTS - 2020 & 2

SHARE-BASED PAYMENTS - 2020 & 2013 Incentive Stock Plan (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021	May 13, 2021	Dec. 31, 2020
Stock Options
Aggregate shares of stock options granted	51,086		1,093
IPO
Stock Options
Exercise price		$ 625		$ 10,375
Omnibus Incentive Stock Plan, 2020
Stock Options
Common stock, capital shares reserved for future issuance		33,000
Omnibus Incentive Stock Plan, 2020 \| IPO
Stock Options
Common stock, capital shares reserved for future issuance		31,907
Aggregate shares of stock options granted		1,093
Omnibus Incentive Stock Plan, 2020 \| IPO \| Minimum
Stock Options
Exercise price		$ 9,625
Omnibus Incentive Stock Plan, 2020 \| IPO \| Maximum
Stock Options
Exercise price		$ 10,375
2013 Incentive Stock Plan
Stock Options
Number of shares authorized		479	479
Number of shares available for grant			13		13
Vesting period		4 years

SHARE-BASED PAYMENTS - Assumpti

SHARE-BASED PAYMENTS - Assumptions utilized for option grants (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
SHARE-BASED PAYMENTS
Risk Free Interest Rate, Minimum		0.34%
Risk Free Interest Rate, Maximum		0.85%
Expected Dividend Yield		0%
Expected Volatility		58%
Expected Life (years)	0 years	5 years 2 months 4 days

SHARE-BASED PAYMENTS - Stock-_2

SHARE-BASED PAYMENTS - Stock-based Compensation - Stock options granted (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
SHARE-BASED PAYMENTS
Total grant-date fair value of the options granted					$ 4,696,605
Stock-based compensation expense	$ 101,500	$ 119,759	$ 207,094	$ 258,852
Unrecognized compensation cost related to non-vested stock option	370,907		$ 370,907		$ 577,999
Share-based arrangement, non-vested weighted average period			10 months 24 days		1 year 6 months 21 days
Sales and marketing expense
SHARE-BASED PAYMENTS
Stock-based compensation expense	$ 28,798	$ 28,798			$ 57,596	$ 551,948
General and administrative expenses
SHARE-BASED PAYMENTS
Stock-based compensation expense					$ 421,442	$ 3,325,897

LEASE OBLIGATIONS (Details)_2

LEASE OBLIGATIONS (Details) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
LEASE OBLIGATIONS (Details) - USD ($)	Apr. 30, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Operating lease agreements
Rent expense	$ 17,257	$ 37,580	$ 195,060	$ 210,265	$ 469,482	$ 945,216	$ 816,790
Security deposit	19,500
Right of use asset, net		$ 339,085		$ 339,085		102,349
Accounting Standards Update 2016-02
Operating lease agreements
Right of use asset, net	$ 250,244
Discount rate	6%
Stateside
Operating lease agreements
Maximum Rent base						9,000
Minimum Rent base						$ 3,100

CONTINGENCIES (Details)_2

CONTINGENCIES (Details)

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

May 30, 2023 USD ($)

May 16, 2023

Mar. 21, 2023 USD ($)

Feb. 07, 2023 USD ($)

May 18, 2022 USD ($)

May 18, 2021 USD ($)

Dec. 21, 2020 USD ($)

Sep. 24, 2020 USD ($)

Mar. 31, 2021 USD ($) item

Aug. 31, 2020 USD ($) item

Mar. 31, 2023 USD ($)

Jun. 30, 2023 USD ($)

Dec. 31, 2022 USD ($)

Nov. 09, 2023 USD ($)

Nov. 09, 2022 USD ($)

Litigation Matters

Settlement amount payable to vendor

$ 50,190

Judgement received

$ 496,000

Trading Day Immediately Preceding Period

30 days

Gross Proceeds Common Stock Indemnification Claims

$ 9,100,000

Value of shares issued

$ 25,000

$ 5,000,003

Common Stock

Litigation Matters

Value of shares issued

$ 5

H&J Purchase Agreement

Litigation Matters

Trading Day Immediately Preceding Period

30 days

Gross Proceeds Common Stock Indemnification Claims

$ 9,100,000

Transfer of Membership Interests

229,000

Value of shares issued

$ 1,400,000

H&J Purchase Agreement | Common Stock | Subsequent events

Litigation Matters

Trading Day Immediately Preceding Period

5 days

Lawsuits filed related to prior services rendered

Litigation Matters

Damages sought

$ 100,000

$ 96,900

Number of lawsuit settled | item

lawsuit against Bailey 44 related to a retail store lease

Litigation Matters

Damages sought

$ 1,500,000

Non-payment of trade payables

Litigation Matters

Damages sought

$ 43,501

$ 182,400

Non-payment of trade payables | Subsequent events

Litigation Matters

Damages sought

$ 43,501

$ 182,400

Non-payment of trade payables | Lawsuits filed related to prior services rendered

Litigation Matters

Damages sought

481,000

Additional damages sought

$ 296,000

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	12 Months Ended
INCOME TAXES (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
INCOME TAXES
Income tax benefit (provision)		$ 1,100,120
Deferred tax assets before valuation allowance	$ 16,733,582	13,103,268
Increase in valuation allowance	$ 3,630,314	$ 3,081,497
Tax rate	28%	0%
Non-deductible impairments of goodwill and intangible assets	$ 17,700,000
Amortization of non-cash debt issuance costs	6,500,000
Operating loss carry forward indefinitely	$ 59,865,000	$ 46,896,000
Aggregate percentage of ownership	50%
Change in ownership percentage in common stock	5%

INCOME TAXES - Deferred tax ass

INCOME TAXES - Deferred tax assets and liabilities by source (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Net operating loss carryforwards	$ 16,733,582	$ 13,108,371
Deferred tax liabilities:
Depreciation timing differences		(5,103)
Valuation allowance	$ (16,733,582)	$ (13,103,268)

SUBSEQUENT EVENTS - (Details)

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Aug. 21, 2023

Jun. 21, 2023 USD ($) shares

Apr. 07, 2023 USD ($)

Jan. 11, 2023 $ / shares shares

Oct. 21, 2022

May 18, 2021

May 12, 2021

Sep. 30, 2022 shares

Jun. 30, 2023 USD ($) $ / shares

Jun. 30, 2023 USD ($) $ / shares shares

Dec. 31, 2022 USD ($) $ / shares

Dec. 31, 2021 USD ($) $ / shares

Feb. 28, 2023 USD ($)

Nov. 29, 2022 shares

Apr. 08, 2022 USD ($)

Subsequent Events

Number of shares issued

50,890

Common stock par value (in dollars per share) | $ / shares

$ 0.0001

Promissory note payable | $

$ 5,613,839

$ 9,000,000

$ 3,500,000

Net proceeds | $

$ 3,280,360

$ 2,779,910

Reverse stock split conversion ratio

0.01

0.064

Aggregate cash payment agreed to pay | $

$ 229,000

Issuance of common stock pursuant to disposition | $

1,357,043

$ 1,357,043

Securities purchase agreement | April Notes

Subsequent Events

Aggregate principal amount | $

$ 3,068,750

Original issue discount | $

$ 613,750

D.Jones (H&J Seller) | H&J Settlement Agreement

Subsequent Events

Aggregate cash payment agreed to pay | $

$ 229,000

Issuance of common stock pursuant to disposition (in shares)

78,103

Percentage of membership interest transferred

100%

Issuance of common stock pursuant to disposition | $

$ 1,400,000

$ 1,357,043

Subsequent events

Subsequent Events

Promissory note payable | $

$ 4,000,000

Reverse stock split conversion ratio

0.04

Subsequent events | Securities purchase agreement | April Notes

Subsequent Events

Aggregate principal amount | $

$ 2,208,750

Original issue discount | $

408,750

Net proceeds | $

$ 1,800,000

Increased percentage of face value of the notes, if notes are not repaid in full by the maturity date or if any other event of default occurs

120%

Percentage of annual interest rate for notes, if notes are not repaid in full by the maturity date or if any other event of default occurs

20%

Common Warrant

Subsequent Events

Warrants issued to purchase common stock

19,000

Volume-Weighted Average | $ / shares

$ 97.875

Number of shares resulting from conversion

32,086

Common Warrant | Subsequent events

Subsequent Events

Warrants issued to purchase common stock

19,000

Volume-Weighted Average | $ / shares

$ 97.875

Number of shares resulting from conversion

32,086

Exercise price | $ / shares

$ 95

Warrants exercisable term

5 years

Pre-funded warrants

Subsequent Events

Number of shares issued

32,086

Warrants issued to purchase common stock

32,086

Volume-Weighted Average | $ / shares

$ 97.875

Number of shares resulting from conversion

32,086

Pre-funded warrants | Securities purchase agreement

Subsequent Events

Warrants issued to purchase common stock

66,007

Pre-funded warrants | Subsequent events

Subsequent Events

Common stock par value (in dollars per share) | $ / shares

$ 0.0001

Warrants issued to purchase common stock

32,086

Volume-Weighted Average | $ / shares

$ 97.875

Number of shares resulting from conversion

32,086

Private Placement

Subsequent Events

Number of shares issued

19,000

Private Placement | Subsequent events

Subsequent Events

Number of shares issued

19,000

Common stock par value (in dollars per share) | $ / shares

$ 0.0001

Aggregate amount issued to investor

5,000,000